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Abstract  
Background: Antimicrobial resistance is a global public health threat, with antibiotic 
resistance (ABR) increasing rapidly. In China, the high rate of antibiotic use is a key contributor 
to the country’s ABR problems, and the paediatric use of antibiotics by healthcare providers 
and parents has been identified as a particular challenge. However, limited research has 
examined providers’ and parents’ antibiotic-related behaviour, with particularly few 
qualitative studies having been conducted, and none in urban China. This research examines 
influences on healthcare providers’ and parents’ behaviour regarding the use of antibiotics 
for children in urban China. 
Methods: Informed by a review of English-language and Chinese-language studies, a 
qualitative study of healthcare providers and a multi-method study of parents were 
conducted in Chinese to explore factors influencing their antibiotic-related behaviour. The 
study site was Taiyuan city, a medium-sized city in central China. Qualitative data were 
transcribed verbatim, translated from Chinese to English, and analysed using framework 
analysis. Quantitative data were analysed using difference tests and regression analysis. 
Results: The two key influences on the paediatric antibiotic-related behaviour of healthcare 
providers were: (i) parental influences, including public understandings of disease and 
treatment within traditional Chinese medicine (TCM) and Western medicine, and maintaining 
trust and good relationships with parents, and (ii) the organisational context relating to 
China’s healthcare system and national policies. The main influences on the paediatric 
antibiotic-related behaviour of parents related to their lack of antibiotic-related knowledge, 
their understandings of TCM and Western medicine, and their access to and interactions with 
healthcare providers. 
Conclusions: Although it is a small-scale study located in one urban setting, this research 
highlights influences on healthcare providers’ and parents’ paediatric antibiotic-related 
behaviour operating from individual to organisational and cultural levels. Promoting more 
appropriate paediatric use of antibiotics in China will require better understanding of the 
provider-patient relationship and the wider cultural and healthcare contexts, especially in 
relation to the relative influence of TCM and Western medicine. 
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Preface 
This thesis describes an exploratory study of the influences on paediatric use of antibiotics by 
healthcare providers and parents in China. Antimicrobial resistance has become one of the 
most serious global public health problems causing substantially increased infectious disease 
mortality and morbidity, as well as a considerable economic burden (Chan et al., 2012; Neill, 
2014; WHO, 2015). With respect to human antimicrobial resistance, it is antibiotic resistance 
(ABR) that has increased most rapidly around the world. Low and middle-income countries 
with the highest burden of infectious disease are seriously affected by human ABR, 
particularly China (Bartoloni, 2007; ESRC, 2014; WHO, 2015A). In China, the resistance rates 
of the most common bacteria to clinical antibiotics are very high, with the prevalence of many 
antibiotic resistant strains ranking amongst the highest in the world (Xiao et al., 2011). Data 
from China’s hospitals and primary care institutions, retail pharmacies and the public indicate 
that antibiotics are widely and inappropriately used by all of these groups, and inappropriate 
use of antibiotics for children is a particular concern (Currie et al., 2013; Fang, 2014; Zeng et 
al., 2012). This suggests that healthcare providers and parents are key constituencies related 
to paediatric antibiotic use and ABR in China; factors influencing their behaviours with respect 
to the use of antibiotics are therefore important research areas. 
 
This thesis develops a social ecological framework (SEF) to inform and guide the review of 
literature and empirical studies. The SEF is a concentric causative ‘web’, which has a range of 
influences on the outcome of interest (the use of antibiotics) situating it within multiple layers 
from micro (individual)- to macro (policy)- level (Schneider & Stokols, 2009). Under the 
18 
 
guidance of the SEF, a review of both English- and Chinese-language records relating to 
influences on healthcare providers’ and the public’s use of antibiotics was undertaken, and 
empirical studies were conducted with healthcare providers and parents living in one city in 
central China. Study sites, including hospitals, community health institutions, retail 
pharmacies and nurseries, and participants were contacted through personal networks, an 
approach that is sensitive to China’s Confucian-based cultural contexts and organisational 
background (Liu, 2006; Park & Lunt, 2015). There were in total 26 healthcare providers, 12 
parents of nursery children, and 98 parents of ill children recruited in this doctoral research. 
A qualitative approach was used for the study of healthcare providers, with semi-structured 
interviews conducted with 26 healthcare providers. The study of parents was undertaken 
using a multi-method design, including a qualitative component of three focus groups on 
parents of nursery children (12 parents in total), and a quantitative component of a 
questionnaire survey undertaken in two hospital paediatric clinics and completed by a total 
of 98 parents of ill children.   
 
This thesis consists of seven chapters. Chapter 1 provides an overview of the background 
relevant to the thesis’ focus on factors contributing to the paediatric use of antibiotics by 
healthcare providers and parents in China. Chapter 2 then describes the theoretical 
perspectives and the review of literature in the thesis, followed by a brief introduction of the 
research questions and approaches in Chapter 3. Chapters 4, 5 and 6 describe the empirical 
studies of healthcare providers and parents undertaken for the thesis. Specifically, the 
qualitative study of healthcare providers is discussed in Chapter 4 and Chapter 5, each 
chapter focusing on an important influence on healthcare providers’ paediatric use of 
19 
 
antibiotics. These two chapters have also contributed to two journal papers. Chapter 6 then 
turns to the multi-method study of parents. Finally, findings from the thesis are drawn 
together in Chapter 7, which provides a synthesis of the key study findings and discusses 
implications, future research and conclusions. 
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Chapter 1. Overview of human antibiotic resistance and the use of 
antibiotics with a focus on China
 23 
1.1 Introduction 
Antibiotic resistance (ABR) has become a major specific challenge within the larger problem 
of human antimicrobial resistance (AMR), which has serious public health impacts and causes 
a major economic burden worldwide (WHO, 2015, 2015A; Neill, 2014). The use of antibiotics 
is the most important factor contributing to ABR problems, relating to both the volume of 
antibiotic consumption and the way antibiotics are used (Barbosa & Levy, 2000; Byarugaba, 
2004; Levy, 1982, 1998, 2001; Pettersson, 2011). Similar to other low and middle-income 
countries (LMICs), China is seriously affected by ABR (Xiao et al., 2011). In China, the 
healthcare system consists of the health supervision system, the health service delivery 
system, and the health financing system, which are independent but inter-related, and 
traditional Chinese medicine (TCM) and Western medicine are practised alongside each other 
in China’s healthcare system (Mossialos et al., 2016). Research has shown that antibiotics 
have been widely and inappropriately used, especially for children, in hospitals, primary care 
institutions, and retail pharmacies among China’s healthcare system, as well as by the public 
(Currie et al., 2013; Fang, 2014; Zeng et al., 2012). Concerned about these problems, the 
Chinese government launched a set of antibiotic-related policies in the 2011 antibiotic-
related reforms, which extended policies introduced during the 2009 healthcare reforms and 
other wider policies (Mossialos et al., 2016; Xiao & Li, 2013, 2015). 
 
This thesis includes two reviews of literature: a broader review on antibiotic use and 
resistance in China (discussed in this chapter) and a more systematic search and review on 
influences on healthcare providers’ and parents’ antibiotic use in China (discussed in Chapter 
2). For the broader review presented in Chapter 1, relevant research and background material 
 24 
about ABR and antibiotic use in China was identified using the University of York Library 
search tool – Yorsearch; this search tool was used to identify paper-based books and PhD 
theses. For journal papers, three search tools – the MEDLINE Ovid, Wan Fang database (an 
online database of Chinese journals accessed through http://www.wanfangdata.com.cn/) 
and Google Scholar – were mainly used (see the search strategies in Appendix A). For the 
focused review (Chapter 2), the MEDLINE Ovid and Chinese National Knowledge 
Infrastructure (CNKI) were used. More detail on the more systematic search and review using 
MEDLINE Ovid and CNKI is provided in section 2.2.2. In addition, websites including the World 
Health Organisation (WHO), the World Bank, and GOV.UK were used to identify relevant 
evidence published in English, including empirical data and policy documents. Some official 
Chinese websites, such as the National Health and Family Planning Commission (NHFPC) 
website, were used to identify relevant Chinese data and policy documents. The initial review 
(conducted in 2015/2016) was updated in June 2017 by reference checking and citation 
searching from the most relevant studies. 
 
There are five sections in this chapter: 
• 1.1 provides an introduction; 
• 1.2 describes the development of ABR and the use of antibiotics and ABR in LMICs and 
China; 
• 1.3 provides the context of China and reviews antibiotic use in hospitals and primary 
care settings, pharmacies and among the general public; 
• 1.4 describes the recent reforms and policies relevant to antibiotic use in China; and 
• 1.5 concludes this chapter. 
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1.2 Human antimicrobial and antibiotic resistance, with a focus on low and 
middle-income countries and China 
1.2.1 Antimicrobial and antibiotic resistance in humans  
Although global deaths caused by infectious diseases have continued to decrease gradually 
in recent decades, some infectious diseases remain a human health challenge worldwide, 
particularly for populations in LMICs (WHO, 2007, 2011, 2014). Considering the health burden 
caused by infectious diseases, antimicrobials (Box 1) have become one of the most important 
forms of treatment to reduce the spread and impact of infectious diseases (PAIH, 2015). 
However, while antimicrobials are widely used by humans to treat infections, and have saved 
many lives over the past decades, AMR in humans has emerged and rapidly spread across a 
wide range of microorganisms, and has become an increasingly serious global problem (PAIH, 
2015; WHO, 2015). AMR is defined as the ability of microbes to survive an attack by 
antimicrobials that were previously effective against them (Bebell & Muiru, 2014; WHO, 
2015). This means the infectious diseases become harder, or even impossible to, treat by the 
standard treatment; in consequence, the prevention of infectious disease will be less effective 
and the period of illness will be prolonged, which increases the risk of the spread of disease 
to others and to the social and economic cost of the disease (WHO, 2014B; Bartoloni, 2007; 
Chan et al., 2012; Neill, 2014). Because of human AMR, infectious diseases that were 
previously treatable by antimicrobials are again becoming major threats. AMR in animals, 
such as food-producing animals and pets, has also emerged following the introduction of 
antimicrobials into agriculture (Lloyd, 2007; Wallinga & Burch, 2013). However, there are only 
a few confirmed cases where animal-related AMR has been the cause of AMR among humans 
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(less than 4%), and the most of antimicrobial-resistant human microorganisms are not from 
animal sources (Lloyd, 2007). 
 
Box 1 What is an antimicrobial? 
The term ‘antimicrobial’ refers to any substance, of natural or synthetic origin, that works to 
destroy or inhibit the growth of microorganisms, for example by disrupting the synthesis of 
proteins within the cell. Antimicrobials include all agents used to treat infectious diseases 
caused by microorganisms, such as antibiotics, antivirals, and antifungals, among others (MSU, 
2011; WHO, 2015). 
 
According to a study carried out by RAND Europe and KPMG, human AMR is estimated to 
cause 700,000 deaths annually worldwide and, without urgent action, the number of global 
deaths due to human AMR is projected to increase to 10 million by 2050 (Neill, 2014). A 
systematic review also found that, for certain microorganisms (Escherichia coli, Klebsiella 
pneumonia, and Staphylococcus aureus), patients infected by resistant strains have worse 
clinical outcomes compared with patients infected by susceptible strains (WHO, 2014A). In 
addition, it is estimated that the economic burden caused by human AMR will contribute to 
a reduction of 2-3.5% in Gross Domestic Product (GDP) by 2050, which would be equal to 100 
trillion US$ (Neill, 2014). Human AMR threatens the effective treatment of infectious diseases 
caused by various pathogens1. Among bacterial diseases, a growing number of common 
diseases such as pneumonia, tuberculosis (TB) and diarrhoea have become harder or even 
impossible to treat. There were 480,000 new cases of multidrug-resistant TB worldwide 
                                                        
1 This includes bacterial diseases like tuberculosis (TB), viral diseases like HIV and influenza, and parasitic diseases like malaria (WHO, 2015). 
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reported in 2013, which are associated with higher healthcare expenditure and higher risk of 
death (WHO, 2015). Antibiotic (Box 2) resistant strains such as Escherichia coli and 
Staphylococcus aureus are increasingly widespread around the world (Bebell & Muiru, 2014; 
WHO, 2014A).  
 
Of the different forms of resistance to antimicrobials, the development of ABR has increased 
most rapidly around the world and has become one of the biggest global health threats (ESRC, 
2014; WHO, 2015A). Meanwhile, there are major gaps in ABR-related knowledge, as this 
problem is complex and multifaceted (WHO, 2014B). Although data from different regions of 
the world have not yet been coordinated, surveillance carried out by the WHO indicates that 
resistance of common human pathogenic bacteria has reached levels with huge costs for 
human health and the economy (WHO, 2014A). For instance, human ABR is estimated to 
cause 25,000 deaths and cost more than US$1.5 billion every year in the European Union 
alone (WHO, 2015A). Therefore, ABR in humans is a very important dimension of AMR that is 
causing concern worldwide. 
 
Box 2 What is an antibiotic? 
The antibiotic is a type of antimicrobial that is produced by microorganisms to inhibit the 
growth of other microorganisms, and therefore used to prevent and treat bacterial infections. 
(MSU, 2011; Sengupta et al., 2013). 
 
1.2.2 The origins and factors contributing to antibiotic resistance 
Like antibiotics, ABR was a naturally-occurring phenomenon long before antibiotics were 
used by humans (D’Costaet al., 201; Martínez, 2008). A recent study identified ABR genes 
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from 30,000-year-old Beringian permafrost sediments (D’Costa et al., 2011). Indeed, 
considering antibiotics have been produced by environmental microorganisms for millions of 
years, it is not surprising that the ABR should be similarly ancient. The mechanisms of ABR 
originating from the natural environment include inherent resistance and acquired resistance 
(Sjölund, 2004; Van Wyk, 2015). Through many millions of years of evolution in an 
environment with antibiotics, some bacteria today are intrinsically resistant to some types of 
antibiotics as, for example, there is a lack of a target in the bacteria’s body for antibiotics to 
work against (Martínez, 2008). Meanwhile, ABR genes are carried by most antibiotic 
producers, and even by some bacteria that do not produce antibiotics themselves (Allen et 
al., 2010; Fajardo et al., 2008). Acquired resistance means that the ABR genes could be 
acquired from other bacteria through spontaneous mutation or horizontal transfer (Davies, 
1994; Martínez, 2008; Martínez & Baquero, 2000). 
 
Although ABR is an inevitable biological process that originates from nature, its development, 
such as how rapidly the resistance evolves among bacteria, is strongly influenced by the 
selective pressures that can be either natural or social (Allen et al., 2010; Barbosa & Levy, 
2000; Sjölund, 2004). Among the different selective pressures, an especially important one is 
related to human antibiotic use, which can drive the development of ABR through either 
mutation or transfer (Barbosa & Levy, 2000; Martínez, 2008). The use of antibiotics has been 
identified as the single most important factor contributing to ABR in many studies (Byarugaba, 
2004; Huttneret al., 2010; Simonsenet al., 2004). 
 
While it is widely accepted that antibiotic use is a major factor in ABR, the pathway from 
antibiotic use to resistance is complex and multifaceted, and is heavily influenced by societies 
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and human activities (Goossens, 2009; Rubin & Samore, 2002). In general, the selective role 
of antibiotic use related to ABR is associated not only with the volume of antibiotic 
consumption, but also the way antibiotics are used (Barbosa & Levy, 2000; Levy, 1982, 1998, 
2001; Pettersson, 2011). It is clear that increased antibiotic use in human treatment is a 
driving force behind human ABR, with evidence from both empirical studies and a long history 
of observation (Gerdinget al., 1991; McGowan, 1983; Møller, 1989; Rubin & Samore, 2002). 
For example, a study in Iceland demonstrated that antibiotic use in the community was 
strongly associated with the resistance to penicillin in pneumococci in children (Arason et al., 
1996). The positive correlation between antibiotic use and resistance has been confirmed by 
ABR surveillance studies in Europe (Goossens, 2009; Goossens et al., 2005). Animal ABR also 
emerged after antibiotics were used in agriculture either as a growth promoter or for 
treatment (Lloyd, 2007).  
 
Another factor related to the use of antibiotics that contributes to human ABR is the way 
antibiotics are used; inappropriate use of antibiotics is a key factor accelerating the 
development of ABR (Hildreth et al., 2009; Rubin & Samore, 2002; Van Wyk, 2015). Based on 
the definitions of rational medicine use (Holloway & van Dijk, 2011) and inappropriate 
medicine use (Zuckerman et al., 2006), inappropriate antibiotic use is defined here as the use 
of antibiotics that should be entirely avoided, antibiotics that are used in dosages or for 
durations that not meet patients’ individual requirements, or the use of antibiotics that is not 
at the lowest cost to patients and the community. The forms of inappropriate antibiotic use 
contributing to human ABR include both the overuse and misuse of antibiotics. Overuse of 
antibiotics is when antibiotics are unnecessarily used in human treatments, such as 
unnecessary antibiotic prescribing practices. Misuse of antibiotics includes the inappropriate 
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dose, duration, and/or frequency of antibiotic use in human treatment (Low, 2001). For 
instance, the risk of resistance to penicillin pneumococci in humans has been found to be 
associated with antibiotic use at a low dose and for a long duration (Guillemot et al., 1998). 
 
In conclusion, although ABR is a natural phenomenon, the spread and scale of this natural 
biological process is social and shaped by human activities. This, in turn, is highly related to 
both the total amount of antibiotic consumption and inappropriate use of antibiotics (WHO, 
2015). 
 
1.2.3 Human antibiotic resistance and antibiotic use in low and middle-income countries 
Although human ABR is a global public health issue, this problem is more serious in LMICs, 
which are also referred to as developing countries 2  (Bartoloni, 2007). The WHO has 
highlighted that the use and inappropriate use of antibiotic drugs accelerate the development 
of ABR, while some issues such as inadequate healthcare resources and ineffective control 
measures encourage the further spread of ABR (WHO, 2012, 2015).  
 
Compared with high-income countries (HICs), LMICs suffer from a higher infectious disease 
burden3 (Bartoloni, 2007; Bebell & Muiru, 2014; Murray et al, 2013). In LMICs, infectious 
                                                        
2. There is no established convention for the designation of ‘developed’ and ‘developing’ countries or areas in either the World Trade 
Organization or United Nations (UN, 2013; WTO, 2015).  World Trade Organisation (WTO) members can define themselves as ‘developed’ 
or ‘developing’ countries (WTO, 2015). The World Economic Situation Prospects classifies all countries in the world into three categories: 
developed economies, economies in transition and developing countries (UN, 2015). The World Bank uses ‘developing’ to denote LMICs 
when classifying countries by region, but it also notes that it is not implied that countries in the same income groups are experiencing the 
same development status (World Bank, 2015). 
3. ‘Disease burden’ refers to the overall impact of disease and injuries at the individual level, society level, or to the disease cost for the 
economy. The WHO global burden of disease measures disease burden by a time-based method of disability-adjusted-life-year, which 
combines years of life lost from premature death and years of life lived in less than full health states (WHO, 2015B). 
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diseases remain a major cause of morbidity and mortality, which has led to a huge amount of 
antibiotics being used (Sosa et al., 2010; WHO, 2011). Adding to the infectious disease burden, 
the burden from ABR and healthcare-associated infections4 has been very high in all LMICs 
(Bebell & Muiru, 2014). In LMICs, the frequency of healthcare-associated infections among 
risk populations, such as patients in intensive care units (ICUs) and new-borns, is several times 
higher than in HICs (WHO, 2011A). For instance, a systematic review of the burden of 
healthcare-associated infection in LMICs indicated the pooled healthcare-associated 
infection density5 in adult ICU was as high as 47.9 per 1000 patient-days6, which was at least 
three times higher than the densities reported by the USA (Allegranzi et al, 2011). Evidence 
also suggests that the inappropriate use of antibiotics is very common in enteric infections 
and respiratory tract infections among LMICs. ABR resulting from the misuse of antibiotics in 
treating pathogens, such as Salmonella enterica serotype Typhi, Streptococcus pneumoniae 
and Mycobacterium tuberculosis, poses a grave public health threat in LMICs, especially for 
neonates, patients with acquired immune deficiency syndrome (ADIS) or in ICUs (Bebell & 
Muiru, 2014; Kollef & Fraser, 2001; Okeke et al, 2005). The burden from ABR also includes a 
great economic burden, which contributes to poverty in LMICs, which can, in turn, lead to 
increased ABR. In addition, there are other issues that may adversely influence the use and 
                                                        
4. Health care-associated infections, which are also called ‘nosocomial’ and ‘hospital’ infections, usually affect patients in a hospital or other 
health-care facility, and are not present or incubating at the time of admission. They also include infections among health staff, as well as 
infections that patients acquire in the hospital or facility, but appear after discharge. Data about health care-associated infections are often 
limited and low quality in LMICs (WHO, no date).   
5. ‘Health care-associated infection density’ refers to the number of infection episodes per 1000 patient-days or device-days (Allegranzi et 
al, 2011). 
6. ‘Patient-day’ is a unit used by health care facilities or planners for accounting, each day represents a unit of time during which the health 
services are used by a patient. So 10 patients in hospital for 1 day is equal to 10 patient-days. 
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inappropriate use of antibiotics, such as poor regulation and an inadequate ABR surveillance 
system, as well as limited health care resources. 
 
1.2.4 Human antibiotic resistance and antibiotic use in China  
As noted above, ABR is a challenge in all LMICs. Based on published ABR studies, the Asian 
region has become the epicentre of ABR worldwide with a high prevalence of drug resistance 
in some globally important strains (Zellweger et al., 2017), such as hospital-acquired and 
community-acquired methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-
intermediate Staphylococcus aureus (VISA), and multi-drug resistant Pseudomonas 
aeruginosa, among others (Kang & Song, 2013; Lai et al., 2014; WHO, 2014A). China is one of 
the largest countries and the second largest economy in the world, with a population in 2015 
of 1.371 billion (World Bank, no date; World Bank, 2017). With the fastest sustained GDP 
growth (averaging around 10% growth per year) over the last three decades, China has been 
reclassified by the World Bank from its initial position as a low-income country to an upper-
middle-income country (Schellekens, 2013; World Bank, 2015, 2017). However, in common 
with other Asian countries, China has a serious human ABR problem.  
 
The modern antibiotic era began around 1930s-1940s when sulphonamides and penicillin 
were introduced (Aminov, 2010). Antibiotic discovery then came into a ‘golden age’ between 
the 1950s and 1970s, with nearly half of the classes of antibiotics known today being 
discovered in that period (Silver, 2011; WHO, 2014A). In China, although data about the 
evolution of antibiotic use since the founding of the People’s Republic of China are limited, 
the widespread and inappropriate of human antibiotic use is likely to related to China’s first 
stage health reform (from the mid-1980s to the end of 1990s) and the economic reforms from 
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1978. During this period, the old public healthcare system nearly broke down as the economic 
reforms led to the collapse of the foundations of healthcare system – people’s communes in 
rural areas and state-owned enterprises in cities (Chan et al., 2008; Dong, 2001; Mossialos et 
al., 2016). The subsequent first-stage health reform mainly focused on introducing market 
incentives and highlighted privatisation and localisation of healthcare services, dramatically 
reducing national subsidies to the healthcare system and allowing it to earn income from 
sales of services and drugs (Chan et al., 2008; Hsiao, 1995; Wang & Wang, 2007). As a 
consequence, hospitals in cities and independent entrepreneurs, who were formerly 
‘barefoot doctors’ in rural areas, soon began to compensate for the losses of subsidies and 
enhance their income by prescribing and selling unnecessary drugs. Because providers are 
the dominant partner in the provider-patient relationship, patients are entirely powerless 
when dealing with providers’ inappropriate use of drugs but just purchase their decisions 
(Ramesh et al., 2014; Xu et al., 2010). It is likely that the widespread and inappropriate use of 
antibiotics started in this time period.  
 
As the privatisation initiated by health reform progressed, pharmaceutical enterprises also 
came out of direct governmental control and eventually became business entities, which 
made China’s pharmaceutical market more competitive (Li et al., 2014). Moreover, with the 
policies and regulations introduced in economic reforms, such as the ‘open door’ policy,  the 
Chinese pharmaceutical market gradually became attractive to foreign multinational ‘pharma’ 
companies and started to grow rapidly from early 1990s (Chan & Daim, 2011; Sun et al., 2008). 
For instance, the gross sales of drugs maintained a growth rate around 20% per year from 
1986 to 1990, and the growth rates in the pharmaceutical industry had become much faster 
than other kinds of industry in China by the end of 1990s (Dong et al., 1999; Li et al.,2014). 
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The fast growth of pharmaceutical market and drug sales would also promote the wide use 
of antibiotics in China.  
 
Nowadays, human ABR has become a serious problem in China, with high total antibiotic 
consumption and widespread inappropriate use of antibiotics and, in turn, high resistance 
rates of most common bacteria to clinical antibiotics. For instance, the proportion of MRSA 
and carbapenem-resistant Acinetobacter baumannii has reached nearly 50% of isolates in 
recent years (Xiao et al., 2011). China also had the fastest average growth rate of human ABR 
between 1994 and 2000 worldwide (Heddini et al., 2009). 
 
1.2.4.1 Human antibiotic resistance in China 
While Chinese ABR surveillance started in the 1980s, it was only carried out in a few hospitals 
with particular strains (Xiao et al., 2011). Since then, China has established two nationwide 
ABR surveillance networks named Mohnarin and CHINET, which operate alongside some 
provincial ABR surveillance programmes (Wang et al., 2006; Xiao, 2008; Xiao et al., 2011). The 
Mohnarin has been overseen by the University of Zhejiang, and provides the widest set of 
AMR data from 84 member hospitals across China in 2008 (Xiao, 2008; Xiao et al., 2011). The 
CHINET is overseen by the University of Fudan, and includes AMR data from 16 tertiary 
hospitals (14 general hospitals and 2 children hospitals) in 2009 (Hu et al., 2014; Xiao et al., 
2011). However, as the main sources of Mohnarin and CHINET’s AMR data come from their 
member hospitals, data on ABR in primary care settings are still limited in China (Xiao, 2008). 
Based on the reports from Mohnarin and CHINET, there is an upward trend in ABR in clinical 
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bacterial isolates in China, with a serious threat from multi-drug resistant and pan-drug 
resistant strains in some specific regions (Hu et al., 2014, 2015; Wang et al., 2013). 
 
In China, the most common gram-positive strains are Staphylococcus aureus, Enterococcus 
spp. and Streptococcus pneumoniae, with a prevalence of 9.13%, 8.73% and 1.8% in 2014, 
respectively (Hu et al., 2015; Xiao et al., 2012). Resistance to methicillin of Staphylococcus 
aureus has been identified as a particular problem in China. The MRSA was first detected in 
China in the 1970s with a prevalence of approximately 20% (Li et al., 2001). Since then, studies 
carried out by Mohnarin indicate that the prevalence increased rapidly and reached a peak in 
2008, when more than 60% of Staphylococcus aureus isolates were resistant to methicillin; 
by 2011, it had decreased to 50.5% (Xiao et al., 2011; Xiao et al., 2012). More recent data 
from CHINET suggest that the prevalence of MRSA gradually decreased to 44.6% in 2014 (Hu 
et al., 2015). However, it is still high in global terms, compared with a prevalence of 17.4% 
and 11.0% in the EU and the UK in 2014, respectively (ECDC, 2015). In addition, the 
distribution of MRSA is distinctive in the eastern regions and big cities, such as Beijing and 
Shanghai, which are regarded as highly-developed areas in China (Xu et al., 2010). Alongside 
the problem of MRSA, CHINET suggested that the rate of methicillin-resistant coagulase 
negative Staphylococcus (MRCNS) has also been very high in China, and increased to 83.0% in 
2014 (Hu et al., 2015).  
 
For gram-negative bacteria, based on data from Mohnarin and CHINET, the most common 
species in China are Escherichia coli and Klebsiella spp. (all belonging to the 
Enterobacteriaceae family), Acinetobacter spp. and Pseudomonas aeruginosa (Hu et al., 2015; 
Xiao et al., 2012). The Escherichia coli and Klebsiella spp. are the strains most widely 
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distributed in China and have a strong association with hospital-acquired infections. Generally 
in China, the resistance of Escherichia coli and Klebsiella pneumoniae to cephalosporin and 
fluoroquinolones is high (Xiao et al., 2011). The mechanism of resistance to cephalosporin in 
the Enterobacteriaceae family (including Escherichia coli and Klebsiella pneumonia) is their 
production of extended-spectrum β-lactamases (ESBLs). Based on the Mohnarin report of 
2011, the rates of ESBLs producing Escherichia coli and Klebsiella pneumoniae have been 71.2% 
and 50.3%, respectively (Xiao et al., 2012). The CHINET 2014 report also indicated that the 
ESBLs producing strains accounted for 55.7% of Escherichia coli and 29.9% of Klebsiella spp., 
and the resistance rates of Escherichia coli to first-generation7 cephalosporin (Cefazolin), 
second-generation cephalosporin (Cefuroxime) and third-generation cephalosporin 
(Cefotaxime) were 71.1%, 62.8% and 62.0%, respectively. Moreover, the resistance rates of 
Escherichia coli to ciprofloxacin, gentamycin, piperacillin and trimethoprim/sulfamethoxazole 
have all been higher than 50% in China (Hu et al., 2014, 2015; Wang et al., 2013). In addition, 
multi-drug resistance becomes more common among Enterobacteriaceae in China. The 
carbapenem resistance, multi-drug resistance and pan-drug resistance in Pseudomonas 
aeruginosa and Acinetobacter spp. also emerged in China, which is similar to some Western 
countries (Xiao et al., 2011; Hu et al., 2014, 2015; Wang et al., 2013). For instance, Xiao et 
al.’s (2011) study indicated that the rate of pan drug-resistant Pseudomonas aeruginosa was 
2.1% in 2008 in China. 
 
                                                        
7 Generation terms come only in case of Penicillin and Cephalosporin, which are classified depending on (i) their action on the cell wall of 
gram positive and gram negative bacteria and (ii) their spectrum.  
 37 
1.2.4.2 Human antibiotic use in China 
As noted in the previous section (section 1.2.2), the most important contributor to ABR is the 
wide and inappropriate use of antibiotics, a pattern that is found across Asia as well as in 
China specifically (Cars et al., 2008; Goossens, 2005; Song, 2015). China has an extremely high 
total antibiotic usage. Data from the Chinese Academy of Sciences estimated that 162,000 
tons of antibiotics were consumed in China in 2013, which accounted for half of the total 
global antibiotic usage. Among total antibiotic usage in China, human consumption accounted 
for approximately 48%, which was equivalent to 77,760 tons (Zhang et al., 2015). The per 
capita consumption of antibiotics and frequency of antibiotic use are very high in China as 
well. In 2013, the per capita antibiotic consumption in China was nearly 6 times than that of 
the UK8. For antibiotic use frequency (Box 3), based on a systematic review of antibiotic usage 
in China, the overall outpatient antibiotic use frequency was 50.3% between 2000 and 2012, 
compared with the antibiotic use frequency of 15.3% in the USA at the same time. The 
average antibiotic use frequency ranged from 40% to 50% in other LMICs (Yin et al., 2013). 
Other issues that are common in other LMICs also appear to be exacerbating the spread of 
human ABR in China, such as inadequate control measures, poor accessibility to health care 
resources and undeveloped national ABR surveillance systems (Alubo, 1994; Verma et al., 
2014; Xiao, 2008). 
 
 
                                                        
8 Author’s calculation. In the UK, the population was 64.1 million in 2013, and the usage of antibiotics by humans in 2013 was 641 tons. In 
China, the population was 1.357 billion in 2013 while the usage of antibiotics by humans in 2013 was 77,760 tons (World Bank; Zhang et al., 
2015). 
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Box 3 What is the antibiotic use frequency? 
Antibiotic use frequency is the proportion of encounters (between a patient and a healthcare 
provider) with an antibiotic prescribed, and it could be used in inpatient, outpatient, and 
emergency situations, among others (Zou et al., 2014). 
 
The proportion of encounters with an antibiotic prescribed is an indicator used to measure the 
performance of health practitioners related to rational or irrational use of drugs, which is 
developed by the International Network for Rational Use of Drugs (Li et al., 2012). This indicator 
is calculated by ‘dividing the number of encounters during which an antibiotic is prescribed, by 
the total number of encounters surveyed’ (WHO, 1993, pp.14).  It is only concerned with 
whether antibiotics are prescribed for a patient; therefore, for a patient prescribed antibiotics, 
no matter how many types of antibiotics are prescribed for them, the number of patient 
encounters during which an antibiotic is prescribed is still one (He, 2013). 
 
Recent studies also point to widespread inappropriate use of antibiotics in China, particularly 
in the provision of medical services to patients, in pharmacies and among the public, which 
highlights the important role of healthcare providers and the public in relation to antibiotic 
use and resistance in China (Chan et al., 2012; Lv et al., 2014; Mao et al., 2015; Sun et al., 
2015; WHO & MoH, 2013). Therefore, the next section will describe China’s healthcare system 
and consider evidence on antibiotic use and inappropriate use in different key parts of China’s 
healthcare system. 
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1.3 The context and antibiotic use in China   
1.3.1 Healthcare system in China 
Since the founding of the People’s Republic of China in 1949, the healthcare system has 
experienced several waves of reforms as part of China’s wider economic reforms (Meng, et 
al., 2012). Today’s healthcare system is comprised of three independent but inter-related 
sub-systems: a health supervision system, a health service delivery system, and a health 
financing system (Chan et al., 2008; WHO, 2015C) (see Figure 1).  
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Figure 1 Structure of China’s healthcare system 
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China’s health supervision system exerts tight control over the healthcare system through 
the NHFPC. This national-level administration governs local authorities at provincial, 
municipal and county levels. There is no independent health administration at the township 
level. In consequence, the State Council, NHFPC and their local authorities govern the overall 
healthcare system in China. The health service delivery system mainly consists of a public 
health service system and a medical service delivery system (WHO, 2015C). The public health 
service system includes disease control and prevention institutions, maternal and child health 
institutions, and public education institutions, among others. The medical service delivery 
system consists of hospitals from ministerial to county levels and primary care institutions 
(Ma et al., 2014; NHFPC, 2014). The health financing system is based around three basic 
medical insurance schemes 9  and related administrative departments. Total health 
expenditure (THE) in China consists of government expenditure, social expenditure, and out-
of-pocket payments in the health financing system (Mossialos et al., 2016; WHO, 2015C).  
 
The retail pharmacy is also an important part of China’s health service provision and provides 
pharmaceutical services. Although most drugs in China are still distributed from pharmacies 
within hospitals and primary care institutions, the retail pharmacy sector is rapidly growing 
(Mossialos et al., 2016; WHO, 2015C). All drug-related activities in retail pharmacies are 
supervised by the China Food and Drug Administration (CFDA) and its local authorities at 
                                                        
9 They included Urban Employee Basic Medical Insurance (UEBMI) and Urban Resident Basic Medical Insurance (URBMI) for urban areas, 
and New Rural Cooperative Medical Scheme (NRCMS) for rural areas. 
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provincial, municipal and county levels (WHO, 2015C). In 2012, the total pharmaceutical 
expenditure accounted for approximately 40% of THE in China (Mossialos et al., 2016). 
 
Health is an important component of the Chinese social welfare system. Despite the 
remarkable success of healthcare reforms and the expansion of the Chinese social welfare 
system, health inequities are still long-standing problems, with the most evident imbalance 
in healthcare provision being that between urban and rural areas (Chan et al., 2008; Gao et 
al., 2018). In 2004, the per capita health expenditure was CNY 1,261.9 (US$ 203.4) in cities 
while only CNY 301.6 (US$ 48.6) in rural areas (MoH, 2006). Although the Chinese government 
has introduced three basic medical insurance schemes since 1998, a marked urban-rural 
differential in the insurance benefit is still evident (e.g. the 50%-80% impatient 
reimbursement in urban areas compared with 20%-60% in rural areas in 2010) (Barber & Yao, 
2010; Gao et al., 2018; Meng et al., 2012). Additionally, there is a particular lack of health 
human resources, including both doctors and nurses, in rural areas (Hou & Ke, 2015; NBSC, 
2016; Yang & Dong, 2014). Along with the inequities between rural and urban areas, the low 
coverage of basic medical insurance schemes for migrant workers in the cities is still a 
problem (Chan et al., 2008; Yip et al., 2012), although UEBMI was expanded to cover them 
during 2009-2011 (Hu et al., 2013). The Chinese government has identified benefiting migrant 
workers as a particular goal for their basic medical insurance scheme-related work in 2018 
and beyond (Lancet, 2018). These inequities, therefore, lead to significant differences with 
respect to the health benefits and health conditions between non-migrant urban residents 
and rural and migrant populations, such as the high malnutrition and underweight rates for 
rural children in comparison with children in urban areas (Gao et al., 2018; Tang et al., 2018).  
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In conclusion, China’s healthcare system is a web of complex interactions among different 
sub-systems, and continues to face challenges in terms of health inequities. Within this 
healthcare system, the thesis of the present study is mainly related to the medical service 
delivery system (hospitals and primary care institutions) and retail pharmacies, marked in red 
in Figure 1. More detailed information on these institutions is therefore provided below; 
while details in relation to the health supervision and health financing systems are provided 
in Appendix B. 
 
1.3.1.1 Hospitals 
China’s hospitals provide both inpatient and outpatient care services. In China, hospitals are 
subdivided according to size and function; i.e., primary hospitals (20—100 ward beds), 
secondary hospitals (101—500 ward beds), and tertiary hospitals (>501 ward beds). Primary 
and secondary hospitals primarily provide basic medical services and preventive health care 
whereas tertiary hospitals focus more on severe and complicated diseases, as well as 
responsibilities for conducting medical education and research. Hospitals are then divided 
into three classes at each level; the A class hospitals are the best, the B class hospitals are 
intermediate, and the C class hospitals are general and basic, according to medical standards, 
hospital management, the availability of certain equipment and whether medical research is 
performed (Xie et al., 2010). Apart from the classification based on the size and functions, 
hospitals can also be categorised into public hospitals, which are owned and overseen by the 
  
44 
 
government, and private hospitals, as well as general hospitals and specialized hospitals 
according to their target diseases (Xie et al., 2010). 
 
Within the medical service delivery system, hospitals are the cornerstone, delivering more 
than 90% of China’s inpatient, and a substantial amount of outpatient, services (Yip et al., 
2012). In 2008, more than 50% of urban patients and 17.3% of rural patients chose to directly 
visit hospitals for healthcare services (MoF, 2009). Among all hospitals, the general tertiary 
hospitals are the main healthcare provider. Data suggest that, among all hospitals, most 
healthcare services were delivered by tertiary hospitals in China. In 2013, almost half (49.4%) 
of hospital healthcare services were delivered by tertiary hospitals, whereas 43.4% and only 
7.2% were delivered by secondary and primary hospitals, respectively (NHFPC, 2014A). At 
same time, compared with private hospitals, 89.8% of hospital visits took place in public 
hospitals in 2013 (NHFPC, 2014A). In addition, most of China’s health resources, such as 
healthcare institutions’ 10  bed and health staff, are concentrated in hospitals (Statistical 
Information Centre of NHFPC, 2016). For instance, 73% of healthcare institutions’ beds were 
located in hospitals in 2012 (NHFPC, 2014). Additionally, about 70-80% of pharmaceutical 
sales in China come from hospitals (Mossialos et al., 2016). 
 
                                                        
10 The healthcare institution refers to any institution that obtains the Practice License of Healthcare Institution of the People’s Republic of 
China or certificates from relevant authorities, and provides medical and healthcare related services or undertakes medically related 
research. The healthcare institutions include hospitals, primary care institutions, professional public health institutions such as the 
specialized disease prevention and treatment centre, and other relevant healthcare institutions (MoH, 1994; NHFPC, 2014; NHFPC, 2017). 
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1.3.1.2 Primary care institutions 
The primary care system is a relatively weak, but rapidly growing, sector of China’s healthcare 
system (Chan et al., 2008; Mossialos et al., 2016; Wang et al., 2012). Still in a roll-out stage, 
knowledge about the primary care system, as well as the effects of policies focused on it, 
remain insufficient (Li et al., 2017). This system includes community health institutions (CHIs) 
in the city and township health centres, as well as village clinics in rural areas; the CHIs further 
consist of community health centres and community health stations. In the urban areas, these 
community-based institutions are a new type of healthcare institution in China, introduced 
beginning in 1997 and strengthened in 2006 (Bao, 2007; Li, 2012). Through delivering both 
public health services and primary care services, the CHIs are defined as combining functions 
of prevention, health care, general medical care, health education, rehabilitation and 
supervision of family planning into one (Hao, 2007). The community health centres are the 
main element of the CHIs in China, whereas the community health stations, one level below 
community health centres, serve as a supplement to healthcare services and are overseen by 
CHIs (Zhongyangbianban et al., 2006). In China, there are mainly four kinds of organizational 
types of CHIs, including government operated CHIs, hospital operated CHIs, social 
organizations operated CHIs and individual CHIs (Bao, 2007; Hao, 2007). The CHIs can also be 
divided into public institutions and private institutions in line with their registration types 
(Statistical Information Centre of NHFPC, 2016). 
 
As strengthening the primary care system has been defined as one of five pillars of China’s 
2009 health reforms (discussed below in section 1.4.3), the number of primary care 
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institutions is rapidly increasing (Mossialos et al., 2016; Yip et al., 2012). In 2012, the total 
number of CHIs has reached 33,562 in urban areas, and the numbers of township hospitals 
and village clinics were 39,097 and 653,419 in rural areas, respectively (NHFPC, 2014). By 2016, 
the total number of CHIs further increased to approximately 34,000 (NHFPC, 2017A), which 
has increased around 100% from 2005 to 2014 (Statistical Information Centre of NHFPC, 
2016). In addition, the proportion of primary care visits among all healthcare institution visits 
reached 57.4% in 2014 (Statistical Information Centre of NHFPC, 2016); in 2016, primary care 
institutions provided 55% of outpatient care services and 18% of inpatient care services (Li et 
al., 2017). 
 
However, there are still weaknesses in China’s primary care institutions, such as the limited 
provider facilities. A national survey of 3,602 primary care institutions pointed to a very high 
proportion of village clinics that could not provide basic clinical tests; for example, 96% were 
unable to conduct a blood test (Li et al., 2017). Moreover, the general practitioners (GPs) and 
village doctors, the backbone of primary care institutions, are often inadequately trained and 
underpaid. Data from the National Statistics Yearbook indicated that, in 2015, still 31% of GPs 
failed to meet the educational level requirement (junior medical college) in CHIs and township 
health centres, while 12% of village doctors did not meet the educational level of a technical 
school in village clinics11 (NHFPC, 2017B). Li et al.’s (2017) national survey further indicated 
                                                        
11 There are three educational levels required for providers in primary care institutions: medical college, junior medical college and technical 
school. Completing medical college or the lower level – junior medical college, are required to become a licensed GPs or licensed assistant 
GP, respectively, in CHIs and township health centres; people with these educational levels then need to pass the national doctor practicing 
exam in order to be licensed. After completing technical school one is able to become a so-called village doctor without a formal licence in 
village clinics (Li et al., 2017). 
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that over one-fifth of GPs among CHIs and township health centres were unlicensed, with a 
particularly high proportion (37%) of unlicensed GPs working in community health stations; 
moreover, the post-qualification training for GPs was insufficient. Additionally, GPs and 
village doctors were found to have the incomes lower than the average in China, along with 
low job satisfaction and high occupational burnout (Li et al., 2017). The policies issued under 
the 2009 healthcare reforms, such as increases in the total subsidy for the primary care 
system and providing a subsidy to compensate for the loss of income resulting from zero 
mark-up (ZMU) policies12, appeared insufficient in improving the incomes of primary care 
institutions (Gao et al., 2012; Li et al., 2017).  
 
The quality of healthcare services delivered by primary care institutions was questioned by 
many studies, specifically related to incorrect diagnosis and unnecessary treatments (Su et 
al., 2017), including antibiotic treatment (Li et al., 2017; Yin et al., 2013). The public also 
distrust the primary care institutions. Duckett et al.’s (2016) study noted that 13% and 88% 
of 3,680 participants would go directly to hospitals for minor and major illness, respectively, 
and the higher rates of hospital utilization were associated with a higher distrust in primary 
care institutions (Duckett et al., 2016). Another national survey also referenced the lower 
trust levels in primary care institutions as one of major reasons patients choose to go to 
hospitals directly for healthcare services (Li et al., 2017). 
 
                                                        
12 ZMU policies are discussed in section 1.4.3 in more detail. 
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1.3.1.3 Retail pharmacies  
Most hospitals and primary care institutions have their own pharmacies, and these 
pharmacies are the main drug distributors in China (WHO, 2015C; Mossialos et al., 2016). For 
instance, it was suggested that, in 2009, drugs sold by hospitals’ pharmacies accounted for 
over 70% of the total drug sales in China (Fang et al., 2013; Sun et al., 2008). Compared with 
pharmacies within hospitals and primary care institutions, retail pharmacies have developed 
fast in China since the implementation of China’s 2009 healthcare reforms, which forced 
hospitals to transfer from selling drugs to being more focused on providing medical services 
(State Council, 2015). Pharmaceutical sales by retail pharmacies grew by an average of 20% 
each year from 1978 to 2009 (Fang et al., 2013), and, by 2014, there were over 400,000 retail 
pharmacies (Fang, 2014).  
 
In China, there are two types of pharmacists covered by two different pharmacist 
qualification systems. The professional qualification system is overseen by the CFDA and 
Ministry of Human Resources and Social Security (MoHRSS), and pharmacists working under 
this system are called Licensed Pharmacists (MOHR & CFDA, 1999). People who plan to 
become a licensed pharmacist must obtain the Licensed Pharmacist Certificate by passing the 
national pharmacist licensing exam. After that, they need to register their certificate with the 
provincial regulatory authorities so that they can work at their registered institutions (MOHR 
& CFDA, 1999), and they are required to attend post-qualification development in order to 
gain approval for re-registration every three years (CDFA, 2003; MOHR & CFDA, 1999). In 
China, the pharmacists permitted to work in retail pharmacies are all licensed pharmacists. 
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However, the standard set for achieving qualification via the pharmacist licensing exam has 
been reported as low by some studies (Fang et al., 2013; Huang, 2007), as the minimum 
qualification for sitting the exam is ‘a secondary technical school diploma and a major in 
pharmacy or related disciplines (e.g., medicine, chemistry, biology or nursing)’ (Fang et al., 
2013, pp.524).  
 
Regulations issued in 2012 stipulated that newly-opened retail pharmacies must be staffed 
by licensed pharmacists; by 2015, licensed pharmacists were required to be present at retail 
pharmacies during business hours in order to provide pharmaceutical services to consumers 
(Fang et al., 2013; State Council, 2012). Additionally, it is currently regulated that, in China, 
the juridical person (person in charge) of retail pharmacies can only be a licensed pharmacist 
(CFDA, 2015). With respect to the sale of antibiotics, based on earlier regulations and the 
‘Administrative Regulations for the Clinical Use of Antibiotics’ launched in 2012, antibiotics 
can only be sold with a prescription by licensed pharmacists in retail pharmacies (MoH, 
2012A). However, the phenomena of licensed pharmacists being absent during business 
hours and selling OTC antibiotics are both still very common in China’s retail pharmacies, even 
after 2012 (Fang, 2014; Jiang et al., 2013; Yu, 2013).  
 
The second pharmacist qualification system is the specialized system that is overseen by the 
NHFPC. NHFPC-qualified pharmacists work in healthcare institutions, mainly hospital 
pharmacies, and are assigned a special title (ranging from assistant pharmacist, pharmacist, 
pharmacist-in-charge, and deputy chief pharmacist to chief pharmacist) (Fang et al., 2013). 
For hospital pharmacists, people with a pharmacy education background can start to get into 
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this system by being employed by the hospital. After that, they need to take the exam for the 
particular special title in order to obtain the special title qualification certificate (MoH & 
MOHR, 2001). The hospital where they work will then assess whether to award the special 
title to them based on a comprehensive set of qualifications, including the special title 
qualification certificate, professional performance, English and computer skills and published 
papers, among others (MOHR, 2000). For CHIs, only pharmacists working at government-
operated CHIs are covered by the specialized system (Zhongyangbianban et al., 2006). In 
addition, a Licensed Pharmacist Certificate is not mandatory for pharmacists working under 
the specialized system (Fang et al., 2013). 
 
1.3.2 Chinese culture and two medical systems in China 
1.3.2.1 Chinese culture 
The term of culture refers to ‘the collection of values, beliefs, behaviours, customs, and 
attitudes that distinguish a society’ (Fan, 2000, pp.3). In China, despite rapid social changes 
and marked differences between regions, Chinese culture remains stable and held in common, 
and continues to shape people’s attitudes and behaviour while establishing social norms and 
standards (Fan, 2000).  
 
Chinese culture is therefore seen as a set of core values underlying China’s social interactions 
in a long period of time and shaping people’s behaviour to adapt them to the group where 
they are embedded (Hofstede, 1980);  these core values, which are highly influenced by 
traditional culture, are related to different dimensions, ranging from interpersonal relations 
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(e.g. face and guanxi), family and society (e.g. loyalty to superiors), to nature (e.g. unity of yin 
and yang, harmony between man and nature) (Fan, 2000; Peng, 2003). Shaped by its four-
thousand-year history, it is not surprising that traditional culture, with the core of 
Confucianism, remains central to Chinese society. As Confucianism highlights Five Constant 
Virtues and five basic human relations (wulun) that ensure a harmonious relationship in 
family and society, a large number of Chinese core cultural values are related to interpersonal 
relations and family/society rooted in Confucianism, such as hierarchical relationships and 
observing this order in family and society, keeping harmonious relations with others, and the 
importance of ‘face’ – a person’s reputation (Fan, 2000). The high proportion of cultural 
values with an interpersonal and family orientation also underline the importance of the 
family in Chinese culture and society; moreover, family relations are always defined through 
the male versions of language, which indicates the predominant position of the male in the 
family in China (Fan, 2000). Apart from traditional cultural values, there are also some 
contemporary Chinese cultural values, such as the values of guanxi, which means the 
personal network, in Chinese business philosophy (Fan, 2000).  
 
1.3.2.2 Traditional Chinese medicine and the dual use of medical systems 
Chinese culture has endured during rapid social change in China and across Chinese 
populations within and beyond Mainland China (Fan, 2000), and continues to influence their 
health and health-related awareness (Chen, 2001). Among various cultural values in China, 
Taoism is the second major Chinese philosophy and religion that highlights the harmony 
between human beings and nature, and expands the idea of ‘yin-yang’ (Chen, 2001). Based 
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on the principle, Chinese people divide all phenomena into two contrary components, such 
as sun and moon, man and women, and hot and cold, and always keep the balance of the two 
opposite forces, which governs the way of Chinese life (Chen, 2001). TCM is a holistic medical 
practice system that originates from ancient China and has been practised for more than 2000 
years and is also built around this theory. The ultimate goal of TCM is to control the harmony 
and balance of ‘yin-yang’ within the human body and between humans and the wider 
environment, in order to maintain the source of vital energy and human life – ‘qi’ (Cheung, 
2011). Specifically, TCM has been used to diagnose, prevent and cure human diseases based 
on two fundamental theories, yin-yang and five elements (wu-xing) (Lao et al., 2012; Wang & 
Li, 2005). It understands the body and life from theories associated with organs (zangfu), 
meridian (jingluo), energy (qi) and blood (xue), and attributes the causes of diseases to six 
excesses (liuyin), seven emotions (qiqing) and diet and fatigue (yinshilaoyi), among others (Yin 
& Zhang, 2006). The TCM treatment methods are also different from those of Western 
medicine. They include herbal medicines, acupuncture and moxibustion, Chinese massage 
(tuina), exercises (qigong) and diets, while surgical operation is seldom used (Lao et al., 2012; 
WHO, 2001). 
 
TCM was the medical practice dominating China until the early nineteenth century, when 
Western medicine knowledge was brought in by Protestant missionaries and rapidly 
developed in China after the collapse of the Qing dynasty (Chueng, 2011). It has been noted 
that, in 2006, over 80% of hospitals in China were the general hospitals, which mainly provide 
Western medicine services, and the growth rate of general hospitals was much faster than 
that of TCM hospitals over the last few decades (Xu & Yang, 2009). However, there are 
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numerous differences between these two medical systems as they evolved from totally 
different cultural and historical contexts. For instance, focusing on keeping the balance within 
the human body (xing shen tong yi) and between humans and nature (tian ren he yi), TCM 
highlights the important role of the internal relationships between the human mind, human 
body and environment in preventing and treating diseases; however, Western medicine 
always tries to identify the specific disease-causing agents (Qiu, 2015). Some key theories, 
which can be understood within a TCM perspective, such as ‘qi’, have no equivalent in 
Western medicine and cannot be measured or explained by modern science and medicine 
(Qiu, 2015). Additionally, the characteristics of TCM that originate from philosophy and art 
make its treatment more likely to be an individualized practice, which is difficult to reproduce, 
whereas Western science and medicine highly emphasize treatment reliability and replication 
(Bryman, 2008; Qiu, 2015). 
 
In the light of the rapid development of Western medicine and the enduring importance of 
TCM in China, studies and policies have explored the potential similarities in these two 
systems and have tried to use them together. For instance, Qiu’s (2015) study reported that, 
even though focusing on opposite aspects, both TCM and Western medicine are systems that 
integrate medical and social phenomena together; this study also connects TCM’s diagnostic 
process, which is from the whole-organism level, to the Western medicine discipline of 
structural health monitoring (Qiu, 2015). The official policy since the 1980s has been to 
promote the dual and equal use of TCM within the national healthcare system, with more 
ambitious plans to combine TCM with Western medicine initiated in 2007 (Mossialos et al., 
2016; Qiu, 2015; WHO, 2001). The State Administrations of Traditional Chinese Medicine 
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(SATCM) and its local authorities are responsible for supervising the development of TCM in 
China (WHO, 2001, 2015C). It was established in 1985 and now is directly led by the NHFPC; 
as noted in Hesketh & Zhu’s (1997) study, China is globally unique in that TCM and Western 
medicine are practised alongside each other at every level of the healthcare system (Hesketh 
& Zhu, 1997). 
 
With respect to the delivery of TCM services, there were over 40,000 TCM-related institutions 
in 2014, and TCM services accounted for around 18% of total healthcare services (Qiu, 2015; 
Statistical Information Centre of NHFPC, 2016). It was also indicated by one study that, among 
all general hospitals in China, 90% of them had TCM departments, while most TCM hospitals 
provide both TCM and Western medicine services; TCM outpatient visits made up over 30% 
of total outpatient visits in China (Xu & Yang, 2009). For primary care institutions, national 
data indicated that 98% of community health centres and 94% of township health centres 
provided TCM services in 2016 (NHFPC, 2017A). The wide provision of TCM services in the 
primary care system was also reported by another nationwide survey that noted 76% of 
community health centres and 69% of township health centres accessed had a TCM 
department (Li et al., 2017). The sale of TCM drugs also accounted for about 30% of total 
pharmaceutical expenditure in 2012, with a particularly higher proportion, 44% of drug sales, 
in the retail pharmacy (Mossialos et al., 2016). In addition, in professional education, rather 
than only focusing on TCM theories, the TCM curriculum also includes Western medicine, 
such as physiology in their curriculum (Xiao, 2004). Therefore, TCM has been regarded as the 
common philosophy by Chinese people and is well accepted and used alongside Western 
medicine in China’s health-related system. 
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The use of TCM theory in interpreting illnesses has been reported in studies focusing on both 
the population of Mainland China and on other Chinese societies, such as Taiwan and 
overseas Chinese populations (Chung et al., 2014). For instance, a study in Mainland China 
noted that the majority of the population believed in TCM, even though most of them 
preferred to seek Western medicine treatment rather than TCM treatment when they are 
unwell (Xu & Yang, 2009). A large household survey of 42,819 people undertaken in China in 
2003 found that, although Western medicine was more popular among Chinese people with 
54% of people choosing to use Western medicine alone, 25% of the participants preferred 
integrated TCM/Western medicine treatment and 12% preferred TCM treatment only, 
respectively (Xu & Yang, 2009). A more recent study also found that approximately 60% of 
the population in Hong Kong and Mainland China had consulted a TCM practitioner at least 
once (Cheung, 2011). 
 
1.3.3 Antibiotic use and inappropriate use by different parts of the healthcare system and 
the public in China 
1.3.3.1 Antibiotic use and inappropriate use in hospitals and primary care institutions 
In China, hospitals are a major place where antibiotics are consumed (sales volume of 
antibiotics accounting for 25% of the total drug sales in hospitals) (Tao et al., 2013), and the 
antibiotic use frequency (see Box 3) among both hospital inpatients and outpatients is very 
high (Currie et al., 2013). However, the marked differences in socio-economic development, 
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such as healthcare resources and the health status across China, mean that the patterns of 
antibiotic use may be different in urban and rural areas (WHO, 2015C). 
 
Table 1 summarises the reported inpatient antibiotic use frequency among some hospitals in 
urban areas prior to 2011; the antibiotic use frequency ranged from 45.1% to 85.1% in 
different cities’ general hospitals, which was all much higher than the percentage use of 
antibiotics recommended by the WHO (≤ 30%) (WHO, 2006). Data from a hospital in the study 
location for this thesis – Taiyuan city – are included in the studies; antibiotic use is again very 
high, with an antibiotic use frequency of 67% among 33 inpatients in the respiratory 
department and 69% among 29 inpatients in the nephrology department of Taiyuan Centre 
Hospital, respectively (Deng, 2009). Of Taiyuan city, a study also showed that, among 4,399 
antibiotic prescriptions collected in 2005 from the sampled hospital in Taiyuan city, 1,889 
(42.94%) of them were inappropriate (Dong et al., 2006).A nationwide epidemiological study 
also found an average antibiotic use frequency of 68.9% among inpatients and an average 
antibiotic use intensity (Box 4) of 80.1 defined daily doses (DDDs) per 100 patient days in 
China in 2010 (Wang & Chou, 2013).  
 
To address this high level of antibiotic use, the Ministry of Health (MoH) (NHFPC from 2013) 
introduced the three-year strategy – ‘National Special Campaign for Clinical Use of Antibiotics’ 
– in 2011 (discussed below in section 1.4.2). This stipulated the limitations on antibiotic use 
intensity and antibiotic use frequency in hospitals (Bao et al., 2015; MoH, 2012; Tao et al., 
2013), and there is evidence that the high inpatient antibiotic use has been gradually 
decreasing since the introduction of this strategy. One study focused on 65 general hospitals 
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in China that indicated that the use of antibiotics dramatically decreased from 2010 to 2014 
as a result of the strategy, with the average antibiotic use frequency in inpatients and 
outpatients dropping from 62.9% to 35.3% and from 44.2% to 28.4%, respectively (Bao et al., 
2015). The success of the strategy is also supported by data from individual hospitals. For 
instance, a cross-sectional study indicated that antibiotic use frequency on one particular day 
in 2014 was 42.4% among 1,306 inpatients in a selected general hospital (Wang & Li, 2015). 
In addition, a study of 420 hospitals spread across most regions of China reported that, 
between 2008 and 2011, there was a decline in antibiotic use intensity in both second-line 
and third-line antibiotics (Tao et al., 2013). 
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Table 1 Antibiotic use frequency among hospital inpatients in urban areas of China 
Region Hospital Name Period Sample 
Size 
(cases) 
Antibiotic 
Use 
Frequency 
Luoyang, Henan Province No. 534 Hospital of PLA 2007.03-2008.02 284 45.1% 
 
Xiangtan, Hunan Province 
 
Xiangtan Centre Hospital 
2001.06.30  
N/A 
48.4% 
2003.06.30 62.9% 
2005.06.30 60.4% 
Nanchong, Sichuan Province Anonymous hospital 2011.09-2011.12 3526 51.67% 
Jingzhou, Hubei Province Anonymous hospital 2005.11-2006.04 479 54.49% 
Hefei, Anhui Province No.105 Hospital of PLA 1996.01-1998.12 9853 57.2% 
Datong, Shanxi Province Anonymous hospital 2010.01-2012.01 500 60.6% 
Jiujiang, Jiangxi Province No.1 Jiujiang Hospital of People 2005.01-2005.12 1315 65.1% 
Taiyuan, Shanxi Province 
(study site for the current 
study) 
Taiyuan Centre Hospital 2008.10-2008.12 33 67% 
Taiyuan, Shanxi Province 
(study site for the current 
study) 
Taiyuan Centre Hospital 2008.10-2008.12 29 69% 
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Qingdao, Shandong Province Qingdao City Hospital 2001.04-2001.10 577 74.87% 
Guangzhou, Guangdong 
Province 
Centre for Cancer Control & Prevention of Zhongshan 
Medical University 
2001.06-2001-07 739 75.37% 
Lanzhou, Gansu Province Affiliated Hospital of Lanzhou Military Region Lintong 
Sanatorium 
2008.01-2008.06 531 77.4% 
Cangnan, Zhejiang Provice Cangnan County Traditional Chinese Hospital 2003.01-2005.01 900 77.78% 
Chengdu, Sichuan Province Sichuan Hospital of People 2002.03-2002.04 602 78% 
Chengdu,  Sichuan Province Chongzhou Hospital of People 2002.01-2003.12 1069 85.12% 
 
Source from: Deng, 2009; Li et al., 2002; Liang et al., 2001; Lin, 2004; Liu et al., 2000; Liu et al., 2006; Ren, 2012; Tang et al., 2002; Wang et al., 2010; Wang et al., 2011; Wang & Qin, 2010; Wang & 
Zhou, 2007; Yi et al., 2006; Zhang, 2005; Zhang et al., 2006; Zhao & Xu, 2014.
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Box 4 What is the antibiotic use intensity? 
Antibiotic use intensity is measured by the DDDs per 100 patient days, which is a standardized 
measurement approach of drug usage recommended by the WHO (WHO, 2012; Zou et al., 
2014). The WHO’s definition of DDD is the assumed average maintenance dose per day for a 
drug used for its main indication in adults (WHOCC, 2009). 
 
However, despite evidence of a reduction in antibiotic use in general hospitals, antibiotic use 
among children is reported to still be a problem (Zou et al., 2014). China has had an extremely 
high antibiotic use frequency among inpatient children for a long time, especially in the 
treatment of upper respiratory tract infections (Cui et al., 2011; Hu, 2006; Zhang et al., 2009). 
Based on a five-point prevalence survey (conducted in 2001, 2003, 2005, 2008 and 2010) in 
tertiary hospitals across all 31 provinces of Mainland China, the use of antibiotics remained 
high in paediatrics departments, despite an overall decreasing paediatric antibiotic-using 
trend from 2001 to 2010 (Li et al, 2013). The high antibiotic use among children was also 
identified in a study focusing on the five largest children’s hospitals in four highly-developed 
cities in China, which reported that the mean antibiotic use intensity between 2002 to 2006 
was nearly twice as much as France’s across a similar period (Zhang et al., 2008; Zou et al., 
2014), along with very high antibiotic use frequency reported by individual children’s 
hospitals (He, 2012; Li & Wu, 2007; Wang, 2006; Xie & Wu, 2006; Zheng et al., 2008). For 
instance, one study of antibiotic use in Shanxi Province (the province where the current study 
is located) showed that 87.3% of 1,000 child inpatients used antibiotics in the sampled 
hospital in 2007 (Yang & Shi, 2008).  
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The high antibiotic use by child inpatients has persisted, even after the three-year strategy. 
Zou’s 2011-2012 study highlighted that antibiotic use remained high in children’s hospitals, 
even though it had declined in other specialist hospitals; specifically, the mean inpatient 
antibiotic use frequency in children’s hospitals increased from 71.91% to 76.86% during this 
period, and remained much higher than the national standard level (60%) (Zou et al., 2014). 
For example, antibiotic use frequency was reported to be as high as 97.7% of 286 child 
inpatients between 2011 and 2013 in one hospital in Qionghai city, located in the southern 
area of China (Su, 2013). Furthermore, the use of antibiotics among child outpatients is also 
very high in China (Zhang et al, 2008A; Zou et al., 2014). 
 
In contemporary China, primary care institutions have become the major healthcare 
providers, delivering 4.10 billion out of a total of 6.88 billion healthcare services in 2012 (WHO, 
2015C). However, compared with antibiotic use in hospitals, the use of antibiotics in primary 
care settings remains little studied and reliable information is lacking (Wang et al., 2014). A 
study focusing on urban CHIs across China indicated that, among 230,800 prescriptions 
collected between 2007 and 2009, there were more than 40% of prescriptions containing 
antibiotics, with the proportion of doctor-patient encounters resulting in antibiotics being 
prescribed being twice the WHO standard (20.0%-26.8%) (Li et al., 2012; Isah et al., 1997). Of 
the total prescriptions prescribed in 24 community health centres across the country in 2009-
2011, it also found that 52.5% of 7,311 outpatient prescriptions and 65.4% of 2,888 inpatient 
prescriptions contained antibiotics (Wang et al., 2014). Extensive antibiotic use in CHIs was 
also found in studies of individual CHIs, with the reported antibiotic use frequency ranging 
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from 41.68% to 57.7% (Huang, 2012; Wang & Chen, 2005; Yue & Zhu, 2014). However, unlike 
hospitals where the use of antibiotics has been controlled by the ‘National Special Campaign 
for Clinical Use of Antibiotics’ and many other programmes, there is still no effective drug 
management programme focused on primary care settings in China (Xiao, 2012; Xiao & Li, 
2013). Although the essential drug list (EDL) policies (discussed below in section 1.4.3) were 
implemented in primary care settings in 2009, the inappropriate use of antibiotics remained 
common among primary care institutions in China (Chen et al., 2010; Song et al., 2014; Yang 
et al., 2013; Yao et al., 2015).  
 
The information about antibiotics use in rural areas of China is limited and less clear than in 
urban areas (Sun et al., 2010). However, the limited evidence all points to the wide use of 
antibiotics in the rural areas. A study analysing prescriptions collected from 680 village clinics 
across 10 western provinces of China in 2005 found that the proportion of prescriptions 
including antibiotics was 48.43% (Dong et al., 2008). The few studies focusing on antibiotic 
use in rural areas further indicated the antibiotic use frequency in sampled county hospitals 
and village clinics was consistently above 60% (Liao & Guan, 2012; Lin et al., 2006; Ma et al., 
2002; Wang et al., 2014; Zhang, 2013). In addition, a 2008 study, investigating antibiotic use 
in rural areas of one wealthy province (Shandong Province) and one poor province (Ningxia 
Province), also indicated that the proportion of prescriptions in which antibiotics were 
prescribed were 40.3% of total prescriptions in Shandong’s county hospitals and 58.8% of 
Ningxia’s county hospitals, with an increasing trend over time in township hospitals and 
village clinics of both provinces (Sun et al., 2010). It was reported that antibiotic use was 
extremely high among children in township hospitals, with evidence that nearly 100% of child 
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inpatients’ prescriptions included antibiotics among 22 township hospitals in Hubei Province 
(Ma et al., 2013). Antibiotics are also inappropriately used among children, with evidence that, 
between 2007 and 2008, unnecessary antibiotic prescriptions occurred for 43% of 226 child 
patients (under 14 years old) in two county hospitals and three township hospitals in two 
medium-developed provinces of China (Liang et al., 2011). 
 
1.3.3.2 Antibiotic use and inappropriate use in pharmacies 
In China, most drugs, including antibiotics, are dispensed from drug companies to wholesalers, 
and then to the hospital’s and primary care institution’s pharmacies, or to retail pharmacies, 
and finally to consumers (WHO, 2015C). Therefore, between antibiotics prescribed by doctors 
and finally used by consumers, the pharmacies have a very important intermediate and 
dispensing role. However, information about antibiotic use related to pharmacies is very 
limited in China. 
 
For pharmacies in hospitals and primary care institutions, one study of 420 hospitals across 
the country indicated the proportion of sales volume for antibiotics decreased from 23.80% 
in 2009 to 19.40% in 2011 as a result of the three-year strategy in hospitals (Tao et al., 2013). 
It has also been suggested that pharmacist interventions can improve rational antibiotic use 
in China (Penm et al., 2013). For instance, by comparing the total cost of antibiotics in two 
independent respiratory hospital wards – one with pharmacist intervention and one without 
– between July 2009 and April 2010, Shen et al.’s (2011) study indicated that the total cost of 
antibiotics in the ward with pharmacist interventions was USD 832.0±373.0, which was 
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significantly lower than that of the ward without pharmacist interventions (USD 943.9±412.0). 
A separate study similarly reported that pharmacist interventions on prophylactic antibiotic 
use are effective, with evidence that, after applying pharmacist interventions from 2011, the 
rate of using antibiotics in clean operations decreased from 100% of 36 patients in 2010 to 7% 
of 69 patients in 2013 in the selected hospital (Zhou et al., 2015). 
 
For retail pharmacies, a rural study in Jiangxi Province found that, among all medicines in 8 
retail pharmacies, antibiotics had the highest average sales volume (Yu et al., 2013). Although 
national or provincial data about sales volume of antibiotics in retail pharmacies are rare, 
studies report that the inappropriate use of antibiotics – selling antibiotics without 
prescription – is very common. Self-medication with antibiotics is prevalent among the public 
in China and the retail pharmacy is one of the main sources for the public to acquire non-
prescription antibiotics (Fang, 2014; Fang et al., 2012). One study, focusing on 213 retail 
pharmacies in Shaanxi Province and having one encounter in each pharmacy, showed that 
72.8% of 213 encounters relating to paediatric diarrhoea successfully obtained antibiotics 
without a prescription, while the rate of obtaining non-prescription antibiotics for adult 
respiratory infections accounted for 95.8% of those 213 encounters (Jiang et al., 2013). 
Evidence of Liao et al.’s (2003) study similarly indicated the rate of obtaining non-prescription 
antibiotics for paediatric diarrhoea were 37.5% and 95% for adult respiratory infections of 40 
encounters in retail pharmacies.  
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1.3.3.3 Antibiotic use and inappropriate use by the general public  
In China, the role of patients in antibiotic use and inappropriate use has been reported to be 
increasing (Cars et al., 2008). In one study focusing on antibiotic use among the general 
population of Hong Kong, 80.6% of 465 participants recalled they had been prescribed 
antibiotics (Chan et al., 2012). Studies based on one particular city in Mainland China also 
reported that residents commonly used antibiotics. Additionally, antibiotics are widely used 
by parents for their children in China, with evidence that 85.8% of 183 children (under 7 years 
old) in a study carried out in Shandong Province were found to be treated with antibiotics 
when they have colds (Zhao et al., 2013). Another study reported that, among 1,487 rural 
parents who had children between 0 to 3 years of age in Hebei Province, 88.54% of the 480 
parents with educational at high school level or above had used antibiotics on their children 
when they were feverish, while 91.56% of 1,007 parents with levels at secondary school or 
below used antibiotics on their children when they were feverish (Yang et al., 2010). As this 
suggests, antibiotics are widely used among the general public and on children by parents in 
China. 
 
Alongside the high antibiotic use rate, it has been reported by many studies that the use of 
antibiotics by patients is often inappropriate. When individuals are not well or symptoms 
develop, their understandings of what is wrong are likely to be different and the actions they 
take to seek help will also differ (Gabe et al., 2004); for instance, some people may seek 
professional health care while others may self-treat or do nothing (Li et al., 2012). In China, 
because of the long-standing factors related to the high price of healthcare services, low trust 
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levels in some healthcare institutions and low levels of benefits provided by medical 
insurance schemes (discussed in section 1.3), self-treatment, including self-medication of 
antibiotics, is increasing rapidly (Li et al., 2012; MoH, 2004, 2009; Pan et al., 2012; Yip et al., 
2012). Data from a survey carried out by the CFDA indicated that, among 7,915 respondents, 
1,892 (23.9%) chose to self-medicate with antibiotics when they had symptoms of a cold 
(Fang, 2014). Different studies suggested a high rate of self-medication with antibiotics 
among the general public, ranging from 22.09% to 44.8%, and an even higher parental 
medication rate, with 59.4% of 1,459 children medicated at least once by their parents (Bi et 
al., 2000; Chen, 2003; Hou et al., 2013; Li et al., 2015). It was noted in Bi et al.’s (2000) urban 
study that, among the parentally-medicated children (59.4% of 1,459 participants), more than 
half received parental self-medication six or more times during one year. Parental medication 
of children with antibiotics is also very common in rural areas, with evidence from one study 
of 854 parents that the rate of parental medication with antibiotics was as high as 62% (Yu et 
al., 2014). Self-medication and parental medication with antibiotics has been demonstrated 
to be one of the contributing factors for inappropriate use of antibiotics, which is associated 
with unnecessary antibiotics and incorrect antibiotics, among other factors (Grigoryan et al., 
2010; Jose et al., 2013; WHO, 2012).  
 
Non-adherence 13  to antibiotic treatment is another common phenomenon related to 
inappropriate antibiotics used by patients in China. Data from a meta-analysis indicated that 
                                                        
13 The adherence is defined as ‘the extent to which a person’s behaviour-taking medication, following a diet, and/or executing lifestyle 
changes, corresponds with agreed recommendations from a health care provider’ by the WHO (2003). It could be associated with a wide 
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poor adherence to treatment was associated with increased mortality (Aronson, 2007; 
Simpson et al., 2006) and with treatment failure as well as higher costs of treatment (Kardas, 
2006; Pechère et al., 2007). With respect to antibiotic treatment, the patterns of non-
adherence are various, such as failing to start the prescription, discontinuing an antibiotic 
before the course is complete, taking more or less of the dose than prescribed and taking a 
dose at the wrong time, among other issue, which are all examples of inappropriate antibiotic 
use (Kardas, 2006). In China, non-adherence to antibiotic therapy is common among patients. 
A global survey of non-adherence to antibiotic treatment showed that, in China, only 2.2% of 
284 respondents were defined as adhering to treatment, for example, following dosage 
instructions and not saving antibiotics, which was much lower than rates in other countries, 
such as the Netherlands (68.0%) and the USA (54.8%) (Pechère et al., 2007). This was 
supported by another study indicating that, among antibiotic therapies for outpatients with 
acute infections in one city of China, only 40.1% of 162 outpatients completely adhered to 
their therapies (Chen et al., 2015). Another study carried out in Chongqing city in China also 
reported that 76.92% of 300 respondents chose to stop using antibiotics immediately when 
they felt better (Zeng et al., 2012). 
 
In conclusion, antibiotics are widely and inappropriately used in hospitals and primary care 
institutions, pharmacies, and by the public in China. In response to this serious problem, a 
range of reforms and policies related to the use of antibiotics have been introduced by the 
                                                        
range of health-related behaviour, such as taking medication appropriately, and the quality of the relationship between patients and health 
care providers is a core element of adherence (WHO, 2003). 
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Chinese government in order to control antibiotic use and ABR in China. In the next section, 
information on these reforms and policies is provided.  
 
1.4 Policies related to the use of antibiotics   
1.4.1 Overview of policies related to the use of antibiotics in China 
In China, the development of national-level policies related to antibiotic stewardship began 
in the 2000s (Zhang, 2011). This included several national guidelines, such as the ‘Principles 
for Clinical Use of Antibiotics’ and the ‘National Formulary (2010 edition)’ issued in 2004 and 
2010 (MoH et al., 2004; MoH, 2010; Zhang, 2011), respectively, as well as relevant regulations, 
such as ‘Provisions for Supervision of Drug Distribution’ (CFDA, 2007). However, over the past 
few decades, the inappropriate use of antibiotics was still reported to be very common in 
China, due to the lack of legal power of these guidelines and the weak enforcement of existing 
regulations (Xiao & Li, 2013).  
 
The Chinese government began a new round of healthcare system reforms in 2009, seeking 
to provide universal health coverage to all residents (State Council, 2009). This led to the 
implementation of a set of policies, such as the EDL and ZMU policies (discussed below in 
section 1.4.3), which are also relevant to the appropriate use of antibiotics. Along with EDL 
and ZMU policies, a new strategy that ran from 2011 to 2013 focused particularly on 
antibiotics use was implemented by the national government, with the issuing of a new 
regulation in 2012. Following this 3-year period (2011-13), an improvement in hospital 
antibiotic use was observed (Xiao & Li, 2013; Xiao & Li, 2015). More policies have 
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subsequently been introduced in order to limit the inappropriate use of antibiotics in China. 
A timeline of important policies related to the use of antibiotics in China is shown in Figure 2 
and a brief introduction to these polices is given in Table 2.  
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Figure 2 Timeline of policies related to the use of antibiotics in China 
 
 
 
 
 
 
 
 
 
 
 
 
2003 
 
 
2004 
 
2005 
 
2006 
 
2007 
 
2008 
 
2009 
 
2010 
 
2011 
 
2012 
 
2013 
 
2014 
 
2015 
 
2016 
 
2017 
 
 
 
 
 
 
 
 
 
 
The first national guidelines 
– Principles for Clinical Use 
of Antimicrobials  
Provisions for Supervision of Drug 
Distribution – regulating the 
distribution of prescribed drugs should 
based on prescriptions 
Administrative Regulations for the 
Clinical Use of Antibiotics– the 
strictest regulation so far for 
appropriate use of antibiotics 
Adapted from the Table 2 
National Essential Drug 
List (2012 edition) and 
zero mark-up policies – 
removing the 15% mark-
up on drug sales from 
primary health system 
National Special Campaign for the 
Clinical Use of Antibiotics from 2011 
to 2013 – strategies for appropriate 
use of antibiotics 
Present study 
undertaken in 
2016 
Regulations 
Strategies 
& 
Guidelines 
National Drug Safety ‘twelve-five’ 
Programme – requiring all pharmacies to have 
pharmacists by 2015 
Administrative Regulations for 
Prescription – standardizing 
prescription procedures for 
physicians 
National Essential Drug List (Elementary 
edition) and zero mark-up policies – 
removing the 15% mark-up on drug sales 
from primary health system 
The national guideline – 
Principles for Clinical Use 
of Antimicrobials (2015 
edition)  
Issuing the Work Arrangements in 
2012 for deepening Healthcare 
System Reforms – removing 15% 
mark-up from public hospitals 
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Table 2 Content and implementation date of policies related to appropriate use of antibiotics in 
China 
Field Date Policies Main content 
 
 
 
 
 
 
 
Regulations 
2007 Administrative 
Regulations for 
Prescription 
• Standardizing and supervising physicians’ 
prescribing practices; 
• Setting punishments and legal responsibilities for 
violating the regulations. 
2007 Provisions for 
Supervision of 
Drug Distribution 
• Provision of supervision for drug purchase, sale, and 
storage for different stakeholders, including selling 
prescribed drugs with prescriptions and under the 
supervision of licensed pharmacists or qualified 
staff;  
• Setting punishments and legal liabilities for violating 
the regulations. 
2012 Administrative 
Regulations for 
the Clinical Use 
of Antibiotics 
• Regulating responsibilities, the manner of the work, 
as well as stricter punishment and legal liabilities 
related to the use of antibiotics for different 
stakeholders, from MoH, local authorities, 
healthcare institutions, and health professionals 
including physicians, pharmacists and 
microbiologists. 
 
 
 
 
 
 
 
 
2004, 
2015 
Principles for 
Clinical Use of 
Antimicrobials 
• The principles for the rational use of antibiotics, 
including the priority given to oral antibiotics over 
other modes of treatment; 
• The management of the clinical use of antibiotics; 
• Pharmacological characteristics of antibiotics and 
recommendations for antibiotic treatment for 
infections. 
2009, 
2012 
EDL and ZMU 
policies 
• A list of national essential drugs that should be sold 
without price mark-ups;  
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Strategies 
& 
Guidelines 
• Requiring all government-operated primary care 
institutions to only sell essential drugs, while other 
medical institutions should procure and use national 
essential drugs as a priority. 
2011-
2013 
National Special 
Campaign for the 
Clinical Use of 
Antibiotics 
• Setting responsibilities related to antibiotic use for 
MoH and local authorities as well as healthcare 
institutions; 
• Setting a range of antibiotic-related targets for 
healthcare institutions, such as the limitations on 
proportions of prescriptions with antibiotics; 
• Setting tasks related to supervision and summary. 
2012 National Drug 
Safety ‘twelve-
five’ Programme 
• A set of principles, objectives and tasks related to 
national drug safety, including one requiring every 
pharmacy to have pharmacists and ensuring their 
presence during pharmacy’s opening hours by 2015. 
2012 Issuing the Work 
Arrangements in 
2012 for 
deepening 
Healthcare 
System Reforms 
• A range of tasks in order to deepen healthcare 
reforms, including one to remove the 15% mark-up 
on drug sales from public hospitals. 
Source from: CFDA, 2007; MoH, 2011, 2012, 2012A, 2013, 2013A; NHFPC, 2015; State Council, 2012; 
Xiao & Li, 2015. 
 
As shown in Figure 2, the roll-out of antibiotic-related reforms began in 2011, and was 
influenced by China’s 2009 round of healthcare reforms. The present study was undertaken 
in 2016, in the context of the new antibiotic-related strategies and policies instituted since 
2009. Therefore, section 1.4.2 and section 1.4.3 provide more detail about the three-year 
strategy, the new regulations and related policies.
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1.4.2 2011 antibiotic-related reforms  
Considering the global public health threat of AMR, the WHO selected ‘Antimicrobial 
Resistance: No action today, no cure tomorrow’ as the World Health Day theme for 2011 
(WHO, 2011B). Influenced by the WHO, the MoH in China began a three-year strategy named 
‘National Special Campaign for the Clinical Use of Antibiotics’ from 2011 to 2013. It was 
centred on the regulation of ‘Administrative Regulations for the Clinical Use of Antibiotics’, 
with a special focus on the rational use of antibiotics in secondary and tertiary public hospitals 
(Xiao & Li, 2013; Xiao & Li, 2015). The ‘Proposal of National Special Campaign for the Clinical 
Use of Antibiotics’, an important component of this strategy, was issued as part of its 
implementation from 2011, and was updated in 2012 and 2013 (MoH, 2011, 2012, 2013). 
These documents indicate that this strategy is related to all types and levels of healthcare 
institutions as well as the MoH and local authorities, with a special focus on the secondary 
and tertiary hospitals; the documents also set several targets during this three-year strategy 
period, such as: 
• With respect to antibiotic procurement, the maximum number of types14 of antibiotics 
being stocked should be no more than 50 in the tertiary public general hospital and 35 in 
the secondary public general hospital; however, there were no limitations set for CHIs 
and retail pharmacies.  
• The MoH set limitations on the proportion of patients prescribed antibiotics for hospitals. 
                                                        
14 There are hundreds of types of antibiotics, which can be grouped into broader classes (NHS, 2016). For instance, the ‘National Essential 
Drug List (2012 edition)’ in China listed 43 types of essential antimicrobials, and then classified them into 14 classes (discussed below in 
section 1.4.3). 
  
 74 
In general hospitals, the antibiotic use frequency (Box 3) for inpatients should be no more 
than 60%, and the proportion of prescriptions containing antibiotics should be no more 
than 20% for outpatients and 40% for emergency patients, respectively. The antibiotic use 
intensity (Box 4) in the hospitals should be no more than 40DDDs per 100 patient days.  
• Required regulars check and evaluation of antibiotic prescriptions and medical records; a 
range of administrative penalties were introduced for physicians who violated the 
standards, such as having their level of antibiotic prescription rights lowered. 
• Other targets, such as clinical training, building the list of restricted level of antibiotics, 
accrediting physicians’ antibiotic prescribing rights in grades 15 , ABR and utilization 
surveillance, among others, were set (Xiao & Li, 2015; MoH, 2013). 
 
On 13th February 2012, the regulations became tighter. ‘Administrative Regulations for the 
Clinical Use of Antibiotics’ were issued by the MoH; this came into force on 1st August 2012. 
This regulation only focused on antibiotics, and then clearly set out the roles, responsibilities 
and liabilities of different stakeholders, including health administrative authorities, medical 
institutions and healthcare professionals, in order to promote and enforce the rational use of 
antibiotics (Xiao & Li, 2013; Xiao & Li, 2015; MoH, 2012A). For instance, regulations were 
designed to encourage physician adherence to guidelines that required examination of 
patients’ clinical presentation and laboratory test results. It was stipulated that physicians 
                                                        
15 It was stipulated in Action 24 of ‘Administrative Regulations for the Clinical Use of Antibiotics’ that, physicians with different special titles 
could be awarded different antibiotic prescribing rights. Specifically, deputy chief physicians and chief physicians can be awarded the rights 
to prescribe special restricted antibiotics, while physicians-in-charge can be awarded the right to prescribe restricted antibiotics. Physicians 
with the lowest special title can only be awarded the rights to prescribe non-restricted antibiotics. All these rights will be awarded after 
physicians pass the specific training and evaluation (MoH, 2012A). 
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who violated the regulations would be punished in a range of ways, from a financial penalty 
to legal liability, depending on the severity of the violation (Xiao & Li, 2015; MoH, 2012A). 
 
The three-year strategy and regulation highlighted the role of the ‘Principles for Clinical Use 
of Antimicrobials’, which led to its update in 2015. The new edition – ‘Principles for Clinical 
Use of Antimicrobials (2015 edition)’ – includes four main parts. These are the general 
principles of appropriate use of antimicrobials, the management of clinical antimicrobials, the 
pharmacological characteristics of antimicrobials and recommendations for their treatment 
of infections and clinical experience-based principles of the antimicrobial selection for 
common infections. For instance, this guideline indicates that making a diagnosis of a 
bacterial infection and prescribing antibiotics should based on relevant indications, such as 
laboratory test results and that, during antibiotic treatment, oral antibiotics should be given 
in priority over other modes of treatment, for example, intravenous antibiotics (NHFPC, 2015).  
 
1.4.3 China’s 2009 healthcare reforms and other pharmaceutical policies in China 
The financial reforms in China have led to a rapid rise of healthcare cost for people, 
particularly for rural residents, since the 1980s, as a result of the decreased coverage and the 
low impatient reimbursement rate of medical insurance schemes (Hsiao, 2007; Meng et al., 
2012). The proportion of out-of-pocket expenditures 16  in THE was thus continuously 
increased from 21.2% in 1980 to 60.0% in 2001(CNHDRC, 2017). Concerned about these 
                                                        
16. They are the health expenditures paid by patients directly where health insurance does not cover the full cost of health services (OECD, 
2011). 
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problems, in 2009, the State Council launched a three-year national plan, the 
‘Implementation Plan of the Main Areas of Healthcare System Reform in the Near Future 
(2009-2011)’, to deepen the healthcare system reform in China. With the first phase goal of 
achieving comprehensive universal health coverage by 2020, it set up five areas, which were 
also called the five pillars (Meng et al., 2012). The five pillars include primary care service 
delivery, essential medicines, public health, insurance and public hospital reforms, that would 
be the focus in this new round of China’s healthcare system reform (State Council, 2009). 
With the plan, the insurance coverage has expanded and healthcare-related financial burden 
on people has largely decreased (Fu et al., 2018). For example, the proportion of out-of-
pocket expenditures in THE declined from 60.0% to 28.8% in between 2001 and 2016 
(CNHDRC, 2017).  
 
One of these five pillars was building the national essential drugs system (State Council, 2009). 
At its core is the EDL, which is designed to provide basic healthcare services to all residents 
and promote the rational use of drugs (Xiao et al., 2016). Together with the EDL, the ZMU 
policy was introduced as part of the national essential drug system to sell drugs at cost, with 
aims to prohibit healthcare institutions from charging the 15% mark-up on selling drugs17 
(Mossialos et al., 2016; MoH et al., 2009A; State Council, 2009A). The essential drug system, 
including EDL and ZMU policies, was initially applied at 30% of the government-owned 
primary care institutions in every province (autonomous region/municipality) in 2009 
(Mossialos et al., 2016; MoH et al., 2009, 2009A). The latest version of the EDL is the ‘National 
                                                        
17 The policy of 15% mark-up on price is discussed in next paragraph.  
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Essential Drug List (2012 edition)’, which was implemented in 2013; for antimicrobials, there 
were in total 14 classes18 of 43 types of antimicrobials included. They all belong to first-line 
antimicrobials, meaning they can be used without restriction (MoH, 2013A). In order to better 
enforce the essential drug system, the government then issued relevant documents that 
required government-owned primary care institutions to all stock and dispense national 
essential drugs, and further required that other healthcare institutions should procure and 
use national essential drugs as a priority. A target was set: the proportions of the volume of 
national essential drugs sold should reach 40%-50% and 25%-30% of total volume of drugs 
sold in secondary and tertiary hospitals, respectively (NHFPC, 2013). The importance of 
implementing the essential drug system within the different levels of medical institutions was 
consistently highlighted by government documents issued in the years that followed (State 
Council, 2014; NHFPC, 2015; State Council, 2016). 
 
The 15% mark-up policy was introduced in 2006 in China, which allowed county and higher-
level healthcare institutions to charge a mark-up of a maximum of 15% on the sales of drugs 
to compensate for decreases in government funding. However, the 15% mark-up policy also 
had negative consequences, including overprescription and prescription of expensive drugs 
by physicians (Mossialos et al., 2016; NDRC et al., 2006). Therefore, in 2009 when China’s 
healthcare system reform, the EDL and ZMU policies, was introduced to gradually remove the 
incentive of 15% mark-up (Mossialos et al., 2016; State Council, 2009). Another key area of 
                                                        
18  The 14 classes of antimicrobials are penicillin, cephalosporin, aminoglycoside, tetracycline, macrocyclic lactone, other antibiotics 
(including clindamycin and fosfomycin), sulfonamide, quinolone, nitro imidazole, nitro furan, anti-tuberculosis, anti-leprosy, anti-fungal and 
anti-viral drugs, respectively. 
  
 78 
the healthcare reform’s five pillars – public hospital reform – also required the gradual 
removal of the 15% mark-up from public hospitals (State Council, 2009). Since then, the ZMU 
policies began to be implemented in different healthcare institutions. It was found that this 
policy has almost universally been implemented in government-owned primary care 
institutions combined with the EDL (Mossialos et al., 2016; Xi et al., 2015). With respect to 
the public hospitals, by the end of 2014, there were 66% of counties that had removed the 
15% mark-up in their county hospitals and an increasing number of urban hospitals began to 
remove the mark-up (State Council, 2015). The national government also called for the ZMU 
policies to be implemented in all county hospitals and urban hospitals by 2015 and September 
of 2017, respectively (Mossialos et al., 2016; State Council, 2015; State Council, 2017).  
 
Additionally, the national government has been concerned about drug distribution, including 
antibiotics, in retail pharmacies. From 2004, it was required that antibiotics must be 
dispensed with prescriptions in retail pharmacies (CFDA, 2004). In 2012, a new policy was 
introduced, the ‘National Drug Safety ‘twelve-five’ Programme’, which required that newly-
operating retail pharmacies must be owned or managed by licensed pharmacies; moreover, 
licensed pharmacists must be presented in the retail pharmacy during its opening hours 
(State Council, 2012).  
 
1.5 Conclusions  
From the above review, it is clear that human ABR is a serious global public health problem, 
and LMICs, particularly China, are seriously affected by it. As antibiotics are widely and 
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inappropriately used in the provision of medical services, drug dispensing via pharmacies and 
among the public, particularly for children, the healthcare providers (including paediatricians, 
GPs and pharmacists) and parents are key constituencies related to antibiotic use and 
resistance in China. Therefore, it is important to understand more about the factors 
influencing their behaviour with respect to use of antibiotics among children, and the next 
chapter will focus on the relevant literature that sheds light on healthcare providers’ and 
parents’ antibiotic-related behaviour related to children.
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Chapter 2. A review of factors contributing to the use of antibiotics 
for children in China
  
 81 
2.1 Introduction 
As noted in the previous chapter, the use of antibiotics is the single most important factor 
contributing to human ABR (Byarugaba, 2004; Huttner et al., 2010; Simonsen et al., 2004), 
and China, which shows both extremely high total antibiotic consumption and widespread 
inappropriate use of antibiotics, is a major contributor to global antibiotic use (WHO & MoH, 
2013; Zhang et al., 2015). As discussed in section 1.3.3, the rates of antibiotic use and 
inappropriate use for children by healthcare providers in hospitals, primary care settings and 
pharmacies, and by parents, are particularly high compared with those of adults in China. 
However, compared with studies on HICs, much less is known about healthcare providers’ 
and parents’ views and experiences of antibiotic use for children in China. Therefore, building 
on Chapter 1, this chapter provides a review of research studies relevant to understanding 
factors contributing to the use of antibiotics by healthcare providers and parents for the 
treatment of conditions in children (hereafter ‘the use of antibiotics for children’ will be used 
in the thesis) in China. It reviews studies of the general public alongside studies where the 
focus is on children.  
 
There are five sections: 
• 2.1 provides an introduction; 
• 2.2 describes how the research review was conducted; 
• 2.3 and 2.4 review evidence on influences on healthcare providers’ antibiotic-related 
behaviour on the public’s and parents’ antibiotic-related behaviour. In each section, 
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the evidence is summarised under the spheres of influence highlighted in the 
framework (e.g. individual level influences, interpersonal influences etc.); 
• 2.5 concludes the review and considers limitations and gaps in the evidence. 
 
2.2 Undertaking the review of research literature of factors contributing to the 
use of antibiotics for children in China 
A broad range of research is of potential relevance to this thesis, including studies conducted 
beyond China. Therefore, a systematic approach was applied. Specifically, there were two 
stages to the review: (i) identifying and developing a framework through which to understand 
the influences on the use of antibiotics for children in China, and, using this framework; and 
(ii) undertaking a review of research relevant to factors influencing the use of antibiotics for 
children in China. The review included searching for relevant papers in both English and 
Chinese language journals using two electronic databases. 
 
2.2.1 Identifying a framework to capture the influences on the use of antibiotics for children 
in China 
The relevant background reading made clear that there were a wide range of inter-connected 
factors influencing antibiotic use, and frameworks that represented these influences were 
very helpful in understanding the context and patterns of use. Therefore, it was decided to 
use a framework to guide the review.  As there was no framework that fitted this research 
area, a framework was developed using published frameworks and papers concerned more 
broadly with AMR and ABR. Three widely-cited papers were selected, each providing an 
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overview of factors from different angles and each with an accompanying framework. They 
proved to be very helpful in building this research framework and guiding the research review.  
 
Among these papers, the first paper (Byarugaba, 2004) looks at risk factors related to ABR in 
general, while the second (Okeke et al., 1999) focuses particularly on socioeconomic and 
behavioural factors contributing to ABR, and the third (Simonsen et al., 2004) discusses ABR 
risk factors from an ABR containment and surveillance perspective. The first two papers focus 
on developing countries (which are also referred to as LMICs), countries in the same economic 
grouping as China, while the third provides a more generic perspective on risk factors for ABR 
relevant to different geographical and socioeconomic settings (Byarugaba, 2004; Okeke et al., 
1999; Simonsen et al., 2004). For reference, the three frameworks derived from the three 
papers, respectively, are included in Appendix C. By analysing and comparing the factors 
identified in the three frameworks, it was possible to gain a comprehensive overview of 
factors contributing to human antibiotic use and then build a framework more relevant to 
this thesis’ focus. Figure 3 presents the framework derived from these frameworks. It includes 
two key drivers of human antibiotic use (patient-related factors and healthcare provider-
related factors, highlighted in bold); as the Figure’s key indicates, these were identified in all 
three frameworks.   
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Figure 3 Factors contributing to human antibiotic use in low and middle-income countries: A framework developed from three reviews 
   
Human AB use 
Economic & 
political factors*# 
Healthcare provider-
related factors*#@ 
Poor quality of 
AB#@ 
Patient-related 
factors*#@ 
Availability of AB 
without 
prescription# 
Poor patient 
compliance*#@ 
Lack of knowledge*#@ 
Financial interest*#@ 
AB: antibiotic; 
*: factors identified from Byarugaba, 2004; 
#: factors identified from Okeke et al., 1999; 
@: factors identified from Simonsen et al., 2004. 
Bold boxes show the key influences that are noted by all three papers 
Contribute to 
Interact with 
Lack of quality monitoring#@ 
Degraded ABs, expired ABs, 
counterfeit ABs, etc.# 
Consultation# 
Misconceptions & attitudes*#@ 
Lack of AB diagnostic 
facilities*#@ 
Essential drug list#@ 
Patient expectations*@ 
Self-medication*# 
Advertising pressures* 
Patient expectations* 
Guidelines#@ 
Health service 
provision institutions*# 
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In this framework, a wide range of influences related to human antibiotic use identified by 
the three papers are grouped into five inter-connected drivers (healthcare provider-related 
factors, patient-related factors, poor quality of antibiotics, economic and political factors, and 
health service provision institutions), along with a range of factors that the papers noted as 
underlying these drivers. Two of these drivers of human antibiotic use (patient-related factors 
and healthcare provider-related factors) are highlighted in bold. As the Figure’s key indicates, 
patients and healthcare providers were identified as particularly important influences on 
human antibiotic use in all three papers. The other three drivers were only mentioned by two 
papers. Consultation between patients and healthcare providers was noted as a key process 
mediating the interactions between healthcare provider- and patient-related factors 
contributing to antibiotic use. In addition, the framework represents the drivers’ directions 
of influence. While all contribute to human antibiotic use, the five drivers can also interact 
with each other; the set of underlying factors under each driver are identified as influences 
related to a particular driver.  
 
Some limitations of the framework presented in Figure 3 should be noted. Firstly, some 
factors could be situated under multiple drivers located at different levels, but these multi-
level relationships are not fully represented by this framework. For instance, it was 
highlighted by papers that government guidelines on human antibiotic use were an influence 
on healthcare providers’ behaviour, and this is where government guidelines is located in 
Figure 3; however, the guidelines could also be treated as a political factor and located at this 
more macro level.  Secondly, and more importantly, even this simplified framework is too 
complex to be operationalised within a single doctoral study.   
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The framework was therefore further refined and simplified.  This was done by drawing on 
the social ecological framework (SEF), which provided an alternative way of representing the 
influences on human antibiotic use and was found to be particularly helpful. The SEF is a 
framework that takes into account dynamic and reciprocal interrelationships between 
individuals and their environments. Therefore, in the SEF, a variety of influencing factors on 
the outcome of interest (the use of antibiotics) are situated within a causative ‘web’ which is 
separated into multiple levels, with the individual level located in the centre and surrounded 
by a set of concentric circles (or layers) ranging from micro- to macro-level (Schneider & 
Stokols, 2009). The most well known framework within public health is based around a SEF. 
This is the Dahlgren and Whitehead’s (1991) ‘rainbow’ model of the main determinants of 
health, which identifies influences on health as a series of arcs running from the individual 
level up to the societal level. The SEF is widely used within the public health and healthcare 
sector, for example by the USA’s Centers for Disease Control and Prevention for health 
promotion (CDC, 2015; Schneider & Stokols, 2009).  
 
Figure 3 was simplified and restructured using Dahlgren & Whitehead’s ‘rainbow’ model, with 
SEFs developed for this study to represent the complex factors contributing to the use of 
antibiotics for children in China (Figure 4 presents the SEF for healthcare providers and Figure 
5 presents the SEF for parents). This framework was informed by the review of literature of 
factors influencing the use of antibiotics; it was then revised in light of the findings of the 
study of this thesis. As the importance of healthcare provider- and patient- (including parent) 
related factors was highlighted by Figure 3 and the healthcare providers and parents were 
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identified as key constituencies related to antibiotic use in the review in section 1.3.3, they 
were regarded as the individual in their own SEF, and therefore located in the centre of the 
SEF and surrounded by a set of concentric layers influencing their behaviours from micro- to 
macro-levels (Table 3). 
 
The frameworks were then used to inform the structure of literature review and the design 
of the data collection instruments (the interviews conducted with healthcare providers and 
the focus groups and survey questionnaire with parents). As is described below in Chapters 
4, 5, and 6, the topic schedules for the interviews either included questions that asked directly 
about the factors (e.g. for healthcare providers ‘Do you ever find that some parents make 
clear they wish you to prescribe antibiotics for their child?’ and for parents ‘Do you treat your 
child with antibiotics by yourself when he/she is ill or symptomatic?’) or enabled these factors 
to be discussed through indirect questions (e.g. for health care providers ‘What factors do 
you think usually influence a physician/GP/pharmacist’s antibiotic prescribing behaviour?’).  
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Figure 4 A social ecological framework representing some of the key factors contributing to 
healthcare providers’ behaviour with respect to the use of antibiotics for children in China 
 
Adapted from: The review of research, findings from this study and Figure 3 
 
Figure 5 A social ecological framework representing some of the key factors contributing to 
parents’ behaviour with respect to the use of antibiotics for children in China 
 
Adapted from: The review of research, findings from this study and Figure 3 
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Table 3 Factors influencing healthcare providers’ and parents’ behaviour with respect to the use of 
antibiotics for children in China 
 Healthcare providers Parents 
Individual level Individual knowledge and attitudes 
(TCM and Western medicine) toward 
diseases and antibiotic use, and 
personal experience 
Individual knowledge and attitudes 
(TCM and Western medicine) 
toward diseases and antibiotic use, 
personal experience, age, gender, 
and socio-economic circumstances 
Interpersonal level Patients and parents, and other 
healthcare providers 
Healthcare providers, particularly 
physicians and pharmacists, as well 
as their family members and 
friends 
Community level Workload and time, guidelines, training, 
and limited diagnostic test technology 
Mass media related factors 
Organisational 
level 
Financial incentives, basic medical 
insurance schemes, retail pharmacies, 
and health service delivery systems 
Pressures from employers and 
schools, health service delivery 
system, basic medical insurance 
schemes, and retail pharmacies 
Policy level Policies and regulations relevant to the 
use of antibiotics 
Policies and regulations relevant to 
the use of antibiotics 
  
2.2.2 Approach used for reviews of research related to factors influencing the use of 
antibiotics for children in China 
As noted in section 1.1, the broader literature review work started from the first year of the 
PhD programme (2015/2016), when an initial set of studies related to the use of antibiotics 
and ABR was identified. Reference checking and citation searching were then undertaken on 
this set of studies, which revealed that most of the published research on the use of 
antibiotics and resistance was based on HICs and there were particularly few studies focusing 
on influences on the use of antibiotics in China. Therefore, more systematic searches for 
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evidence on influences on antibiotics use in China were undertaken in the second year of the 
PhD programme (2016/2017). It was then updated in June and July 2017 by reference 
checking and citation searching from the most relevant studies. 
 
2.2.2.1 Search methods and criteria for identification of papers 
The systematic searches included both English and Chinese language research. Chinese 
language journals were searched because of the study setting (China). There are a large 
number of Chinese language journals published in China, but the large majority are not 
indexed in major English language databases; for example, only 82 out of more than 5,000 
Mainland Chinese journals were indexed for MEDLINE in 2007 (Fung, 2008). However, the un-
indexed papers are particularly likely to contain China-based studies and data related to 
antibiotic use and ABR, and therefore be a key resource for this doctoral study. Moreover, 
there is an increasing awareness of a potential language bias in the public health evidence 
base as major databases largely exclude languages other than English (Fung, 2008; Fung, 
2008A). As an example, language bias was found to lead to an underestimation of the 
protective effect of interventions in random control trials of complementary and alternative 
medicine (Klassen et al., 2005). However, while there is increasing recognition of the potential 
contribution of Chinese language studies, concerns have been expressed about study quality 
(Fung, 2008).  
 
It was decided that, to increase the comprehensiveness and relevance of the review and to 
avoid potential language bias, both English and Chinese language research would be 
  
 91 
systematically searched (Fung, 2008A).  Quality appraisal of studies from Chinese language 
journals included in the review was undertaken.  A range of quality appraisal tools was 
considered (CASP, 2017; Chung et al., 2014; NIH, 2014; Wells et al.) and a widely-used tool 
was identified as suitable (Hawker et al., 2002).  It has been developed for appraising the 
quality of qualitative studies but provides a set of criteria that can also be applied to 
quantitative studies. It was therefore used for both study designs (qualitative and 
quantitative). Studies in the review located through MEDLINE were not subjected to quality 
appraisal as this is built into the selection process for journals in MEDLINE (NIH, 2017). 
 
For the systematic searches (English and Chinese language), two key electronic databases 
were used: MEDLINE Ovid and Chinese portal of Chinese National Knowledge Infrastructure 
(CNKI), respectively. MEDLINE Ovid is a major and widely used bibliographic database that is 
used ‘to indicate journals of importance’ (Fung, 2008, pp.11). It is updated daily and contains 
journal citations and abstracts in English covering the international literature on biomedical 
and life sciences, including healthcare, pharmacy, and the humanities. There were around 
5,500 journals published in approximately 40 languages indexed in MEDLINE Ovid (UoY). It is 
also widely used in systematic reviews on health-related research focusing on China (Chung 
et al., 2014; Southern et al., 2016). 
  
There are six Mainland Chinese bibliographic databases19; among them, CNKI, Wan Fang 
database and VIP are reported to be the most widely used (Fung, 2008; Li, 2011). As noted in 
                                                        
19 The six mainland Chinese bibliographic databases are Chinese Biomedical Literature Database (CBM), Chinese Medical Current Content 
(CMCC), Chinese National Knowledge Infrastructure (CNKI), VIP information (VIP), Wan Fang database, and iLib (Fung, 2008). 
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section 1.1, Wan Fan database was used to search for Chinese language research in the 
broader review. However, when compared with Wan Fang database, CNKI is more 
comprehensive and better suited to advanced searches (cnki.net; Li, 2011; WANFANG DATA; 
VIP). For instance, with respect to the journal coverage, CNIK provides more extensive 
coverage of journals in the Social Sciences and Humanities than Wan Fang database. CNKI 
also has a faster updating speed than Wan Fang Database and VIP (Li, 2011). Therefore, CNKI 
was chosen as the database for Chinese language research in this more systematic search and 
review. Specifically, CNKI (having both a Chinese portal and English portal) is one of the main 
Mainland Chinese databases that provides not only journal articles, but also degree theses, 
conference proceedings and newspapers, among others. There were 1,336 and 3,135 Chinese 
journals in the category of ‘Medical, pharmaceutical and hygiene/health sciences’ and ‘Social 
sciences I & II’, respectively, according to the Chinese portal of CNKI (accessed in August 2017). 
The Chinese language abstract and links to the authors, journal issue and journal citation are 
contained in the Chinese portal of CNKI (cnki.net).  
 
There were no restrictions on study design. Therefore, all observational studies, such as 
cohort studies and cross-sectional studies, and experimental studies (e.g. randomised 
controlled trials) were included. Quantitative, qualitative and mixed/multi-methods research 
designs were all included. As the factors influencing on healthcare providers and the public’s, 
including parents’, behaviour with respect to the use of antibiotics in China were the outcome 
of interest, papers which reported any relevant influences were included in this review. 
Papers whose main outcome did not, or unclearly, related to factors on healthcare providers 
or the public’s antibiotic related behaviour in China were excluded.  
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2.2.2.2 Data collection 
In line with Figures 3 to 5, two systematic searches were undertaken of each database, one 
searching for records of ‘factors influencing healthcare providers’ behaviour with respect to 
the use of antibiotics in China’, and the other searching for records of ‘factors influencing the 
public’s and parents’ behaviour with respect to the use of antibiotics in China’. The keywords 
used in the searches of MEDLINE Ovid and the Chinese portal of CNKI were as similar as 
possible. However, compared to MEDLINE Ovid, the Chinese portal of CNKI allowed fewer 
advanced search strings and searching. For instance, in the advanced search of the Chinese 
portal of CNKI, although Boolean operators could be used they are restricted to a combination 
of two words or synonyms, and there are many limitations in combining sets of search terms 
together to produce more complex search strings. The search strings on the Chinese portal of 
CNKI and MEDLINE Ovid were slightly adjusted in order to find a manageable number of 
studies and ensure the studies were as relevant as possible to the topic. The search strategies 
are provided in Appendix D and the results of the searches are shown below in Table 4.  
 
Table 4 Information on records located and included via searches undertaken on two databases 
 Search One Search Two 
Databases MEDLINE Ovid Chinese portal of CNKI* MEDLINE 
Ovid 
Chinese portal of 
CNKI 
Searching 
content 
Factors 
influencing 
the use of AB 
by healthcare 
Factors 
influencing the 
use of AB by 
doctors and in 
Factors 
influencing 
the use of AB 
by hospital & 
Factors 
influencing 
the use of AB 
by the public 
Factors 
influencing the 
use of AB by the 
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providers in 
China 
retail 
pharmacies in 
China 
CHI-based 
pharmacists in 
China 
and parents 
in China 
public and 
parents in China 
No. of 
records 
located 
 
217 
 
47 
 
749 
 
222 
 
44 
No. of 
records 
included 
 
65 
 
8 
 
55 
 
21 
* The search one of CNKI for ‘factors influencing the use of antibiotics by healthcare providers in China’ was 
separated into two searches to ensure the search terms and search strings on CNKI and MEDLINE Ovid were as 
similar as possible. It was because: (i) there was no accurately equivalent term of ‘healthcare provider’ in Chinese; 
(ii) there were too many records related to clinical pharmacists while only a few on other kinds of providers, such 
as doctors, based on the result of search one on CNKI. 
 
Among records located via MEDLINE Ovid, via search one 65 out of 217 records related to 
healthcare providers and via search two 55 out of 222 records related to parents and the 
public were selected for review. For search one of CNIK for ‘factors influencing the use of 
antibiotics by healthcare providers in China’, there were in total 796 (749+47) records 
identified. Of this set, most (749) were about hospital and CHIs-based pharmacists and only 
47 records were about doctors and retail pharmacies. Of the 749 records, the large majority 
were focused on influences on clinical pharmacists’ use of antibiotics in hospitals. Therefore, 
only the most widely cited papers were reviewed. Finally, among records located through the 
Chinese CNKI portal, 29 records were selected for review, including 8 out of 796 records 
identified via search one related to healthcare providers and 21 out of 44 records identified 
via search two related to parents and the public. In conclusion, there were in total 149 records 
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included in this review, including 120 (65+55) English language records and 29 (8+21) Chinese 
language records. 
 
2.2.2.3 Comparison between English and Chinese language records and quality appraisal 
Comparing records located via MEDLINE Ovid and the Chinese portal of CNKI, there were a 
few papers published in Chinese among the records located via MEDLINE Ovid, and most of 
these papers were also located via the same search on the Chinese portal of CNKI. Most 
studies found via the Chinese portal of CNKI were published in Chinese and only two were 
published in English; however, these two English language papers were not located via the 
same search on MEDLINE Ovid. When compared with records found in MEDLINE Ovid, most 
records identified from the Chinese portal of CNKI were based on a few or a single institution 
in a particular city/county, such as an individual hospital in one city. In contrast, records 
identified from MEDLINE Ovid tended to focus on a wide range of regions across China. In 
addition, as noted above, there was a particularly high proportion of records found via the 
Chinese portal of CNKI focusing on influences on antibiotic use in hospitals, while the 
proportion of records concerned with different kinds of healthcare providers was relatively 
balanced among records in MEDLINE Ovid. 
 
Chinese language papers can be divided into two types: those with and those without an 
English title, abstract and keywords. The first (with an English title, abstract and keywords) 
were usually published in what are referred to as ‘core journals’. These are journals indexed 
in at least one of China’s three core journal databases (Comprehensive List of Titles of Chinese 
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Core Journals; Chinese Science Citation Database; Chinese Science and Technology Paper 
Citation Database), and indexing in these databases is used to identify top journals in a 
particular field. The second type (without an English title, abstract or keywords) were usually 
not published in a core journal. Among the Chinese language papers located via two searches 
in this review, most papers with an English title, abstract and keywords were published in the 
national level journals and/or China’s core journals, and tended to provide more information 
(such as more detailed methodology and results) compared with papers without an English 
title, abstract and keywords.  
 
Quality appraisal was undertaken of 29 Chinese language papers (with and without an English 
title, abstract and keywords) that were included in this review (Appendix E). The large 
majority had a low quality score, with those with an English title, abstract and keywords 
having a higher score; for example, a discussion of ethics and information on ethical approval 
were absent in almost of all Chinese language papers (only one paper with an English title, 
abstract and keywords briefly mentioned ethics). However, none of these 29 Chinese 
language papers were excluded, as they provide local-level evidence from a particular 
province or city/county that is not available from MEDLINE Ovid. These local-level studies can 
cover populations of considerable size and, at this sub-national level, can be more accurate 
than national-level data (Fung, 2008). Moreover, there are other examples of reviews that 
cover papers published on the Chinese journals even though they have the low quality (Fung 
& Cairncross, 2006; Chung et al., 2014). In consequence, records found from both MEDLINE 
Ovid (120 papers) and CNKI (29 papers) were used in the literature review, but most evidence 
  
 97 
were drawn on papers located through MEDLINE Ovid for reasons of their higher quality and 
the more detailed information they provided. 
 
The results of the literature review are discussed in section 2.3 and section 2.4, focusing on 
factors influencing healthcare providers’ behaviour (2.3.2) and the public’s and parents’ (2.4.2 
and 2.4.3) behaviour with respect to the use of antibiotics in China. 
 
2.3 Influences on healthcare providers’ use of antibiotics  
2.3.1 Factors related to antibiotic prescribing by healthcare providers in high-income 
countries 
Studies in HICs point to multiple influences on healthcare providers (hereafter ‘providers’)’ 
behaviour with respect to the use of antibiotics, with these influences operating across a 
range of levels in the SEF, including individual factors (e.g. the lack of professional antibiotic 
knowledge), interpersonal factors (e.g. patients’ expectations and demands), organisational 
factors (e.g. financial incentives offered by different organizations) and policy-level factors 
(e.g. the basic medical insurance schemes) (Petursson, 2005; Tonkin-Crine et al., 2011). 
Qualitative studies conducted in either single or multiple HICs indicate that lack of knowledge 
is an influential factor in inappropriate antibiotic use, along with particular characteristics, 
such as physicians’ professional ethos (Brookes-Howell et al., 2012; Ebert, 2007; Petursson, 
2005). Pressure from patients has been identified as a key factor contributing to providers’ 
antibiotic prescribing decisions. A systematic review examining qualitative research on GPs’ 
attitudes and experience of antibiotic prescribing found that, in HICs, GPs’ perceptions of 
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patient-centred care were related to their antibiotic prescribing decisions, with decision 
making influenced by their perceptions of patients/parents’ concerns about their disease 
(Tonkin-Crine et al., 2011). In addition, workplace pressures, such as a high workload and 
limited time, pressure from complying with guidelines and other organizational factors (e.g. 
open access to physicians) were all identified as factors influencing providers’ antibiotic 
prescribing decisions in HICs (Tonkin-Crine et al., 2011; Petursson, 2005). 
 
For factors influencing providers’ use of antibiotics for children, further insight is provided by 
a more recent systematic review of qualitative studies in HICs of prescribing decisions in 
primary care for acute childhood infections. It indicated that the child’s symptoms, perceived 
pressure from parents, along with broader influences related to financial incentives, 
workplace pressures, as well as parents’ workplace and daycare providers were factors 
underlying clinicians’ decisions to prescribe antibiotics (Lucas et al., 2015). A further cross-
sectional qualitative study in the UK also noted that parental influences and the limited time 
allowed for each consultation affected doctors’ antibiotic prescribing behaviour (Horwood et 
al., 2016). 
 
2.3.2 Factors related to the antibiotic prescribing behaviour of providers in China 
In contrast to the extensive evidence for HICs, there are very few studies focusing on factors 
influencing providers’ antibiotic prescribing decisions on patients, including ill children, in 
China, despite the fact that providers are one of the most important constituencies related 
to antibiotic use (Chan et al., 2012; Gould, 2008). As noted in section 1.3.3, studies focusing 
on hospitals, primary care institutions and pharmacies in China have all suggested that the 
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wide and inappropriate use of antibiotics is very common among providers, particularly for 
antibiotics used for children. This, in turn, contributes to the consistently high antibiotic 
overprescribing rate and thus to the very high level of total antibiotic consumption in China 
(Heddini et al., 2009; Li et al., 2012; Reynolds & McKee, 2008; Sun et al., 2015; WHO, 2006). 
Below, factors related to antibiotics prescribed by providers in China are described, based on 
relevant papers published in English and Chinese found through the systematic search 
undertaken for this thesis. 
 
2.3.2.1 Individual factors related to the use of antibiotics  
Similar to studies in HICs, a systematic review on observational studies of irrational use of 
medicines in China and Vietnam points to the lack of knowledge among providers as 
contributing to the inappropriate use of antibiotics in China (Mao et al., 2015). The findings 
from studies undertaken in different individual provinces in Mainland China all demonstrate 
that doctors’ medical knowledge level was related to their use of antibiotics; doctors who had 
a higher level were more likely to prescribe antibiotics appropriately (Jiang et al., 2012; 
Rahmanjan et al., 2013; Wang et al., 2013). However, most studies, either focusing on 
hospitals or primary care institutions, or one particular specialty in the hospital, indicated that 
the antibiotic-related knowledge among doctors was inadequate (Ding et al., 2014; Du et al., 
2009; Su et al., 2012; Wang et al., 2013; Wu, 2009; Zhang, 2015). In a cross-sectional self-
administered questionnaire survey of physicians from a range of healthcare institutions 
(including tertiary hospitals, secondary hospitals and CHIs) in Taiyuan city of Shanxi Province 
(the location for this thesis’ study), overall antibiotic-related knowledge among doctors was 
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much lower than expected. Knowledge was related to a number of individual factors, and was 
higher among doctors who worked at tertiary hospitals, who worked in the internal medicine 
department, who had the professional title of chief physician and who attended antibiotic-
related training (Bai et al., 2016). Another questionnaire-based study similarly reported that, 
among 70 paediatricians from four hospitals in Tai’an city of Shandong province, antibiotic-
related knowledge was poor, with evidence that the proportion of participants who passed 
(threshold for passing is 60/100 points) the antibiotic-related knowledge test was as low as 
50% (Xie & Zhang, 2014).  
 
Other individual factors have also been identified as influencing doctors’ antibiotic use (Lam 
et al., 2003; Lin et al., 2010; Wang et al., 2013). For instance, a retrospective cross-sectional 
study undertaken in 10 county hospitals in Anhui Province found that doctors who were older 
or more senior tended to prescribe more antibiotics; the explanation given is that the Chinese 
occupational grading system allowed doctors with higher professional titles to prescribe more 
types and higher levels of antibiotics (discussed in section 1.4.2, pp. 74) (Wang et al., 2013). 
In addition to age, the final academic degree and specialty were identified as factors 
contributing to the differences in doctors’ antibiotic usage in this study (Wang et al., 2013). 
The influence of age and specialty was also reported by a secondary data analysis of the 
Taiwan National Health Insurance Research Database between 2005 and 2006, with 
differences in doctors’ prescribing practices with respect to broad-spectrum antibiotics on 
ambulatory care visits for female urinary tract infections related to their age and specialty 
(Lin et al., 2010). In particular, doctors whose specialty was obstetrics and gynaecology were 
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found to be more likely to prescribe antibiotics than other specialties in both the studies 
focusing on Taiwan and Anhui Province of China (Lin et al., 2010; Wang et al., 2013). 
 
A study focusing on 188 doctors in rural areas of Shandong Province pointed to a gap between 
physicians’ reported antibiotic-related knowledge and behaviour and their actual practice in 
prescribing antibiotics. It compared what the doctors said they would do with respect to cold 
symptoms with their actual prescribing practice, as reflected in the prescriptions issued via 
the organisations in which the doctors worked. The study found that, although 87% of the 
doctors in the study said that they would refuse to prescribe antibiotics to patients with a 
common cold, even when patients insisted on them, more than half of prescriptions for 
common cold in their working institutions included antibiotics (Sun et al., 2015).  
 
2.3.2.2 Interpersonal factors related to the use of antibiotics 
A postal questionnaire survey of 801 family doctors identified that maintaining patients’ and 
their carers’ satisfaction with the medical care they received, and thus avoiding medico-legal 
problems, were important factors that contributed to family doctors over-prescribing 
antibiotics for upper respiratory tract infections (Lam et al., 2003). Another postal study in 
Hong Kong explored the use of antibiotics by 46 primary care doctors; it also found that 
patients or their carers who demanded antibiotics or who attended follow-up consultations 
were significantly more likely to be prescribed antibiotics (Lam et al., 2009). In addition, it was 
reported that children with parents who were healthcare professionals, such as physicians, 
pharmacists or nurses, were less likely to receive antibiotics than other children, suggesting 
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parents’ medical knowledge has an influence on physicians’ antibiotic prescribing behaviour 
in Taiwan (Hunag et al., 2005). 
 
However, the systematic search of English and Chinese databases located very few studies 
conducted in Mainland China that focus on patient or parental influence on providers’ 
behaviour. Only four studies conducted in Mainland China were located. Reynolds & McKee’s 
(2009) qualitative study focused on Guizhou Province found that doctors could prescribe 
unnecessary antibiotics for patients with the common cold in response to patient pressure. 
Additionally, an experimental audit study carried out in two cities and one rural county in 
China reported that displaying knowledge related to the appropriate use of antibiotics by 
patients significantly reduced antibiotic prescription rates (Currie et al., 2011). This finding 
was confirmed by a similar audit study of hospitals in a large unnamed Chinese city, which 
reported that doctors’ antibiotic prescribing behaviour was related both to patient demand 
for antibiotics, even for conditions where antibiotics were unlikely to be effective, and to 
doctors’ perceptions that patients want antibiotics (Currie et al., 2014). With respect to 
factors influencing providers’ use of antibiotics for children, only one qualitative study, 
conducted with 35 village doctors, 12 primary caregivers and 17 healthcare system-related 
directors, was identified. In that study, the pressure for antibiotic treatment from primary 
caregivers and the financial pressure to retain patients (rather than lose them to another 
source for antibiotic treatment) were found to be the main factors contributing to doctors’ 
antibiotic prescribing decisions (Zhang et al., 2016).  
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Alongside patients and parents, studies also suggested that pharmacists were an important 
influence on physicians’ behaviour with respect to the use of antibiotics in China. A 
randomised controlled study undertaken in one unnamed tertiary hospital in China found 
that pharmacist interventions with physicians at ward level significantly reduced the 
inappropriate use of antibiotics for inpatients with respiratory tract infections (Shen et al., 
2011). A larger systematic review focused on clinical pharmacy services’ influences on the 
quality use of medicines in hospitals in China showed that pharmacist interventions had 
positive impacts on the appropriate prescribing of antibiotics by physicians (Penm et al., 
2014). It also noted that antimicrobial stewardship has become an important part of clinical 
pharmacy services, with 44% of the papers included in this review focusing on antimicrobials 
(Penm et al., 2014). More recent studies also demonstrate that pharmacists play a key role in 
the appropriate use of antibiotics in a range of areas, such as antibiotic use in urology or 
cardiothoracic surgery (Jiang et al., 2014; Zhou et al., 2016; Zhou et al., 2015). 
 
2.3.2.3 Community (workplace) and organisational factors related to the use of antibiotics 
In studies in HICs as well as Hong Kong, the pressures of workload and time are commonly 
identified as factors influencing doctors’ antibiotic prescribing behaviour (Lam et al., 2003; 
Kumar et al., 2003; Horwood et al., 2016; Tonkin-Crine et al., 2011). In the studies focusing 
on Mainland China found through this review, none identified these workplace factors as a 
major influence. However, workplace factors related to the implementation of antibiotic 
stewardship were noted as important. Continuing education programmes, practical 
guidelines and diagnostic facilities were reported as positively related to doctors’ appropriate 
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use of antibiotics for patients and children (Hou et al., 2014; Li et al., 2013; Liu et al., 2008; 
Sun et al., 2015; Yang et al., 2014). For instance, a before and after intervention study on the 
Beijing Children’s Hospital reported that, after introducing an antibiotic use guideline and 
antimicrobial spectrum chart to paediatricians, there was a reduction in both the rate of 
antibiotic cost per patient day and the most frequently used antibiotics (third-generation 
cephalosporin) in the paediatric intensive care unit (Ding et al., 2008). In addition, Zhang et 
al.’s (2016) qualitative cross-sectional study focusing on antibiotic prescribing by doctors for 
children in rural China pointed to avoiding complications and uncertainties as influential 
factors of village doctors’ antibiotic prescribing behaviour, and attributed these uncertainties 
to the lack of diagnostic tests at village clinic level. 
 
Review of antibiotic use has identified financial factors as contributing to the inappropriate 
prescribing of antibiotics by providers in China (Mao et al., 2015). A cross-sectional 
questionnaire survey carried out in the rural areas of three provinces with low, middle and 
high levels of economic development, respectively, in China reported that doctors’ antibiotic 
prescribing decisions were influenced by the health financing system (whether patients paid 
through insurance or out-of-pocket payments), health financing methods (whether 
healthcare facilities were paid by the general budget or a fee-for-service (FFS) method), and 
payment methods for providers (salary or bonus) (Dong et al., 1999). 
  
As noted in Appendix B, hospitals in China are mainly paid by basic medical insurance schemes 
and individuals through the FFS structure, while government subsidies for hospitals are very 
limited. For instance, the government subsidy, insurance, and individual payments accounting 
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for 21%, 30%, and 49%, respectively, among total funding for public hospitals in China in 2010 
(Mossialos et al., 2016). Therefore, studies have uncovered evidence to suggest that some 
hospitals encourage physicians to sell more and costlier drugs to patients in order to balance 
hospitals’ losses from reduced government subsidies and thus increase financial revenues. In 
turn, physicians working in hospitals are driven to prescribe more antibiotics by systems of 
staff bonus tied to the revenues that they bring in (Currie et al., 2014). Audit studies carried 
out in China by Currie et al. (2013, 2014) looking at the influence of financial incentives and 
patient demand showed that the antibiotic prescription rate in audited hospitals was 10% 
when patients did not ask for antibiotics and 14% when they did; when combined with a 
financial incentive, the rate rose to 55% without patient demand and 85% with patient 
demand. 
 
The influence of financial incentives on providers’ inappropriate antibiotic prescribing 
behaviour has also been reported by studies focusing on primary care institutions (Jiang et al., 
2012; Li et al., 2012). For instance, using an interrupted time series design with comparing 
medical records in community health centres in the Baoan district of Shenzhen city one year 
before and one year after government structure reform, Liang et al.’s (2014) study found that 
the decrease in prescribing antibiotics was positively related to separating community health 
centre staff’s income from the volume and cost of medical services and prescriptions. It was 
supported by one matched-pair cluster-randomized study undertaken in rural areas of China, 
which indicated that implementing capitation with the pay-for-performance method instead 
of using the FFS led to a 15% reduction in antibiotic prescriptions among primary care 
institutions (Yip et al., 2014). Furthermore, one study focusing on community health centres 
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in urban China found that the percentage of prescriptions containing antibiotics prescribed 
by private community health centres (37.17%) was higher than that among public community 
health centres (30.14%), which also suggested the influence of financial incentives on 
overprescribing of antibiotics, as private institutions usually lack government funding and 
therefore staff incomes rely more on the sales of drugs (Yin et al., 2015). Similar findings 
related to a significant low antibiotic prescription rate in public sectors were also reported by 
observational studies of primary care institutions in Hong Kong (Lam et al., 2003; Wong et al., 
2016).  
 
Additionally, it has been reported that NRCMS, one of the basic medical insurance schemes 
in China’s healthcare system, could contribute to the overprescribing of antibiotics among 
doctors in rural areas (Dong et al., 1999; Jiang et al., 2011; Sun et al., 2009). As noted in 
Appendix B, the NRCMS was introduced by the Chinese government in 2003 with the goal of 
achieving comprehensive coverage of rural residents by 2020 (Hu et al., 2008). A study, 
comparing the medical records related to the use of antibiotics among one county with 
NRCMS and one county without NRCMS in Shandong Province in 2005, pointed to a 
significantly higher percentage of prescriptions containing antibiotics in the county with 
NRCMS (the percentage was 74.2% in the county with NRCMS and 59.3% in the county 
without), suggesting that the inappropriate use of antibiotics was exacerbated by the NRCMS 
(Sun et al., 2009). However, the review undertaken for this thesis found no paper relating to 
the influence of two other basic medical insurance schemes, the UEBMI and Urban Resident 
Basic Medical Insurance (URBMI), on providers’ antibiotic prescribing behaviour. 
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Since China’s 2009 healthcare reforms, there have been several policies introduced to tackle 
financial issues in the healthcare system, such as the EDL and ZMU policies (discussed in 
section 1.4.3). However, there are few studies that have been undertaken since the most 
recent healthcare reforms (Gong et al., 2015; Song et al., 2014; Xiao et al., 2016; Yang et al., 
2013; Yao et al., 2015), and the impact of EDL and ZMU policies is considered in more depth 
in the next sub-section.  
 
2.3.2.4 Policy-related factors related to the use of antibiotics 
As noted in section 1.4, there have been major policy initiatives in China designed to support 
appropriate prescribing behaviour by providers, particularly with respect to antibiotics. 
Evidence relating to these policy changes is summarized below. 
 
The three-year strategy and other antibiotic use-related policies 
China’s first nationwide antibiotic containment guideline, the ‘Principles for Clinical Use of 
Antibiotics’ was implemented in 2004 (discussed in section 1.4.2) (MoH et al., 2004). An 
antibiotic-related study analysing five children’s hospitals’ central computer databases 
between 2002 and 2006 indicated that this guideline was only effective in reducing the 
inappropriate use of penicillin and first-generation cephalosporin (Zhang et al., 2008); similar 
studies also focusing on antibiotic use data in pulmonology wards and outpatients among 
these five hospitals, and it was found that antibiotics were still overused (Zhang et al., 2008; 
Zhang et al., 2009). Moreover, because the guideline was not a legal requirement, the 
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inappropriate use of antibiotics has remained very common in China after 2004 (Xiao & Li, 
2013). In 2011, a three-year national strategy, ‘National Special Campaign for the Clinical Use 
of Antibiotics’, backed by China’s stricter antibiotic use regulation (discussed in section 1.4.2) 
was introduced by the MoH (NHFPC from 2013) (MoH, 2013). As reviewed in section 1.3.3, 
studies demonstrated that this strategy was effective in controlling antibiotic use in some 
types of hospitals; however, the use of antibiotics in the children’s hospitals remained a 
problem.  
 
The EDL and ZMU policies 
Since the implementation of the EDL and ZMU policies (introduced in section 1.4.3) in 2009, 
there were few studies focusing on its effects on rational use of medicines, including 
antibiotics, and the outcomes are not clear. With respect to its impact on providers in primary 
care institutions, a nationwide study of drug use by primary care providers indicated that the 
EDL and ZMU policies were promoting the appropriate use of antibiotics (Gong et al., 2015). 
Through comparing prescriptions collected in 35 cities across China from 2007 to 2011, there 
was evidence that institutions that implemented these policies had a significantly lower 
proportion of prescriptions with antibiotics and of prescriptions with multiple antibiotics than 
those that had not implemented the policies. It also found the proportions of prescriptions 
with antibiotics and with multiple antibiotics decreased by 7% and 2%, respectively, after the 
implementation of the EDL and ZMU policies (Gong et al., 2015).   
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However, other nationwide or provincial studies have suggested that, although overall drug 
use improved and relevant costs decreased following the implementation of the EDL and ZMU 
policies, the inappropriate use of antibiotics remained common among primary care 
institutions (Song et al., 2014; Yang et al., 2013; Yao et al., 2015). For instance, it was reported 
in a retrospective survey of 39 primary care institutions selected to represent a range of 
socioeconomic development levels that the EDL and ZMU policies had had little effect on the 
appropriate use of antibiotics (Xiao et al., 2016). Additionally, a cross-sectional survey that 
assessed the effect of the 2004 version EDL on drug manufacturers, hospital pharmacies and 
retail pharmacies was conducted in two provinces in 2007, and indicated that there had been 
relatively little change in the production and supply of medicines. It pointed to the low rates 
of production of essential drugs (around 50%-60%) and the low availability of essential drugs 
in drug manufacturers and pharmacies in these two provinces. The reported factors that 
influenced the behaviour of manufacturers and retail pharmacies were highly related to 
financial considerations, such as market demand, price, and profit margins, among others 
(Chen et al., 2010). 
 
2.3.3 Conclusions on this section 
In contrast to the extensive evidence for HICs, the systematic search undertaken in two key 
databases (MEDLINE Ovid and CNKI) located very few studies focusing on factors that 
influenced providers’ antibiotic prescribing decisions on patients, despite the fact they are 
one of the most important constituencies related to antibiotic use in China. The identified 
influences on providers’ antibiotic prescribing decisions operated across a range of levels in 
the SEF, indicating influences from the individual (e.g. the lack of professional antibiotic 
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knowledge), interpersonal (e.g. patients’ expectations), and community and organisational 
levels (e.g. continuing education programmes and financial incentives) to the policy level (e.g. 
three-year strategy and EDL and ZMU policies). Furthermore, compared with other levels, 
evidence on the interpersonal level, related to patients’ or parental influences on providers’ 
behaviour, was particularly limited, with as few as three studies in Mainland China conducted 
on patients’ influences and only one study on parental influences.  
 
2.4 Influences on the public’s and parents’ use of antibiotics  
2.4.1 Factors related to the use of antibiotics among the public and parents in high-income 
countries 
As ABR has become a serious global public health threat, research on the public’s knowledge 
and attitudes towards antibiotics and ABR has also increased, with most of the studies 
focusing on HICs. Two recent systematic reviews of the global population’s knowledge and 
attitudes about antibiotics and ABR, respectively, concluded that a lack of knowledge about 
antibiotics and ABR among the general population was an important factor (Gualano et al., 
2015; McCullough et al., 2015). This included misconceptions about ABR as a form of 
resistance developed in the individual’s body rather than in microbes, and a lack of 
understanding about the kinds of microbes and disease organisms that antibiotics were 
effective against (Gualano et al., 2015; McCullough et al., 2015). Further studies undertaken 
in either multi-HICs or the UK only also reported the public’s misconception that ABR referred 
to changes in the human body (Brookes-Howell et al., 2011; Ipsos, 2016). A further study 
analysed data from a population-based survey (total population 29 million) in the United 
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States undertaken by FoodNet and found misconceptions that antibiotics were effective 
against a cold and could prevent more serious diseases after catching a cold; demographic 
factors, including socioeconomic status, educational level, sex and age, had impact on an 
individual’s knowledge and attitudes related to antibiotics and ABR (Eng et al., 2003). 
 
Along with research on the knowledge and attitudes about antibiotics and ABR, there are 
numerous studies in HICs exploring interactions between patients and doctors and patients’ 
expectations of antibiotics in relation to their use of antibiotics. Factors located at various 
levels of the SEF were identified as relevant to patients’ expectations of antibiotics in a review 
of studies in HICs. These factors included patients’ symptoms, knowledge and previous 
experience of antibiotics, the need to return to work organisations or schools, and trust in 
doctors, while doctor-patient communication also played a key role in reducing patient 
demand and expectations and improving patient satisfaction (Davey et al, 2002). It was 
further reported that receiving information or reassurance was positively associated with 
meeting patients’ expectations and with greater satisfaction during the consultation, which 
highlighted the potential for misunderstanding patients’ concerns and the importance of 
effective communication between doctors and patients in HICs (Butler et al., 1998; Welschen 
et al., 2004). 
 
With paediatric use of antibiotics recognised as central to the wider problem of antibiotic use 
and ABR, studies focusing on factors related to the use of antibiotics for children by their 
parents in HICs are very common. With respect to parents’ knowledge and attitudes about 
antibiotics, a lack of antibiotic-related knowledge was found among 1,247 parents of children 
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age 0-14 in a multicentre cross-sectional study in Italy, with being male, having a lower 
educational level and being unemployed associated with lower levels of knowledge (Bert et 
al., 2016). Similar to studies focusing on the public in HICs, interactions between doctors and 
parents in the consultation have been widely discussed (Cabral et al., 2015; Cabral et al., 2016; 
Mangione-Smith et al., 2015). A systematic review of studies focusing on antibiotic 
prescribing decisions on acute childhood infections in primary care in HICs found that, during 
the consultation, parents would want antibiotic prescriptions when they perceived antibiotics 
would be useful to their children’s illness and they felt pressures from daycare providers or 
their employees, while reluctance to accept antibiotics was mainly due to concerns about the 
side-effects of antibiotics. Moreover, this systematic review identified a gap in the 
consultation needs of parents and doctors. Parents were more concerned about the medical 
diagnosis and decision-making but doctors sought to shorten the consultation and, at the 
same time, satisfy parents (Lucas et al., 2015). A further systematic review of studies 
particularly focusing on communication in consultations for children’s acute illness in HICs 
also pointed to the different concerns between parents and doctors with the potential to 
affect antibiotic prescribing decisions in the consultation (Cabral et al., 2014). 
 
Compared with the many studies conducted in HICs, there are very few studies focusing on 
factors related to the use of antibiotics among the public and parents in China, with studies 
exploring the interactions between doctors and patients being a particularly noticeable gap. 
The next two sections will describe factors influencing antibiotic use among the public 
(section 2.4.2) and parents (section 2.4.3) in China, with evidence again derived from papers 
published in English and Chinese found from the systematic search of two key databases.  
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2.4.2 Factors related to the use of antibiotics among the public in China 
2.4.2.1 Individual factors related to antibiotic use and resistance  
In China, national data relating to knowledge and attitudes on antibiotic use and resistance 
among the public are very limited; research related to antibiotic use and resistance is usually 
undertaken at the level of the individual province or area (Gili et al., 2014). Studies 
undertaken in a range of urban areas in Mainland China all indicated that the public’s 
knowledge related to the use of antibiotics is inadequate (Lin et al., 2015; Tian et al., 2014; 
Xiong et al., 2015; Ye et al., 2014). For instance, one questionnaire survey conducted between 
March and August 2014 in Jiangbei district of Ningbo city reported that only 31.5% (560) of 
1,778 respondents were able to correctly identify what antibiotics are, even though 72% of 
them believed they knew (Lin et al., 2015). This study also indicated that 56.5% of 
respondents believed that antibiotics were helpful for viral infections, which is much higher 
than the same belief in the UK; a UK-based survey in 2015 of 1,524 adults found that only 38% 
thought that antibiotics could treat viral infections (Lin et al., 2015; Ipsos, 2016).  
 
Questionnaire surveys looking at rural areas similarly reported that antibiotic-related 
knowledge among rural residents in China is inadequate (Tan et al., 2014; Zhao et al., 2013). 
A qualitative study undertaken in four villages in the middle and east of China identified a 
range of misconceptions and attitudes related to antibiotic use among villagers, such as 
associating antibiotics with ‘xiaoyanyao’ (anti-inflammatory drugs) or a belief in a never-
ending line of antibiotics, along with very low levels of awareness of ABR among villagers from 
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poorer households and a common misunderstanding that the human body developed 
resistance to antibiotics among villagers who had heard of ABR (Jin et al., 2011). It has also 
been found that people in rural areas have less adequate knowledge and correct attitudes 
regarding the use of antibiotics, when compared with urban residents (Ma et al., 2014; Wang 
& Wang, 2013). In addition, studies focusing on particular populations in Mainland China, 
such as patients or university students, all reported that knowledge was inadequate and 
attitudes were only moderately accurate with respect to antibiotic use and ABR (Chen & 
Wang, 2014; Huang et al., 2013; Li & Tong, 2013; Lv et al., 2014; Tian et al., 2015; Wang et al., 
2013).  
 
Findings from studies in Hong Kong point to the better antibiotic-related knowledge among 
the general public.  A cross-sectional phone survey carried out in 2006 in Hong Kong showed 
that, among 1,002 general residents, most of them had adequate knowledge and appropriate 
attitudes regarding antibiotic use (You et al., 2008).  Another more recent mixed method 
study of more than 2,500 adults in Hong Kong found that the public were aware of the clear 
message ‘not to abuse antibiotics’. It noted, however, that awareness of antibiotic resistance 
still needed to be improved, pointing to a gap between knowledge of antibiotic use and 
knowledge of resistance among the public in Hong Kong (Wun et al., 2013).  
 
Based on this thesis’ literature review, educational level is the factor most commonly 
identified across studies in China as related to the public’s antibiotic-related knowledge; 
people who had a higher educational level were more likely to have better knowledge (Lin et 
al., 2015; Tan et al., 2014; Ye et al., 2014). Factors such as age, gender, history of chronic 
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diseases and material circumstances have also been identified as related to knowledge of 
antibiotics (Jin et al., 2011; Lin et al., 2015; Tian et al., 2014; Ye et al., 2014). In addition, 
studies comparing antibiotic-related knowledge between rural and urban areas, and 
comparing medical students and non-medical students, emphasized the importance of 
rural/urban location and having a medical background (Liu et al., 2013; Ma et al., 2014; Zhu 
et al., 2015). 
 
Antibiotic-related knowledge has been found to be related to antibiotic non-adherence and 
self-medication. As noted in section 1.3.3.3, non-adherence to antibiotic treatment is a 
behaviour highly related to the inappropriate use of antibiotics, which is particularly 
widespread among the public in China (Pechère et al., 2007). Despite its importance, the 
searches identified very little evidence on non-adherence relating to China. Antibiotic-related 
knowledge was identified as a factor related to antibiotic non-adherence in a questionnaire 
survey of 465 Hong Kong urban residents, where there was a significantly higher prevalence 
of antibiotic non-adherence among residents with poor antibiotic knowledge (Chan, et al., 
2012).  
 
Self-medication with antibiotics is another form of inappropriate antibiotic use that may 
contribute to ABR, and is also demonstrated to be connected to antibiotic-related knowledge 
(Goossens, 2009; Huang et al., 2013; Jose et al., 2013). A cross-sectional questionnaire survey 
focusing on Weifang city in China found that, among 354 residents, participants who did not 
know what antibiotics are were more likely to self-medicate with antibiotics than those who 
did (Xiong et al., 2015). However, in contrast, university student-based questionnaire surveys 
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in different regions of China reported that prior knowledge of antibiotics was a risk factor for 
self-medication with antibiotics (Lv et al., 2014; Pan et al., 2012; Zhu et al., 2015). This finding 
is further supported by another study comparing university students with and without health-
related backgrounds, which suggests that the proportion buying antibiotics without a 
prescription was significantly higher among medical students (645/791) than non-medical 
students (207/321) (Liu et al., 2013). 
 
Household circumstances, another individual-level factor, have also been reported to 
influence people’s antibiotic-related knowledge and behaviour related to antibiotic use; 
however, their specific effects on the use of antibiotics are still not clear. For instance, a 
questionnaire survey focusing on 558 residents in Nanjing and Suzhou city in China showed 
that average monthly income was the major predictor of participants’ antibiotic knowledge 
and behaviour; residents with higher average monthly incomes had higher medication use 
scores in the study, which meant they had better antibiotic use behaviours (Wang & Wang, 
2013). This finding was further supported by another cross-sectional study in which, among 
data collected by questionnaires from 210 inpatients, participants with monthly incomes 
higher than 3,000 CNY (456 US$)20 had better knowledge of antibiotics and more appropriate 
antibiotic use behaviour (Chen & Wang, 2014). However, in Pan et al.’s (2012) university 
student study, a higher income, as measured by a higher allowance (>500 CNY (76 US$)21), 
was a risk factor for self-medication with antibiotics; students with a higher allowance had a 
significantly higher rate of self-medication with antibiotics. In addition, studies found that 
                                                        
20 Exchange rate: 1 US$= 6.5798 CNY (on 30th May 2016) 
21 Exchange rate: 1 US$= 6.5798 CNY (on 30th May 2016) 
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other demographic factors, such as older age, female gender, and area of residence (rural, 
rather than urban) were risk factors for self-medication with antibiotics among Chinese 
university students (Liu et al., 2013; Lv et al., 2014; Pan et al., 2012; Zhu et al., 2015). In a 
global survey that included China, age was found to be a factor that was negatively correlated 
with antibiotic non-adherence in China, as well as in other countries such as Japan and the 
Netherlands (Pechère et al., 2007). 
 
2.4.2.2 Interpersonal (patient-provider) factors related to antibiotic use and resistance  
Although interactions between providers and patients, with respect to the use of antibiotics, 
have been widely discussed in studies in HICs, as noted in section 2.3.2.2, research in China 
focusing on these interpersonal influences is still limited. Providers, including doctors and 
pharmacists, have been consistently identified as important sources for different groups in 
China to obtain antibiotic-related information (Lv et al., 2014; Reynolds & McKee, 2011; Zhao 
et al., 2013). However, the process through which the public gets information from providers, 
such as the details of interactions and communication between them, are not discussed in 
these studies. Only one cross-sectional self-administered questionnaire survey, conducted in 
Hong Kong more than two decades ago, mentioned patient expectations and their influences 
on consultations with doctors. The study found that, despite common misconceptions that 
medications and antibiotics were needed for upper respiratory tract infections, the 
proportion of patients and guardians who came specifically for antibiotics were not high and 
they would accept doctors’ decisions of no medication (Chan, 1996). However, patient 
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expectations, and the interaction between providers and patients may have changed since 
the 1990s.  
 
2.4.2.3 Cultural and community-level factors related to the use of antibiotics 
This thesis’ literature review found little evidence on this ‘layer’ and the broader layers of the 
SEF. It only located studies on the influence of TCM and media on the use of antibiotics among 
the public in China.  
 
Understandings of illnesses and treatments through both the Western medicine and TCM 
perspectives by the Chinese population has been widely reported by many studies, including 
research on Chinese people in both Mainland China and in other Chinese societies such as 
Taiwan, and overseas Chinese populations (Chung et al., 2014). However, only one study 
focusing on the influence of a TCM perspective on the use of antibiotics among Chinese 
populations was identified for the literature review. In this study, a questionnaire survey 
conducted with 2,471 participants in Hong Kong, those who usually attended a TCM 
practitioner were less likely to use antibiotics and were more concerned about the side effects 
of antibiotics and ABR than people who usually attended Western medicine providers. They 
also had a clearer awareness of the types of disease that antibiotics were effective against. 
However, they were less likely to complete a full course of antibiotic treatment than Western 
medicine-attenders (Wun et al., 2014). Additionally, Wun et al.’s (2014) study found that 
female participants and those with lower household incomes were more likely to use TCM, 
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which is similar to findings from other studies on the attitudes and use of antibiotics among 
Chinese in Hong Kong (Chung et al., 2007; Chung et al., 2009). 
 
In a large qualitative study undertaken in the Guizhou Province of China, factors influencing 
the overuse of antibiotics in China was one part of the study focus, and the role of media and 
medical advertising in influencing the use of antibiotics was highlighted by participants 
(doctors and university students) (Reynold & McKee, 2009, 2011). In this study, one doctor 
attributed self-medication with antibiotics to the advertising of antibiotics in media, and 
another doctor believed that people could be adversely influenced by medical advisements 
because relevant regulations were not enforced. University students who participated in this 
study acknowledged that people would follow advertisements to purchase drugs including 
antibiotics to treat minor diseases (Reynolds & McKee, 2009, 2011). Furthermore, another 
questionnaire-based survey of university students identified the media as a major source of 
antibiotic-related knowledge, with over 60% of participants reporting that they received 
information related to antibiotics from the media, such as through TV advertisements and 
the internet (Lv et al., 2014) 
 
2.4.3 Factors related to the use of antibiotics among parents in China 
In China, little is known about factors influencing the parental use of antibiotics for their 
children. In this thesis’ literature review, only five English language studies and ten Chinese 
language studies were identified. All the studies were cross-sectional and quantitative 
questionnaire surveys. Among the English language papers, three focused on Mainland China, 
including two papers reporting on studies conducted in rural areas and one reporting the 
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results of a study conducted in urban areas; the remaining two English language papers were 
related to studies in Hong Kong. The Chinese language studies included both rural and urban 
areas in Mainland China. However, the majority only assessed the antibiotic-related 
knowledge of parents, and had limitations (noted in section 2.2.2.3, pp.96) which are 
commonly found in Chinese language papers, such as providing less detailed information on 
methods and results or being small-scale research; these limitations were particularly evident 
for studies without an English title and abstract (Fan, 2010; Zheng, 2012). Therefore, evidence 
about factors influencing the use of antibiotics for children by their parents in China remains 
very limited, particularly with respect to the urban areas of Mainland China.   
 
Beyond this small set of studies, there is broader evidence of extremely high antibiotic use 
frequency among children in China over a long period (noted at section 1.3.3). In studies 
focused on HICs, parental behaviour has been identified as a key factor, with studies noting 
that a lack of knowledge and awareness of antibiotics and treatment may contribute to 
inappropriate parental behaviour (Huang et al., 2005; Horwood et al., 2016; Lucas et al., 2015). 
In China, all the questionnaire surveys located through the search of databases – both those 
focusing on urban areas and those conducted in rural areas – pointed to low levels of 
antibiotic-related knowledge among parents, and factors including the age, educational level, 
and material circumstances were commonly identified as contributors to their knowledge 
(Ding et al., 2015; Ding et al., 2015A & 2016; Fan, 2010; Wang, 2013; Yu et al., 2014; Zheng, 
2012). Furthermore, it was found by Zheng’s (2012) study that mothers had better knowledge 
of antibiotics than fathers; the author explained that this was likely to reflect the fact that 
  
 121 
mothers are more centrally involved in the development of children and, therefore, are likely 
to care more about acquiring information related to their children’s health.  
 
As noted in section 2.4.2.1, antibiotic-related knowledge is highly associated with the public’s 
antibiotic use behaviour in China, including antibiotic non-adherence and self-medication 
with antibiotics, but the effects vary among different groups. Among studies focusing on 
Chinese parents, it was found that some kinds of antibiotic-related knowledge (Ding et al., 
2015A; Wun et al., 2012; Yu et al., 2014) and higher educational levels (Bi et al., 2000; Wang 
et al., 2017) were positively related to appropriate antibiotic use behaviour. For instance, a 
cross-sectional study conducted with 854 rural parents indicated that parents who did not 
know antibiotics should be prescribed by doctors were more likely to purchase OTC 
antibiotics (Yu et al., 2014).  It was also noted in an audit study carried out in 18 hospitals of 
two unnamed Chinese cities that parents’ limited knowledge of antibiotics was a contributor 
to the inappropriate use of antibiotics for children (Currie et al., 2011). However, Yu et al.’s 
(2014) study also noted that there was no association between parents’ total score of 
antibiotic-related knowledge and their behaviour of self-medicating children with antibiotics.  
 
The review identified one study with evidence about parental medication of children with 
antibiotics, a questionnaire survey conducted with around 1,500 parents in Hefei city (Bi et 
al., 2000). Alongside antibiotic-related knowledge and educational level, it was found that 
maternal characteristics – for example, socio-economic status – were particularly associated 
with parental medication, while there was no relationship between parental self-medication 
and the father’s characteristics (Bi et al., 2000). The key role of mothers in their children’s 
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development has been highlighted by the WHO; it is also strongly associated with China’s 
social and cultural background, where the mother is commonly responsible for looking after 
children (Bi et al., 2000; WHO, 2003A). The child’s age and the severity of their disease were 
also identified as being relevant to parental self-medication of children; children who were 
older or with minor illnesses were more likely to be parentally medicated with antibiotics (Bi 
et al., 2000; Wang et al., 2017). In addition, studies have demonstrated that the availability 
of obtaining antibiotics without a prescription, the media and the insurance status of parents 
all had impact on parental medication with antibiotics of children, which suggested influences 
from a broader community and organizational level (Bi et al., 2000; Yu et al., 2014).  
 
With respect to another form of inappropriate antibiotic-using behaviour – non-adherence to 
the child’s prescribed antibiotic treatment, factors located in individual and interpersonal 
level, including parents’ age and educational level, concern about side-effects of antibiotics, 
and better communication between parents and doctors, were found to be influential factors 
(Ding et al., 2015; Wun et al., 2012; Yu et al., 2014). Furthermore, different to Chan et al.’s 
(2012) questionnaire survey on Hong Kong residents’ antibiotic non-adherence and 
knowledge, Ding et al.’s (2015) study pointed to factors (parents’ younger age and higher 
educational level) relating to better antibiotic-related knowledge as contributors to non-
adherence to the child’s antibiotic treatment by parents. The authors also noted that, for 
parents who are older or have lower educational levels, although they have higher adherence 
to the child’s antibiotic treatment, they simply follow doctors’ decisions rather than 
purposefully adhering to them (Ding et al., 2015). Finally, it has also been found that parents’ 
poor adherence to doctors’ advice was associated with their behaviour with respect to 
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parental antibiotic medication of their children, suggesting an association between these two 
types (non-adherence to antibiotic treatment and parental medication) of antibiotic use 
behaviour (Yu et al., 2014). 
 
In the small number of relevant studies, the doctor was the main source for parents to obtain 
antibiotic-related information in rural areas of China (Bi et al., 2015; Yu et al., 2014). Although 
only including evidence from one rural study, it reported that the interaction between doctors 
and parents was very highly related to parents’ antibiotic use behaviour (Yu et al., 2014). 
Evidence from Yu et al.’s (2014) study indicated that parents who the study team assessed as 
having positive communication with physicians during the consultation had a higher antibiotic 
adherence rate than those who reported having fewer opportunities to communicate with 
physicians. It was also reported in a retrospective analysis on National Health Insurance data 
in Taiwan that children with parents who were well educated in medical matters, such as 
physicians, pharmacists and nurses, were less likely to receive antibiotics for common colds, 
upper respiratory tract infections, and acute bronchitis than children whose parents were 
non-medical personnel (Huang et al., 2005). During the consultation, it was found in Yu et 
al.’s (2014) rural study that over half of parents had directly requested antibiotics from 
doctors on at least one occasion. In a study of rural parents in Shandong Province, having a 
child over the age of three was associated with a high level of over-expectation for antibiotics 
(Ding et al., 2015). However, there were no studies focusing on the influence of parent- 
provider interaction on parents in the urban areas of Mainland China.  
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2.4.4 Conclusions on this section 
Few studies focusing on factors related to the use of antibiotics among the public and, 
particularly parents, in China were found through the systematic search of two databases, 
however many more studies were found in HICs. Moreover, among the identified China-
based studies, most focused on the individual level of SEF and noted the public’s and the 
parents’ inadequate knowledge and personal characteristics as influences on their 
inappropriate antibiotic use behaviour. Very few studies focused on interpersonal (patient- 
provider) and community-level factors and no studies discussed influences from broader 
levels, including organisational factors and policy-related factors. Therefore, with respect to 
factors influencing patients’ and parents’ use of antibiotics in China, the systematic search 
found very limited evidence and a particular gap in relation to factors influencing antibiotic-
related behaviour at ‘layers’ above the individual level in the SEF.  
 
2.5 Conclusions 
In conclusion, the literature review relating to influences on providers’ and parents’ use of 
antibiotics for children in China progressed through two stages – identifying a framework and 
undertaking a review guided by this framework. The search and review identified a major gap 
in the literature relating to influences on providers’ and the public’s, particularly parents’, use 
of antibiotics in China in comparison to the extensive evidence presented in high-income 
country contexts.  
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When the relevant records were located within the different levels of the SEFs, it was clear 
that there was particularly limited evidence at the interpersonal level: the influence of 
providers and patients, including parents, on the behaviour of both groups with respect to 
the use of antibiotics in China. Another key finding was the dearth of qualitative studies in 
China, particularly in the setting with a profile of the typical city. Specifically, this review 
located only two qualitative studies, which both investigated factors influencing providers’ 
antibiotic prescribing decisions in rural areas of China (Reynolds & McKee, 2009; Zhang et al., 
2016); no qualitative study focused only on parents was located.  
 
Along with the identification of research gaps, the literature review showed the very low 
number of Chinese language records indexed in the major international database, particularly 
in comparison with the huge amount of Chinese language records located in the Chinese 
database. Therefore, in line with Fung’s (2008) study, this literature review points to the 
importance of searching and reviewing literature published in languages other than English 
to increase the comprehensiveness of the review and to avoid potential language biases. 
Despite the large number of Chinese language studies, many were of relatively low quality 
based on Hawker’s quality criteria. Consequently, this review also pointed to the urgency of 
improving the quality of studies published in Chinese language journals, particularly regarding 
ethics and the study context, in order to enable them to be more widely indexed in 
international databases and to provide high quality information.
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Chapter 3. Overview of research design 
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3.1 Overall research question and objectives 
The overall research question was informed by the literature review on factors influencing 
healthcare providers’ and the public’s behaviour with respect to the use of antibiotics in China 
in Chapter 2. As discussed in Chapter 1, the inappropriate use of antibiotics for children by 
healthcare providers in hospitals, primary care settings and pharmacies, and by parents, is a 
particular challenge in China. The literature review in Chapter 2, however, pointed to a major 
knowledge gap in relation to influences on providers’ and the public’s, particularly parents’, 
use of antibiotics in China. It further indicated that research was predominantly quantitative 
with very few qualitative or mixed/multi-methods studies. Therefore, this thesis aims to shed 
light on influences on providers’ and parents’ paediatric antibiotic use behaviours, in relation 
to the following overall research question, which was established to address gaps identified 
in the literature review: 
- What are the factors influencing healthcare providers’ and parents’ behaviours with 
respect to the use of antibiotics for children in China? 
The thesis has two specific objectives: 
(i) To undertake a qualitative study of providers to explore factors influencing their use 
of antibiotics for children 
(ii) To undertake a multi-method study of parents to explore factors influencing their use 
of antibiotics for their children  
Each objective has its own research questions, which are stated in the Chapters 4, 5, and 6. 
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3.2 Research approach: Study design 
The thesis combines a range of research approaches. As noted in the previous section (section 
2.2), the literature review progressed through two stages – identifying a framework and 
undertaking a review guided by the framework. The broader background reading on AMR and 
ABR-related research made clear that there were multiple influences operating at different 
levels. This background reading thus informed an initial SEF, which was then further refined 
within two SEFs to guide the review and the empirical research. Providers and parents, 
respectively, were located in the centre of the two SEFs, and were surrounded by a set of 
concentric layers influencing their behaviours from micro- to macro-level. The systematic 
searches and review guided by the SEFs were then conducted on two key electronic databases 
– MEDLINE Ovid and CNKI – to locate English and Chinese language research, respectively. 
Building on the literature review and the SEFs, the thesis draws on a set of primary studies to 
address its two objectives. Figure 6 summarises the study design and how the primary studies 
relate to these objectives. 
 
As shown in Figure 6, a qualitative approach was chosen to explore influences on providers’ 
antibiotic use for children. Such approaches can allow in-depth interpretations of participants’ 
views and experiences (Pope & Mays, 2006; Ritchie & Lewis, 2013), and are well-suited to 
exploratory studies that focus on specific settings (Hammersley & Atkinson, 2007; Holloway, 
2008). In addition, it was not possible to get access to large populations of providers to 
undertake a broader survey. The qualitative data were analysed by framework analysis. 
Further details of the methodology are provided in Chapters 4 and 5.  
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Figure 6 Research methods used to address the overall research question and two objectives in 
the study 
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A multi-method study, involving qualitative and quantitative components, of parents was 
chosen to explore factors influencing parents’ antibiotic-related behaviour. Combining the 
two components in a multi-method design can provide a richer understanding of the research 
topic (Byrne & Humble, 2007; Morse, 2003; Esteves & Pastor, 2004). Therefore, in this study, 
the quantitative component focused on parents’ knowledge, views and behaviour, in order 
to provide a broad picture of influences on parental use of antibiotics and the qualitative 
component was used to explore influences on parental antibiotic-related behaviour in greater 
depth. The qualitative and quantitative data were analysed separately using framework 
analysis and statistical methods, respectively. Details of the multi-method study are provided 
in Chapter 6. Finally, findings from providers and parents are compared and interpreted 
together in Chapter 7. 
 
3.3 Research approach: Ethics and access in China 
China does not have a national research ethics system (an in-country research governance 
and approval process) (Huang & Pan, 2009) or, as far as the researcher can ascertain, one that 
operates at an organisational level (e.g. hospital). Furthermore, there is a lack of public and 
professional understanding of ‘research ethics’ as the concept and process are understood in 
Western and high-income countries, and the consequent challenges of adapting the research 
governance approaches developed in these countries to Chinese culture and ethical 
principles are little discussed (Huang & Pan, 2009; Liu, 2006). Ethics-related concerns are still 
limited to medicine and research focusing on specific diseases, such as AIDS (Huang & Pan, 
2009). Within medicine and health care as a whole, ethics education is also very limited and, 
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while there is legislation designed to protect patients, implementation lags behind (Gao et al., 
2015). Research governance procedures therefore need to take account of, and be sensitive 
to, these cultural and organisational contexts, with culturally appropriate processes for 
approval and access to study sites and for informed consent from research participants. These 
processes, discussed below, were approved by the Research Governance Committee of the 
Department of Health Sciences at the University of York.  
 
In this study, personal connections and networks were used to gain entry to the study sites 
and participants, an approach that, as other studies have noted, is sensitive to Confucian-
based cultures; these studies also relied on personal contacts to secure support for approval 
and execution (Liu, 2006, 2007; Park & Lunt, 2015). In China, the anonymous and formal 
approaches associated with surveys based on random samples can be viewed with suspicion 
and fear, while trust is engendered by contacts made through personal relationships, 
particularly those of family and friends (Huang & Pan, 2009; Liu, 2006, 2007). The study 
validity is reduced when participants are suspicious and stressful, as people are more likely 
to refuse to participate in the study (Huang & Pan, 2009); moreover, the suspicion increases 
the social desirability bias, where participants may give what they believe to be the socially 
acceptable account in a society where there is a strong culture of conformity (Gobo, 2011; 
Liu, 2006). Therefore, as shown in Figure 7, personal networks were used in all the primary 
studies.  
 
In the study of providers, study sites, including hospitals, CHIs and retail pharmacies, were 
accessed through senior staff of these institutions identified through personal networks, and 
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most of participants were then introduced by these senior staff members. Similarly, for the 
qualitative part of the parent study, the study sites (nurseries) were accessed through the 
nurseries’ administrators who were identified through personal networks and participants 
were then recruited by those administrators. For the quantitative part of the parent study, 
access to the hospital paediatric clinics was secured via the senior clinic staff identified 
through personal networks. Participants (parents) were then directly recruited by the 
researcher who approached as many as possible within the clinic opening hours (convenience 
sample).  
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Figure 7 Recruitment of participants for the different research methods used in the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The process of securing informed consent again took account of the cultural context and 
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Liu, 2006). Huang & Pan’s (2009) study noted that Chinese people will be wary when required 
to provide a signature or even to show their handwriting; even if formalised written consent 
can be obtained, it risks increasing participant stress and burden (Huang & Pan, 2009). These 
difficulties were confirmed by senior staff and administrators, particularly those working at 
community health stations and nurseries, during the pilot visit in China in Sept/Oct 2015. They 
warned that it is not usual to ask participants to sign a consent form, especially for research 
that does not have a Chinese collaborator. Written consent can also affect data validity by 
increasing the possibility that participants give socially acceptable accounts (Huang & Pan, 
2009; Liu, 2006). Therefore, a culturally appropriate consent process was used in my 
qualitative and quantitative studies to address these concerns and to protect the validity of 
data. Participants were given, and individually taken through, the Information Sheet by the 
researcher, with any queries answered; verbal consent was then requested and, where given, 
was formally recorded by the researcher (Appendix F). Such alternative approaches to 
securing informed consent have been noted in other studies (Adams et al., 2007; Bhutta, 
2004).  
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Chapter 4. Healthcare providers’ accounts of parental influences on 
their behaviour with respect to the use of antibiotics for children 
 
A shorter version of this chapter was published in the Journal of Community Medicine and 
Public Health Care (See Appendix G). 
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4.1 Introduction 
Antimicrobial resistance (AMR) is one of the most serious global public health problems (Chan 
et al, 2012; Neill, 2016; WHO, 2015), and ABR has become a particular challenge (ESRC, 2014; 
WHO, 2015A). Between 1994 and 2000, China recorded the most rapid increase in rates of 
human ABR worldwide (Heddini et al., 2009); the prevalence of many antibiotic resistance 
strains has ranked amongst the highest worldwide (Xiao et al., 2011). A key driver of ABR in 
China is its high rates of use and inappropriate use of antibiotics (Currie et al., 2011; Heddini 
et al., 2009; Zhang et al., 2006). China accounts for around half of the world’s total antibiotic 
consumption, of which human consumption accounts for 48% (Zhang et al., 2015). At 138g 
per person per year, individual consumption in China is 10 times higher than in the United 
States (Li et al., 2014). Studies point to high rates of inappropriate prescribing by providers, 
including hospitals (Sun et al., 2015; Xie et al., 2015), primary health care institutions (Li et al., 
2012; Wang et al., 2014), and retail pharmacies (Fang, 2014).  A study of primary care records 
across six provinces at different stages of economic development found that over 60% of 
antibiotics were incorrectly prescribed (Wang et al., 2014). 
 
High rates of paediatric use and misuse are recognised to be a particular challenge in China. 
Studies of child inpatients report that a very high proportion of patient encounters result in 
an antibiotic prescription, ranging from 62% to 98% (He, 2012; Li & Wu, 2007; Wang, 2006; 
Xie & Wu, 2006; Yang & Shi, 2008; Zheng et al., 2008), much higher than the 30% rate 
recommended by the WHO (WHO, 2006). Retail pharmacies have been identified as a major 
source for OTC antibiotics for the public (Fang, 2014), with evidence from one study indicating 
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that over 70% of encounters for paediatric diarrhoea resulted in the sale of antibiotics 
without prescription (Jiang et al., 2013). Government concerns about the overuse and 
inappropriate use of antibiotics resulted in the MoH (NHFPC from 2013) in China launching a 
three-year strategy in 2011, backed by much stricter regulations on antibiotic prescribing 
(Xiao & Li, 2013, 2015; MoH, 2012A). These are designed to ensure physician adherence to 
protocols that require examination of the patient’s clinical presentation and laboratory test 
results (Li, 2014; Mossialos et al., 2016; Xiao & Li, 2015).  
 
However, non-clinical factors, and perceived parental pressure in particular, are known to 
influence providers’ behaviour with respect to antibiotic use. A systematic review of 
qualitative studies in HICs of prescribing decisions in primary care for acute childhood 
infections indicated that perceived pressure from parents was one of factors underlying 
clinicians’ decisions to prescribe antibiotics (Lucas et al., 2015). Parental influences on doctors’ 
antibiotic prescribing behaviour were also noted in a more recent study in the UK (Horwood 
et al., 2016). More limited evidence for LMICs suggests that patient and parental pressure are 
again factors influencing clinicians’ antibiotic prescribing decisions (Kumar et al., 2008; 
Sivagnanam et al., 2004).  
 
However, very few studies have been in China, where TCM is integrated into the healthcare 
system (WHO, 2001). While qualitative studies can shed a unique light on providers’ 
perceptions and experiences of influences on their behaviour with respect to antibiotic use 
(Pope et al., 2006; Ritchie & Lewis, 2013), most of these studies are quantitative (Currie et al., 
2011; Currie et al., 2014; Huang et al., 2005; Lam et al., 2003; Lam et al., 2009). There were 
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only two qualitative studies focusing on China located via the literature review undertaken 
for this thesis. A qualitative study in Guizhou Province found that patient expectations were 
an influence on providers’ use of antibiotics. Guizhou Province is a poor southern 
mountainous province, with a large ethnic minority population (Reynolds & McKee, 2009), 
very low life expectancy (Mossialos et al., 2016), and low per capita health expenditure 
(National Health Development Research Centre, 2013; Statistical Information Centre of 
NHFPC, 2016). A more recent qualitative study conducted with village doctors, parents and 
directors in the healthcare system in rural China also identified the pressure for antibiotic 
treatment from parents, along with the financial pressure to retain patients, as major factors 
contributing to doctors’ antibiotic prescribing decisions for children under 15 years with 
upper respiratory tract infections (Zhang et al., 2016).  
 
To my knowledge, this is the first qualitative study in a city and one with a profile typical of 
Mainland China. This study aims to build on the limited existing evidence by focusing on 
providers’ perceptions of parental influences on their behaviour with respect to antibiotic use 
for children, with research question established as: 
- What are the parental influences on providers’ behaviours with respect to the use of 
antibiotics for children in urban China? 
 
Study context 
As noted in section 1.3.1.1, hospitals are the cornerstone of China’s healthcare system, with 
more than 90% of China’s inpatient and outpatient services delivered by hospitals (Yip et al., 
2012), and most of China’s health resources, such as inpatient bed and health staff, also 
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concentrated in hospitals (Statistical Information Centre of NHFPC, 2016). Additionally, about 
70-80% of pharmaceutical sales in China come from hospitals (Mossialos et al., 2016). 
Hospitals operate within a 3-tier system, each tier divided into three levels (A, B and C) 
(Mossialos et al., 2016). The highest tier is the tertiary A hospitals; they are commonly large 
public hospitals serving large populations, for example a city and its surrounding rural 
communities.  
 
Compared with hospitals, the primary care system, including CHIs (including community 
health centres and smaller community health stations) in cities and township hospital centres 
in rural areas, is relatively weak, although it is growing rapidly, particularly CHIs with the total 
number increasing by 100% from 2005 to 2014 (Mossialos et al., 2016; Wang et al., 2012; 
WHO, 2015C). In addition, the retail pharmacies are another rapidly growing sector, with an 
average 20% growth in annual pharmaceutical sales from 1978 to 2009 (Fang, 2014). 
 
TCM (discussed in section 1.3.2.2), which has been practised in China for more than 2000 
years, is a holistic system used to diagnose, prevent and cure human diseases (Lao et al., 2012; 
Wang & Li, 2005; Yin & Zhang, 2006). Among its distinguishing features is an understanding 
of diseases as unbalanced yin-yang, which is the fundamental theory, in the human body 
caused by factors such as six excesses (liuyin) (including excesses of heat, wind, cold, dryness, 
dampness and summer heat) (Yin & Zhang, 2006). TCM understands the body’s structure and 
functioning as the ‘constitution’, which is associated with interactions among organs (zangfu), 
meridian (jingluo), and energy (qi) and blood (xue). The organs (zangfu) can be further divided 
into five yin organs (wuzang), including heat, liver, spleen, lungs and kidneys, and six yang 
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organs (liufu), including stomach, small intestine, large intestine, gallbladder, urinary bladder 
and triple energiser, which are connected by the meridian and work together for the body’s 
functioning (Yin & Zhang, 2006). TCM treatment methods include herbal medicines and diets, 
which are markedly different from those of Western medicine that surgical operation is 
commonly used (Lao et al., 2012; WHO, 2001).  
 
The integration of TCM into the national healthcare system has been promoted since the 
1980s, with the Chinese government supporting equality in the development of TCM and 
western medicine (Mossialos et al., 2016; WHO, 2001). In 2014 there were over 40,000 TCM-
related institutions (Statistical Information Centre of NHFPC, 2016), and TCM services 
accounted for around 18% of the total healthcare service provision (Qiu, 2015). A survey of 
all hospitals in China found that 90% had TCM departments, and TCM outpatient visits made 
up over 30% of total outpatient visits (Xu & Yang, 2009). The sale of TCM drugs also accounted 
for about 30% of total pharmaceutical expenditure in 2012, with a particularly higher 
proportion, 44% of drug sales, in the retail pharmacy sector (Mossialos et al., 2016). While 
the evidence is limited, it indicates that the majority of the Chinese population believes in 
TCM, although most prefer to rely on Western medicine treatment rather than TCM 
treatment when they are unwell (Cheung, 2011; Xu & Yang, 2009).  
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4.2 Methods 
4.2.1 Study area and subjects 
The study was carried out in Taiyuan city, the provincial capital of Shanxi Province in central 
China, between April and July 2016. The total GDP of Shanxi Province ranked 24th of all 31 
provinces, autonomous regions and municipalities in Mainland China, and its provincial per 
capita health expenditure was very close to the national average (Statistical Information 
Centre of NHFPC, 2016). Taiyuan city is a medium-size city of 3.65 million population (in 2014), 
with an average development among China’s cities (Statistical Information of Shanxi, 2015); 
it is neither among the most prosperous cites like Beijing or Shanghai, nor the poorest cities 
such as Guizhou or Gansu Province (Pan & Wei, 2015). 
 
Hospitals (the highest tier is tertiary A hospitals), as well as CHIs (including community health 
centres and the smaller community health stations) and retail pharmacies, are important 
parts in Taiyuan city’s healthcare system. Therefore, participants were recruited from across 
these healthcare sites: from two of the city’s major tertiary A hospitals (one general and one 
children’s hospital), together with six CHIs (three community health centres and three 
community health stations) and five retail pharmacies; one potential study site (a CHI) refused. 
The final sample consisted of 20 providers, including six paediatricians from the two hospitals, 
six GPs, one from each of the six CHIs, together with four licensed pharmacists and four 
pharmacy staff from five retail pharmacies (Table 5). No invited participants refused. All the 
paediatricians and GPs were qualified (physician qualification certificate and occupational 
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certificate); three of the four licensed pharmacists were qualified with a licensed pharmacist 
certificate and all of the four pharmacy staff were qualified with a retail certificate. 
 
Table 5 Profile of healthcare providers interviewed regarding parental influences on their 
behaviour with respect to the use of antibiotics for children 
 Sex Age Position 
Male  Female 30-39 40-49 50< 
Paediatricians  2 4 3 3 0 Physician-in-charge 
(middle-level)  
GPs 3 3 1 2 3 GPs 
Licensed 
pharmacists 
0 4 0 4 0 Licensed pharmacist 
Pharmacy 
staff 
0 4 3 1 0 Counter staff 
 
 
As noted in section 3.3, the recruitment method was adapted to the cultural context of the 
study to avoid low response rates and social desirability biases (Gobo, 2011; Liu, 2006). Both 
study sites and participants were therefore enrolled via personal connections and networks. 
Specifically, the study sites were accessed through the gatekeepers identified through 
personal networks in the pilot work for this study. They were senior-level staff or 
administrators in the paediatric department of hospitals, CHIs and retail pharmacies. Most of 
participants in this study were then introduced by the gatekeepers, with additional 
participants suggested by those already recruited to the study. 
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4.2.2 Data collection 
Semi-structured interviews were undertaken using three interview guides, for (1) 
paediatricians and GPs (2) licensed pharmacists and (3) pharmacy staff, respectively. The 
interview guides (see Table 6 for topics relevant to this study) were informed by evidence 
from earlier studies and revised in the light of the pilot work. Specifically, the topics focused 
on exploring factors that influenced providers’ behaviour with respect to the use of 
antibiotics for children, which drew on Sun et al. (2015) and Reynolds & McKee’s (2009) 
studies focusing on China, as well as studies exploring factors influencing providers’ use of 
antibiotics in HICs (Brookes-Howell et al., 2012A, 2012B; Butler et al., 1998; Petursson, 2005). 
All interview guides were translated into Chinese.  
 
Table 6 Interview guides: Topics relevant to influences on healthcare providers’ behaviour with 
respect to the use of antibiotics for children 
Interview guide for paediatricians/ GPs 
1. (Warm-up question) What are the antibiotics most commonly prescribed here for 
children? 
2. What proportion of children who visit here are prescribed antibiotics as part of their 
treatment? 
3. What is the general diagnosis process for ill children who are prescribed antibiotics? 
4. For what symptoms or illnesses do you think a paediatrician/GP might consider 
prescribing antibiotics for ill children? 
5. What symptoms or illnesses do you think would lead a parent to expect the prescribing 
of antibiotics for their children? 
6. What factors do you think usually influence a paediatrician’s/GP’s antibiotic prescribing 
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behaviour? Are there any circumstances in which you think a paediatrician/GP would 
prescribe antibiotics to child patients when they are not necessary? 
7. Have you ever experienced or heard about parents who make it clear that they want 
antibiotics to be prescribed to their child during a consultation? 
8. If a paediatrician/GP refused a request for antibiotics from a child patient’s parents, do 
you think that the paediatrician/GP would worry about the dissatisfaction of the 
parents? 
9. Do you think that there is sufficient communication between doctors and parents in 
consultations in Taiyuan city? 
10. Have you ever experienced or heard about parents who refuse an antibiotic 
prescription for their child during a consultation? 
Interview guide for licensed pharmacists and pharmacy staff 
1. (Warm-up question) What are the antibiotics most commonly sold here for children? 
2. For what symptoms or illnesses might you consider using antibiotics for children? 
3. Have you ever experienced or heard about parents who want to purchase antibiotics 
for their ill child without a prescription? 
4. Have you ever experienced or heard about retail pharmacies that sell antibiotics 
without a prescription? 
5. Have you ever experienced or heard about licensed pharmacists who prescribe 
antibiotics for ill children? 
6. What factors do you think usually influence a licensed pharmacist/pharmacy staff’s 
behaviour in relation to antibiotic dispensing? 
7. Have you ever tried to intervene when you become aware of possible inappropriate 
use of antibiotics for an ill child by his/her parents? 
 
Interviews were conducted face-to-face by the researcher (female) and, in line with 
participant preference, recorded by either by audio-recorder or notes and the location of 
each interview was chosen by participants. Generally, interviews with paediatricians and GPs 
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were undertaken in their clinics, while interviews with licensed pharmacies and pharmacy 
staff were undertaken in the retail pharmacies. The interviews ranged in length from 15 to 90 
minutes. The content related to participants, such as the background setting and the features 
participants displayed, were also collected by audio-recoding and field notes. 
 
4.2.3 Ethics statement 
Ethical approval for this study was granted by the Research Governance Committee in the 
Department of Health Sciences at the University of York. All ethics related documents were 
translated into Chinese. Participants were made aware that taking part in the study was 
entirely voluntary and they were free to withdraw at any time. No incentives were offered 
and informed consent was obtained from all the participants. No identifying information was 
collected and all transcripts were stored on a secure server at the University of York. 
 
4.2.4 Data management and analysis 
All audio-recorded interviews were transcribed and then translated from Chinese to English; 
translations were checked for ambiguities in meaning (e.g. Chinese concepts without an 
English equivalent) by researcher’s supervisors, Professor Hilary Graham and Professor Piran 
White (female and male, respectively) prior to data analysis.  
 
Data from the three participant groups (paediatricians; GPs; licensed pharmacists and 
pharmacy staff) were analysed separately using framework analysis. Framework analysis is a 
qualitative data analysis method increasingly used in health research and progresses through 
a set of stages (Brookes-Howell, 2012A; Furber, 2012; Gale et al., 2013; Srivastava & Thomson, 
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2009).  In the first stage, transcripts were read and re-read, and then, in the second stage, 
views and experiences that recurred within and across the transcripts were noted and 
collated into themes to build an overarching framework. The draft framework was discussed 
with my supervisors. Each transcript was then indexed using the themes in the framework. 
Common themes emerged across the transcripts, indicating data saturation (Saunders et al., 
2018). One set of themes related to parental influences on the providers’ antibiotic behaviour; 
this set of themes recurred across the provider groups (paediatricians; GPs; licensed 
pharmacists and pharmacy staff). The other major theme – related to organisational 
influences on providers’ antibiotic prescribing behaviour – is discussed in Chapter 5. This 
study was reported following the COREQ (Consolidated criteria for REporting Qualitative 
research) guidelines (Tong et al., 2007) (Appendix H).  
 
4.3 Results 
The results represent providers’ perspectives, which capture the perceptions and accounts of 
parental influences on their antibiotic-related behaviour from all providers. These influences 
clustered into broad themes (Table 7). Providers discussed how interactions with parents 
relating to child antibiotic use was influenced, firstly, by the public’s understanding of disease 
and treatment and secondly, by parental trust and, finally, particularly for providers in CHIs 
and retail pharmacies, by the need to maintain a good relationship with parents.  
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Table 7 Themes related to parental influences on healthcare providers’ behaviour with respect to 
the use of antibiotics for children 
Theme Sub-theme 
Public’s understandings of 
disease and treatment  
Public’s understandings of the causes and treatment of 
disease built around TCM 
Public’s understandings of disease 
Public’s understandings of antibiotics and antibiotic-
related  treatment 
Parental trust Distrust of the healthcare system 
Maintaining parental trust and avoid complaints 
Maintaining a good relationship 
with patients 
Familiarity 
Business concerns 
 
4.3.1 Public’s understandings of disease and treatment 
Most (18 out of 20) providers referred to the public’s understandings of disease and 
treatment when describing how they made decisions about prescribing antibiotics for ill 
children. Here, three sub-themes were evident, relating to the public’s understanding of (i) 
TCM, (ii) disease and (iii) antibiotics and antibiotic treatment. These were discussed 
respectively by 9, 5 and 18 study participants. 
 
4.3.1.1 The public’s understandings of the causes and treatment of disease built around 
TCM 
Parents were seen to understand their children’s symptoms through a TCM perspective, and 
providers commonly communicated with parents during the consultation using TCM terms 
and theories. Providers said parents believed that being ill is associated with a child’s 
constitution, a TCM term refers to relatively stable features related to the structure and 
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function of the human body; parents also attributed the causes of different diseases to 
internal excessive heat (shanghuo), being cold 22  (zhaoliang) or spleen and stomach 
disorders23 (piweishitiao). In the parents’ mind, a child’s poor appetite was caused by spleen 
and stomach disorders, being cold was related to catching a cold and internal excessive heat 
was related to both catching a cold and inflammation. 
‘They are most interested in why their child suffers from this disease, and 
whether [it is because] their child’s constitution is like that [more susceptible 
to this kind of disease] during the communication with doctors.’ 
[Paediatrician 3] 
‘For the general public, [they believe] anti-inflammatory drugs should be 
used, without a doubt, when people are suffering from the internal excessive 
heat and [therefore having] inflammation.’ [Paediatrician 5] 
‘Sometimes consumers’ diseases are caused by the internal excessive heat 
or the inflammation, so we will recommend some drugs which are helpful 
against internal excessive heat to them.’ [Pharmacy Staff 1] 
Parents were seen as understanding that a course of TCM treatment would take longer than 
one based on Western medicine treatment; Western medicine was seen as providing the 
faster route to recovery. TCM treatments were regarded by parents as more suitable for 
chronic or minor diseases and the early stage of treatment and, more generally, for health 
promotion.   
                                                        
22 This term refers to exposure to a low temperature, which is associated with two, the wind and cold, of the six excesses (Yin & Zhang, 
2006).  
23 The spleen is one of five yin organs and the stomach is one of six yang organs. They are connected by the meridian and work together 
for digestion and absorption. The spleen and stomach disorder refers to the unhealthy state associated with the spleen and stomach’s 
dysfunction, which will cause symptoms like poor appetite, nausea, digestive issues, diarrhoea, among others (Yin & Zhang, 2006).  
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‘People nowadays like to use the Western medicine [including antibiotics] 
just because it can cure the disease faster.’ [GP 2] 
‘Overall, some young patients prefer to use Western medicines as they want 
to recover quickly, while the aged patients and patients with chronic 
diseases prefer traditional Chinese medicines more.’ [GP 4] 
‘Sometimes you [paediatrician] consider that the ill child’s disease is a viral 
infection, and he/she only needs some [TCM] drugs to relieve symptoms, 
such as against internal excessive heat. However, they [parents] will feel that 
you have not taken the disease seriously. ... They will think that you don’t 
prescribe any [useful] drugs... They will also think that these drugs you 
prescribed cannot cure diseases. Therefore, they will expect antibiotics that 
they consider can cure the disease quickly.’ [Paediatrician 3] 
‘We will explain to them [people who are keen on using antibiotics] like 
‘antibiotics are not good when used too much, why would you always want 
to use them? For sore throat, you can use some Chinese patent medicines, 
such as Niuhuang Jiedupian and Niuhuang Qingxinwan, which are helpful 
against your internal excessive heat’. Then they will accept our 
recommendations and say like ‘that’s ok. I will try them and come back for 
anti-inflammatory drugs tomorrow if they are not useful’. [GP 6] 
 
The providers noted that the co-existence of TCM and Western medicine resulted in parents 
having different degrees of trust in the two systems. A majority of providers considered that 
trust in TCM was related to parents’ concerns about Western medicine, including their 
resistance to using antibiotics for childhood illnesses. For example, parents may prefer to use 
TCM treatments because they consider they have fewer side effects.   
‘...these parents refuse to use antibiotics very firmly and insist on using oral 
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traditional Chinese medicines. ... There are some parents who insist on using 
traditional Chinese medicines; they only accept traditional Chinese 
medicines.’ [Paediatrician 4] 
‘R: I also know some parents who very much prefer to use Chinese massage 
when their child is ill.  
GP1: Yes, there are [parents who refuse an antibiotic prescription]. They all 
trust traditional Chinese medicine more.’ [GP 1] 
‘Moreover, most patients prefer to use traditional Chinese medicines 
considering their few side effects.’ [GP 4] 
 
In contrast, there were parents who were seen as not trusting TCM, and therefore refusing 
to use it and only using Western medicines, such as antibiotics. 
‘There are various kinds of parents. ...Some parents [only accept antibiotics 
and] say things like ‘my child will never recover unless using anti-
inflammatory drugs’ based on their previous experience.’ [Paediatrician 2] 
‘There are these kinds of patients who really want to use antibiotics. ... [They 
think] if you [doctors] don't use antibiotics for them, what other kinds of 
drugs can be used and cure their diseases? In addition, some patients do not 
trust traditional Chinese medicine, so they will refuse to use this kind of 
drugs [Traditional Chinese medicines].’ [GP 6] 
 
4.3.1.2 The public’s understandings of disease 
Most providers referred to public misunderstandings of disease aetiology, progression and 
treatment. Parents were seen as unable to distinguish between pathogens including bacteria, 
viruses and mycoplasma, which are all potential causes of inflammation and disease. Further, 
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they were seen as not understanding that some diseases are self-limiting and, while such 
conditions resolved spontaneously without specific treatment, symptoms could be expected 
to persist during this period. At the same time, parents were not clear that treatment is a 
process in which symptom-relief is not instant but takes time. 
‘Like when you told them [parents] about bacteria, mycoplasma, and virus, 
they only know those are pathogens but cannot distinguish the differences 
between them.’ [Paediatrician 1] 
‘Nowadays, parents always require that their child’s disease should be cured 
very quickly when visiting a doctor. But actually, some diseases are self-
limiting and their recovery needs a process; so, some diseases will recover 
without treatment some days later.’ [GP 2] 
‘They [parents] usually cannot understand and accept the idea that the 
treatment of diseases is a process. The purpose of visiting a doctor for this 
kind of parent is to control the disease in their children as soon as possible.’ 
[Paediatrician 1] 
 
Fever – symptoms relating to an excess of heat that occupies a central place within TCM – 
and inflammation were often used as examples to illustrate these misunderstandings.  
Providers noted that parents believed childhood fever must be caused by inflammation and 
should not be tolerated, beliefs seen to contribute to parental demand for anti-inflammatory 
medication.   
‘Many parents who visit here believe that there are inflammations as long 
as their children have a fever.’ [Paediatrician 4] 
‘For herpangina, many parents cannot understand it [the treatment of this 
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disease]. ...However, the fever of an ill child may still persist even though I 
have used anti-viral drugs for him/her. ...But the parents will say things like 
‘why don’t you prescribe anti-inflammatory drugs to my child as he/she is 
feverish? Why you don’t use them for him/her?’’ ... They just believe that 
the fever is wrong even if they understand that the [treatment of] disease is 
a process.’ [GP 3] 
 
4.3.1.3 The public’s understandings of antibiotics and antibiotic treatment 
Parental understandings of antibiotics were seen as shaped by wider public perceptions of 
fever, inflammation and anti-inflammatory medication. Providers pointed a common 
misunderstanding that antibiotics and anti-inflammatory drugs were the same; antibiotics 
could and should, therefore, be used to treat any kind of inflammations. 
‘Parents are not very clear about the concept of antibiotics. The public is not 
clear about it even now. ...the public still believe that the antibiotic is the 
same as an anti-inflammatory drug and is used to treat inflammation. 
Actually, the thing they [the public] call an ‘anti-inflammatory drug’ is an 
antibiotic.’ [Paediatrician 5] 
‘It might be a habit of Chinese people that they want to use anti-
inflammatory drugs whenever they feel a little uncomfortable. Actually, the 
‘anti-inflammatory drugs’ they refer to are antibiotics. People treat 
antibiotics as a panacea to cure any diseases.’ [Paediatrician 1] 
‘Some parents will [demand antibiotics]! If you don’t use antibiotics for ill 
children who have, for instance, a fever, their parents will think that you 
don’t care about their child, or they may worry that their child’s disease may 
become worse if antibiotics are not used. ...This is related to our national 
context.’ [Paediatrician 6] 
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‘The first one [symptoms that lead a parent to expect antibiotics for their 
child] is fever. When the ill child’s fever has lasted for several days, their 
parents will definitely demand antibiotics in order to cure their child.’ [GP 5] 
 
Alongside the belief that antibiotics were anti-inflammatory therapies, providers pointed to 
examples of other public misunderstandings about antibiotics. These included the 
misperception that, to be effective, drugs, including antibiotics, should be   administered 
intravenously and that a full course of antibiotics was three days.  
‘For many inpatients in our department, their parents will think that you 
don't treat their child’s disease at all if an intravenous infusion is not used.’ 
[Paediatrician 6] 
‘Some of them only use antibiotics for three days (one course). For example, 
if I ask them to use antibiotics for three days, they will stop using antibiotics 
by themselves after three days and not go for a further consultation. When 
I ask them why they don’t come here for further consultation, they say that 
they think antibiotics should only be used for three days, so they stop using 
them after that. They believe three days is a full course.’ [Paediatrician 4] 
 
Parents were seen to clearly locate antibiotics within Western medicine, and regard imported 
antibiotics as superior to domestic ones. In contrast to beliefs about TCM, parents were seen 
as regarding antibiotics as powerful drugs that could cure any disease and, therefore, should 
be used for any condition, including minor discomfort. Providers pointed to a widespread 
belief that antibiotics provided the only effective cure for potentially serious childhood 
ailments; in consequence, parents were keen to use antibiotics when their child had 
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symptoms like a fever or cough. In addition, parents thought that antibiotics could cure both 
minor diseases and serious diseases more quickly than TCM methods.  
‘People nowadays like to use the Western medicine [antibiotics] just because 
it can cure the disease faster.’ [GP 2] 
‘Moreover, most parents believe that the imported drugs are much better 
than the domestic one.’ [Licensed Pharmacist 1] 
‘They [patients] think only antibiotics can cure their diseases quickly. If you 
don't use antibiotics for them, what other kinds of drugs can be used and 
cure their diseases?’ [GP 6] 
 ‘They [parents] usually have no concerns about the harm caused by the 
abuse of antibiotics. They don’t know that.’ [Licensed Pharmacist 2] 
While some parents were seen as concerned about their child taking antibiotics, this was 
again linked to their lack of knowledge. 
‘They [parents] only know that antibiotics have side-effects, some parents 
even believe that antibiotics are very dangerous. ...But they aren’t clear 
about the specific information about antibiotics at all, such as what side 
effects antibiotics may lead to.’ [Paediatrician 2] 
‘...They [parents] aren’t clear about the specific information about 
antibiotics at all, such as what side-effects antibiotics may lead to. All their 
information comes from Baidu [the most widely used search engine in 
China].’ [Paediatrician 2] 
‘After all, most people don’t have the medical-related knowledge. Yes, you 
will not understand this information [antibiotics and ABR] at all if you don’t 
have a medical background. Even for us who have some medical-related 
background, we are not clear about it.’ [Licensed Pharmacist 1]  
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‘As patients don’t have antibiotic-related knowledge, generally, they will 
listen to the doctor’s recommendation and comply with the doctor’s 
prescription. ... If doctors prescribe unnecessary antibiotics several times for 
patients, the patients will be used to it and they may want to use antibiotics 
as long as they have similar diseases.’ [Pharmacy Staff 2] 
 
4.3.2 Parental trust  
Fourteen out of 20 providers described how the importance of parental trust influenced their 
paediatric antibiotic-related behaviour. Within this broad theme, two sub-themes were 
apparent: distrust of the healthcare system and, maintaining parental trust and avoiding 
complaints. These two sub-themes were evident in interviews with, respectively, 9 and 13 
providers.  
 
4.3.2.1 Distrust of the healthcare system 
Providers spoke about a widespread distrust of China’s healthcare institutions among parents. 
All three groups spoke about parental suspicions that the healthcare services were delivered 
to generate profits for providers rather than treat patients’ diseases. GPs also pointed out 
that parents did not trust the quality of healthcare services provided by CHIs, such as GPs’ 
professional medical skills, when compared with the hospital.  
‘And now, there is a phenomenon that patients feel the aim of doctors is to 
earn money from them, such as bringing money out of the patients’ pocket 
and then putting it into the doctors’ pocket. Therefore, patients will feel very 
suspicious of doctors. Yes, it seems that patients do not trust doctors, yes, a 
lack of trust.’ [Paediatrician 5] 
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‘Moreover, we have found some consumers complained that amoxicillin was 
becoming less effective. Yes, we have met this kind of situation. So we might 
recommend other drugs that could be combined with amoxicillin to 
consumers, but they wouldn’t trust us. They think that we just want to sell 
other drugs.’ [Pharmacy Staff 2] 
‘After all, this is only a community health centre, and trust is a problem. .... 
Therefore, the problem in the CHI may be that the trust level is relatively 
low.’ [GP 2] 
‘Many patients will suspect that the antibiotics [you prescribed for them] 
are not enough as they feel their disease is serious. Therefore, sometimes 
they will require you to add other antibiotics to their treatment, or have 
other requirements.’ [GP 3] 
 
4.3.2.2 Maintaining parental trust and avoiding complaints 
Considering the widespread public distrust, providers noted their concern for building and 
keeping the trust of parents. In such circumstances, it was seen as not worth jeopardising 
parental trust for the sake of an antibiotic prescription.  
‘When parents become dissatisfied or angry with you due to your refusing 
[them to prescribe antibiotics], they will challenge you in an aggressive way 
and the things you said. They will not trust you anymore no matter how you 
explain (your refusal] to them. I think it is a worse situation than prescribing 
unnecessary antibiotics to them.’ [Paediatrician 1] 
‘If they [consumers] really want antibiotics, we will … [sell antibiotics to 
them; otherwise, they will not trust you and buy antibiotics elsewhere].... 
You see, there are so many pharmacies in this street alone.’ [Pharmacy Staff 
1] 
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The majority of providers noted that their antibiotic-related practice was influenced by 
concerns about avoiding complaints. This could include prescribing antibiotics for children 
when their parents continued to demand them and when parents were very anxious, citing 
concerns about their personal safety and about formal complaints. For instance, some 
paediatricians described how, when a parent continued to demand antibiotics for their child 
even after it had been clearly explained that antibiotics were not necessary, they would ask 
the parent to sign the case report notebook, and then acquiesce to their demand.  
‘However, for some parents with a low quality24, if you do not use antibiotics 
for their children straight forwardly and there is an indication of bacterial 
infection some days later, they will be very angry and ask you like ‘why you 
did not use antibiotics on the first day I came here?’ or ‘why you use 
antibiotics so late?’. That is the problem for us. There is a huge variation in 
population quality in our country.’ [Paediatrician 1] 
‘It [parental demand] will definitely influence me. As the relationship 
between physicians and patients is very bad, it is a lie if I say there is no 
influence. It is impossible ... It will definitely cause the dissatisfaction of 
parents [if you refuse their request] ...It will be best if they can understand 
[when physicians explain the reasons to them]. For those parents who 
cannot understand, like they strongly demand you do something and 
sometimes they even threaten your personal safety, I will ask them to sign 
their signature [and then do as they demand]. I will also write my advice to 
them on their case report notebook.’ [Paediatrician 2] 
                                                        
24 ‘Quality’ does not have a direct English-language equivalent. It can encompass a parent’s educational level (so ‘low quality’ can include 
parents with less education), but it has a broader meaning. The closest equivalent to ‘quality’ may be ‘cultural capital’, a concept that refers 
to individual assets that come with, but are broader than, education, like knowledge, self-confidence, verbal skills, style of dress etc.. 
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‘Yes, and we once had a patient who requested us to infuse penicillin. But 
we didn’t want to give him a penicillin infusion considering [the emergency 
accidents]. Then he became very angry and abused us...Yes, there are this 
kind of patients who really want to use antibiotics.’ [GP 6] 
In addition, providers in retail pharmacies mentioned that satisfying consumers’ 
requirements and, therefore, avoiding risk was regarded as a factor influencing their 
behaviour with respect to antibiotic dispensing. 
‘For instance, when consumers cannot get the antibiotics they really wanted, 
some of them will think that you intentionally refuse their requirements and 
become very angry. Moreover, they will not trust you no matter how you 
explain it to them, and they will blame you like ‘Such a poor pharmacy!’’ 
[License Pharmacist 4] 
‘Secondly, I think the customer’s wishes [requirements] are another factor 
[influencing the selling of OTC antibiotics from retail pharmacies]. As they 
are just retailers, we need to satisfy the consumer’s requirements.’ 
[Pharmacy Staff 2] 
 
4.3.3 Maintaining a good relationship with patients 
Providers in CHIs and retail pharmacies additionally described how the importance of 
maintaining a good relationship with parents influenced their antibiotic-related behaviour 
with respect to children. Two sub-themes were evident, related to (i) familiarity (discussed 
by 6 providers) and (ii) maintaining their income stream (discussed by 12 providers).  
 
  
 159 
4.3.3.1 Familiarity 
The concept of ‘familiarity’ was mentioned by providers in both CHIs and retail pharmacies. 
These providers described parents with whom they had built a good relationship as ‘familiar 
parents’, and believed providers and familiar parents trusted each other more. Familiarity, 
and the harmonious relationship with parents that it fostered, could help to counter the 
broader public distrust of CHIs.  
‘I think it [the trust] is a key factor [in GP’s working with patients in 
CHIs]. ...So I think the relationship between GPs in the community health 
station and patients is very harmonious. The GPs in the community health 
station also said to me like ‘we are just the community health station and 
we are not famous doctors. If our attitudes (to patients) are bad, no one will 
come here’. Yes, so their relationship is very harmonious.’ [GP 5]  
Accounts from providers in CHIs and retail pharmacies suggested that their decisions about 
using antibiotics for children would differ depending on their relationship with the parent. 
The majority thought they were less likely to prescribe unnecessary antibiotics for familiar 
parents’ children because these parents trusted them and they could, therefore, be 
persuaded more easily when they demanded antibiotics. However, one provider (quoted 
below) said she would be more careful about prescribing antibiotics for new patients, as she 
did not know their case histories. In addition, most providers in retail pharmacies 
acknowledged that they would sell OTC antibiotics to familiar parents.   
‘For some parents where we know each other very well, I can say that it is 
possible to persuade them [not to use unnecessary antibiotics] through my 
own efforts; however, for other parents, I will finally prescribe [unnecessary] 
antibiotics for their child just because of the psychological comfort it brings ... 
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People who are familiar with you will trust you, so they can accept your 
suggestions that antibiotics are not needed for their ill child.’ [GP 3] 
‘For our community health station, I am not familiar with other medical 
institutions, I will prescribe antibiotics to the returning patients who have 
previously had infused antibiotics at this station. For the new patients, I will 
be more prudent in using antibiotics because I am afraid of some emergency 
accidents.’ [GP 6] 
‘Well, they [consumers] should provide prescriptions if you don’t know them. 
For consumers who are familiar with you, they can get any drugs they want. 
To be honest, if I am familiar with you, I will try my best, such as asking for 
help from other people who also work at the retail pharmacies, to provide 
the drugs you want. Yes, this is the situation. But for the strangers, they must 
provide prescriptions.’ [Licensed Pharmacist 1] 
 
4.3.3.2 Business concerns 
Most providers in CHIs, particularly in community health stations, noted that maintaining 
good relationships with patients had an economic dimension. Prescribing antibiotics for ill 
children was seen to help ensure parents’ re-consultation which, in turn, was essential for the 
CHI’s survival and therefore for their own livelihood. They expressed concern that not 
prescribing antibiotics for ill children would lead parents to not come back to their CHI if their 
child’s health deteriorated or if they became ill again. Additionally, providers in the retail 
pharmacies mentioned that selling OTC antibiotics was related to maintaining the pharmacy’s 
income and making a profit. In contrast, none of the hospital-based providers (paediatricians) 
discussed economic concerns as an influence on their behaviour. 
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‘...if you don’t prescribe antibiotics to their ill child this time and they find 
that their child’s fever lasts after visiting here, they will not come back here 
for their next visit, but they will visit another medical institution or buy 
antibiotics [from retail pharmacies] by themselves. ...The roles of the retail 
pharmacy and doctor are different. A doctor needs a good reputation and 
the trust of patients. Only if you cure the patients this time, will they come 
back again when they are ill next time. Through this process, you can earn 
your reputation.’ [GP 3] 
‘For the GPs in the CHIs, one of the main characteristics of them [GPs] is that 
you must control patients’ symptoms, and then patients will come back to 
your clinic when they become ill again.... if no patients come again, you will 
not be able to survive.’ [GP 6] 
‘They [consumers] can get OTC antibiotics from other places even though 
we refused their requirement. So how can we deal with this problem?... 
Anyway, if you firmly refuse their requirements, they can get them from 
other retail pharmacies...’ [Licensed Pharmacist 4] 
‘The profit [is the main influence on the sale of antibiotics in the retail 
pharmacies]. They [sell drugs] as they think it can make a profit, particularly 
for small-scale retail pharmacies. The sale of antibiotics can also make 
profits, although the profits might not be very high. But if there are not any 
profits, no retail pharmacy will do it, particularly for small-scale retail 
pharmacies.’ [Pharmacy Staff 3] 
 
4.4 Discussion 
To the researcher’s knowledge, this is the first city-based qualitative study in China exploring 
providers’ perceptions of parental influences on their antibiotic-related behaviour. Like other 
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qualitative studies, the sample size was relatively small and it captured providers’ accounts 
of their behaviours (rather than direct observations of their interaction with parents) (Arroll 
et al., 2002; Björnsdóttir & Hansen, 2002; Brookes-Howell et al., 2012A; Hart et al., 2006). 
However, its qualitative approach enabled detailed understanding of provider perspectives 
pointing to three sets of parental influences – the public’s understanding of disease and 
treatment, parental trust, and the need to maintain good relationships with patients, on their 
behaviour with respect to the use of antibiotics for children.  
  
The use of TCM theory in interpreting illnesses among Chinese populations has been reported 
by many studies, including in Mainland China, other Chinese societies such as Taiwan, and 
overseas Chinese populations (Chung et al., 2014). In my study, providers widely understood 
and accepted that the public interprets illnesses through a TCM perspective, and this 
appreciation exerted an influence on clinical decision-making. Various TCM terms as well as 
TCM theories were noted by providers when they described the consultation with parents, 
such as internal excessive heat, a term that was commonly used to explain and interpret 
aetiology and symptoms based on the yin-yang – a foundational theory of TCM as well as a 
Chinese core cultural value (Fan, 2000). As noted by other studies focusing on Chinese 
populations (Bishop et al., 2009; Lwe-Ting, 2005; Xu et al., 2006), providers in the present 
study also observed that the public’s perceptions of the TCM system was often a mirror 
opposite of Western medicine system and antibiotics. Combined with a lack of knowledge 
and misunderstandings of disease aetiology, progression and treatment, including antibiotic 
treatment, the way in which parents viewed TCM and Western medicine resulted in them 
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becoming particularly keen or reluctant to use antibiotics for their children. This in turn, 
influenced providers’ behaviour with respect to the use of antibiotics for children. 
 
Parents were seen as distrusting China’s medical institutions and having particular suspicions 
about CHIs when compared with hospitals, a finding in line with Duckett et al.’s (2016) 
national survey. This survey pointed to the significant levels of distrust of providers across the 
Chinese population, but higher levels (26% of participants reported distrust) of clinics, 
including CHIs, and much lower levels (6% of participants reported distrust) of hospitals 
(Duckett et al., 2016). Therefore, as the present study found, maintaining parental trust was 
a key concern among providers. Bosley et al.’s (2018) HIC-based systematic review noted trust 
as the foundation of a high quality relationship between clinicians and parents, which was as 
one of the main themes relating to influences on parental attitudes toward antibiotic 
prescribing in children. Another systematic review of qualitative studies related to the 
patient-doctor relationship in HICs also referred to trust as one key element (Ridd et al., 2009). 
Similar to these two systematic reviews (Bosley et al., 2018; Ridd et al., 2009), providers noted 
the importance of maintaining parental trust for parents’ acceptance of their antibiotic 
prescribing decisions, including the depth of the patient-doctor relationship.  
 
A previous HIC-based study reviewing 133 GPs and 3,918 of their consultations noted that 
familiarity with patients was helpful with respect to GPs’ clinical decision-making process 
(Hjortdahl, 1992). Another noted it was valuable in saving time in consultations with children; 
familiarity also influenced the overall use of resources in consultations, such as laboratory 
tests and the degree of medicine use (Hjortdahl & Borchgrevink, 1991). Similarly, providers 
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in the present study noted that they were less likely to prescribe unnecessary antibiotics to 
familiar patients, citing that these patients were easier to persuade. The interview data 
collected for this study further suggested that less familiarity with the child patient would 
make providers more careful about prescribing antibiotics; this fits with a qualitative study 
undertaken in nine EU countries that found that clinicians’ antibiotic-prescribing decisions 
were associated with their familiarity with patients’ background medical history and 
continuity of care (Brookes-Howell et al., 2013).  
 
Studies of antibiotic prescribing decisions focusing on HICs as well as rural China have also 
pointed to providers’ concerns about maintaining good doctor-patient relationships and 
avoiding complaints and/or loss of patients to other providers (Bjornsdottir et al., 2002; 
Butler et al., 1998; Hart et al., 2006; Horwood et al., 2016; Tonkin-Crine et al., 2011; Zhang et 
al., 2016). The widespread concern about avoiding complaints among providers, and the 
broader public distrust of providers in China, has led to an increase of medico-legal problems 
and mental stress, as well as physical attacks on providers (Gong & Zhang, 2006; Huang et al., 
2012; Zheng, 2006).  
 
The present study also found differences among providers with respect to concerns about 
maintaining a good relationship with parents to ensure their re-consultation, which was only 
reported by providers in CHIs and retail pharmacies. Because of the status and funding 
structure of China’s hospitals, hospital-based providers have fewer concerns about losing 
patients and, in consequence, about their job security and the hospitals’ survival (Duckett et 
al., 2016; Mossialos et al., 2016). The workload and time pressures that result from the high 
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level of demand for hospital appointments also means hospital-based providers have fewer 
opportunities to be more familiar with parents and therefore to worry about their lack of 
‘familiarity’ (Beam, 2014; Woodhead, 2014; Yin 2017). In contrast, providers in the primary 
care system have to rely heavily on patient retention, which enables them to provide more 
medical services and increase their incomes25. These financial pressures have increased as 
the remuneration from drug sales gradually reduced following the implementation of the EDL 
and ZUM policies in the 2009 healthcare reform (discussed in section 1.4.3), while the subsidy 
for basic public health services was also reported as modest (Ding et al., 2013; Zhang et al., 
2015). In this study, providers in retail pharmacies mentioned that financial incentives – 
maintaining the pharmacy’s income and making a profit – were influences on their antibiotic-
dispensing behaviour. As well as the importance of drug sales for the income of providers in 
retail pharmacies, studies have noted the weak implementation of regulations and a shortage 
of well-trained personnel in retail pharmacies in China (Fang 2014; Fang et al., 2013; Reynolds 
& McKee, 2009). 
 
Alongside the EDL and ZUM policies, China has introduced a set of new regulations aiming to 
govern antibiotic prescriptions and sales among providers, including stricter antibiotic use 
regulations in China (‘Administrative Regulations for the Clinical Use of Antibiotics’) (MoH, 
2012A). These organisational influences were also reported by providers and will be discussed 
in Chapter 5. However, although these organisational influences could be potential 
                                                        
25 For providers in the primary care system, their income mainly consisted of the basic salary, remuneration and profits from drug sales, 
the governmental subsidy for providing public health services and a general fee for providing medical services (Zhang et al., 2015). 
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explanations of providers’ recognition of parental influences on their behaviour, they made 
no reference to these factors when describing parental influences on their behaviour.  
 
4.5 Conclusions 
This study provides important evidence on providers’ perceptions of parental influences on 
their behaviour with respect to antibiotic use for children in a city with a profile typical of 
Mainland China. As noted by providers, antibiotic prescribing decisions on children are 
directly influenced by the context in which they work: by the public’s understanding of 
disease and treatment, parental trust and, particularly for providers in CHIs and retail 
pharmacies, the financial imperative of maintaining good relationships with parents. The 
study therefore suggests that interventions to reduce providers’ paediatric use of antibiotics 
should address these wider cultural and system-level factors. This includes information 
campaigns to promote public understanding of antibiotics and the risks of misuse, as well as 
wider health system reforms. Important here are strengthening the primary care system, in 
line with the Healthy China 2030 plan (CPC Central Committee & State Council, 2016) and 
reward systems within the retail pharmacy sector that reward the quality of clinical decision 
making (Mossialso et al., 2016). 
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Chapter 5. Healthcare providers’ accounts of organisational 
influences on their behaviour with respect to the use of antibiotics 
for children 
 
A short version of this chapter has been published in the Public Health Open Access (see 
Appendix I).  
  
 168 
5.1 Introduction 
As noted in previous chapters, China has been seriously affected by ABR (Xiao et al., 2011), 
which is driven by its high rates of use and inappropriate use of antibiotics (Currie et al., 2011; 
Heddini et al., 2009; Zhang et al., 2006). The paediatric use of antibiotics by providers is 
recognised to be a particular challenge (He, 2012; Jiang et al., 2013; Li & Wu, 2007; Yang & 
Shi, 2008; Zheng et al., 2008). Drawing on data from interviews, it was noted in Chapter 4 that 
parental influences, including public understanding of disease and treatment, parental trust, 
and the need to maintain a good relationship with parents, were identified by providers as 
influences on their antibiotic-prescribing decisions for children. The literature review-based 
framework used to frame this study (see Figures 4 and 5 in Chapter 2) suggests that these 
interpersonal factors operate within the context of wider organisational influences. As the 
SEFs indicated, organisational influences, such as provider facilities and staffing as well as 
policies, were indeed evident in the interviews. Concerned about the inappropriate use of 
antibiotics, the MoH (NHFPC from 2013) introduced antibiotic-related reforms in 2011, 
mainly including a three-year strategy – National Special Campaign for the Clinical Use of 
Antibiotics – and much stricter regulations on antibiotic prescribing (Xiao & Li, 2013, 2015; 
MoH, 2012). Wider policies removing financial incentives from drug prescriptions were also 
introduced in the 2009 healthcare reforms to promote the appropriate use of antibiotics 
(Mossialos et al., 2016; State Council, 2012A). Therefore, an understanding of organisational 
influences following the reforms from 2011 on providers’ behaviour with respect to the use 
of antibiotics for children is of importance.  
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Studies have suggested that the high rates of inpatient antibiotic use decreased in China’s 
hospitals after the implementation of three-year strategy in 2011 (Bao et al., 2015; Hou et al., 
2014; Wang & Li, 2015). However, there is little evidence on the organisational factors that 
influence providers’ behaviour with respect to the use of antibiotics. There have been only a 
few quantitative studies undertaken since the rollout of the antibiotic-related strategy in 
2011, and none of these have focused on the paediatric use of antibiotics, regarded as a 
particular challenge in China. One national study of Chinese county hospitals in rural areas 
suggested that doctors’ attitudes to China’s EDL policies were an influence on their antibiotic 
prescribing behaviour (Wang et al., 2013), but otherwise specific evidence on organisational 
or institutional influence is sparse. A study in rural areas of Shandong Province reported that 
financial influences, as well as antibiotic-related training, were related with the prescriptions 
of antibiotics (Sun et al., 2015). An audit study carried out in a large unnamed Chinese city 
between 2011 and 2012 also pointed to the important influence of financial incentives on 
providers’ antibiotic-prescribing decisions, even when faced with patients’ demands. This 
study noted that, when prescribing and dispensing were carried out in separate institutions, 
patients’ demands for antibiotics had little influence on physicians’ antibiotic prescribing rate; 
however, the antibiotic prescribing rate dramatically increased from 55% (patients did not 
demand antibiotics) to 85% (patients demanded antibiotics) when physicians believed that 
patients would purchase these antibiotics at the hospital pharmacy (Currie et al., 2014).  
 
Only one qualitative study undertaken after 2011 focused on the paediatric use of antibiotics. 
It explored more general factors related to village doctors’ antibiotic-prescribing decisions for 
children under 15 years with upper respiratory tract infections, and pointed to the lack of 
  
 170 
diagnostic test technologies as one of the influential factors (Zhang et al., 2016). However, 
the marked differences in socio-economic development across China – particularly 
differences in healthcare resources and health-related policies – mean that rural-based 
studies may not capture influences on providers’ behaviour in urban settings (WHO, 2015C).  
 
The present study was undertaken in 2016, five years after the 2011 three-year strategy was 
instituted. To the researcher’s knowledge, this is the first city-based qualitative study 
undertaken since 2011 that focuses on organisational influences on providers’ antibiotic use 
behaviour. It aims to explore providers’ perceptions of organisational influences on their 
behaviour with respect to the use of antibiotics for children in a city with a profile typical of 
Mainland China, with the research question as: 
- What are the organisational influences on providers’ behaviour with respect to the use 
of antibiotics for children in urban China?  
 
Study context  
As discussed in section 1.3.1, China’s healthcare system is composed of three systems – a 
health supervision system, a health service delivery system, and a health financing system 
(Chan et al., 2008; WHO, 2015C). The health supervision system, including a range of 
departments from central to local levels, has oversight of the health service delivery system, 
and the health financing system is based around three basic medical insurance schemes 
(Mossialos et al., 2016; WHO, 2015C). In China’s health service delivery system, hospitals are 
the cornerstone (Yip et al., 2012), while the primary care system, including CHIs in urban areas, 
is weak but growing rapidly (Mossialos et al., 2016; Wang et al., 2012; WHO, 2015C).  
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Hospitals operate within a 3-tier system, each tier divided into three levels (A, B and C) 
(Mossialos et al., 2016). The highest tier is the tertiary A hospitals; they are commonly large 
public hospitals serving large populations, for example a city and its surrounding rural 
communities. CHIs provide both generalist clinical care and basic public health services (Li et 
al., 2017), and they can be divided into the government-owned institutions and 
nongovernment-owned institutions (including hospital operated CHIs, social organization 
operated CHIs and individual CHIs) (SCOPSR et al., 2006; Statistical information centre of 
NHFPC, 2016). There are still many unclear points for the primary healthcare system in China, 
as noted in a review, ‘despite the importance of primary health care in China and its recent 
reforms, there is insufficient knowledge about both the current system and the effect of recent 
policy changes’ (Li et al., 2017, pp.2584). Most hospitals and CHIs have their own pharmacies 
and they still dominate China’s pharmaceutical sales (Mossialos et al., 2016); however, over 
recent years, retail pharmacies have become a rapidly growing sector, with an average 20% 
growth in annual pharmaceutical sales from 1978 to 2009 (Fang, 2014). 
 
As noted above and discussed in section 1.4.2, China introduced a three-year strategy in 2011 
with several targets to promote the appropriate use of antibiotics (Xiao & Li, 2013). The 
strategy was then underwritten by the ‘Administrative Regulations for the Clinical Use of 
Antibiotics’ (Xiao & Li, 2013, 2015) and by guidelines for providers (‘Principles for Clinical Use 
of Antimicrobials’). A key feature of this set of policies is that they required physicians’ 
adherence to guidelines that physicians should appropriately prescribe antibiotics following 
a careful check of patients’ clinical presentation and laboratory test results (MoH, 2012A).  
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The appropriate use of antibiotics are supported by EDL and ZMU policies, and public hospital 
reform, introduced by the national government in 2009 (Duckett et al., 2016; Mao & Chen, 
2015) (discussed in section 1.4.3). In summary, the national essential drug system and ZUM 
policies required all government-owned primary care institutions to stock national essential 
drugs and dispense them with no mark-up between wholesale and retail price, and further 
encouraged other types of healthcare institutions, such as secondary and tertiary hospitals 
as well as nongovernment-owned primary care institutions, to procure and provide national 
essential drugs with zero mark-up as a priority and ensure a certain use proportion (NHFPC, 
2013). The public hospital reform called for the ZUM policies to be implemented in all county 
public hospitals and urban public hospitals by 2015 and 2017, respectively (Mossialos et al., 
2016; State Council, 2015, 2017). By breaking the link between drug sales and income, these 
policies are also encouraging the appropriate use of antibiotics (Mossialos et al., 2016).  
 
5.2 Methods 
5.2.1 Study area and subjects 
Details of the study city are given in Chapter 4, together with information on the recruitment 
method (section 4.2.1). In brief, participants were recruited across the healthcare sites noted 
in section 4.2.1 (two hospitals, six CHIs and five retail pharmacies), along with another public 
secondary A hospital. For the six CHIs, two were government-owned CHIs (one community 
health centre and one community health station) and four were hospital-owned CHIs (two 
community health centres and two community health stations), as the core roles of 
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government-owned institutions are highlighted by Chinese government (Bao, 2007; SCOPSR 
et al., 2006; State Council, 2009B). Moreover, in the study city, the majority of CHIs are 
government- or hospital-owned (Wang et al., 2009).  
 
The final sample consisted of 26 providers; no invited providers refused. Along with the 20 
providers described in section 4.2.1 of Chapter 4, there were three additional pharmacists 
from two tertiary A hospitals, one pharmacist from the secondary A hospital, and two 
pharmacists from the two community health centres, among the six CHIs. These six 
pharmacists were not included in the analysis of Chapter 4 (parental influences), as parental-
related factors were not identified as an influence on their behaviour, which was concerned 
with the dispensing of antibiotic prescriptions issued by the doctors. The profile of the four 
hospital-based pharmacists and two community-based pharmacists is shown in Table 8. All of 
them were qualified with an occupational certificate and two of them also had a licensed 
pharmacist certificate, along with their occupational certificate. The profile of the other 
participants has been provided in Chapter 4 (see Section 4.2.1 and Table 5).  
 
Table 8 Profile of healthcare providers interviewed regarding organisational influences on their 
behaviour with respect to the use of antibiotics for children 
 Sex Age Position 
Male  Female 30-39 40-49 50< 
Hospital 
pharmacists 
1 3 2 2 0 One chief pharmacist 
One deputy chief pharmacist 
Two pharmacist-in-charge 
0 2 0 2 0 One deputy chief pharmacist  
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Community 
pharmacists 
One pharmacist-in-charge 
 
5.2.2 Data collection 
Semi-structured interviews were undertaken using four interview guides, for (1) 
paediatricians and general practitioners (GPs) (2) licensed pharmacists (3) pharmacy staff and 
(4) pharmacists in hospitals and CHIs, respectively. The interview guides for the first three 
groups are provided in Chapter 4 (Section 4.2.2); the interview guide used for pharmacists in 
hospitals and CHIs is summarised in Table 9. 
 
Table 9 Interview guide: Topics relevant to influences on healthcare providers’ behaviour with 
respect to the use of antibiotics for children 
Interview guide for pharmacists in hospitals and CHIs 
1. (Warm-up question) What are the antibiotics most commonly sold here for children? 
2. For what symptoms or illnesses might you consider using antibiotics in children? 
3. Have you ever experienced or heard about any parents who want to purchase 
antibiotics for their ill child without a prescription? 
4. Have you ever experienced or heard about any pharmacies who sell antibiotics without 
a prescription? 
5. Have you ever experienced or heard about pharmacists who prescribe antibiotics for ill 
children? 
6. What factors do you think usually influence a pharmacist’s behaviour in relation to 
antibiotic dispensing? 
7. Have you ever tried to intervene when you became aware of possible inappropriate 
use of antibiotics for an ill child by physicians or his/her parents? 
 
  
 175 
5.2.3 Ethics statement 
All reasonable ethical guidelines were followed in this research, more detail on this is 
provided in Chapter 4 (section 4.2.3).  
 
5.2.4 Data management and analysis 
Data from four provider groups (paediatricians; GPs; licensed pharmacists and pharmacy staff; 
hospital-based and CHI-based pharmacists) were transcribed and translated, and then 
analysed separately using framework analysis. Details of the data management and analysis 
are given in Chapter 4 (section 4.2.4). The set of themes related to the organisational 
influences reoccurred across all four provider groups. This study was reported following the 
COREQ guidelines (Tong et al., 2007) (Appendix J). 
 
5.3 Results 
Organisational influences on providers’ antibiotic-related behaviour were discussed by all 26 
study participants. Providers noted how their behaviour with respect to the use of antibiotics 
for children was influenced by China’s healthcare system and national policies. These 
influences could be located within domains identified in the SEF (Figures 4 and 5 in Chapter 
2) relating to the organisational influence layer and policy layer. Although policy-related 
influences are located at a higher level of the SEF, they influenced providers through their 
workplace setting, so were generally perceived as organisational factors by providers. Within 
these two broad layers, themes relating to China’s healthcare system clustered around 
provider facilities and staffing, financial considerations, and interactions between different 
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healthcare institutions; themes relating to national policies focused on (i) guidelines and 
regulations on the use of antibiotics, as well as (ii) the enforcement of regulations and 
protocols. As located in the SEF, these two sets of themes in the organisational and policy 
layers are inter-related and interactive; however, they are distinguished here as two broader 
themes for clarity of presentation, and their interactions are discussed later in the discussion 
section (section 5.4). 
 
5.3.1 China’s healthcare system 
Most (25 out of 26) providers described how factors related to China's healthcare system 
influenced their antibiotic-related behaviour for children. Here, three sub-themes were 
evident, relating to the influence of (i) provider facilities and staffing, (ii) financial 
considerations, and (iii) interactions between different healthcare institutions. These were 
discussed respectively by 23, 16 and 16 study participants. 
 
5.3.1.1 Provider facilities and staffing 
Most providers, particularly paediatricians and GPs, noted the important role of diagnostic 
facilities, such as the laboratory-based blood tests, in their decisions related to using 
antibiotics for children. Their accounts suggested that blood-testing facilities were widely 
available in hospitals and community health centres, enabling providers to obtain results 
quickly. For example, in response to questions about the symptoms or illnesses that make a 
provider consider prescribing antibiotics for ill children, providers noted: 
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‘We will mainly base decisions [to prescribe antibiotics for ill children] on the 
blood test results. If the result indicate the ill child’s disease is a bacterial 
infection, we will use antibiotics.’ [GP 2] 
‘For the use of antibiotics, we will either base [the decision] on our clinical 
experience or the results of antimicrobial sustainability test (AST).’ [Hospital 
Pharmacist 3] 
‘This...one thing is the blood test. If the [result] of the blood test indicates 
that the disease is bacterial infection, I will consider [prescribing antibiotics]. 
This is the most important one.’ [Paediatrician 2] 
‘The blood test is fast. [It takes] half an hour to [get the result], generally. 
For the mycoplasma test... the result will be available in the afternoon if you 
do it in the morning, and you will get the result tomorrow if you do it in 
today’s afternoon.’ [Paediatrician 2] 
 
While some providers regarded the results of laboratory tests as the most important factor 
in their clinical decision-making, the limitations of diagnostic facilities were also widely noted. 
These included the limited availability of test facilities in community health stations and their 
relatively low accuracy; moreover, there was a delay on obtaining results for some types of 
tests, which led providers to base their antibiotic prescribing decisions only on their clinical 
experience.  
 ‘I will ask them to do the blood test [in the hospital near us if parents 
demand antibiotics for their ill child]. For community health centres, they 
can do the blood test in their centre; however, our community health station 
cannot do the blood test.’ [GP 1] 
‘As the results of the sputum culture and antimicrobial sustainability test 
(AST) cannot be obtained as quickly when patients come to the hospital – 
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for AST, the results can only be obtained after three days, [so] the use of 
antibiotics in the first three days is all based on the physician’s experiences.’ 
[Hospital Pharmacist 3] 
The shortage of other relevant healthcare-related resources, such as emergency equipment 
and inpatient beds, was also mentioned by providers as a factor influencing their antibiotic 
prescribing behaviour.  
‘For the new patients, I will be more prudent in using antibiotics because I 
am afraid of some emergency accidents. You know, we don't have any 
equipment for the emergency accidents. … Yes, so I think this factor will 
influence me towards prescribing antibiotics.’ [GP 6] 
‘Inappropriate prescriptions are relatively common due to the inadequate 
health resources. For the paediatric department, although there are not so 
many child patients and parents now, they will crowd into the whole 
department in the winter. Therefore, antibiotics like cephalosporin, which 
should be used two or three times per day by intravenous infusion, cannot 
be achieved.’ [Hospital Pharmacist 1] 
 
Alongside the facilities, a majority of providers pointed to the shortage of health professionals 
when considering influences on the use of antibiotics for children. Compared with hospitals, 
there was a lack of well-qualified doctors working at CHIs.  
‘Moreover, the doctors who are capable will usually not choose to work at 
the community level.’ [Community Pharmacist 2] 
The shortage of pharmacists was widespread across all healthcare institutions in the study: 
providers based in hospitals and CHIs spoke of the need for more hospital-based and clinical 
pharmacists, while those working in the retail pharmacies focused on the need for more 
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licensed pharmacists. In addition, the professional quality of pharmacists, particularly 
licensed pharmacists, was questioned by providers.  
‘For the lack of pharmacists, I think there is a lack of clinical pharmacists, 
who can guide the use of drugs. ... Uh…in theory, it should have an influence 
[on the use of antibiotics], as pharmacists should be more professional than 
physicians with respect to the use of drugs. But…you know… the 
[professional] level of our pharmacists cannot reach that high [to guide the 
use of drugs].’ [Hospital Pharmacist 3] 
‘Uh... the lack of pharmacists [is one factor that influences the sale of 
antibiotics in the retail pharmacies], as many retail pharmacies actually 
don’t have a pharmacist [working at their pharmacies during opening 
hours], the pharmacists only rent their Licensed Pharmacist Certificate to 
the retail pharmacies.’ [Licensed Pharmacist 2] 
‘I don’t think they [licensed pharmacists working at retail pharmacies] 
should be called ‘pharmacists’. I think they are equal to the retail staff as 
they don’t have a pharmaceutical background.’ [Hospital Pharmacist 1] 
 
Providers regarded the training, both that provided in their own healthcare institutions and 
by the wider healthcare system, as a factor influencing their antibiotic use decisions.  
‘Another factor [influencing my antibiotic-prescribing decisions] is the 
training, for example, the frequency of antibiotic-related training held for 
us.’ [Paediatrician 2] 
Additionally, when talking about the sources of antibiotic-related knowledge and awareness, 
most providers noted that they acquired antibiotic- and antibiotic resistance-related 
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information as part of their training, including their initial training and post-qualification 
training. Only a few supplemented this with information through the internet. 
‘Moreover, I can get the information from my post-qualification training, 
and many people [pharmacy staff] are studying for the Licensed Pharmacist 
Certificate. Yes, our retail pharmacy staff will also be trained before we can 
sell drugs in the retail pharmacies, and antibiotic-related knowledge is 
included into our training.’ [Pharmacy Staff 3] 
‘In addition, we can update our antibiotic related knowledge through the 
publicity from the drug companies, and some information on the internet.’ 
[GP 3] 
 
5.3.1.2 Financial considerations 
None of the providers referred to financial pressures and incentives as influences on the use 
of antibiotics in hospitals, even though the ZMU policies had not been implemented in the 
hospitals in Taiyuan city.  
‘Well, I think the commercial interests don’t have impacts on the hospital. 
Our hospital will only earn 15% of the retail price of all drugs as a 
profit26. ...Moreover, a new policy which stops the hospital from earning 
money by selling drugs has been introduced in many provinces, and it will 
be implemented in Shanxi province soon.’ [Hospital Pharmacist 1] 
                                                        
26 It was noted in the context section that the essential drugs were only a portion of all drugs stocked and dispensed in hospitals, and ZMU 
policies were to be implemented in all urban hospitals by 2017. Moreover, Hospital Pharmacist 1 discussed in the later part of the interview 
that the ZMU policies would be implemented soon in this hospital. Therefore, it is indicated that, at the point when the interview was 
conducted, the ZMU policies were not implemented in the study city’s hospitals and they were continuing to mark up the prices of drugs. 
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Similar to hospitals, the implementation of EDL and ZMU policies in retail pharmacies were 
not compulsory during the fieldwork period; however, providers in all four groups noted that 
financial concerns were major factors contributing to antibiotic-related behaviour in retail 
pharmacies. 
‘The [retail] pharmacies are run for [profits]. After all, they are heavily 
influenced by the market, so they will put making a profit in the first place.’ 
[Paediatrician 2] 
‘The profit [is the main influence on the sale of antibiotics in the retail 
pharmacies]. They [sell drugs] as they think it can make a profit, particularly 
for small-scale retail pharmacies. The sale of antibiotics can also make profit, 
although the profit might not be very high. But if there are not any profits, 
no retail pharmacy will do it, particularly for small-scale retail pharmacies.’ 
[Pharmacy Staff 3] 
 
In CHIs, although providers working at the government-owned institutions noted that EDL 
and ZMU policies were fully followed and financial factors were no longer an influence on the 
use of antibiotics in CHIs, the majority of providers still acknowledged that financial 
considerations would influence CHI-based providers’ antibiotic prescribing decisions, 
particularly those working in community health stations.  
‘All drugs we use here belong to the ‘National Essential Drug List’, we can 
only use drugs from this list. … We don’t earn profit from it [selling drugs], 
and the retail price of drugs is equal to the purchase price.’ [GP 127] 
                                                        
27 GP1 worked at a government-owned community health station, and therefore, as discussed in the study context section, all drugs stocked 
and dispensed in this station were to be essential drugs with zero mark-up. 
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‘They [community health stations] should sell drugs mainly based on the 
‘National Essential Drug List’, but actually, they are mainly based on the 
amount sold and profit [when selling drugs].’ [Community Pharmacist 2] 
 
5.3.1.3 Interactions between different healthcare institutions 
Providers from all four groups pointed to an appreciation of how antibiotic use was the 
outcome of interactions between healthcare institutions. They noted that hospitals remained 
the main providers in China; this more tightly regulated sector was preferred over CHIs by 
parents who additionally had access to OTC antibiotics from retail pharmacies. In 
consequence, hospital-based providers suffered from the pressures of high workloads and 
limited time, which influenced their communication with parents during consultations and, 
in turn, their antibiotic-related care of children. Providers in CHIs noted how this hierarchical 
relationship influenced how they managed demands from parents for antibiotics for their 
child. This systems-level perspective ran across the interviews. 
‘Many patients will go directly to the hospital rather than visit a CHI first. 
Yes, I think the majority of our patients are like that [who will go to the 
hospital directly]. ... In the busiest period, we can see 50-60 children in one 
morning. So it will take 3-4 minutes to see one ill child. Yes, as you see 60 
children within 4 hours, it takes 4 minutes for each child.’ [Paediatrician 6] 
 ‘For some parents who insist and require us to use antibiotics for their ill 
child, as we seldom use antibiotics here, I will say like ‘you need to do a test 
if you strongly require the use of antibiotics’. …So in this situation, we 
actually transfer this type of patients to the hospital. Moreover, some 
parents prefer to use better [more expensive or imported] antibiotics for 
their child. For this type of parents, I will also ask them to go to the hospital…’ 
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[GP 1] 
‘As you come here and ask me to diagnose your child’s disease, I will make 
my decision on your child about whether antibiotics are needed; but if you 
insist on demanding antibiotics, you can choose to go to the higher level 
hospital.’ [GP 2] 
 
Providers considered that the more tightly regulated use of antibiotics in hospitals had 
worsened antibiotic use in retail pharmacies. For example, some interviewees noted that 
paediatricians would ask patients to purchase unnecessary antibiotics from retail pharmacies, 
as prescriptions issued within the hospitals were restricted by regulations. For these 
interviewees, including some paediatricians and hospital pharmacists, retail pharmacies were 
regarded as a solution when faced with parents who made strong demands for antibiotics.  
‘On one hand, these physicians understand antibiotics should not be used 
for particular diseases and they are afraid of the checks and punishment 
from the hospital; on the other hand, they still feel it is too risky to not 
prescribe antibiotics even though antibiotics are not needed. Therefore, they 
choose to prescribe antibiotics and ask patients to buy them out of the 
hospital, so the hospital cannot find out about their inappropriate antibiotic 
prescribing behaviour.’ [Hospital Pharmacist 1] 
‘Exactly, [antibiotic use is regulated less strictly in the retail pharmacies.] 
[This situation has become worse] after antibiotic use became strictly 
regulated in the hospital. As there is the standard of antibiotic use frequency 
in the hospital, [some doctors] will even recommend to patients that they 
buy antibiotics in the retail pharmacies.’ [Hospital Pharmacist 2] 
At the same time, most providers in retail pharmacies regarded hospitals and CHIs as the 
primary source of inappropriate antibiotic-related behaviour. As most consumers did not 
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have medical-related knowledge, they would strictly follow doctors’ prescriptions when 
purchasing antibiotics in retail pharmacies.  
‘Therefore, the doctor is the key. As most families only have one child, 
parents usually bring their child to the hospital [when they are unwell], and 
most of them will comply with the doctors’ suggestions. They will purchase 
drugs strictly based on the prescriptions no matter what kinds of drugs are 
prescribed by doctors.’ [Licensed Pharmacist 1] 
 
5.3.2 National policies and guidelines  
All of the 26 providers referred to national policies when discussing the use of antibiotics for 
children. Within this broad theme, two sub-themes were evident, relating to guidelines and 
regulations connected to the use of antibiotics and to the enforcement of regulations. These 
sub-themes were discussed respectively, by 26 and 25 providers.  
 
5.3.2.1  Guidelines and regulations related to the use of antibiotics 
Accounts from providers suggested that they were deeply influenced by the guidelines and 
protocols launched with the three-year strategy – ‘National Special Campaign for the Clinical 
Use of Antibiotics’. The guidelines highlighted by this strategy, which relate to prescribing 
antibiotics based on laboratory test results, were noted by all hospital- and CHI-based 
providers, as well as one of four licensed pharmacists when describing how they diagnosed 
disease and made antibiotic prescribing decisions for children.  
‘Yes, the national government issued some documents for the strategy – 
such as the ‘Principles of Clinical Use of Antibiotics’ that particularly focus 
  
 185 
on the abuse of antibiotics – to reduce the amount of antibiotics used. ... Yes, 
I think all these policy-related factors are able to reduce the usage of 
antibiotics, but this guideline [‘Principles of Clinical Use of Antibiotics’] is the 
most important one.’ [Hospital Pharmacist 3] 
‘Antibiotics should be used when you are infected by bacteria and have 
[bacterial infection] indications. They [antibiotics] are prescribed drugs, and 
must be sold with prescriptions.’ [Licensed Pharmacist 4] 
Other requirements in the protocols and guidelines, such as restrictions on the proportions 
of the prescriptions containing antibiotics, the priority given to oral antibiotics over other 
modes of treatment, and inspections of the use of antibiotics by pharmacists, were also 
discussed by providers.  
 ‘Moreover, there are restrictions on prescribing antibiotics for us, such as 
the proportion of prescriptions containing antibiotics.’ [GP 3] 
However, providers noted problems with adhering to the guidelines and how this could work 
against their appropriate use of antibiotics.  
‘However, when it is very ambiguous, there will be no guideline for me to 
identify [whether it is a viral infection or bacterial infection]. ... Yes, so it 
[using antibiotics] cannot only rely on the guideline. Yes, and it is also related 
to our organisational system.’ [Paediatrician 4] 
‘And sometimes the blood test has a bias. Sometimes we face a confusing 
situation like we send two samples collected from the same patient at the 
same time to two different laboratories, and the results are largely different, 
with one high blood test result and one low blood test result.’ [Paediatrician 
5] 
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Providers in hospitals and CHIs referred to the influence of wider policies, such as EDL and 
ZMU policies, on the drug lists in their workplace.  
‘You [hospitals] must purchase the drugs that are covered by the ‘National 
Essential Drug List’ as a priority, and you can then choose some special drugs 
[that are not covered by the list], such as higher-level drugs, through the 
discussion among [experts in the hospital]. But you must choose drugs from 
the ‘National Essential Drug List’ first, yes, this is regulated by the national 
government.’ [Hospital Pharmacist 4] 
‘All drugs we used here belong to the ‘National Essential Drug List’, we can 
only use drugs from this list.’ [GP 1] 
For providers in retail pharmacies, all of them mentioned the regulations in relation to the 
fact that pharmacists cannot prescribe drugs; however, only licensed pharmacies noted that 
antibiotics should only be sold with a prescription when they described how they dispensed 
antibiotics. 
‘Antibiotics must be sold with prescriptions and cannot be sold only based 
on your requirements. Yes, the sale of antibiotics must be based on 
prescriptions issued by physicians. The situation is the same in retail 
pharmacies, where antibiotics also must be sold with prescriptions, as it is 
regulated that all prescribed drugs in retail pharmacies must be sold with 
prescriptions.’ [Licensed Pharmacist 3] 
‘No [pharmacists cannot prescribe antibiotics for children]. Only physicians 
can prescribe drugs.’ [Pharmacy Staff 4] 
 
Requirements linked to the basic medical insurance schemes (discussed in section 1.3.1) were 
regarded by some hospital-based providers as factors that influence their antibiotic 
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prescribing decisions. In contrast, these influences were not discussed by providers in CHIs 
and retail pharmacies.  
‘I think another factor [that will have impact on prescribing antibiotics] is 
the medical insurance schemes, as most people in China have joined a 
medical insurance scheme, either the social medical insurance [Urban 
Employee Basic Medical Insurance or Urban Resident Basic Medical 
Insurance] or the New Rural Cooperative Medical Scheme. They impose 
restrictions on the drug selection.’ [Paediatrician 6] 
‘We will not be influenced by this factor [medical insurance schemes]. Yes, I 
don’t care about it.’ [GP 6] 
 
5.3.2.2 The enforcement of regulations and protocols 
All providers discussed the enforcement of antibiotic-related regulations and protocols in 
healthcare institutions, which suggest it had an influence on their use of antibiotics. From 
providers’ accounts, it appeared that they considered that overall enforcement had improved.  
‘The antibiotic use standard in the hospital [influences my antibiotic 
prescribing behaviours]. Every hospital has the antibiotic use standard; [my 
antibiotic prescribing behaviour is influenced by] whether the enforcement 
of the standard is good.’ [Paediatrician 2] 
‘Therefore, I think the enforcement of antibiotic use regulations will only 
become better and better as our government is paying more attention to 
the problem of abusing antibiotics. ...In fact, antibiotic use has been 
regulated strictly in the hospital.’ [Hospital Pharmacist 2] 
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However, in line with views expressed with respect to diagnostic facilities (section 5.3.1.1) 
and financial influences (section 5.3.1.2), providers’ accounts suggested that the set of 
policies issued since 2009 was better enforced in higher-level healthcare institutions, 
particularly in tertiary A hospitals, compared with CHIs.  
‘The [enforcement of] antibiotic use regulation is [becoming more stringent] 
step by step, so the use of antibiotics [in the hospital] might be more 
regulated than the lower level [of healthcare institutions]. Yes, the higher 
the level of the medical institution, such as the secondary A or tertiary A 
hospitals, the more regulated the use of antibiotics will be.’ [Hospital 
Pharmacist 3] 
At primary care level, compliance with antibiotic-related regulations was weaker in 
community health stations than community health centres.  
‘However, the situation in the community health stations is different [from 
community health centres]. Although there are also some inspections in 
community health stations, it is very uncommon. Moreover, the 
management in the community health stations is relatively...flexible. Like 
what I said above, as the proportion of prescriptions containing antibiotics 
is required to be no more than 20%, they can separate non-antibiotic drugs 
into several prescriptions to tackle the inspections.’ [GP 4] 
‘To be honest, the enforcement of regulations in community health stations 
and retail pharmacies is still very weak, and these areas are the flaws of 
[antibiotic use regulations]. But it is very hard to be stringent about the 
enforcement of regulations in these areas.’ [Community Pharmacist 2] 
 
As policies issued by the 2009 health reforms and 2011 antibiotic-related reforms were not 
mainly focused on retail pharmacies, the enforcement of this set of policies in retail 
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pharmacies was not noted by providers. However, all providers pointed to the poor 
enforcement of regulations focusing on retail pharmacies, including problems of selling 
antibiotics without prescriptions, licensed pharmacists being absent during business hours in 
retail pharmacies, and the inappropriate prescription of antibiotics by doctors employed in 
retail pharmacies.  
‘There are differences [related to the use of antibiotics between different 
healthcare institutions]. In the hospital’s pharmacy and CHI’s pharmacy, you 
cannot buy any drugs without a prescription. ...But for the retail pharmacy... 
you can get any drugs you want [and you don't need a prescription].’ [GP 2] 
‘But most retail pharmacies cannot go as far as that [selling antibiotics with 
the prescription], and their enforcement of regulations is relatively not 
stringent. So consumers can buy whatever they want [including antibiotics] 
in these retail pharmacies.’ [Paediatrician 5] 
‘Some of them [retail pharmacies] don’t have [licensed pharmacists]. 
Generally, licensed pharmacists will send their certificate to the small-scale 
pharmacies but not work there. For the large-scale pharmacies, they usually 
also have a doctor working there. But, honestly, the doctors are very 
unprofessional, and they dare not diagnose the disease for you.’ [Licensed 
Pharmacy 1] 
With respect to the poor compliance with regulations in retail pharmacies, financial 
incentives and an ineffective supervision system were noted by providers as major factors. 
‘This kind of situation [selling antibiotics without prescriptions] will not 
happen in the hospitals, but it might happen in the retail pharmacies. ...But 
the retail pharmacies are also concerned about their drug sales amount, so 
they may sell prescribed drugs without a prescription sometimes.’ [Hospital 
Pharmacist 3] 
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‘Moreover, it [selling antibiotics without prescriptions] is because the 
control and management provided by the [municipal] Food and Drug 
Administration is not effective, and therefore, OTC antibiotics can still be 
purchased from retail pharmacies.’ [Licensed Pharmacist 2] 
 
In addition, some providers talked about their concerns about the unintended consequences 
of over-stringent enforcement of antibiotic-related regulations, and noted that the national 
government should balance various factors in the policy-making process, such as the inequity 
of healthcare resources in China. 
‘So if you want to restrict the use of antibiotics strictly, you must forbid their 
usage in all healthcare institutions, including the private clinics. Yes, only in 
this way can you control the abuse of antibiotics. However...the national 
government needs to consider a variety of factors when making a policy. If 
there are no antibiotics in all clinics, for some villages only having one 
private clinic [and no other higher-level healthcare institutions], how could 
a patient be treated when his/her disease is very serious and antibiotics are 
indeed needed to be used? Actually, this situation is very common [in the 
rural areas], and our national government also feels very embarrassed 
about it.’ [Community Pharmacist 2] 
‘However, if the enforcement is too stringent and all retail pharmacies have 
to be closed, what will the Food and Drug Administration work for? Who will 
they oversee as all retail pharmacies are closed? Yes, and then the officers 
in the Food and Drug Administration will lose their jobs too...So this is the 
situation.’ [Licensed Pharmacist 4] 
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5.4 Discussion 
To researcher’s knowledge, this is the first city-based qualitative study in China exploring 
providers’ perceptions of organisational influences on their behaviour, with respect to the 
use of antibiotics for children five years after the introduction of antibiotic-related reforms. 
As noted in Chapter 4, this study has limitations related to its small sample size and its focus 
on provider accounts, rather than their actual behaviours. Additionally, it is cross-sectional 
and, therefore, cannot compare provider views pre and post 2011, but relies on comparisons 
that providers made about practices prior to and following the reforms. However, its 
qualitative approach has provided insight into provider perspectives. This study indicates that, 
in the period after the 2009 health reforms and 2011 antibiotic-related reforms, providers 
considered a set of organisational influences – healthcare facilities and staffing, financial 
incentives, and national policies – as factors influencing their antibiotic-related behaviour for 
children, factors in turn situated in the wider context of China’s healthcare system as a whole.  
 
Accounts from providers suggested wide influences of national policies on their behaviour 
with respect to the use of antibiotics on children, which are related to both the 2009 and 
2011 reforms. The three-year strategy – ‘National Special Campaign for the Clinical Use of 
Antibiotics’ – was the most widely reported policy among providers in this study. It also 
appeared to be the most important organisational influence on providers’ behaviour, which 
is supported by evidence from this study as most providers noted their concerns about this 
strategy, as well as evidence from another study that the high antibiotic usage in hospitals 
has been gradually decreasing since its implementation in 2011 (Bao et al., 2015). Additionally, 
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the interview data from the present suggested that this three-year strategy promoted the 
adherence to guidelines among providers. In China, the nationwide guidelines related to the 
use of antibiotics, named ‘Principles for Clinical Use of Antimicrobials’, was implemented as 
early as 2004 by the Ministry of Health; however, studies undertaken prior to the roll-out of 
this strategy indicated that the guidelines’ effects on promoting appropriate use of antibiotics 
for children were limited (Zhang et al., 2008A, 2008B). Reynolds & McKee’s (2009) study even 
pointed to providers’ perceptions of the lack of actual clinical guideline at any level of China’s 
healthcare system. In contrast, as the three-year strategy highlighted this guideline, the 
important role of this guideline has been widely noted by providers in the present study.  
 
Despite the important influences of the three-year strategy on providers, accounts noted that 
facilities within the healthcare system influenced providers’ use of antibiotics and their 
compliance with this strategy. Similar to hospital-based providers, providers in CHIs referred 
to laboratory test results as an important influence on their antibiotic prescribing decisions 
for children. However, data suggested that the different status and resourcing levels of 
healthcare institutions in China’ healthcare system, for example the constraints relating to 
the limited diagnostic facilities at the primary care level (particularly for community health 
stations), resulted in lower compliance with requirements related to laboratory test result 
among providers in CHIs and, in consequence, different behaviour with respect to the use of 
antibiotics.  
 
This fits with findings from LMIC focused studies that described how the uncertainty related 
to the limited availability and unaffordability of diagnostic facilities influenced providers’ 
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antibiotic-related behaviour (Nkengasong et al., 2018; Wilson et al., 2018). For instance, a 
study conducted in India indicated that GPs prescribed antibiotics when they could not 
distinguish whether an infection was viral or bacterial, as medical tests were not available at 
their public facilities and patients could not afford the test from private labs (Kotwani et al., 
2010). Similarly, Zhang et al.’s (2016) qualitative study undertaken after the reforms also 
pointed to a lack of diagnostic tests in village clinics in rural China and its influences on doctors’ 
inappropriate antibiotic-prescribing behaviour. The lack of diagnostic facilities at the primary 
care level has also been noted by a nationwide survey (Li et al., 2017).  
 
Providers in hospitals and CHIs noted the EDL and ZMU policies influenced the institutional 
drug lists, but few providers noted these policies’ influences on their antibiotic-prescribing 
decisions for children. Moreover, as noted in section 1.4.3, the EDL and ZMU policies are 
mainly focused on the primary care level, such as CHIs, to reduce incentives to prescribe 
unnecessary drugs (Li et al., 2017; Xi et al., 2015); however, evidence from the present study 
suggested financial considerations among providers in different healthcare institutions were 
not in line with the policies’ focus. The interview data indicated that this set of policies 
seemed to have limited influences in CHIs, with evidence that providers still referred to 
making profit from prescriptions as a contribution to the use of antibiotics in CHIs, particularly 
community health stations. In contrast, for providers in hospitals, it appeared that financial 
incentives had no influence on their antibiotic use, even though the ZMU policies had not 
been implemented in the hospital of the study city (Taiyuan city).  
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The present findings relating to these financial policies and incentives’ influences at CHIs are 
similar to studies undertaken in various provinces in China, which noted that the EDL and 
ZMU policies had no effect on the inappropriate use of antibiotics at the primary care level 
(Song et al., 2014; Xiao et al., 2016; Yang et al., 2013), even after the introduction of 
antibiotic-related reforms (Jiang et al., 2015; Wang et al., 2014; Xi et al., 2015). In China, 
despite increased government subsidies at the primary care level since the 2009 healthcare 
reforms, the CHIs are still facing problems of underutilization as well as low incomes 
compared with the hospital (Li et al., 2017), which means that financial concerns were more 
evident in their decision-making about the use of antibiotics for children. Each patient 
encounter therefore mattered, with concerns about maximising sales and ensuring patient 
loyalty. These problems under the healthcare system as a whole conflicted with the aims of 
the EDL and ZMU policies to reduce the financial incentives. In addition, although the 
importance of the EDL has been highlighted as one of five pillars of the 2009 healthcare 
reforms, there is no national pharmaceutical policy framework in China, which strongly 
challenges EDL’s implementation (Mossialos et al., 2016). Together with provider facilities in 
different healthcare institutions, these findings pointed to how the structure of the 
healthcare system influenced policies’ effects on providers’ use of antibiotics. 
 
However, with respect to financial incentives’ influences in the hospital, Currie et al. (2014) 
and Sun et al.’s (2015) studies, undertaken in 2011-2012 and 2012, respectively, suggested 
that hospital-based providers’ antibiotic-prescribing behaviour was influenced by financial 
incentives (profits), which were different from the present study. These two studies were 
undertaken a few years earlier than the present research, when the 2009 healthcare reforms 
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were at their early stage. Moreover, the complex health supervision system in China, 
involving horizontal fragmentation across different ministries and vertical fragmentation 
from central to local governments, as well as the variation in social and economic 
development across China, is likely to lead to non-transparency in policy-making and 
differences in policy implementation on the ground (Mossialos et al., 2016). 
 
In the studies of HICs, the organisational factors including high workload and limited time 
have been identified as factors that influence providers’ antibiotic-related behaviour for 
children in primary care (Horwood et al., 2016; Lucas et al., 2015). These factors were also 
noted by providers in the present study; however, they appeared to combine in different 
ways among providers working in different parts of China’s healthcare system, pointing to 
the structure of China’s current healthcare system as an overarching factor shaping the 
organisational influences on providers’ antibiotic-related behaviour. In China, the hospital 
sector has been particularly affected by the rapid increase in patient demand over the last 
several decades (Mossialos et al., 2016). China has a long-lasting problem of overutilization 
of hospitals for all forms of healthcare provision; even after the 2009 healthcare reform, 
hospitals are still the main provider (WHO, 2015C), with higher levels of trust and resources 
than other primary care institutions in China (Duckett et al., 2016; Li et al., 2017; Mossialos 
et al., 2016). High patient demand and the resulting pressure on the hospital paediatricians 
in the present study required them to maintain high levels of patient throughput, a factor 
that appeared to increase pressures on them to prescribe antibiotics. In contrast to the 
hospitals, China’s primary care system is weak and faces multiple challenges, including a lack 
of trust from the public, being staffed with less educated workers and being under-resourced 
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(Li et al., 2017; Mossialos et al., 2016). Moreover, it was reported that patients were not 
switching from hospitals to the primary care system after the first few years of the 2009 
reform (Mossialos et al., 2016). Consistent with this picture, providers in the present study 
who worked at CHIs did not report the workload pressures described by the hospital 
paediatricians. 
 
The retail pharmacies are a relatively independent sector in China’s healthcare system, mainly 
supervised by the China Food and Drug Administration and controlled by regulations that are 
different from those for hospitals and primary care institutions (WHO, 2015C). Similar to 
studies focusing on the antibiotic distribution in China’s retail pharmacies (Fang, 2014; Fang 
et al., 2013; Jiang et al., 2013), this study found that antibiotics were inappropriately used in 
retail pharmacies, with poor enforcement of regulations, a lack of licensed pharmacists, and 
financial incentives that were considered influential factors by providers. In addition, while 
the data are limited to a small-scale study, they suggest that the tighter enforcement of 
regulations in hospitals and CHIs as a consequence of the reforms may result in retail 
pharmacies with poorer enforcement of antibiotic-related regulations becoming relatively 
more significant as a source of unnecessary antibiotics. Consumers could purchase 
unnecessary antibiotics prescribed by doctors from the retail pharmacies, or, as no retailers 
in this study mentioned the need for a prescription, they could get OTC antibiotics from the 
retail pharmacies when doctors refuse their antibiotic demands. This indicated that the 
influences of one particular policy were linked with the healthcare system as a whole, 
transforming the inappropriate use of antibiotics by moving from institutions with stringent 
enforcement to poor enforcement. Moreover, there were some further concerns about the 
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adverse consequences of over-stringent enforcement in the whole system, considering the 
challenges of health inequity (Chan et al, 2008), accessibility and affordability of healthcare 
service for some people (Yip et al., 2012), as well as a lack of health professionals in rural 
China (Hou & Ke, 2015). 
 
In addition, for all policies discussed above, their enforcement and influences on providers’ 
antibiotic-related behaviour could be relevant to their legal power and severity level. 
Compared with the relatively poor enforcement of pharmaceutical-related regulations in 
retail pharmacies, the strong effects of the three-year strategy on the use of antibiotics may 
be related to the fact that it is underwritten by strict regulation – ‘Administrative Regulations 
for the Clinical Use of Antibiotics’ – which set punishment from an economic penalty to legal 
liability (Xiao & Li, 2013, 2015). However, the maximum penalty set for the illegal sale of 
antibiotics in retail pharmacies is only 1,000 CNY (152 USD)28 (CFDA, 2007).  
 
5.5 Conclusions 
This study provides evidence of providers’ perceptions of organisational influences on their 
behaviour with respect to the use of antibiotics for children in the period after the 2009 
health and 2011 antibiotic-related reforms. From the providers’ accounts, the three-year 
strategy appeared to be the most widely reported organisational factor influencing their 
antibiotic-related behaviour for children, along with other organisational factors, such as 
                                                        
28 Exchange rate: 1 USD= 6.59 CNY (in 10th Oct 2017) 
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provider facilities and workload, that differentially influenced providers’ behaviour in 
different institutions. The present study, therefore, points to the importance of strengthening 
the relatively weaker parts of China’s healthcare system – the primary care sector and retail 
pharmacies – through an increase of government investment and subsidy and launching more 
effective regulations (Lancet, 2018). Additionally, it indicates the importance of 
understanding organisational influences in the context of China’s healthcare system as a 
whole, as the interactions and relationships between healthcare institutions were identified 
as important overarching factors shaping providers’ antibiotic-related behaviours.  
 
Together with Chapter 4, this study suggests that providers believed that parental and 
organisational influences are the two most important factors contributing to their antibiotic-
related prescribing behaviours. Having focused in Chapters 4 and 5 on providers’ perspectives, 
Chapter 6 focuses on the other key constituency in decision-making about the use of 
antibiotics for children, namely parents. 
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Chapter 6. Parents’ accounts of influences on their behaviour with 
respect to the use of antibiotics for children  
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6.1 Introduction 
Studies of China have pointed to high rates of inappropriate paediatric use of antibiotics in 
hospitals (Li et al., 2013; Zou et al., 2014), primary care systems (Li et al., 2012; Liang et al., 
2011), retail pharmacies (Jiang et al., 2013; Liao et al., 2013) and by parents (Yu et al., 2014), 
and have identified this inappropriate use as a major contributor to the problem of ABR in 
China (Currie et al., 2011; Heddiniet al., 2009; Zhang et al., 2006). In line with this evidence, 
providers and parents were highlighted in the frameworks discussed in Chapter 1 as two 
particularly important influences on paediatric use and inappropriate use of antibiotics in 
China. Additionally, drawing on data from the interviews conducted for this study, Chapter 4 
suggested that providers believed that parental influences are one of the important factors 
contributing to their behaviour with respect to the use of antibiotics for children. Parents are 
the other key constituency in the use and inappropriate use of antibiotics for children, and 
have influence on providers’ decision-making about paediatric antibiotic use, and as such this 
chapter describes factors influencing parents’ behaviour related to the use of antibiotics for 
their children. 
 
With paediatric use of antibiotics being recognised as central to the wider problem of 
antibiotic use (Laxminarayan et al., 2013), factors influencing parents’ use of antibiotics for 
their children have been explored by many studies in HICs. In a study of 1,247 parents of 
children age 0-14 in Italy, a lack of antibiotic-related knowledge was noted as being linked to 
parental attitudes and habits that resulted in the inappropriate use of antibiotics for children 
(Bert et al., 2016). Communication and interactions between doctors and parents in the 
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consultation process have also been widely identified as influencing parents’ antibiotic-
related decisions (Cabral et al., 2014, 2015, 2016). A systematic review of studies in HICs 
further noted that, during consultation, parents want antibiotic prescriptions when they 
believe that antibiotics would be efficacious for their children’s current illness or felt 
pressures from daycare providers or employees, while their reluctance to accept antibiotics 
was mainly due to their concerns about the side effects of antibiotics (Lucas et al., 2015). It 
also identified a divergence between the consultation needs of parents and doctors. Parents 
were more concerned about the medical diagnosis and decision-making process but doctors 
sought to shorten the consultation and, at the same time, satisfy parents (Lucas et al., 2015). 
 
Compared with HICs, very little is known about influences on parental behaviours with 
respect to the use of antibiotics for children in Mainland China. Very few (in total five studies) 
were located through literature search on both English (MEDLINE Ovid) and Chinese (CNKI) 
databases, and all those studies found were quantitative (Bi et al., 2000; Ding et al., 2015, 
2015A; Wang et al., 2017; Yu et al., 2014). Similar to studies of HICs, the role of physicians 
was noted as an important influence on parents’ use of antibiotics for their children in two 
Chinese studies, undertaken in rural areas of Jiangxi province in 2012 and rural areas of 
Shandong provinces in 2014, respectively (Ding et al., 2015; Yu et al., 2014). Studies in rural 
China pointed to a lack of antibiotic-related knowledge among parents (Ding et al., 2015, 
2015A; Yu et al., 2014). Ding et al. (2015) also indicated a combination of over-expectation, 
under-expectation and a lack of antibiotic knowledge and noted how this combination of 
factors could result in parents inappropriately using antibiotics for children. Additionally, 
socio-demographic characteristics, including the age and number of children and place of 
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residence, as well as ease of access to antibiotics without prescriptions in retail pharmacies 
and storing antibiotics at home, were found to be associated with parental medicating 
behaviour (Yu et al., 2014). 
 
The marked differences in socio-economic development and health-related policies across 
China mean rural-based studies may not capture the influences on parents’ behaviour in 
urban settings (WHO, 2015C). However, there have been only two studies conducted in urban 
China exploring factors relating to the parental use of antibiotics for their children. One 
questionnaire-based study, undertaken over two decades ago, reported that, among 1,459 
parents in Hefei city in 1995, the mother’s educational level and socio-economic status, the 
age and severity of diseases of the children, and ease of access to antibiotics from doctors 
and retail pharmacies all influenced parental medication of antibiotics for children (Bi et al., 
2000). The other more recent study of 310 parents in Changsha city similarly noted that the 
age of the children, parents’ educational level and whether the children ever accepted 
antibiotic prescriptions from doctors significantly influenced the parents’ use of antibiotics 
for their children (Wang et al., 2017). 
 
While these quantitative studies (three in rural and two in urban areas of China) have 
identified a range of influences on parents’ use of antibiotics for children, qualitative studies 
can shed a unique light on the perceptions held by parents of influences on their antibiotic-
related behaviour and contextual understandings (Johnson & Onwuegbuzie, 2004; Pope et 
al., 2006; Ritchie & Lewis, 2013). However, to date, there has been no qualitative study of 
parents in China. Considering there are advantages to both types of study and there are very 
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few studies in China, this chapter seeks to add to both the quantitative and qualitative 
evidence. Moreover, the diversity of China, and the recent unprecedented economic growth 
and rapid changes in its healthcare system, underline the need for further studies (Mossialos 
et al., 2016). Therefore, a multi-method study was conducted to explore the influences on 
parents’ behaviour with respect to the use of antibiotics for their children in China. The aim 
of the quantitative study was to explore parents’ knowledge of antibiotics and ABR, and 
antibiotic-related behaviour on children, as well as factors influencing their antibiotic-related 
behaviour. The aim of the qualitative study was to obtain contextual data regarding parents’ 
perceptions of influences on their use of antibiotics for children. 
 
This study builds on the particularly limited evidence in Chinese urban settings by being 
located in Taiyuan city. As noted in section 4.2.1 of Chapter 4, Taiyuan is a medium-sized city 
with an average GDP (Pan & Wei, 2015; Statistical Information Centre of NHFPC, 2016); it also 
has the highest GDP and yearly income of the public enterprise’ staff among other cities 
within Shanxi province (Shanxi Statistics Bureau, 2017; Taiyuan Health Bureau, 2017). The 
multi-method design involves qualitative and quantitative components that are planned and 
completed independently, and then their results are brought together (Byren & Humble, 
2007; Morse, 2003). By using a multi-method design to collect qualitative and quantitative 
data, a richer picture of influences on parental behaviour regarding the use of antibiotics for 
their children can be developed. The main reason to recruit participants from different 
populations (outpatient clinic and nurseries) relates to the access to study sites for these 
different components. For instance, semi-structured interviews were found to be unsuitable 
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for participants in the outpatient clinics due to the crowded and busy clinic setting and the 
time constraints on parents waiting with their children. 
 
6.2 Qualitative study of parents’ perceptions of influences on the use of 
antibiotics for their children 
6.2.1 Research question and method 
As noted in the end of section 6.1, the qualitative component aims to obtain contextual data 
regarding parents’ perceptions of factors influencing their use of antibiotics for children, and 
thus to answer the research question: 
- What are the influences on parents’ behaviour with respect to the use of antibiotics for 
children in urban China? 
The following sub-sections provided a detailed description of the study design and methods. 
  
6.2.1.1 Study area and subjects 
Focus groups were recruited from two of the city’s major nurseries: one is a large general 
nursery providing day-care for children of working parents, the other is an affiliated nursery 
of a medical university, which provides day-care focusing mainly for children of university 
staff, as well as others of parents who do not work there. The study sites and participants 
were recruited by the gatekeepers identified through personal networks in the pilot work 
(the recruitment process is discussed in section 3.3.3 of Chapter 3). At the beginning of the 
fieldwork, it was only possible to secure the support of one general nursery through the 
  
 205 
researcher’s personal networks and only three participants were recruited for a focus group. 
The other nursery, a university affiliated nursery, was therefore recruited pragmatically at a 
slightly later stage to recruit more participants and focus groups to maximise the quality of 
data (Twinn, 1998). 
 
For gaining participants, the heads of the nurseries contacted nursery children’s parents 
through group messaging by mobile phone to elicit interest, and parents who were interested 
in the study then responded to participate. As the focus groups were planned to be 
undertaken after the day-care service finished (i.e. when parents came to pick their children), 
the main difficulty the heads had in gaining parental interest was problems related to the 
time, for instance, the focus group discussion started too late and was time-consuming. The 
researcher was not involved in this recruitment process and therefore had no influence on 
the number of parents recruited or on the social composition of the sample.  
 
6.2.1.2 Data collection 
Focus groups are a qualitative data collection method that is increasingly used in health 
research (Twinn, 1998). They can enable in-depth information on complex topics to be 
obtained within a short time (White & Thomson, 1995), as well as reduce the pressures and 
anxiety that participants may experience in one to one interviews (Twinn, 1998). It is a 
method that has been successfully used in China; Twinn (1988) found that Chinese 
populations were willing to discuss issues, including sensitive and controversial topics, in 
groups. This was supported by the finding during the pilot work for this study where parents 
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would talk more openly in a group with other parents, compared with in an individual 
interview. Therefore, the focus group method was undertaken with parents in this study. 
 
A topic guide (see a summary of topic guide in Table 10 and the full version in Appendix K) 
was used for focus group discussion. This was informed by evidence from earlier studies and 
revised in light of pilot work, and included open questions, such as introductory and probing 
questions, and a vignette, a short piece of writing about a fictional character or scenario 
designed for this research (O’Dell et al., 2012). The vignette questions can be helpful in 
grounding participants’ views and accounts of behaviour in particular situations with a more 
concrete context, and allow participants to discuss issues from a non-personal and less risky 
perspective (Bryman, 2008; Hughes, 1998). Therefore, the vignette and open questions were 
used together to examine parents’ behaviour regarding their use of antibiotics for children 
and to explore factors influencing this behaviour. The topic guide was translated into Chinese 
before the focus groups were run. 
 
As presented in Table 10, focus group discussions began with a brief introduction to the study, 
followed by the vignette and open questions. The vignette was a short story about a 4 year-
old girl becoming ill and how her parents responded. It included five stages, designed to 
describe the development of the girl’s illness and the symptoms step by step (Figure 8). For 
the first four stages, participants were asked (i) what the girl’s parents should do and (ii) why 
they thought the girl’s parents should respond that way; for the last stage, participants were 
asked to discuss if they believed that antibiotics cured the 4 year-old girl’s illness. For both 
nurseries, focus groups were carried out in the nursery’s classroom. The discussions ranged 
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in duration from 30 to 120 minutes. All focus group discussions were conducted face-to-face 
by the researcher and recorded by audio-recorder in June 2016. Field notes were completed 
after each focus group to record the settings. 
Table 10 Summary of focus group topic guide 
Main topic areas Specific Approaches 
Introductions Explain rationale for the study  
An overview of 
parents’ behaviour 
when their children 
are unwell 
Using open questions to ask parents to recall what they did 
when their children were unwell, including whether antibiotics 
were used, and why  
Using a vignette to explore parents’ understandings and their 
management of an unwell nursery-aged girl and the factors 
influencing their behaviour, including their use of antibiotics 
Seeking professional 
care for their children 
Showing parents a list of childhood symptoms and exploring 
parents’ expectations of antibiotic prescriptions from doctors 
Using open questions to examine parents’ antibiotic-related 
behaviour during the consultation and the influencing factors, 
mainly including: 
Demanding or being reluctant to accept an antibiotic 
prescription for their children; 
Communicating with the provider and their satisfaction; 
Compliance with the antibiotic prescription for their children 
Parental medication of 
antibiotics for their 
children 
Using open questions to seek information on parents’ behaviour 
related to their parental use of antibiotics for their children and 
the factors affecting this, and the main source of the OTC 
antibiotics 
Antibiotics and ABR Showing a list of antibiotics’ side-effects to parents and 
exploring their understandings of antibiotics 
Exploring parents’ understandings of ABR through open 
questions 
Participant profile and 
wrap-up 
Collecting participants’ information through questionnaire and 
providing an opportunity for parents to ask questions 
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Figure 8 The vignette used to explore parents’ responses to their child’s illness 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stage one 
Emma is a 4-year-old girl in this nursery who has been previously healthy. One day 
in November, she starts to have the symptom of a runny nose and looks slightly 
tired. 
Stage four 
Emma’s parents take her to a paediatrician in the hospital immediately on the 4th 
day when she becomes worse. After the consultation, the paediatrician diagnoses 
Emma’s disease as a viral flu and prescribes some antiviral drugs for Emma. Emma’s 
parents use these drugs according to the physician’s prescription. However, 
Emma’s symptoms continue. 
 
Stage five 
Finally, Emma’s parents start to use antibiotics on her by themselves and do not 
take her to any doctors or return for a further consultation. And after another five 
days, Emma recovers and remains healthy. 
 
Stage two 
Her parents do nothing, and on the 3rd day, she complains of feeling congested, 
having copious green nasal discharge, and intermittent headaches. She looks tired 
and slightly pale. But on examination she does not have a temperature. 
 
Stage three 
Emma’s parents treat her with some antiviral drugs and Chinese patent medicines 
by themselves from the 3rd day. However, on the next day (the 4th day), Emma 
becomes worse and has a low-grade fever with intermittent cough. 
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6.2.1.3 Ethics statement 
As discussed in Chapter 4 (section 4.2.3), ethical approval was granted by the Research 
Governance Committee of the Department of Health Sciences at the University of York. 
Parents who were introduced by the heads of nurseries were informed that taking part in the 
study was entirely voluntary and they were free to withdraw at any time before they agreed 
to take part. No incentives were offered to parents and informed consent was obtained from 
all participants.  
 
6.2.1.4 Data management and analysis 
Audio-recorded data were transcribed and then translated from Chinese to English; 
translations were checked for ambiguities in meaning (e.g. Chinese concepts without an 
English equivalent) by Professor Hilary Graham and Professor Piran White prior to data 
analysis. Transcripts were analysed together using framework analysis to identify influences 
on parents’ behaviour with respect to the use of antibiotics for children. The process of data 
analysis was the same as in the work undertaken for the interviews with providers (discussed 
section 4.2.4). However, as participants were recruited from two different groups – the 
affiliated nursery and general nursery – checks were also performed to find whether themes 
or sub-themes were drawn disproportionately from one group or another during this data 
analysis process. Reporting this qualitative component adhered to the COREQ guidelines 
(Tong et al., 2007), and a COREQ Checklist was included in the appendix (Appendix L).  
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6.2.2 Results 
The final sample consisted of three focus groups of 12 parents in total. Two focus groups 
(focus group 1 and focus group 2 included four and five participants, respectively) were 
recruited from the medical university affiliated nursery and one (focus group 3 with three 
participants) from the general nursery. Most participants (n=10) were mothers. Participants 
all lived in Taiyuan city and were aged 30-39 years. Participants were not asked directly how 
many children they had, but the response to questions indicated that most parents had one 
child, although two parents noted that they had two children. Most of their children (13 out 
of 14) were aged 3-7 years (preschool age). Other participant characteristics are presented in 
Table 11. This indicates that the sample was well-educated, and more advantaged then the 
general population in Shanxi province, as well as the nationwide population (Shanxi Statistics 
Bureau, 2011; State Council Population Census Office & Population and Employment 
Statistics Division of National Statistics Bureau, 2012), and none lived in a household with an 
income less than 25,000 CNY. Additionally, as the affiliated nursery delivers day-care services 
mainly focusing on the university’s staff, participants recruited from this nursery had a higher 
potential to undertake health-related jobs. Among the nine participants within focus groups 
1 and 2, three were involved in health-related jobs, with one in focus group 2 working as a 
doctor and two (one participant in focus group 1 and one participant in focus group 2) 
working as nurses. 
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Table 11 Participant profile of focus group study 
Participants Affiliated nursery General 
nursery 
FG 1 FG 2 FG 3 
Sex Male 0 2 0 
Female 4 3 3 
 
Educational 
level 
High school/secondary 
technical college 
0 1 0 
College/university 3 2 3 
Postgraduate or above 1 2 0 
Occupation Health-related job 1 2 0 
Non-health related job 3 3 3 
 
Yearly 
income of 
household 
Below 10,000 CNY 0 0 0 
10,000-24,999 CNY 0 0 0 
25,000-49,999 CNY 1 1 1 
50,000 CNY and above 3 4 2 
 
As the qualitative and quantitative studies were undertaken simultaneously, analysis of the 
qualitative data was influenced by the analysis of quantitative data. The coding work also 
drew on the coding framework in Chapter 4 related to providers’ perceptions of parental 
influences on their use of antibiotics for children. All study participants spoke about 
influences on their behaviour with respect to the use of antibiotics for children. These 
influences clustered into two broad themes on how parents’ use of antibiotics was influenced: 
firstly, by their understandings of children’s disease and treatment and, secondly, by their 
perceptions of different providers (hospitals, CHIs, retail pharmacies)29. The focus group 
                                                        
29 There were no participants who discussed online sources of antibiotics. 
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excerpts include comments made by a single participant as part of the focus group discussion 
as well as capturing short exchanges between focus group members. 
 
6.2.2.1 Parents’ understandings of their children’s diseases and treatments 
All parents referred to their understandings of children’s diseases and treatments when 
describing whether and how they used antibiotics for their children. Here, three sub-themes 
were evident, relating to (i) their dual use of TCM and Western medicine perspectives, (ii) 
their understanding of antibiotics and antibiotic treatment, and (iii) their personal experience 
and understandings of their particular child. These were discussed respectively by 10, 12 and 
12 study participants across the three focus groups. 
 
(i) Dual use of TCM and Western medicine perspectives among parents 
Parents’ accounts indicated their understanding of diseases and treatments is informed by a 
TCM perspective. In answering the questions in stage one and stage two of the vignette 
(Figure 8) parents described early symptoms and the causes of diseases using TCM 
understandings, for example, the retention of food, catching cold or having excessive internal 
heat. Most parents continued their discussions using TCM-related methods, such as Chinese 
patent medicines, to treat children’s diseases at these early stages. 
 ‘The green nasal discharge will be caused by excessive internal heat, and it 
may combine with catching cold. I will definitely use some drugs that can 
treat both excessive internal heat and cold. In general, I use the drug called 
‘Children Cough and Cold Cleaner’. It is a type of oral liquid and can treat 
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both cold and excessive internal heat. I usually rely more on TCMs and use 
antibiotics as a supplement when treating children’s diseases.’ [Affiliated 
nursery, P4] 
‘Generally, I will not use anti-inflammatory drugs at the start. I will use some 
Chinese patent medicines, or ...as she has runny nose which can be 
connected to the cold, I will use the Paediatric Paracetamol Artificial Cow-
bezoar and Chlorphenamine [Western medicine]. Yes, these kinds of drugs 
are more commonly used by me.’ [General nursery, P12] 
 
In response to a vignette question about what they should do if a child’s symptoms still 
persisted after taking drugs (stage four of the vignette in Figure 8), some parents noted that 
the treatment was a process and the effectiveness of drugs took time. They also said that 
some diseases were self-limiting and could resolve spontaneously without specific treatment. 
 ‘As it is a process when drugs become effective, it is almost impossible that 
the drugs become effective as soon as you take them.’ [Affiliated nursery, P7] 
‘Yes, in general, the course of flu is around 7 days, and it can be cured by 
itself.’ [Affiliated nursery, P9] 
 
Parents drew on TCM and Western medicine perspectives at the same time; parents 
integrated both into their understanding and management of child ailments. For example, 
most parents appeared able to accept both systems; they used TCM treatment for minor 
diseases or at the early stage of the disease, while turning to Western medicine treatment 
when the TCM was not effective.  
‘For instance, when you use TCMs for your children and find they [the 
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traditional Chinese medicines] do not work very well, you will definitely use 
antibiotics on your children then.’ [Affiliated nursery, P4] 
The accounts also suggested some parents’ degrees of trust in one system was influenced by 
their views of the other system. For instance, their trust in TCM was related to their concerns 
about Western medicine, including their resistance to using Western medicine for childhood 
illnesses. Additionally, parents noted that they decided on the use of TCM or Western 
medicine30 based on whether their children found the respective drugs easy to use. Overall, 
the TCM perspective was found to be more prominent among parents from the general 
nursery and these parents appeared to have a greater degree of trust in TCM. 
‘P10: The TCM practitioner said Western medicine can only press the 
symptoms into your body, which makes you look like you are recovering; 
however, the actual causes of the disease are still in your body and cannot 
be cured. For infant massage, you will find your child becomes even worse 
for the first few days after the treatment; but, actually, it is because the root 
of the disease is going outside of your body.  
P11: Exactly. The TCM practitioner is trying to pull the root of the disease 
out. 
P10: After my child was cured by TCM, I brought him to that clinic every time 
when he had a cough or retention of food, and I have seldom gone back to 
the hospital again.’ [General nursery, P10 & P11] 
 
‘I will use TCMs for my children when they are able to swallow them. After 
                                                        
30 In China, the formulation types of TCM are usually liquid while Western medicine’s formulation types are typically capsules, tablets and 
pills, etc. 
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all, [unlike the Western medicines that have been shaped as pills], the TCMs 
are usually hard to take, particularly for children. However, you know, they 
are all related to some general diseases.’ [General nursery, P10] 
 
(ii) The parents’ understandings of antibiotics and antibiotic treatment 
Parental misunderstandings of antibiotics and antibiotic treatment were related to 
inflammation and anti-inflammatory drugs. Accounts indicated that some parents considered 
antibiotics and anti-inflammatory drugs the same; antibiotics could and should, therefore, be 
used to treat any kind of inflammation.  
‘But the only cause of fever is inflammation. If the inflammation cannot be 
controlled, how can the fever be released? ... Yes, [that’s why most parents 
want to use anti-inflammatory drugs once their child has a fever. Anyway, 
there is inflammation.’ [General nursery, P10] 
Parents’ concerns about antibiotics were found to be mainly related to the side effects; 
however, most only described these concerns in general terms, for example, that antibiotics 
are not good for children’s bodies, rather than identifying the specific harms. This, in turn, 
appeared to be linked to a lack of antibiotic-related knowledge among parents. 
‘P5: Nowadays, people only know antibiotics are not good, but they do not 
know why.  
P6: Yes, exactly. For instance, when it refers to the disadvantages of smoking, 
we all know that smoking is harmful to our lungs. However, we are not clear 
about which parts of the body antibiotics are harmful to.’ [Affiliated nursery, 
P5 & P6] 
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‘The side effects of antibiotics are too strong, so I do not want my children 
to rely on antibiotics too much. Moreover, antibiotics are harmful to the 
brain, aren’t they? I avoid using antibiotics in case they cause any harm in 
my children, although I understand the probability is extremely low.’ 
[General nursery, P10] 
 
It was clear that antibiotics were located within Western medicine and, while concerns were 
expressed about their use (see accounts above), parents believed that antibiotics provided 
the only effective cure for potentially-serious childhood conditions, particularly those 
associated with a high temperature fever. In consequence, they would only use antibiotics 
for serious childhood ailments. Some parents also noted that antibiotics could cure disease 
more quickly than TCM methods. 
‘P1: Antibiotics will be used for serious fever, the high temperature fever. 
P2: Yes, that’s true.’ [Affiliated nursery, P1&P2] 
 
‘I will not use anti-inflammatory drugs if she does not have a fever.’ [General 
nursery, P10] 
‘The Western medicine doctors rely more on antibiotics because the 
antibiotics’ effects come very quickly.’ [General nursery, P 11] 
 
With respect to parents’ expectations of antibiotic treatment, fever, sore throat and cough 
were childhood symptoms that most parents considered to lead doctors to prescribing 
antibiotics; moreover, parents, particularly those with a health-related background, 
  
 217 
considered that antibiotics should be prescribed based on the severity of the symptoms or 
on the results of a blood test. For instance, they noted the need for prescribing antibiotics 
only when the fever exceeded 38.5 degrees.  
‘P3: In general, it is fever [that doctors might prescribe antibiotics for 
children]. 
P4: Yes, only fever. For other symptoms doctors will not prescribe 
antibiotics…but if the cough is very serious, the doctors will also suggest 
using antibiotics. 
P3: Exactly. ...For pneumonia, generally, the doctors will prescribe 
antibiotics for bronchial pneumonia.’ [Affiliated nursery, P3 & P4] 
 
‘Generally, it is sore throat. For fever, it depends on the particular 
temperature. Well, [prescribing antibiotics for sore throat] also depends on 
the degree of swelling of the tonsils, and antibiotics should be used when 
the tonsils are purulent. With respect to fever, antibiotics are probably used 
when the temperature exceeds 38.5 degrees. Other symptoms will not 
[contribute to an antibiotic prescribing decision].’ [Affiliated nursery, P8] 
Over half the parents pointed to the importance of the blood test in doctors’ antibiotic-
prescribing decisions and, therefore, their acceptance of this for their children. 
‘Antibiotics will be used for sore throat when the infection has worsened or 
the blood test result is high. However, antibiotics will not be used for aches 
and pains, vomiting or diarrhoea, generally.’ [Affiliated nursery, P9] 
 
‘P12: I think paediatricians in the Children Hospital, I am not sure other kinds 
of hospitals’ doctors, will ask your child to do a blood test firstly, and they 
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will decide whether or not to prescribe antibiotics based on the result of the 
blood test.  
P10: Yes, exactly!’ [General nursery, P10 & P12] 
 
ABR was only discussed in focus groups one and two, where participants were recruited from 
the affiliated nursery, and, within these two focus groups, mainly by parents with health-
related backgrounds. They noted that antibiotics should be used appropriately, for example, 
completing the full course, to prevent ABR. However, rather than a characteristic of particular 
bacteria, ABR was perceived to occur in the human body when the individual’s responsiveness 
to antibiotics was lost, a compromised immune function associated with consistently using 
antibiotics. The response to questions related to ABR also indicated that most parents 
appeared not to be concerned about this issue. 
‘I think we should try our best to use antibiotics based on their treatment 
course, otherwise it will contribute to antibiotic resistance.’ [Affiliated 
nursery, P5] 
‘I am not familiar with antibiotic resistance with the respect to 
pharmaceutical areas; however, I think it is like that you will lose the 
immune function after consistently using a kind of drug. ...Some of them 
[parents] believe that that frequently using antibiotics does not matter, and 
they do not know the terrible influences on the human body caused by 
antibiotic resistance at all.’ [Affiliated nursery, P7] 
 
‘P12: I have not found any influence [of ABR] on me and my child’s daily 
life. ...antibiotic resistance? They [parents] are not concerned about it very 
much. 
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P10: Yes, yes. [General nursery, P10&P12] 
 
(iii) Parents’ personal experience and understandings of their particular child[ren] 
Parents, both those with one child and those with two, described how their understandings 
of children’s diseases became better as their children aged. With the accumulation of 
experience, parents said that they were more likely to parentally-medicate their children with 
drugs, rather than bring them to visit a provider.  
‘My child went to the paediatric emergency once when he was six months. 
We brought him to the hospital because it was the first time he got a fever 
and we did not have any experience. ...Yes. We definitely chose to go to 
hospital when [our] child got a fever for the first time.’ [Affiliated nursery, 
P1] 
‘As I did not have any experience when my children were young, particularly 
for my first child, I always visited the hospital if she felt a little bit 
uncomfortable. But now, as they have grown up and their immune systems 
have become better, I will parentally medicate them with drugs and seldom 
go to the hospital.’ [General nursery, P 11] 
 
Most parents believed the severity of the child’s disease was one of the factors that led them 
to seek professional help. They only visited a provider when their children were seriously ill, 
such as having a long-lasting high temperature fever; otherwise, they would self-treat their 
children. Fever, particularly one exceeding 38.5 degrees, as well as serious cough, were the 
symptoms that were most commonly associated with serious diseases by parents. 
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‘For some minor diseases [we do not need to bring our child to visit a doctor]. 
We have become a kind of ‘family doctor’. ... Yes. It is almost impossible that 
we go to hospital every time the child feel a little uncomfortable, isn’t it?’ 
[Affiliated nursery, P6] 
‘It will be based on his/her (particular situation). For instance, if the 
temperature of his/her fever has reached 38.5 degrees or above, I will 
choose to bring him/her to visit a healthcare provider; otherwise, I will treat 
him/her by myself.’ [Affiliated nursery, P5] 
 
In addition, some parents noted that their understandings of children’s diseases took into 
account their child’s particular characteristics, which differed between children.  
‘P10: So different children have different situations. Some children may get 
used to drinking more water, so their symptoms are very likely to be related 
to a lack of water. For my children, they always drink only a little water every 
day, so they never suffered from any disease caused by a lack of water.  
P11: Different children have different patterns.’ [General nursery, P10 & P11] 
 
6.2.2.2 Providers’ influence on parents’ use of antibiotics for children 
Most parents discussed how (i) familiarity and trust in providers and (ii) the accessibility of 
treatment influenced their use of antibiotics for children. Therefore, within this broad theme, 
these two sub-themes were evident, discussed respectively by 12 and 8 parents.  
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(i) Familiarity and trust in providers as an influence on parents’ antibiotic using behaviour 
Accounts from all focus groups suggested that trust and familiarity were major factors 
determining parents’ choices in healthcare institutions and providers to visit. Most parents 
reported that they would bring their children to the hospital when they needed to visit a 
provider; however, other parents would choose the CHIs or clinics that they were particularly 
familiar with and regarded as trustworthy.  
‘I usually visit some trustworthy doctors in the CHIs, and they would give you 
a satisfactory answer as long as you ask them.’ [Affiliated nursery, P1] 
‘But for me, I prefer to go to some well-known small clinics, such as the one 
I often visit, as it is familiar with my children’s situations, or some other 
clinics that have a good reputation among the public. I will go to these kinds 
of clinics first rather than directly go to the hospital under the situation you 
mentioned above [in stage three of the vignette in Figure 8]. ...Unlike my 
cousin who trusts the large hospital, I usually go to the clinics if my children’s 
diseases are not serious. I think the most important thing is the sense of 
trust.’  [General nursery, P10] 
Parents also noted that they would choose hospitals for serious childhood diseases while 
visiting the CHIs for minor diseases. 
‘For some not serious diseases, we just visit some average level doctors [in 
the private clinics or CHIs] who are familiar with my child’s condition. Like 
the minor cold, we will not go to the hospital. For some very serious diseases 
that cannot be controlled, such as fever with very high temperature and 
purulent tonsils, we will consider going to the hospitals.’ [Affiliated nursery, 
P4] 
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Parents also pointed to the influence of providers on their use of antibiotics for children. Their 
accounts indicated that all parents complied with the providers during the consultation, 
including neither demanding, nor being reluctant to accept, antibiotic prescriptions. They 
noted that they trusted the providers, and the trust in providers was also referenced as a 
factor that influenced their compliance with antibiotic prescriptions for children. 
‘P8: Yes, I think I trust the doctor. At least, they will not inappropriately 
prescribe drugs. ... 
P5: Yes. Moreover, as we trust the doctor, we will strictly comply with their 
prescriptions.’ [Affiliated nursery, P5 & P8] 
 
‘I think the trust is a very important thing. ...For these trustworthy places 
[small clinics], I will fully comply with their suggestions and prescriptions, 
even for taking an injection [that I am normally reluctant to], and they will 
do the skin test as well before taking an injection.’ [General nursery, P10] 
 
(ii) The accessibility of different types of providers 
In all focus groups, parents described how their ability to access different sources of 
treatment – hospitals, CHIs, and OTC antibiotics from retail pharmacies – influenced their 
behaviour, including treating their children themselves. Parents reported feeling hospitals 
were overused by patients, with too many waiting for consultations and outpatient clinic 
environments perceived to expose their children to high infection risks. In consequence, they 
would medicate their children themselves. In addition, they pointed to retail pharmacies as 
their main sources of antibiotics for parentally-medicating. 
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‘P8: The environment in the hospital is also not good and safe, and hospital 
acquired infections are very common and serious. Therefore, we will not go 
to the hospital as long as we can deal with the diseases.  
P6: Yes. They may be infected with other diseases when going to the 
hospital.’ [Affiliated nursery, P6 & P8] 
 
‘Because it is very convenient to purchase [OTC] antibiotics from retail 
pharmacies. We do not need to request antibiotics strongly from doctors.’ 
[Affiliated nursery, P3] 
 
6.2.3 Discussion on qualitative findings 
The qualitative data indicated a co-existence of TCM and Western medicine perspectives 
among parents regarding their children’s diseases and treatments, which confirmed findings 
of providers’ perceptions on the public’s dual use of two medicine systems in Chapter 4, as 
well as findings related to a complementary use of TCM and Western medicine in other 
studies (Chan, 2002; Simpson, 2003). With respect to antibiotics, in line with providers’ 
perceptions noted in Chapter 4, parents clearly located them within Western medicine. Also, 
according to parents’ opposing understandings of TCM and the Western medicine system, 
antibiotics were particularly expected by parents for potentially-serious childhood diseases 
such as fever, sore throat and cough. This is similar to findings in other studies that noted that 
the public’s perceptions of the TCM system was a portal opposite of their perception of the 
Western medicine system (Bishop et al., 2009; Lew-Ting, 2005; Xu et al., 2006). Along with a 
lack of antibiotic and ABR-related knowledge, such as the association between antibiotics and 
anti-inflammatory drugs, the qualitative study pointed to how important the way that parents 
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understand diseases and treatment influenced their behaviour of the use of antibiotics for 
children. 
 
This qualitative study also indicated that parents’ understandings of the severity of children’s 
diseases influenced their antibiotic-related behaviour, including the decisions about 
parentally-medicating their children or seeking professional help, and their expectation of 
being prescribed antibiotics as a result of the consultation. For instance, parents’ 
understandings of TCM and Western medicine meant that antibiotics were often regarded as 
essential for serious diseases and they were particularly expected for conditions that were 
perceived as potentially serious, such as fever. These symptoms were also identified as 
childhood conditions associated with an over-expectation for antibiotic prescriptions by rural 
parents in Ding et al.’s (2015) study. Further, through describing how parents became more 
likely to parentally-medicate antibiotics as their children got older and they understood their 
children’s diseases better, these qualitative data suggested that parents’ antibiotic-related 
behaviour was related to increased personal experience of caring for children. This could also 
possibly explain the findings from the other two quantitative studies in China where the age 
and number of children were positively associated with parents’ self-medicating children with 
antibiotics (Bi et al., 2000; Yu et al., 2014), and that parents’ antibiotic-related behaviour is 
driven by their accumulated experience of their children, but not by the experience of 
antibiotics. 
 
Additionally, the qualitative study indicated that trust and familiarity were key factors 
regarding providers’ influences on parents, including parents’ selection of providers and their 
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compliance with their advice. This is similar to Kerse et al.’s (2004) GP waiting room survey of 
370 patients, which pointed to familiarity as the significant factor relating to patient 
compliance. Specifically, in line with Duckett et al.’s (2016) study and providers’ perceptions 
of  parental trust and familiarity in Chapter 4, parents’ accounts suggested that they have 
higher levels of trust in hospitals, as most parents chose to visit the hospital when their 
children were ill and for serious diseases. In contrast, familiarity was highly valued by parents 
when they chose to visit the CHIs, and they only regarded as trustworthy those CHIs and 
providers with whom they were familiar. The focus group data also pointed to the direct 
effects of trust on providers’ influences on parents, as parents noted that trust was important 
for their acceptance of providers’ decisions, including antibiotic prescriptions, which was also 
noted in studies in HICs and rural China (Bosley et al., 2018; Brookes-Howell et al., 2013; Jin 
et al., 2011; Ridd et al., 2009). With the strengthening of primary care highlighted as a key 
goal in China’s annual government work report in 2018, as well as the Health China 2030 plan 
(CPC Central Committee & State Council, 2016; Lancet, 2018), further research could explore 
how these organisational changes among China’s healthcare system may be influencing 
parents’ use of antibiotics for their children.  
 
6.3 Quantitative study of parents’ knowledge of antibiotics and antibiotic 
resistance and influences on the use of antibiotics for their children 
6.3.1 Research question and method 
As mentioned above, the aim of the quantitative component was to provide a broader picture 
of parents’ antibiotic-related knowledge and behaviour with their children, as well as to 
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explore  influences on parental behaviour regarding the use of antibiotics for children. The 
research questions  were: 
- What are parents’ understandings of antibiotics and ABR and how do they use antibiotics 
with their children? Do parents’ knowledge of antibiotics and ABR and their socio-
demographic characteristics influence their antibiotic-related behaviours? 
Therefore, the objectives of this quantitative part include: 
• Describing the profile of participants, which related to their socio-demographic 
characteristics; 
• Accessing parents’ knowledge related to antibiotics and ABR based on a series of 
knowledge-related questions, and then identifying if there were significant 
differences between the total knowledge score of parents with different socio-
demographic characteristics; 
• Describing parental behaviour regarding the use of antibiotics for children, with the 
focus on (i) parents’ use of prescribed antibiotics for their children at the most recent 
occasion (hereafter ‘prescribed use of antibiotics’, and (ii) whether parents ever used 
antibiotics without prescriptions for their children (hereafter ‘non-prescribed use of 
antibiotics’); and 
• Exploring the influences of parents’ knowledge of antibiotics and ABR, and socio-
demographic characteristics on parental behaviour regarding the use of antibiotics for 
children, including (i) prescribed use of antibiotics, and (ii) non-prescribed use of 
antibiotics.  
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6.3.1.1 Study area and subjects 
As discussed in section 1.3.1.1 of Chapter 1, within hospitals’ 3-tier system (Mossialos et al., 
2016), the highest tier hospital in China is the tertiary A hospitals, which are commonly large 
public hospitals serving large populations. Hospitals still deliver most inpatient services and a 
substantial portion of outpatient services in China, with the general tertiary hospitals being 
reported as the main provider among all hospitals (Mossialos et al., 2016; WHO, 2015C). 
Moreover, as this study focused on parents of children, two of the city’s major tertiary A 
hospitals – one general hospital and one children’s hospital– were identified as study sites. 
They were also the study sites for the two qualitative studies discussed above in Chapter 4 
and Chapter 5, respectively.  
 
Parents of ill children at the paediatric clinic of those two hospitals were defined as potential 
participants, in order to obtain a broader sample of parents than was the case in the focus 
group study (section 6.2) and to more systematically collect parents’ knowledge and 
behaviour related to the use of antibiotics. However, the number of parents recruited in the 
study was relatively low and the recruiting process was difficult, which related to the time 
constraints for inviting parents and for parents to complete the questionnaire, as well as the 
limited resources of the project. Therefore, along with parents of ill children in the paediatric 
clinics, another group of parents – clinic staff – was pragmatically included to supplement this 
study. Another reason of including clinic staff in this quantitative survey is that the 
participants of the qualitative component are recruited from two kinds of nurseries – the 
medical university affiliated nursery and the general nursery, and some parents from 
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affiliated university are undertaking health-related jobs. Therefore, like the focus group study 
that included some parents with health-related background, the clinic staff were the part of 
questionnaire survey participants that were commonly highly educated with a health-related 
background, which made the participant composition of the two aspects of the study more 
similar, and facilitate the comparison and discussion of the aspects together.  
 
Study sites were enrolled via personal connections and networks (discussed in section 3.3.3 
of Chapter 3). Specifically, the study sites were accessed through the gatekeepers identified 
through personal networks in the pilot work for this study. They were senior-level staff or 
administrators in the paediatric department of these two hospitals. To recruit parents of ill 
children, after getting access to the paediatric clinic and being allowed to recruit parents of 
ill children there, the researcher was presented at the outpatient sessions of the paediatric 
clinics and approached parents waiting for their child to be seen by a doctor. The researcher 
started the recruiting process with a brief introduction of herself and the study, after being 
introduced to parents by the senior-level staff, and then invited them to take part. Potential 
participants who were willing to participate were then recruited in the study. If both parents 
of an ill child, or more than one family member, were present at the clinics, the mother was 
invited to take part because, in China, she is the one usually responsible for taking care of 
family members and is, therefore, likely to have the most detailed information on the child 
(discussed in section 1.3.2.1). For the other parent group of clinic staff, potential participants 
were the staff in the outpatient department of the two hospitals and they were made aware 
of the project by the senior-level staff in the outpatient department.  
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6.3.1.2 Data collection 
A 37-item structured questionnaire was developed based on evidence from earlier studies 
and revised in light of the pilot work, in order to collect parents’ knowledge of and views on 
antibiotics and ABR, parental behaviour regarding the use of antibiotics for their children, and 
their socio-demographic characteristics (see a summary of the questionnaire in Table 12 and 
the full version in Appendix M). In summary, the questions accessing parents’ knowledge and 
views mainly drew on the studies of Yu et al. (2014), Lv et al. (2014), and Huang et al. (2013), 
which include a number of questions on knowledge of and attitudes toward antibiotics and 
ABR among parents and Chinese students, respectively. For behaviour-related questions, the 
present questionnaire also drew on the three above studies, together with another two 
studies focusing on self-medication with antibiotics among Chinese students (Pan et al., 2012; 
Zhu et al., 2015). The questionnaire was translated into Chinese before use. 
 
Table 12 Summary of the questionnaire to explore parents’ antibiotic-related knowledge, views 
and behaviour  
Main topic areas Specific approaches 
1. Introductions 1.1 Explain rationale for the study and how to complete the 
questionnaire 
2. Parents’ 
knowledge of and 
views on 
antibiotics and 
ABR 
2.1 Closed-ended questions Q1-Q8, such as multiple choice 
questions and Likert-type scales, relating to parents’ knowledge 
of and attitude toward antibiotics and ABR 
3. Parents’ behaviour 
when their 
3.1 Closed-ended questions (Q9-Q23) relating to parents’ 
behaviour in seeking professional help for their unwell children, 
including:  
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children are unwell 
and using 
antibiotics 
Bringing their children to visit a doctor and the reasons (Q9-
Q10); 
Expecting to or being reluctant to accept antibiotic prescriptions 
for their children, as well as communication and satisfaction 
with the doctor during the consultation (Q11-Q19); 
Parents’ compliance with the antibiotic prescriptions for their 
children (Q20-Q23); 
3.2 Closed-ended questions (Q24-Q29) relating to parents’ 
behaviour of parental medication of antibiotics on children and 
the sources of parentally used antibiotics 
4. Background 
information of 
parents 
4.1 Closed-ended questions (Q30-Q37) relating to socio-
demographic characteristics of parents, including their gender 
and age, educational level, occupation, insurance situation, the 
age of their child, yearly household income, and place of 
residence 
 
The planned sample size was 100, taking into account the limited access to participants and 
the length of the questionnaire, which took approximately 25 minutes for parents to 
complete. A similar sample size has been used in the quantitative component of other health-
related multi-method studies (Giblin et al., 2004; Norris et al., 2009; Tofighi et al., 2017). The 
invitation and recruitment of participants for the questionnaire-based study therefore 
continued until the sample size reached 100, including both parents at the paediatric clinics 
and clinic staff. The questionnaire survey was undertaken from April to June 2016. All 
questionnaires were self-completed by participants immediately after they agreed to take 
part. Generally, for both hospitals, parents of ill children completed the questionnaire in the 
waiting areas of the paediatric clinic, while the hospital staff completed it in their offices.  
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6.3.1.3 Ethics statement 
As noted in section 4.2.3 of Chapter 4, ethical approval was granted by the Research 
Governance Committee of the Department of Health Sciences at the University of York. Both 
groups of parents (parents at the paediatric clinic and the clinic staff) were made aware that 
participating in the study was entirely voluntary and they were free to withdraw at any time 
before they agreed to take part. No incentives were offered to participants and informed 
consent was obtained.  
 
6.3.1.4 Data management and analysis 
Blank questionnaires (n=2), with no answers to any questions, were excluded. Data from the 
remaining questionnaires (n=98) were entered into Microsoft Excel and SPSS for Windows, 
version 24.0 for further analysis. Excel was used to describe the patterns of response in each 
question, and the analysis was then undertaken using SPSS.  
 
Parents’ knowledge related to antibiotics and ABR (part 2.1 in Table 12), as well as prescribed 
use of antibiotics (part 3.1 in Table 12) were further assessed by a scoring scheme, which gave 
a score of 1 for the correct knowledge or behaviour and 0 for the incorrect/uncertain/missed 
responses. As shown in Table 13, questions Q2, Q3, and Q6 were used to assess parents’ 
knowledge with a total score ranging from 0 to 11; to analyse prescribed use of antibiotics, a 
total score (ranging from 0 to 4) was given based on parents’ responses to Questions Q20-
Q23.  
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 Table 13 Scoring scheme relating parents’ knowledge of antibiotics and ABR and prescribed use of 
antibiotics 
Questions used to access the total score of parents’ knowledge of antibiotics and ABR 
Questions Correct response 
Q2. Do you think antibiotics are the same as anti-inflammatories? 
 Yes 
 No 
 Don’t know 
No (1 point) 
Q3. In your opinion, what kind of diseases are antibiotics used for? 
(Check more than one if applicable) 
 Bacterial infections 
 Viral infections 
 Others (specify)____________ 
 Don’t know 
Bacterial 
infections only (1 
point) 
Q6 (i). Higher doses of antibiotics result in faster recovery False (1 point) 
Q6 (ii). Lower doses of antibiotics result in fewer adverse effects False (1 point) 
Q6 (iii). Antibiotic treatment should be stopped as soon as symptoms 
have disappeared 
False (1 point) 
Q6 (iv). Continuing antibiotic use after the full treatment course will 
consolidate the effectiveness of the treatment 
False (1 point) 
Q6 (v). Stopping the antibiotic treatment before the course is 
completed will increase the risk of antibiotic resistance 
True (1 point) 
Q6 (vi). The more expensive antibiotics are, the better and more 
effective they are 
False (1 point) 
Q6 (vii). Broad-spectrum antibiotics (e.g. Amoxicillin) are more effective 
because they can kill a variety of bacteria 
False (1 point) 
Q6 (viii). Antibiotics can only be prescribed by doctors True (1 point) 
Q6 (ix). Antibiotics must be obtained (purchased) with a doctor’s 
prescription 
True (1 point) 
Questions used to access the total score of prescribed use of antibiotics 
Questions Correct response 
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Q20. I used antibiotics on my child in line with the dosage instructions 
that came with the antibiotics. 
 Yes 
 No 
Yes (1 point) 
Q21. My child took the full course of antibiotics. 
 Yes 
 No 
Yes (1 point) 
Q22. I needed to give my child antibiotics at dosages higher than 
instructed. 
 Yes 
 No 
No (1 point) 
Q23. I kept unused antibiotics for future use on my child. 
 Yes 
 No 
No (1 point) 
 
Continuous variables were summarised using the median values and quartiles, and 
categorical variables were reported by the percentage. Differences in total score of 
knowledge between parent groups with different socio-demographic characteristics were 
examined by the Mann-Whitney or Kruskal-Wallis tests. Other differences between the group 
of ill children’s parents and the clinic staff parent group were evaluated by the Mann-Whitney 
test and chi-square test; Fisher’s exact test was used where the sample size was too small for 
the chi square test. With respect to influences on parental behaviour regarding the use of 
antibiotics for their children (including prescribed use of antibiotics and non-prescribed use 
of antibiotics), Spearman rank correlations were used to examine the association between 
the total score of prescribed use of antibiotics and total score of parents’ knowledge, and 
binary logistic regression was used to test the association between whether parents ever use 
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antibiotics without prescriptions and the total score of parents’ knowledge. Binary logistic 
regression models were also used to examine the associations between whether parents 
achieved a full score regarding their use of prescribed antibiotics and their socio-demographic 
characteristics, and between whether parents ever use antibiotics without prescriptions and 
their socio-demographic characteristics. The reference for regression models was the 
category of response with the largest number. Missing data were excluded in the analysis. A 
value of p < 0.05 was considered as statistically significant. 
 
6.3.2 Results 
A total of 100 questionnaires were collected from 78 parents of ill children and 22 clinic staff, 
respectively, with a response rate of 82.6% (100 responded from 121 handed out). After 
excluding two blank questionnaires, the final sample of this quantitative study consisted of 
98 participants; most of them (76 out of 98 participants) were parents of ill children at the 
paediatric clinic of the recruited hospitals during the clinic time, and 22 participants were the 
clinic staff were parents.  
 
The participant profile is shown in Table 14 with information on missing data presented in 
Table 15. The majority of participants in the ill children’s parent group and all participants in 
the clinic staff group lived in Taiyuan city. For both groups, most parents were aged 30-39 
years. Data also indicated that the samples of both groups, particularly the clinic staff, were 
well-educated, and were more advantaged then the general population in Shanxi province, 
as well as nationwide (Shanxi Statistics Bureau, 2011; State Council Population Census Office 
& Population and Employment Statistics Division of National Statistics Bureau, 2012). In 
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addition, most participants of both groups lived in a household with an income of more than 
25,000 CNY. 
 
Table 14 Participant profile of the questionnaire study 
Participants 
 
Number of 
parents (%) 
Number of 
Clinic staff (%) 
Sex Male 13 (18.1) 11 (50.0) 
Female 59 (81.9) 11 (50.0) 
 
Age 
Under 30 years old 12 (16.0) 1 (4.5) 
30-39 years old 21 (68.0) 15 (68.2) 
40 years old and above 12 (16.0) 6 (27.3) 
Educational 
level 
Secondary school 9 (12.0) 1 (4.5) 
High school/secondary technical college 14 (18.7) 0 (0.0) 
College/university 42 (56.0) 10 (45.5) 
Postgraduate or above 10 (13.3) 11 (50.0) 
Insurance Only basic medical insurance scheme 63 (86.3) 22 (100.0) 
Only commercial insurance 4 (5.5) 0 (0.0) 
Both basic and commercial insurances 4 (5.5) 0 (0.0) 
None 2 (2.7) 0 (0.0) 
Age of child <3 (pre-nursery) 15 (21.7) 3 (16.7) 
3child age<7 (preschool) 31 (44.9) 10 (55.6) 
7child age<13 (primary school) 23 (33.3) 5 (27.8) 
Yearly 
income of 
household 
Below 10,000 CNY 8 (11.4) 2 (9.1) 
10,000-24,999 CNY 8 (11.4) 2 (9.1) 
25,000-49,999 CNY 21 (30.0) 6 (27.3) 
50,000 CNY and above 33 (47.1) 12 (54.5) 
 
Place of 
residence 
Taiyuan city 59 (79.7) 22 (100.0) 
Other cities in Shanxi province 8 (10.8) 0 (0.0) 
Rural areas in Shanxi province 6 (8.1) 0 (0.0) 
Other provinces 1 (1.4) 0 (0.0) 
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Table 15 Missing data across the 98 participants 
Socio-demographic characteristics The number of incomplete answers 
Parents Clinic staff 
Sex  4 0 
Age  1 0 
Educational level  1 0 
Insurance  3 0 
Age of child 7 4 
Yearly income of household 6 0 
Place of residence 2 0 
 
6.3.2.1 Parents’ knowledge of antibiotics and antibiotic resistance 
Most participants, including 90.8% of parents in the clinic and 100% of clinic staff, agreed that 
parents should be given more information related to the use of antibiotics for children. The 
doctor and pharmacy staff were identified as two major information sources among both 
parent groups, while the internet and professional training were noted as another important 
information source. With respect to concerns about ABR-related knowledge, 86.8% of 
parents in paediatric clinics were worried that their ABR-related knowledge is not sufficient; 
among clinic staff, 77.3% reported these concerns. 
 
Table 16 shows how parents understand antibiotics as well as their understandings related to 
the use of antibiotics and ABR, which indicates some widespread misunderstandings. For 
instance, there were widespread perceptions that antibiotics are the same as anti-
inflammatory drugs among both parents of ill children (72.4%) and clinic staff (63.6%). 
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Approximately half of parents of ill children as well as clinic staff believed that the 
effectiveness of antibiotic treatment will be consolidated when continuing antibiotic use after 
the full course; similarly, relatively high proportions of parents of ill children (46.1%) and clinic 
staff (40.9%) believed that lower doses of antibiotics result in fewer adverse effects. 
Additionally, among parents of ill children, 86.8% reported that they knew what antibiotics 
are while less than one-third correctly understood that antibiotics can only be used for 
bacterial infections (30.3%). Although clinic staff have a significantly higher correct response 
rate (72.7%) (Chi-square, 2 (1, N = 9831) = 12.84, p <0.01) on this question, 27.3% had 
perceptions that antibiotics can be used for non-bacterial infections.  
 
Table 16 The number and proportion of parents who correctly answered questions related to 
antibiotics and ABR 
Questions Correct response no. (%) 
Parents*  Clinical staff* 
Q2. Are antibiotics the same as anti-inflammatory drugs? 21 (27.6) 8 (36.4) 
Q3. Are antibiotics only used for bacterial infections? 23 (30.3) 16 (72.7) 
Q6 (i) Do high doses of antibiotics result in faster recovery? 59 (77.6) 20 (90.9) 
Q6 (ii) Do lower doses of antibiotics result in fewer adverse 
effects? 
41 (53.9) 13 (59.1) 
Q6 (iii) Should antibiotics treatment be stopped as soon as 
symptoms have disappeared? 
51 (67.1) 21 (95.5) 
Q6 (iv) Will continuing antibiotic use after the full treatment 
course consolidate the effectiveness of the treatment? 
39 (51.3) 12 (54.5) 
                                                        
31 There was one missing case, and it was interpreted as an incorrect response on whether antibiotics only treat bacterial infections. 
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Q6 (v) Will stopping the antibiotic treatment before the 
course is completed increase the risk of ABR? 
41 (53.9) 15 (68.2) 
Q6 (vi) The more expensive antibiotics are, the better and 
more effective they are, is it true? 
69 (90.8) 19 (86.4) 
Q6 (vii) Are broad-spectrum antibiotic more effective because 
they can kill a variety of bacteria? 
56 (73.7) 18 (81.8) 
Q6 (viii) Can antibiotics only be prescribed by doctors? 50 (65.8) 18 (81.8) 
Q6 (ix) Can antibiotics only be obtained with a doctors’ 
prescription? 
52 (68.4) 19 (86.4) 
Note: *There were 1, 2, 2, 2, 3, 6, 1, 4, 3 and 2 participants missing Q3 to Q6 (ix), respectively, among 
parents of ill children, and no missing data among clinic staff.  
 
The median total scores of parents’ knowledge related to antibiotics and ABR (calculated 
based on Table 13) was 6 for the group of ill children’s parents and 8 for clinic staff. Moreover, 
for the group of ill children’s parents, the 25th and 75th percentile were 5.25 and 8.00, 
respectively, and for clinic staff parent group, the 25th percentile was 7.00 and the 75th was 
9.00.  
 
For analyses that examined socio-demographic factors associated with differences in parents’ 
knowledge scores, considering the small numbers involved in this quantitative study and the 
lack of variation on some of the socio-demographic characteristics for the group of clinic staff 
(e.g. insurance scheme), the two groups were examined together, and a new variable relating 
to whether the participant is a clinic staff or not was added. There was a significant difference 
between total scores of knowledge of antibiotics and ABR between clinic staff and parents of 
ill children (Mann-Whitney, U = 480.00, n1 = 76, n2 = 22, p<0.01). Moreover, there was an 
overall significant difference in total scores of knowledge between parent groups with 
different educational levels (Kruskal-Wallis, H = 10.36, df = 3, p<0.05) (Table 17); further 
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pairwise analysis indicated that there was a significant difference between total scores of 
knowledge of parents with secondary school educational level and parents with a 
postgraduate qualification or above (Dunn’s pairwise test, p<0.05).  
 
Table 17 Mann-Whitney and Kruskal-Wallis analysis on the differences between the total scores of 
knowledge of antibiotics and ABR in parents with different socio-demographic characteristics.  
Socio-demographic 
characteristics 
No. of 
parents 
No. of 
groups 
Mann-
Whitney U 
Kruskal-
Wallis H 
p value 
Gender 94 2 731.50 N/A 0.34 
Age of parents 97 3 N/A 2.90 0.24 
Education of parents 97 4 N/A 10.36 0.02 
Occupations (health-
related or not) 
98 2 480.00 N/A <0.01 
Insurance scheme (have 
or not) 
95 2 231.50 N/A 0.58 
Age of children 87 3 N/A 0.89 0.64 
Income of parents 92 4 N/A 7.80 0.05 
Place of residence 
(Taiyuan or other places) 
96 2 465.50 N/A 0.15 
Mann-Whitney or Kruskal-Wallis test was applied depending on the numbers of groups being 
compared. 
 
6.3.2.2 Parents’ behaviour regarding the use of antibiotics for their children 
Most parents, including 72.4% of parents of ill children and 77.3% of clinic staff, respectively, 
acknowledged that whether parents seek professional help for their ill children depends on 
the severity of their condition. During the consultation, potentially-serious childhood 
conditions – fever (56.6% of parents of ill children and 45.5% of clinic staff) and sore throat 
(36.8% of parents of ill children and 45.5% of clinic staff) – were widely reported as conditions 
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that made them expect the doctor to prescribe antibiotics, while antibiotics were less 
commonly demanded for minor conditions, such as a runny nose (2.6% of parents of ill 
children and 9.1% of clinic staff). However, despite being keen on antibiotics, only 21.1% of 
parents of ill children reported that they would demand antibiotics from the doctor for their 
children. In contrast, 53.9% of them recalled that they had on occasion been reluctant to 
accept an antibiotic prescription for their children, with their main concerns being ABR (75%) 
and the side effects of antibiotics (75%). This situation is similar among the clinic staff, in that 
31.8% of them reported they would make clear to the doctor their desire for antibiotics to be 
prescribed, while 63.6% of them have sometimes been reluctant to accept antibiotic 
prescriptions.   
 
The questions related to prescribed use of antibiotics are shown in Table 18. Most parents in 
both groups reported using antibiotics at the right dosage and for the full course for their 
children; however, nearly half (47.4%) of parents of ill children and an even higher proportion 
(68.2%) in the parent group of clinic staff answered that they kept unused antibiotics for 
future use on their children. Data analysis indicated that there were no significant differences 
in prescribed use of antibiotics between the ill children’s group and the clinic staff group 
(Table 19). With respect to the total score of prescribed use of antibiotics (calculated based 
on Table 13), most parents in both groups had a high score with either 3 or the full score of 
4. Specifically, in the group of ill children’s parents, there were 48.7% and 32.9% of parents 
earning a score of 3 and 4, respectively; while 63.6% of clinic staff obtained a score of 3 and 
18.2% obtained a score of 4. In addition, the median was 3 for both groups, and this total 
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score was found to be not significantly different between them (Mann-Whitney, U = 741.00, 
n1 = 76, n2 = 22, p>0.05). 
 
Table 18 The proportion of parents who answered yes in questions related to prescribed use of 
antibiotics 
Questions The proportion of participants 
who answered ‘Yes’ (%) 
Parents* Clinic staff* 
Q20. I used antibiotics on my child in line with the 
dosage instructions with antibiotics. 
85.5 90.9 
Q21. My child took the full course of antibiotics. 86.8 81.8 
Q22. I needed to give my child antibiotics at dosages 
higher than instructed. 
6.6 4.5 
Q23. I kept unused antibiotics for future use on my child. 47.4 68.2 
Note: *There were 10, 9, 11, 10 participants missing Q20, Q21, Q22 and Q23, respectively, among 
parents of ill children; there were 2 participants missing Q20-Q23 among clinic staff. 
 
Table 19 Chi-square tests on differences in prescribed use of antibiotics between parents of ill 
children and clinic staff 
Variables df N 2 p value 
*Q20. I used antibiotics on my child in line with 
the dosage instructions with antibiotics 
1 86 N/A >0.99 
*Q21. My child took the full course of antibiotics 1 87 N/A 0.13 
*Q22. I needed to give my child antibiotics at 
dosages higher than instructed 
1 85 N/A >0.99 
Q23. I kept unused antibiotics for future use on 
my child. 
1 86 2.66 0.13 
Note: *Fisher’s exact test was used as there were more than 20% of expected frequency being less 
than 5 and/or the minimum expected frequency was less than 1 (Field, 2005) 
 
While the appropriate use of prescribed antibiotics among parents in both groups (see Table 
18), data suggested that a majority acknowledged that they have used antibiotics without 
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prescriptions for their children, which accounted for 73.7% of parents of ill children and 68.2% 
of clinic staff, and there was no significant difference between parents of ill children and clinic 
staff (Chi square, 2 (1, N = 9532) = 0.65, p = 0.42). The median number of occasions that 
parents used antibiotics without prescriptions for their children in the last 12 months was 2 
and 1 for parents of ill children and clinic staff, respectively. In addition, the majority of 
parents (65.8% of ill children’s parents and 68.2% of clinic staff) had purchased antibiotics 
without prescriptions, with the retail pharmacies reported to be the main source by both 
groups. 
 
6.3.2.3 Factors influencing parents’ behaviour regarding the use of antibiotics for their 
children 
Based on the objectives of this quantitative study, this section explores the influences of 
parents’ knowledge of antibiotics and ABR and socio-demographic characteristics on their 
parental behaviours, including (i) prescribed use of antibiotics and (ii) non-prescribed use of 
antibiotics. Clinic staff and ill children’s parents were again grouped together for the following 
analyses, and a new variable relating to whether the participant is clinic staff or not was added. 
This was for reason of the small sample size and the lack of variation on socio-demographic 
factors, as well as the similar patterns of use of antibiotics among the two groups discussed 
in section 6.3.2.2.  
 
                                                        
32 There were three missing cases. 
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(i) Influences of parents’ knowledge of antibiotics and antibiotic resistance and their 
socio-demographic characteristics on prescribed use of antibiotics 
The total score of prescribed use of antibiotics (discussed in section 6.3.2.2) and total score 
of parents’ knowledge of antibiotics and ABR (discussed in section 6.3.2.1) were used to 
assess the association between prescribed use of antibiotics and parents’ knowledge. For the 
total score of prescribed use of antibiotics, among 98 participants, the median was 3. 
However, no parent obtained a score of 1 and very few parents obtained scores of 0 or 2; on 
the contrary, 52.0% (51) and 29.6% (29) of parents obtained scores of 3 and 4, respectively. 
For the knowledge of antibiotics and ABR, the majority obtained scores between 6 to 9, with 
a median of 7. It was found that there was no significant association between total score of 
prescribed use of antibiotics and total score of parents’ knowledge (Spearman rank 
correlation, rs = 0.03, N = 98, p = 0.75).  
 
Additionally, the association between prescribed use of antibiotics and parents’ socio-
demographic characteristics was analysed by logistic regression. Because of distribution of 
scores relating to the prescribed use of antibiotics (discussed in section 6.3.2.2, pp.240 ), this 
variable, which originally contained five categories, was reduced to two binary categories: 
parents obtaining a score of 4 and parents obtaining a score of less than 4. There was no 
relationship between whether or not parents obtained the full score and their socio-
demographic characteristics (Table 20).  
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 Table 20 Logistic regression analysis on the association between whether or not parents obtained 
the full score of prescribed use of antibiotics and their socio-demographic characteristics 
Factors Parents* 
B (SE) p value 
Gender (male) -0.27 (0.77) 0.73 
Age of parents (years) 
< 30 0.66 (1.06) 0.53 
30-39 Reference 
 40 0.03 (0.90)  0.98 
Education of parents 
Secondary school -1.02 (1.41) 0.47 
High school/Secondary technical college  0.17 (0.89) 0.85 
College/University Reference 
Postgraduate or above -2.71 (1.16) 0.02 
Occupations (health-related) -0.49 (0.79) 0.54 
Insurance (without insurance schemes) -1.06 (1.28) 0.41 
Age of children (years) 
< 3 -0.25 (0.90) 0.79 
3-7 Reference 
7-12 0.08 (0.68) 0.90 
Income of parents 
< 10,000 CNY 0.86 (0.97) 0.37 
10,000 CNY -24,999CNY -0.44 (0.91) 0.63 
25,000 CNY – 49,999CNY -0.99 (0.70) 0.16 
 50,000 CNY Reference  
Place of residence (other places than 
Taiyuan city) 
-1.05 (0.86) 0.22 
Note: *There were 18 missing cases 
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(ii) Influences of parents’ knowledge of antibiotics and antibiotic resistance and their 
socio-demographic characteristics on non-prescribed use of antibiotics 
The binary variable of whether or not parents ever use antibiotics without prescriptions for 
their children (discussed in section 6.3.2.2) was used to describe non-prescribed use of 
antibiotics, and to assess associations between non-prescribed use of antibiotics and parent’ 
knowledge and between non-prescribed use of antibiotics and parents’ socio-demographic 
characteristics. The median values of total score of knowledge in groups of parents who never 
use antibiotics without prescriptions and parents who ever use antibiotics without 
prescriptions were both 7. The 25th percentile and 75th percentile of the total score of 
knowledge were 6 and 8 in the group of parents who ever use antibiotics without 
prescriptions, while they were 6 and 9 of the group of parents who never use antibiotics 
without prescriptions. In the logistic regression analysis, whether or not parents ever use 
antibiotics without prescriptions for their children was not associated with their total score 
of knowledge of antibiotics and ABR (Table 21), nor their socio-demographic characteristics 
(Table 22). 
  
Table 21 Logistic regression analysis on the association between whether or not parents ever use 
antibiotics without prescriptions for their children and their knowledge of antibiotics and ABR 
Factors Parents* 
B (SE) p value 
Knowledge of ABs -0.12 (0.12) 0.32 
Note: *there were 3 missing cases 
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Table 22 Logistic regression analysis on the association between whether or not parents ever use 
antibiotics without prescriptions for their children and their socio-demographic characteristics 
Factors Parents* 
B (SE) p value 
Gender (male) 0.93 (0.75) 0.22 
Age of parents (years) 
< 30 0.55 (1.09) 0.61 
30-39 Reference 
 40 0.20 (0.95)  0.83 
Education of parents 
Secondary school 1.62 (1.45) 0.27 
High school/Secondary technical college  -1.10(0.92) 0.23 
College/University Reference 
Postgraduate or above -0.75 (0.77) 0.33 
Occupations (health-related) -0.62 (0.73) 0.40 
Insurance (without insurance schemes) 0.20 (1.42) 0.89 
Age of children (years) 
< 3 -0.80 (0.84) 0.34 
3-7 Reference 
7-12 0.97 (0.74) 0.19 
Income of parents 
< 10,000 CNY -1.09 (0.94) 0.24 
10,000 CNY -24,999CNY 0.92 (1.28) 0.47 
25,000 CNY – 49,999CNY -0.16 (0.72) 0.82 
 50,000 CNY Reference  
Place of residence (other places than 
Taiyuan city) 
-0.44 (0.84) 0.60 
Note: *There were 19 missing cases 
 
  
 247 
6.3.3 Summary 
The quantitative study indicated a general lack of knowledge of antibiotics and ABR among 
parents of ill children and clinic staff. It also pointed to their behaviour regarding the 
appropriate use of prescribed antibiotics, including the use of antibiotics at the right dosage 
and the full course for their children, as well as the widespread use of non-prescribed 
antibiotics with the retail pharmacies being regarded as a main source of OTC antibiotics. In 
addition, the study identified that parents’ prescribed and non-prescribed use of antibiotics 
were not associated with either their knowledge of antibiotics and ABR, or their socio-
demographic characteristics. These findings are discussed together with findings from the 
qualitative study in the following section. 
 
6.4 Discussion 
To the knowledge of the researcher, this is the first multi-method study, as well as the first 
qualitative study, in China exploring influences on parents’ behaviour with respect to the use 
of antibiotics for their children. The multi-method design, in which the qualitative and 
quantitative components are undertaken separately and then the results are brought 
together, draws on the strengths of each method and provides a fuller picture of the study 
area (Byrne & Humble, 2007; Morse, 2003). Therefore, in this study, the qualitative section 
described how their understandings of children’s diseases and treatment, and of providers 
influenced their use of antibiotics for their children; the quantitative component further 
assessed their knowledge related to antibiotics and ABR, and identified that parental use of 
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antibiotics for their children was not associated with parents’ antibiotic and ABR knowledge 
and their socio-demographic characteristics, such as educational level.  
 
Previous studies focusing on China noted the lack of antibiotic and ABR-related knowledge 
among parents (Ding et al., 2015, 2015A; Yu et al., 2014). They also discussed the influences 
of providers, the ease of access to antibiotics, and socio-demographic characteristics, such as 
the age and number of children as well as the severity of conditions, on parental behaviour 
regarding the use of antibiotics for children (Bi et al., 2000; Ding et al., 2015, 2015A; Wang et 
al., 2017; Yu et al., 2014). In line with previous studies’ findings, this multi-method study 
pointed to a lack of knowledge and incorrect beliefs about antibiotics and ABR among parents; 
it also shed light on the influences of knowledge on parents’ antibiotic-related behaviour 
through both qualitative and quantitative data. Moreover, this study described how parental 
use of antibiotics for their children was influenced by parents’ understandings of their 
children and trust, and the accessibility of different providers, which is consistent with 
previous studies and gives deeper discussion based on the insights provided by qualitative 
data. 
 
The data from the focus groups and the questionnaire suggested that there was a lack of 
antibiotics and ABR-related knowledge among parents. As noted by studies focusing on rural 
parents in China (Ding et al., 2015, 2015A; Yu et al., 2014), this quantitative study reported a 
relatively low correct response rate on antibiotics and ABR-related questions, such as the 
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difference between antibiotics and anti-inflammatory drugs 33 , among parents. The 
qualitative information further provided detailed information on parents’ misunderstandings 
of antibiotics and ABR. For instance, some of the beliefs held by parents were not based on 
scientific facts (e.g. that antibiotics are not good for children without being able to identify 
specific harms), which may result in their expectations or resistance to the use of antibiotics 
for their children. Also, there were only a few parents who were aware of ABR and were 
concerned about it, and, consistent with qualitative studies of the general population in rural 
China (Jin et al., 2011; Reynold & McKee, 2009), these parents believed ABR was the 
development of resistance to antibiotics in the human body rather than in bacteria. Similar 
misunderstandings have also been noted by providers in their perceptions on parents’ 
understanding of antibiotics and ABR in Chapter 4.  
 
Similar to the studies of Yu et al. (2014) and Ding et al. (2015A), this quantitative study 
indicated that there were no associations between parental use of antibiotics for their 
children and parents’ knowledge of antibiotics and ABR. Additionally, among the two parent 
groups in the quantitative study, although their antibiotics and ABR knowledge scores were 
significantly different, there were no differences in their behaviour regarding the use of 
antibiotics, including parental use of prescribed antibiotics and parentally-medicating with 
antibiotics for their children.  
 
                                                        
33 In China, anti-inflammatory drugs actually include antipyretic-analgesic, anti-inflammatory drugs, and steroid hormones. (Jin et al., 2011) 
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The lack of an association between parents’ knowledge and behaviour may reflect the 
composition of the study samples as the researcher was sampling just one end of a 
distribution; there may be found a correlation if this present study samples a broader 
distribution of educational level . Moreover, based on this qualitative data, this may also be 
related to parents’ understandings of disease and treatment, which influenced their use of 
antibiotics for children being grounded in both TCM and Western medicine perspectives. 
Among Chinese populations, the use of TCM theory in interpreting illnesses is widespread 
(Chung et al., 2014), and, in line with the present findings, a concurrent use of TCM and 
Western medicine in understanding of diseases and treatment was highlighted (Chan, 2002; 
Simpson, 2003). However, among Chinese populations, antibiotics were only located 
conceptually within Western medicine. Therefore, exploring parents’ knowledge of 
antibiotics and ABR, which simply evaluates parents’ understandings of disease and 
treatment through a Western medicine perspective, may be too simplistic an approach to 
reveal the various influences on their use of antibiotics for children. Further research that 
takes an integrated TCM and Western medicine perspective into account could be helpful in 
investigating potential understandings of disease and treatment, including antibiotics, and 
exploring how these understandings influence parents’ antibiotic-related behaviour for their 
children. Along with Chapter 4 that noted how public’s understanding of disease and 
treatment built around TCM and Western medicine influenced providers’ paediatric use of 
antibiotics , this thesis thus pointed to the important influences of the dual use of TCM and 
Western medicine perspectives on providers’ and parents’ behaviour with respect to the use 
of antibiotics for children in China, which is detailed discussed in the next chapter.  
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Studies of parents’ use of antibiotics focusing on HICs and rural China have pointed to the 
important influence of providers on parental behaviour (Cabral et al., 2014, 2015, 2016; Ding 
et al., 2015; Yu et al., 2014). This point was also supported by both the present qualitative 
and quantitative parental studies, with evidence of high parental compliance with providers’ 
antibiotic-prescribing decisions in the consultation as well as parental compliance in the use 
of prescribed antibiotics for their children. As Chapter 4 highlighted the parental influences 
on providers, this thesis described how the interaction between providers and parents 
influenced their use of antibiotics for children in China (discussed in next chapter).  
 
These qualitative and quantitative parental studies both found that the retail pharmacy was 
the main source for parents to purchase antibiotics without a prescription, even though this 
practice has been officially forbidden since 2004 (Fang, 2014). Parents purchasing OTC 
antibiotics is a long-standing problem in China that has been identified in studies undertaken 
before prescription requirements were enforced in retail pharmacies (Bi et al., 2000), as well 
as after the introduction of regulations (Yu et al., 2014). Similar to previous studies (Bi et al., 
2000; Jin et al., 2011; Yu et al., 2014), the present data pointed to how ease of access to OTC 
antibiotics influenced parents’ use of them for their children, and therefore the importance 
of reinforcing the supervision and administration of regulations on dispensing prescribed 
drugs in retail pharmacies. Additionally, along with the qualitative evidence that described 
how difficult it could be to get access to professional care in the hospital and the ease of 
obtaining OTC antibiotics from the retail pharmacy, this study indicated that parents’ 
behaviour of the use of antibiotics was influenced by the healthcare system as a whole. This 
kind of organisational influences was also noted by providers, which was related to how the 
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interactions between different healthcare institutions influenced their paediatric use of 
antibiotics, in the present provider study in  Chapter 5. 
 
Finally, the present results suggested that there was a similar lack of knowledge related to 
antibiotics and ABR in this advantaged group as in the general population (Ding et al., 2015; 
Jin et al., 2011; Yu et al., 2014). In response to the questions about whether antibiotics and 
anti-inflammatory drugs are the same, for example, the proportion of parents giving the 
correct response was 27.6% and 36.4% of the ill children’s parents and clinic staff, respectively, 
similar to the findings of a study conducted with rural parents (34.8%) (Yu et al., 2014). Some 
of the same types of influences on parents’ antibiotic-related behaviour, such as providers, 
were also found both among general populations and this advantaged group (Ding et al., 2015; 
Yu et al., 2014). Further, the qualitative part of the present study suggested a co-existence of 
TCM and Western medicine perspectives in understanding children’s diseases and treatment 
among parents with higher educational backgrounds and incomes. This is consistent with 
findings from other Chinese populations studies, which found that double (TCM and Western 
medicine) consulters were more likely to have higher socioeconomic backgrounds (Chung et 
al., 2007; Chung et al., 2009).  
 
Within the present qualitative study, although all participants were more advantaged than 
the general population, there were still some differences between participants recruited from 
the general nursery and from the university affiliated nursery. The differences were similarly 
found in the quantitative study among parents of ill children and clinic staff. For the 
qualitative part, parents were recruited from two groups (a general nursery and a medical 
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university affiliated nursery) with the majority from the affiliated nursery. This led to some 
sub-themes being drawn disproportionately from one group’s accounts. For instance, parents 
from the general nursery appeared to have greater trust in the TCM, even though the TCM 
perspective was noted by both groups of parents, while concerns about antibiotic treatment 
and ABR arose disproportionately from the affiliated (more advantaged) group, particularly 
for parents with a health-related background. Similarly, within the quantitative study, 
knowledge of antibiotics and ABR was significantly different between participants from the ill 
children’s parent group and the clinic staff group. A possible explanation for these differences 
is that participants from the affiliated nursery in the qualitative study and from the clinic staff 
group in the quantitative study typically had Western medicine-related backgrounds. They 
may, therefore, be more likely to understand diseases and treatment through a Western 
medicine perspective, and, because antibiotics are a type of western medicine, to have 
greater antibiotic-related knowledge. However, as the main aim of this study is to explore 
factors influencing parents’ use of antibiotics for their children, and the sample sizes of both 
qualitative and quantitative studies were small, it would not be appropriate to draw strong 
conclusions from these differences. Further research focusing on a larger sample and 
providing a broader picture would be helpful to investigate these differences in more detail. 
 
Methodological limitations 
When interpreting the results, some limitations of the study need to be borne in mind. First, 
the sample size was small for both the qualitative and quantitative studies. For the qualitative 
study, the number of focus groups and focus group sizes were small – there were only three 
focus groups included and the smallest focus group only had three participants. However, 
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analysis based on the comments of single participants as well as short exchanges between 
parents indicated that all themes reached saturation, meaning that including more 
participants would have been unlikely to increase the breadth of qualitative findings. When 
the findings of the present study were compared with those of other studies focusing on 
influences on parental use of antibiotics, it was found that the key influences identified in 
other studies were also noted in present study. There is a risk that in a small focus group, the 
discussion is dominated by one member and this influences the quality of data (Twinn, 1998). 
However, Twinn’s (1998) study also noted problems in large focus groups related to the 
potential failure to capture full discussion, as well as the inability to go into greater depth on 
different topics (Twinn, 1998). Moreover, while there was a more dominant member in one 
focus group (FG 3), the impact was positive; the dominant member helped to create a friendly 
atmosphere and guide the discussion.  
 
For the quantitative study, participants were recruited from two groups, and both parent 
groups, particularly the clinic staff, were based on small samples. This was principally due to 
the inherent difficulties in recruiting participants and the time constraints imposed by clinic 
schedules; these restricted the time available to invite parents to be involved in the study and 
for study participants to complete the questionnaire. Therefore, similar to other mixed 
method studies with a small sample in the quantitative component (Norris et al., 2009; Tofighi 
et al., 2017), the sample size of this study was determined by practical constraints rather than 
by a power calculation. For quantitative studies, a small sample size can lead to problems in 
interpreting the results, because it does not normally generate reliable or precise estimates 
(Field, 2005; Hackshaw, 2008). Nonetheless, the quantitative component did meet the study’s 
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aim of describing parents’ antibiotic knowledge and their antibiotic-using patterns for 
children in a broader group. Moreover, being an exploratory study, findings from the present 
study mainly focused on informing larger studies rather than generating firm conclusions. 
Therefore, in the analysis of the statistical results, such as associations between parents’ 
antibiotic and ABR-related knowledge and their antibiotic-use behaviours, no strong 
conclusions were based on the results; instead, the potential reasons of yielding certain 
results were discussed and suggestions for further research were provided.  
 
Additionally, there are limitations related to pragmatically recruiting the group of clinic staff 
alongside parents of ill children in the sample. As the socio-demographic characteristics, such 
as educational level and insurance, between clinic staff and ill children’s parents were very 
different, this study’s analysis was based on two different kinds of parent groups rather than 
parents of ill children only, which is different from the initial goal of the study. Moreover, 
although, for most part, these two groups were analysed separately, they were examined 
together in regression models because of the small sample size of both groups and the lack 
of variation on some predictors (Field, 2005), which would also decrease the reliability of the 
regression results.  
 
Secondly, rather than representing the general population of parents in China, the study is 
based on data from relatively socio-economically advantaged parents. This is a consequence 
of the selection of study sites and potential participants. First, as mentioned above in section 
4.1, the study city is more advantaged than the wider Shanxi province with respect to 
residents’ incomes. Moreover, in China, the common situation is that parents with higher 
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incomes would send their children to the nursery while poorer parents may take care of their 
children at home. As the study sites for the qualitative study were two major nurseries in the 
city, including one university-affiliated nursery, potential participants are very likely to have 
higher educational levels and, therefore, higher incomes than the general population. For the 
quantitative study, clinic staff working at the paediatric department in the hospital, who 
usually have a higher educational level than the general population of parents, were recruited. 
In consequence, the sample of this study was relatively advantaged and many participants in 
both components of the study also worked in the healthcare sector and had a health-related 
background, including three of the 12 focus group participants and 22 of the 98 survey 
respondents. Along with the small sample size, these factors therefore limit the wide 
generalisation of the findings. For instance, among the advantaged groups, this study pointed 
to some types of understandings and behaviour related to the appropriate use of antibiotics, 
such as parents’ understandings of compliance with the antibiotic prescription, which have 
not been commonly identified in other studies in China. Nevertheless, similar to the general 
population, there was evidence of a considerable lack of knowledge around what antibiotics 
and ABR are. In addition, some wider issues, such as the use of TCM perspectives in 
understanding diseases and treatment or the use of OTC antibiotics, are very likely to be 
found in the wider population of parents, given that they were evident in the more 
advantaged people recruited to this study. These dimensions will be discussed further below.   
 
Considering these limitations of the present study, a further mixed-method study that 
focused on a larger sample, particularly in the quantitative part, and relied on a random 
sampling method, would be helpful to obtain more widely representative data and reveal the 
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influences on parental use of antibiotics in more detail. A further study should also 
encompass a more general population, such as including parents from less advantaged 
communities who are more likely to care for their children at home. 
 
6.5 Conclusions 
This multi-method study has provided insights into influences on the use of antibiotics for 
children among parents in a city with a profile typical of Mainland China. While both 
components of the study included a relatively advantaged group of parents, they illuminate 
a set of influences on parental behaviour of broader relevance. First, the evidence from the 
study indicates that, rather than being based solely on antibiotic and ABR-related knowledge 
from a Western medicine perspective, parents’ decisions about the use of antibiotics for their 
children are influenced by their understanding of disease and treatment that is built on a 
combination of TCM and Western medicine perspectives, as well as their personal experience 
of taking care of their children. Additionally, the study has shown that providers are another 
important influence on parents’ behaviour with respect to the use of antibiotics for their 
children, and that trust and familiarity, as well as accessibility, are important factors in 
determining their influence. These findings therefore suggest that interventions to reduce 
the use of antibiotics need to include a focus on parents, since even for parents with a high 
educational level and a high income, relatively low levels of understanding of antibiotics and 
ABR were found. In addition, any interventions need to take into account cultural factors, in 
particular the co-existence of TCM and Western medicine perspectives, among Chinese 
populations. Interventions also need to address parents’ trust in and use of the primary care 
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system. This is in line with the Health China 2030 plan that the government has focused on 
strengthening the primary care system and the retail pharmacy sector in China (CPC Central 
Committee & State Council, 2016). 
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Chapter 7. Discussion and conclusions
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7.1 Introduction 
As noted in earlier chapters, high rates of antibiotic use are the key contributors of ABR in 
China, where the prevalence of many antibiotic resistant strains ranks amongst the highest in 
the world (Heddini et al., 2009; Xiao et al., 2011). The paediatric use of antibiotics by providers 
and parents has been identified as a particular challenge (Jiang et al., 2013; Yu et al., 2014; 
Zou et al., 2014; Yang et al., 2010). However, the present literature searches and reviews, 
including both English- and Chinese-language records, found a major gap in research, and 
qualitative research in particular, relating to influences on providers’ and parents’ antibiotic-
related behaviours for children in China. This is the gap that this project has helped to address. 
A qualitative study and a multi-method study were undertaken of providers and parents, 
respectively, in a major city of China. They pointed to a variety of influences on the use of 
antibiotics for children. Building on all previous chapters, this final chapter provides an 
overview of the thesis and highlights insights as well as issues arising from this research.  
 
There are three main parts of this chapter. The first part (section 7.2) summaries key findings 
from the primary studies and discusses the limitations. The second part (section 7.3) then 
discusses empirical chapters together and locates the insights within the SEF and, specifically, 
within the individual, interpersonal and organisational levels. The final part (section 7.4) 
provides conclusions, along with implications related to the use of antibiotics drawing on 
different levels of the SEF, as well as suggestions for further research.  
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7.2 Results and limitations  
This doctoral research is an urban-based study conducted with providers and parents who 
are resident in a major city in China. As a consequence, the study setting is advantaged with 
respect to basic medical insurance benefits and residents’ health conditions due to inequities 
in coverage between rural and urban areas (discussed in section 1.3.1, pp.42). Moreover, it 
was found in both the present and Gao et al.’s (2018) studies that urban residents have a 
higher household income and education than the average level. Gao et al. (2018) further 
indicated that those urban residents with stable, better jobs were better protected by social 
benefits. As the large population of parents in the present study had professional jobs (some 
of the jobs were health-related), they are likely to be more secure and better paid, as 
confirmed by their answers to questions on household income. In consequence, the present 
study is based in advantaged groups in an advantaged setting. This also influenced the 
questions used in questionnaire survey and focus groups of parents; for example, problems 
with affording antibiotics were not asked. 
 
The qualitative study of providers pointed to two key influences on their antibiotic-related 
behaviour. Firstly, they described how parents influenced their antibiotic prescribing, with 
influences clustering under three themes: the importance of (i) public understandings of 
disease and treatment within traditional Chinese medicine and Western medicine, (ii) 
parental trust, and (iii) good relationships with patients (discussed in Chapter 4). Secondly, 
they described the influence of the organisational context. Providers noted that their 
behaviour with respect to the use of antibiotics for children was influenced by China’s 
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healthcare system and national policies, which could be located within domains identified in 
the SEF relating to the organisational level and policy level (discussed in Chapter 5). The multi-
method study, undertaken with an advantaged group of parents, indicated that, rather than 
solely derived from their knowledge of Western medicine, parents’ decisions about the use 
of antibiotics for their children were influenced by understandings of disease and treatment 
that drew on both TCM and Western medicine perspectives, as well as their personal 
experience of taking care of their children. It additionally noted that trust and familiarity, as 
well as the accessibility to providers, were important influences on parents’ behaviour with 
respect to the use of antibiotics for their children (discussed in Chapter 6). 
 
This doctoral thesis provides insight into factors influencing providers’ and parents’ antibiotic-
related behaviours through small-scale studies conducted in a single urban study location. 
The provider study included in 26 providers, and the parental study included three focus 
groups (in total 12 parents of nursery children) together with 98 parents in the questionnaire 
survey. Furthermore, as noted above, the analysis was based on evidence from parents in 
more advantaged groups, and concerns about medical insurance and other economic-related 
influences, such as the cost of medicines, were not reported. Therefore, caution needs to be 
exercised in generalising these findings to broader populations or settings.  
 
Generalisability is a widely recognised issue for qualitative studies. Because qualitative 
studies are characterised by rich data from small samples (Hart et al., 2006; Mustafa et al., 
2014; Petursson, 2005), the application of criteria commonly used to determine the 
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generalisability of quantitative studies can fail to do justice to these strengths and 
contributions (Lewis & Ritchie, 2003). As noted by Lewis and Ritchie (2003), generalisability 
in the context of qualitative studies is more related to the quality and appropriate use of 
original data, and the clear description of the research and study setting, than to sample size 
(Lewis & Ritchie, 2003). As noted in Chapters 4 to 6, the interviews and focus groups were 
conducted in Chinese and data were then translated, verbatim, into English, with any 
ambiguities discussed with the researcher’s supervisors (both of whom were UK researchers) 
in order to identify English words that retained the original meaning of concepts and terms 
for the analysis and interpretation, such as the term ‘quality’ (discussed in section 4.3.2.2, 
pp.157). The content related to participants, such as the background setting and the features 
participants displayed, were also collected by audio-recording and field notes. Furthermore, 
as noted in empirical chapters, in reporting the findings of the qualitative studies, the COREQ 
guidelines were followed (Tong et al., 2007). In addition, although the present research was 
conducted in one city, the study city – Taiyuan city – is medium-sized with average wealth 
and health expenditure (Pan & Wei, 2015; Statistical Information Centre of NHFPC, 2016), 
and therefore represented the profile of a typical city in China.  
  
The present study was based on providers’ and parents’ accounts; beyond my field notes, 
there was no direct observation of participants’ behaviour. Participant accounts of their 
behaviour and the influences on it may not accord with their actual practices and influences. 
For instance, a study focusing on doctors in Shandong province, China indicated that, 
although 87% of the doctors reported in a questionnaire survey that they would refuse to 
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prescribe antibiotics to patients with a common cold, more than half of prescriptions for 
common cold collected from the healthcare institutions in which the doctors were working 
included antibiotics (Sun et al., 2015).  
 
Mindful of this issue, the researcher sought to safeguard the validity of this data by relying 
on culturally appropriate processes of study site selection and participant recruitment, as well 
as data collection. As discussed in section 3.3, personal contacts were relied on to gain entry 
to study sites and participants; personal networks and ‘familiarity’ are recognised to facilitate 
recruitment, participant trust and, therefore, data validity in Confucian-based cultures 
(Huang & Pan, 2009; Liu, 2007; Park & Lunt, 2015). The researcher also used verbal consent 
processes and chose the location and record method of interviews in accordance with 
participants’ preference to address negative concerns, such as fear and suspicion, and to 
further protect the validity of the data (Huang & Pan, 2009; Liu, 2006). Alongside, one group’s 
accounts on their behaviours were compared with the descriptions of their behaviours from 
other groups, as well as field notes of the researcher’s observations, to see the validity and 
credibility of their views.  
 
7.3 Key influences on providers’ and parents’ antibiotic-related behaviours 
These empirical studies (Chapters 4 to 6) have identified three overarching factors influencing 
providers’ and parents’ antibiotic-related behaviours, which could be located within the 
individual level, interpersonal level and organisational level, respectively, of the SEF.  
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7.3.1 Influences located at the individual level of SEF – the dual use of TCM and Western 
medicine perspectives among providers and parents 
Providers described how their perceptions of parents’ use of TCM and Western medicine 
perspectives influenced their antibiotic-prescribing decisions. Similarly, parents’ accounts 
pointed to the dual use of TCM and Western medicine perspectives and their influences on 
their use of antibiotics for children. Taken together, this study points to how understandings 
of disease and treatment drawing on both TCM and Western medicine were shared between 
providers and parents and, therefore, influenced their use of antibiotics for children.  
 
Growing out of Chinese culture, TCM, rather than being only a medical system, is a type of 
philosophy and an art of healing (Liu, 1998; Qiu, 2007; Qiu, 2015; Yin & Zhang, 2006). As noted 
in section 1.3.2.2 of Chapter 1, the dual use of TCM and Western medicine is part of China’s 
healthcare system and health-related education, as well being evident among Chinese 
populations. For instance, Chung et al.’s (2014) systematic review of Chinese populations’ 
views on TCM highlighted the faith in, and lay understanding of, TCM among people in 
Mainland China as well as overseas Chinese populations, and linked their beliefs in TCM to 
Chinese culture and heritage. In line with Chung et al.’s findings, as noted in Chapter 4 and 
Chapter 6, the present study suggested that the TCM is an underlying belief system, along 
with Western medicine theories, and this dual use of TCM and Western medicine influences 
their use of antibiotics for children.  
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What has not been widely reported by previous studies is how antibiotic-related behaviour 
was related to understandings of disease and treatment drawing on both TCM and Western 
medicine. In HICs, Harbarth et al. (2002) explored the cultural perspective’s influences on 
antibiotic treatment in Germany and France and, identified that the wide acceptance of 
alternative medicine – homeopathy – among German parents was related to their much 
lower outpatient antibiotic utilization than French parents (Harbarth et al., 2002). In contrast, 
an observational study focusing on pre-school children in the UK found the use of 
homeopathy was not associated with reduced antibiotic consumption (Wye et al., 2008). 
With respect to China, only one study was located through the literature searches, which 
compared the knowledge, attitudes and practices of antibiotic use between Hong Kong 
residents who usually attend TCM practitioners and those who usually visit Western medicine 
doctors (Wun et al., 2014). Therefore, the present study provides a particularly important 
information to this field.  
 
With respect to the influence of the dual use of TCM and Western medicine on antibiotic-
related behaviour, evidence from this study indicates that providers and parents shared an 
understanding of the strengths and weaknesses of these two systems and located antibiotics 
within Western medicine. As noted in Chapter 4 and Chapter 6, TCM treatments were 
regarded as more suitable for chronic or minor diseases and the early stage of treatment; in 
contrast, Western medicine, including antibiotics, was seen as more effective for diseases, 
particular potentially serious conditions, and for curing diseases more quickly than TCM 
methods. Therefore, providers and parents chose to use TCM or Western medicine based on 
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different conditions and they understood that antibiotics should not be used for some milder 
conditions. Although no previous studies have linked perceptions of the strengths and 
weaknesses of the two systems to antibiotic-related behaviour, understandings of the 
strengths and weaknesses of the two systems among Chinese populations have been widely 
noted. Harmsworth and Lewith’s (2001) survey found a clear consensus among Western 
trained doctors in Mainland China that TCM was useful for chronic illness, while life-
threatening diseases should be treated with Western medicine (Harmsworth & Lewith, 2001). 
A study focusing on Western medical students in Hong Kong similarly noted that TCM was 
considered to be good for milder aliments and chronic diseases (Wong et al., 2006). Among 
the public, TCM and Western medicine were considered as both having strengths and 
weakness by Chinese populations in China as well as overseas; they choose TCM or Western 
medicine based on the specific types of illness (Green et al., 2006; Lam, 2001; Xu et al., 2006).  
 
Previous research noted that Chinese populations regarded TCM as safer and causing less 
adverse effects, and described, based on the dual medical systems, how their perceptions of 
adverse effects made them reluctant to use Western medicine (Bishop et al., 2009; Green et 
al., 2006; Lew-Ting, 2005; Xu et al., 2006; Zhang & Verhoef, 2002). Consistent with this 
evidence, the present study further pointed to similar adverse effect-related concerns 
regarding antibiotic use compared with TCM, which influenced providers’ and parents’ use of 
antibiotics. Wun et al. (2014) described that Hong Kong people who usually attended TCM 
practitioners were more likely to agree that antibiotics had side effects and to refuse 
antibiotic prescriptions than people who usually visited Western medicine practitioners (Wun 
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et al., 2014). As with the present study, they noted how the trust in TCM system was 
associated with resistance to Western medicine-based healthcare and to antibiotics.  
 
In conclusion, while small-scale, the present study addresses an important gap relating to 
understanding of disease and treatment drawing on TCM and Western medicines. Providers’ 
and parents’ understandings of strengths and weaknesses, as well as the adverse effects, of 
these two medical systems influenced their use of antibiotics for children. 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
7.3.2 Influences located at the interpersonal level of SEF – trust and familiarity in the 
provider-parent relationship 
In Chapter 4, providers pointed to parental influences on providers’ antibiotic-prescribing 
decisions for children; the multi-method study (Chapter 6) of parents also highlighted 
providers as an influence on their use of antibiotics for their children. Together, these findings 
pointed to the importance of the interpersonal level of the SEF, and the interrelationship 
between providers and parents in particular. As noted in Chapter 4 and Chapter 6, the 
importance of relationships between providers and parents in HICs has been discussed in a 
recent systematic review (Lucas et al., 2015); China-based studies focusing on village doctors 
and parents also referred to parents and doctors, respectively, as important influences (Ding 
et al., 2015; Yu et al., 2014; Zhang et al., 2016). However, the present literature review located 
no China-based study that looked at both providers and parents to explore them with respect 
to their use of antibiotics.  
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Two systematic reviews based on HIC studies have pointed to the importance of trust in the 
doctor-patient relationship (Bosley et al., 2018; Ridd et al., 2009). Studies focusing on China 
also noted the key role of trust, particularly in the deterioration of the doctor-patient 
relationship when trust was lost (Jing et al., 2013; Yin, 2017). In line with these findings related 
to the importance of trust, this study further pointed to trust being clearly understood by 
providers and parents as a key influence on their use of antibiotics, which was not reported 
by other studies focusing on China. For instance, providers discussed their concerns about 
maintaining parental trust, as well as avoiding undermining trust by refusing parents’ 
demands on antibiotics. Parents noted that trust was an important factor influencing their 
choice of providers to visit and their compliance with their advice.  
 
With respect to building a trusted doctor-patient relationship and its influences on antibiotic 
use, Bosley et al.’s (2018) systematic review pointed to the importance of good 
communication. Similarly, in Chapter 4 of the present study, providers noted the essential 
role of clearly explaining why antibiotics were not prescribed to parents in order to maintain 
their trust. They also described how they would ultimately prescribe unnecessary antibiotics 
to children when their explanation did not work. Along with the role of communication, this 
study further pointed to the organisational differences that influenced trust within provider 
and parent relationships. As with this study, Duckett et al. (2016) and Li et al.’s (2017) 
nationwide surveys found huge differences in public trust in different healthcare institutions, 
with much higher levels of distrust in the primary care system, such as CHIs, compared with 
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hospitals (Duckett et al., 2016; Li et al., 2017). What this study added was the similar concerns 
about the varied trust levels held by providers; CHI and retail pharmacy based providers 
acknowledged that the public’s trust in their institutions was lower than in hospitals.  
 
As this suggests, providers’ and parents’ shared understandings of the varied levels of trust 
in different healthcare institutions were a factor influencing their antibiotic-related 
behaviours; this kind of influence on antibiotic use has not been reported by previous studies. 
Duckett et al.’s (2016) and Li et al.’s (2017) studies referred to the trust level as one of the 
major reasons relating to patients’ choice of healthcare institutions, as lower trust levels in 
primary care institutions led patients to go to hospitals directly for healthcare services. This 
trust-related influence on the choice of healthcare institutions is similar to the present study 
where parents noted that they preferred to first visit hospitals, as they were more trusted 
than other institutions. This study further suggested that the trust was positively related to 
parents’ adherence to hospital-based providers’ antibiotic-related decisions. With respect to 
providers, this study found that providers in hospitals were concerned about maintaining 
parental trust to reduce pressures to prescribe unnecessary antibiotics to meet parents’ 
demands, while providers in CHIs and retail pharmacies noted the importance of familiarity 
to compensate for the low public trust level, which will be discussed below. Additionally, this 
study identified some differences between providers’ and parents’ accounts of trust, with 
parents having a higher level of trust in hospitals than hospital-based providers expected; 
however, given the small sample sizes, it would not be appropriate to draw strong conclusions 
from these differences.  
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Familiarity was emphasized by both providers and parents with respect to provider-parent 
interactions in CHIs and retail pharmacies, where public trust was lower. Previous studies 
(discussed in Chapters 4 and 6) have noted the benefits of familiarity between providers and 
patients, including helping GPs in making diagnostic and therapeutic decisions (Hjortdahl, 
1992; Hjortdahl & Borchgrevink, 1991), as well as improving patients’ medication compliance 
(Kerse et al., 2004), satisfaction (Schers et al., 2005) and enablement (Freeman et al., 2002). 
This study further added evidence that familiarity was used to counter the distrust between 
providers and parents in low-trust healthcare institutions and influenced their antibiotic-use 
behaviour, particularly in CHIs. As noted in Chapter 6, parents only referred to familiar CHIs 
as trustworthy, and trust was highly related to their compliance with providers’ decisions and 
antibiotic prescriptions. This fits with an earlier study that found that patients’ compliance 
with short-term antibiotic prescriptions was strongly associated with knowing the doctor well 
(Ettlinger & Freeman, 1981). With respect to providers, most CHI-based providers in this 
study noted that they would be more prudent in prescribing unnecessary antibiotics for 
familiar parents because these parents were more easily persuaded against antibiotic use 
when demanding antibiotics. Brookes-Howell et al.’s (2012) study in EU countries discussed 
familiarity as an influence on providers’ antibiotic-related behaviour with respect to their 
greater knowledge of the patient’s medical history and continuity of care (Brookes-Howell et 
al., 2012); however, this aspect of familiarity was rarely noted by providers in the present 
study (discussed in Chapter 4).  
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Differences in the relative importance of familiarity can be related to the structure of China’s 
healthcare system and the status of healthcare institutions (i.e. to factors related to the 
organisational and policy levels of SEFs influencing factors located in the interpersonal level). 
For instance, it was noted in Chapter 4 that, compared with providers in CHIs and retail 
pharmacies, hospital-based providers had fewer opportunities to develop ‘familiarity’ with 
parents, as well as fewer financial concerns (Beam, 2014; Li et al., 2017; Mossialos et al., 2016; 
Woodhead, 2014; Yin, 2017). This is likely to be related to inequities in health-related funding 
and facilities between hospitals and other healthcare institutions (Fang, 2014; Li et al., 2017; 
Yip et al., 2012), which also led to the higher level of public trust in hospitals (discussed in 
section 1.3.1 of Chapter 1). Furthermore, as noted in Chapter 4, the financial pressures on 
CHIs have increased since the implementation of EDL and ZUM policies, which made CHI-
based providers rely more on good doctor-patient relationships and patient retention to 
increase their income.  
 
In summary, this thesis added novel evidence on antibiotic use in China by describing how 
trust and familiarity among providers and parents influenced their behaviours related to 
antibiotic use for children. The results of this study pointed to the importance of trust in 
providers’ and parents’ use of antibiotics. Within CHIs and retail pharmacies where the trust 
levels were relatively low, familiarity was used to counter the broader public distrust and, 
therefore, emerged as an influence on providers’ and parents’ antibiotic-related behaviour in 
these healthcare institutions.   
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7.3.3 Influences located at the organisational and policy levels – China’s healthcare system 
and antibiotic-related reforms 
The present qualitative studies (Chapter 5 and Chapter 6) described the influences of provider 
facilities, staffing and financial considerations within China’s healthcare system on the use of 
antibiotics for children, particularly by providers, and how these influences are related to the 
China’s whole healthcare system.  
 
As noted in Chapter 5, studies focusing on HICs have widely reported how uncertainty during 
the diagnostic process can contribute to providers’ inappropriate use of antibiotics (Horwood 
et al., 2016; Tonkin-Crine et al., 2011). In LMICs’ studies, including two qualitative studies of 
China, the uncertainty that influenced providers’ antibiotic-related behaviour was always 
related to limited availability and the unaffordability of diagnostic facilities; as these studies 
have noted, problems relating to diagnostic facilities are a key challenge to accurate diagnosis 
and prognosis, and therefore to effective treatment, in LMICs (Kotwani et al., 2010; 
Nkengasong et al., 2018; Reynolds & McKee, 2009; Wilson et al., 2018; Zhang et al., 2016). 
Similar to these studies, this study noted the key role of diagnostic facilities, such as the 
laboratory-based blood tests, in providers’ antibiotic-prescribing decisions, with some 
providers regarding them as the most important factor.  
 
However, different from previous studies that noted the limited accessibility of diagnostic 
tests (Reynolds & McKee, 2009; Zhang et al., 2016), in this study such concerns were only 
discussed by providers in community health stations, which they compared with what they 
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saw to be the wide availability in hospitals. This fits with a national survey that noted the lack 
of quality-assured diagnostic facilities at the primary care level in China (Li et al., 2017). The 
inequitable distribution of resources between healthcare institutions was found to be an 
influence on providers’ antibiotic prescribing decisions in this study. Previous studies also 
discussed the issues of inadequate training and low incomes among providers in China’s 
primary care system (Gao et al., 2012; Li et al., 2017). In line with these findings, this study 
additionally noted how the lack of well-qualified doctors and the greater financial pressures 
on CHIs compared with hospitals influenced CHI providers’ use of antibiotics. For instance, as 
noted in Chapter 5, while no providers in hospitals spoke about financial considerations in 
the context of their antibiotic-related behaviour, these concerns were widely noted as 
influences on CHI-based providers’ antibiotic-prescribing decisions, which is similar to Zhang 
et al.’s (2016) study focusing on village doctors in China’s primary care system. Zhang et al.’s 
(2016) and the present findings all point to influences stemming from the differential 
development of China’s healthcare institutions on providers’ use of antibiotics.  
 
With respect to parents, data from the focus groups with parents (discussed in Chapter 6) 
also pointed to the unbalanced development of China’s healthcare institutions as a factor in 
their use of antibiotics. As discussed in Chapter 1 and in section 7.3.2 above, hospitals are 
heavily used by patients in China where waiting times are often long and consultation times 
are short (Woodhead, 2014; Mossialos et al., 2016; Yin, 2017). As a consequence, parents in 
this study noted that access to retail pharmacies was easier than hospitals, an availability that 
led them to parentally-medicate antibiotics for their children. This has also been reported in 
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previous studies focusing on parents as well as other populations in China (Lv et al., 2014; Yu 
et al., 2014). 
 
As discussed in Chapter 1 (section 1.4.2), China’s major antibiotic-related policies were 
established in the 2011 antibiotic-related reforms, including the three-year strategy named 
‘National Special Campaign for the Clinical Use of Antibiotics’ and the much stricter 
administrative regulations, which have a particular focus on hospitals. Previous studies have 
indicated the effectiveness of these policies with respect to the use of antibiotics in both 
general and specialised hospitals, with evidence of the decreased antibiotic use frequency 
and antibiotic use intensity (see Box 3 and Box 4 for their definitions) in selected hospitals 
after the issue of the policies (Bao et al., 2015; Zou et al., 2014). Similarly, results from Chapter 
5 pointed to these policies as important influences on the use of antibiotics in hospitals as 
well as CHIs. However, providers’ accounts also noted some unexpected consequences, such 
as how the regulated use of antibiotics in hospitals appeared to have worsened antibiotic use 
in retail pharmacies, and how the limitations of diagnostic facilities, particularly in CHIs, 
influenced adherence to antibiotic-related guidelines. These phenomena have not been 
reported by previous studies focusing on the effectiveness of antibiotic-related policies. 
Therefore, along with evidence of antibiotic-related policies promoting the appropriate use 
of antibiotics, the present study additionally pointed to some adverse unintended 
consequences of antibiotic-related policies, which were related to differences in provider 
facilities in different healthcare institutions, as well as the structure of the whole healthcare 
system in China. 
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Wider policies were also intended to promote the appropriate use of antibiotics. For instance, 
the EDL and ZMU policies are designed to remove financial incentives from drug prescriptions, 
and regulations focus on retail pharmacies to stop the sale of OTC drugs (discussed in section 
1.4.3). However, both previous studies and the present findings (discussed in Chapter 5) 
pointed to the limited effectiveness of EDL and ZMU in promoting the appropriate use of 
antibiotics (Gong et al., 2016; Jiang et al., 2013; Song et al., 2014; Yang et al., 2013), as well 
as of regulations with respect to selling the OTC antibiotics (Fang, 2014;). Furthermore, this 
study identified an economic basis to CHI-based providers prescribing unnecessary antibiotics 
to maintain good relationships with parents and ensure parent retention. It therefore 
suggested that, in contrast to their original aims, the EDL and ZMU policies may contribute to 
the inappropriate use of antibiotics among providers in CHIs, because of the financial 
pressures from reduced remuneration from drug sales following their implementation, as 
well as the inadequate compensation provided via government subsidies for the already-low 
incomes in CHIs. This phenomenon was similarly noted by Chen et al. (2014) and Xiao et al. 
(2016), which described how the unbalanced economic status of healthcare institutions 
represented policy-level factors that worked against providers’ appropriate use of antibiotics. 
Additionally, it was noted by Xiao et al. (2016) that patients’ expectations of antibiotics had 
been further raised by the low price of essential drugs. 
 
In conclusion, present thesis described how facilities, financial considerations and policies 
influenced providers’ and parents’ antibiotic-related behaviours for children. It provided 
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evidence on organisational influences within the whole healthcare system in China after 2009 
health reforms and 2011 antibiotic-related reforms, which has not been widely reported by 
previous studies.  
 
7.3.4 Principal novel contributions of this thesis 
Although this thesis is a small-scale study focusing on one city, it provides three novel 
contributions related to antibiotic use and ABR in China, including (i) the influences of the 
dual use of TCM and Western medicine in understanding diseases and treatment on providers’ 
and parents’ behaviours with respect to the use of antibiotics for children in China; (ii) the 
trust and familiarity in provider-parent relationship that influence their antibiotic-use 
behaviours for children in China; (iii) the broader health contexts and policies’ influences on 
providers’ and parents’ antibiotic-use behaviours for children after China’s recent health 
reforms and antibiotic reforms. 
 
As the SEF is a framework that takes into account reciprocal relationships between individuals 
and their environments, the concentric layers of factors influencing the outcome of interest 
(the use of antibiotics) also inter-relate (Schneider & Stokols, 2009). Evidence from the 
present study indicated that, firstly, the broader layers of organisational and cultural factors 
influenced factors located at the inner layers, which together influenced providers’ and 
parents’ use of antibiotics for children. For example, providers’ and parents’ dual use of TCM 
and western medicine was a factor operating at the individual level, but was also shaped by 
factors operating at broader layers, including the interpersonal (provider-parent 
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relationships), organisational (China’s healthcare system in which TCM and Western medicine 
are practised alongside each other at every level) and cultural/societal levels. China’s 
healthcare system, with its unequal development of hospital and community-based 
institutions, influenced providers’ and parents’ concerns about trust and familiarity, which 
were factors operating at the interpersonal level. Furthermore, the factors located at broader 
levels were also interactive. One example was the finding that positive impacts of antibiotic-
related policies on hospital use of antibiotics offset by increased pressures on other parts of 
the healthcare system (CHIs and retail pharmacies) to provide antibiotics to compensate for 
the loss of income.  
 
7.4 Conclusions  
7.4.1 Implications and recommendations 
Two broad implications can be drawn from the present study, both leading to 
recommendations for future research. The first implication relates to the SEF and its 
contribution to understanding the complicated and reciprocal relationships between factors 
influencing behaviour. A SEF was used in this study to guide both the review of literature and 
the interpretation of results, an approach which has not been used in other research focusing 
on impacts of antibiotic use. By using the SEF, it was able to locate results (influences on the 
use of antibiotics) at the individual level, interpersonal level, and the wider organisational 
level of the SEF, and can therefore draw out implications and recommendations at these 
different SEF levels. 
  
279 
 
 
At the individual level of the SEF, the use of both TCM and Western medicine in parental and 
providers’ understandings and communication around disease and treatment suggests that 
policy-makers need to develop strategies based on the two medical systems, in order to 
promote the appropriate use of antibiotics. Antibiotic-related education programmes, as 
noted in section 2.3.2.3, pp.103-104, have been used as an important strategy in antibiotic 
stewardship to promote the appropriate use of antibiotics by providers in hospitals and the 
primary care level in China. These programmes have trained providers in relation to 
antibiotic-related policies launched by MoH (NHFPC from 2013) (Hou et al., 2014), clinical use 
and management of antibiotics (Bao et al., 2015), and other control methods like prescribing 
antibiotics with different restriction levels (Lin et al., 2013). The present study suggests that 
TCM knowledge relevant to understanding diseases and antibiotic treatments would also be 
important to include in this training. Policy-makers could also take note of the importance of 
TCM perspectives when they draft guidelines or policy documents on the use of antibiotics. 
Practical guidelines were widely applied to eliminate the inappropriate use of antibiotics in 
hospitals in China, such as the use of procalcitonin for guiding antibiotic use (Ding et al., 2013; 
Long et al., 2011; Qu et al., 2012; Tang et al., 2013), and the use of guidelines of ‘Principles 
for Clinical Use of Antimicrobials (2015 edition)’ since the 2011 antibiotic-related reforms (Bao 
et al., 2015; Sun et al., 2015A). The ‘Principles for Clinical Use of Antimicrobials’ guides how 
to prescribed antibiotics for different kinds of diseases, though only in Western medicine 
terms; thus, this study suggests that it might be more helpful to provide the corresponding 
TCM terms and explanations of these diseases in the guidelines.  
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The Chinese government also introduced a public information week (13th November – 19th 
November) in 2017 to promote the appropriate use of antibiotics (NHFPC, 2017C), as part of 
a series of public information campaigns used to reduce the public’s misunderstandings of 
and promote more appropriate use of antibiotics (Cross et al., 2017; Shehadeh et al., 2015; 
Trepka et al., 2001). The present study suggested that, along with providing more information 
about antibiotics themselves and explaining common misconceptions about the conditions 
for which antibiotics are appropriate (NHFPC, 2017C), it could be helpful to align and compare 
TCM-related conditions, such as excessive heat (shanghuo), with Western medicine 
conceptions of similar symptoms (e.g. inflammation and fever) in the information campaign 
for the Chinese public. 
 
The results relating to the doctor-patient level suggest that the inappropriate use of 
antibiotics could be addressed by improving trust and familiarity in the doctor-patient 
relationship. Information campaigns could provide more detailed information on China’s 
healthcare system. For instance, they could note the primary care system is under rapid 
development, citing the large amount of outpatient care services it provided, to reduce public 
misunderstandings and to boost their trust in the primary care system. For hospital-based 
providers, as suggested by a systematic review of HICs (Cabral et al., 2016), guidelines and 
trainings could focus more on how to develop effective communication between providers 
and patients, for example, to help hospital-based providers give essential and understandable 
information to patients within the limited time period (3 – 5 minutes) available for the 
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consultation. Similar training for providers in the primary care system and retail pharmacies 
could focus on communication skills to build patient trust.  
 
Furthermore, differences in the trust level and in the relative importance of familiarity in 
hospitals and CHIs reflect the different development of these healthcare institutions, 
including inequities in, for example, health staff. Together with results located at the 
organisational level, the present study, therefore, would support a further strengthening of 
primary care, such as improving diagnostic facilities, the compensation for income losses 
related to ZMU and EDL policies, as well as greater investment in staff training and support. 
This suggestion is in line with Chinese government’s policy goal that emphasizes primary care 
as a key aspect of its national plan (Lancet, 2018). This study further suggests that policy 
makers could widen the focus of current antibiotic-related policies to include the primary care 
level and retail pharmacies, and could develop new antibiotic-related strategies particularly 
for these healthcare institutions. Finally, as well as developing strategies, this study also 
suggested the importance of improving mechanisms to ensure implementation of existing 
and new policies, such as the effectively implementing the existing regulations on the sale of 
antibiotics in retail pharmacies  
 
The second implication relates to research governance procedures. The dominant approach 
is one developed in Western societies such as the UK and, as other researchers have noted 
(Liu, 2006, 2007; Park & Lunt, 2015), it requires adaptation if it is to be sensitive to the 
organisational contexts and cultural backgrounds of study participants in China. Together 
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with other studies, the present study has implications for how research ethics are understood 
and implemented in study settings other than Western high-income countries, where, in 
addition, there is a lack of familiarity with ‘standard’ (Western) research ethics. It suggests 
that culturally appropriate processes are required to ensure participant trust in the study and 
thus secure access to and approval from study sites as well as informed consent from 
participants. As discussed in section 3.3, such processes offer benefits with respect to data 
validity, particularly in Confucian-based cultures.  
 
7.4.2 Suggestions for further research 
Focusing on both English- and Chinese-language records in the literature review, this study 
pointed to the importance of searching and reviewing literature published in languages other 
than English. Therefore, it is valuable for further studies, particularly when the study setting 
is not an English-speaking area, to review records published in English and the other 
languages used in journals of the country under study, in order to increase 
comprehensiveness. In addition, the quality of records published in other languages should 
be assessed if they are not indexed in international databases. 
 
As mentioned in the section 7.2, insights from this doctoral research are derived from a set 
of small-scale studies based in one major city. It is therefore important to explore these 
findings in studies with larger and more representative samples across multiple settings in 
China. Additionally, this study has pointed to the importance of both TCM and Western 
medicine use in the public’s understanding of disease and treatment. This influence is worthy 
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of further study beyond China in other countries with well-established TCM practices are 
competing with Western medicine, as well as among Chinese population living in other 
countries. Understanding these influences in greater depth and breadth would be the next 
step in developing interventions and policies, and in evaluating their effectiveness.  
 
Furthermore, while there were differences in the themes in provider and parent accounts, 
this study found some common themes, such as the public’s understanding of disease and 
treatment (including antibiotics), and trust and familiarity. However, small sample sizes 
meant that these similar themes could not examined in depth. Therefore, in further studies 
with large sample sizes, it would be interesting to undertake systematic comparisons of 
themes from providers and parents. Confirmation of similar themes would provide a stronger 
empirical basis for informing the design of interventions and policies to promote appropriate 
antibiotic use. 
 
Finally, the development and strengthening of the primary care system means that new 
policies focusing on the primary care level are likely to be launched in the future. Future 
research could, therefore, review and evaluate how new policies and interventions launched 
by the Chinese government affect the use of antibiotics. For instance, studies could compare 
provider and public views on antibiotic use in the primary care system pre and post new 
policies, as well as analyse antibiotic use frequency in the primary care level pre and post new 
policies, to evaluate these policies effects on appropriate use of antibiotics.  
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7.4.3 Conclusions 
This doctoral research sheds light on influences on providers’ and parents’ use of antibiotics 
for children, which has been identified as a major factor in ABR in China. Results from the 
qualitative and multi-method studies pointed to factors operating at different levels of the 
SEF as influencing providers’ and parents’ antibiotic-related behaviours. The key insights 
included the influence of (i) both TCM and Western medicine in parental and providers’ 
understandings and communication around disease and treatment, (ii) trust and familiarity 
in the doctor-patient relationship, and (iii) the healthcare system and antibiotic-related 
reforms. These factors were interactive and can be located at the individual level, 
interpersonal level, and organisational and policy level, respectively, of the SEF. Through 
using the SEF to identify influences on the use of antibiotics for children, this study suggests 
that public knowledge, the provider-patient relationship and the healthcare system are 
important determinants of antibiotic use in China. It also argues for studies based on 
representative samples in multiple settings to explore these influences in greater depth.
  
285 
 
Appendices 
Appendix A – Search strategy for human ABR and antibiotic use in China 
1. The searching strategy for section 1.2.4.1 (human antibiotic resistance in China) 
MEDLINE Ovid (3rd Mar 2016) 
1.Bacterial Infections/ or Anti-Bacterial Agents/ or Drug Resistance, Bacterial/ or 
antimicrobial resistance.mp. or Drug Resistance, Microbial/ or Drug Resistance, Multiple, 
Bacterial/ 
2. limit 1 to (abstracts and English language) 
3. China.mp. or China/ 
4. limit 3 to (English language and full text) 
5. 2 and 4 
6. limit 5 to humans 
7. limit 6 to yr="1949 -Current"(in total 394 published papers) 
 
Wanfang Data ()(3rd Mar 2016) 
The term of ‘CHINET  (date):2010-2016’ and ‘Mohnarin’ were used to identify the 
national surveillance data of antibiotic resistance in China published in Chinese. 
 
2. The searching strategy for section 1.3.3.1 (antibiotic use and inappropriate use in 
hospitals and primary care institutions) 
MEDLINE Ovid (5th Mar 2016) 
1. antibiotic.mp. 
2. China.mp. or China/ 
3. Drug Prescriptions/ or Prescription Drugs/ or Prescriptions/ or Practice Patterns, 
Physicians'/ or prescri*.mp. or Prescription Drug Misuse/ 
4. 1 and 2 and 3 
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5. hospital*.mp. 
6. Public Health/ or Community Health Services/ or community health institution*.mp. 
7. physicians/ or general practitioners/ or hospitalists/ or physicians, primary care/ 
8. doctor*.mp. 
9. prescriber*.mp. 
10. Pediatrics/ or pediatrician*.mp. 
11. 5 or 6 or 7 or 8 or 9 or 10 
12. 4 and 11(in total 41 published papers) 
13. rural .mp. 
14. 12 and 13 (in total 6 published papers) 
 
Wanfang Data ()(5th Mar 2016) 
The term of ‘' (hospital)’, ‘' (inpatients)’, ‘&# (outpatients), ‘# (emergency)’, ‘
% (rural areas)’, ‘  (community)’, ‘! (antibiotic)’, ‘ (use frequency) and ‘
 (use intensity)’ were used to identify studies published in Chinese related to antibiotic 
use for inpatients, outpatient and emergency in hospitals and in community health 
institutions of urban areas in China, as well as antibiotic use in the rural areas of China. 
 
3. The searching strategy for section 1.3.3.3 (antibiotic use and inappropriate use by the 
general public) 
MEDLINE Ovid (8th Mar 2016) 
1. antibiotic.mp. 
2. China.mp. or China/ 
3. Hong Kong/ 
4. Macao.mp. 
5. the public.mp. 
6. Adult/ or general population.mp. 
7. 2 or 3 or 4 
8. 1 and 5 and 6 and 7(in total 14 published papers) 
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9. 1 and 2 and 5 and 6(in total 5 published papers) 
10. Patient Compliance/ or parental medication.mp. or Self Medication/ 
11. Medication Adherence/ or Guideline Adherence/ or adherence.mp. 
12. 10 or 11 
13. 1 and 2 and 12 (in total 14 published papers) 
 
Wanfang Data ()(8th Mar 2016) 
The terms of ‘! (antibiotic)’, ‘ (resident)’, ‘ (usage frequency)’, ‘	
(usage situation) and ‘(abuse)’ were used to identify related evidence of in Chinese 
published studies. 
 
4. The searching strategy for section 1.3.3.2 (antibiotic use and inappropriate use in 
pharmacies) 
MEDLINE Ovid (12th Mar 2016) 
1. antibiotic.mp. 
2. China.mp. or China/ 
3. Pharmacy Service, Hospital/ or dispense.mp. or Drug Prescriptions/ 
4. Pharmacy/ 
5. Pharmacists/ or pharmacists.mp. 
6. 3 or 4 or 5 
7. 1 and 2 and 6(in total 18 published papers) 
 
Wanfang Data ()(12th Mar 2016) 
The terms of ‘! (antibiotic)’, ‘" (retail pharmacy)’, ‘"
 (pharmacist)’ and ‘$
(dispense or sale)’ were used to identify related evidence in Chinese published studies. 
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Appendix B – Information on the health supervision system and the health 
financing system 
Health Supervision System  
In China, the National People’s Congress (NPC) is the highest decision-making body, 
responsible for issuing China’s laws. Apart from the NPC, the People’s Congress at provincial 
and capital city level, as well as the governments from the national level (the State Council) 
to the capital city level, also have the power to issue laws and regulations. Therefore, the 
legislative system in China is composed of administrative laws and regulations issued by the 
NPC and State Council, and the local laws, regulations and rules issued by local People’s 
Congress and local governments (WHO, 2015C). The legislation for the healthcare system is 
produced by the same process as above.  
 
Under the guidance of the health-related legislation and regulations, the health supervision 
system can provide management and administration to China’s healthcare system. The main 
Chinese health administration has four levels, from NHFPC, at the national level, to local 
health authorities at provincial, city and county levels (Chan et al., 2008; WHO, 2015C). The 
NHFPC was transformed by the MOH in 2013 due to a public reform initiated by the State 
Council (WHO, 2015B). It provides central guidance for China’s healthcare system, such as 
health regulations and major public health programmes (Chan et al., 2008). Each level’s 
health administration is the member of the same level’s government and overseen by it; the 
health administration can provide management and guidance to healthcare providers at the 
same level and the lower-level health administration (e.g. the provincial health 
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administration can manage provincial-level healthcare providers and the municipal-level 
health administration) (Bloom & Tang, 2004; Liu, 2004; Yip et al., 2012). Therefore, the NHFPC, 
State Council and their local authorities are the central body of China’s health supervision 
system. 
 
Health Financing System 
The main sources of health funding are the government, insurers (through the basic medical 
insurance schemes) and individuals, and payment methods34 are mixed (Meng, 2005). China 
has a long history of paying for medical services by health insurance schemes and individuals 
through fee for service (FFS) methods, and the government provides subsidies to the medical 
service delivery system by through its global budget35 (Meng, 2005); public health services 
are mainly funded by government subsides (WHO, 2015C). 
 
The basic medical security system is mainly responsible for providing social finance to the 
medical service delivery system, and the basic medical insurance schemes, including Urban 
Employee Basic Medical Insurance (UEBMI), Urban Resident Basic Medical Insurance (URBMI), 
and New Rural Cooperative Medical Scheme (NRCMS) are the main part of China’s basic 
medical security system. Beginning in 1998 they have been carried out by the Chinese 
government to cover specific groups of urban employees, unemployed urban residents, and 
                                                        
34 The payment method is defined as ‘methods of pricing of healthcare services, paying of healthcare providers, and arrangement of 
payment including supplementary measures and contractual relationship between payers and providers’ (Meng, 2005). 
35 The global budget means an overall spending target or limit determined by a government agency that constrains the price and the quality 
of the services provided (Dredge, 2004). For instance, every year, a fixed amount of funding is distributed by the government annually to 
hospitals to pay for all hospital-based services (Sutherland, 2011). 
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rural residents, respectively, in order to achieve comprehensive universal health coverage by 
2020 (Barber & Yao, 2010). The overview of three main medical insurance schemes is shown 
in Table 1. For financing methods of basic medical insurance schemes, the UEBMI is paid by 
employers and individuals (employees), while URBMI and NRCMS are paid by the government 
and individuals (residents) (Yip et al., 2012). In addition, employees in urban areas are 
compulsorily covered by UEBMI while residents are voluntarily enrolled into URBMI and 
NRCMS (Yip et al., 2012).  
 
Table. Summary of three basic medical insurance schemes 
Characteristic NRCMS UEBMI URBMI 
Administration County level Municipal level Municipal level 
Start date 2003 1998 2007 
Participation  Voluntary Mandatory Voluntary 
Populations Rural residents Urban employed Children, students, 
elderly, disabled, other 
non-working urban 
residents 
Current coverage 98.7% (end 2013) 92.4% (2010) 92.9 (2010) 
Enrolment  
(million people) 
802 (end 2013) 274.43 (end 2013) 296.29 (end 2013) 
Revenues 
 
297.25 billion CNY 
(47.85 billion US$) 
(2013) 
706.16 billion CNY 
(113.67 billion US$) 
(2013) 
118.66 billion CNY 
(19.10 billion US$) 
(2013) 
Expenditures 
 
290.92 billion CNY 
(46.83 billion US$) 
(2013) 
582.99 billion CNY 
(93.84 billion US$) 
(2013) 
97.11 billion CNY 
(15.63 billion US$) 
(2013) 
 
Source of revenues 
Government (at 
central and local 
levels) and individuals 
(2013) 
Employers and 
employees 
Government (at central 
and local levels) and 
individuals (2013) 
 Central 
government 
(/person/year)  
120 CNY  
(same in 2014) 
0 CNY 120 CNY 
(same in 2014, 2015) 
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Local 
government 
(/person/year)  
160CNY (200 in 2014) 
The central 
government pays 80% 
(128 CNY) of 160 CNY 
for western areas’ 
local governments and 
60% (96 CNY) of 160 
CNY for central areas’ 
local governments. 
Central government 
subsidies for eastern 
areas’ local 
governments tend to 
be lower. 
0 CNY 160 CNY (200 in 2014, 
260 in 2015) 
The central government 
pays 80% (128 CNY) of 
160 CNY for western 
areas’ local 
governments and 60% 
(96 CNY) of 160 CNY for 
central areas’ local 
governments. Central 
government subsidies 
for eastern areas’ local 
governments tend to be 
lower. 
Employers  
(/person/year) 
0 (No employer) 5%-7% of employee’s 
salary 
0 (No employer) 
Individuals 
(/person/year) 
70 CNY (90 in 2014) 2% of employee’s salary 70 CNY (90 in 2014, 120 
in 2015) 
Total revenues per 
person per year 
370.59 CNY 
(59.65 US$) (2013) 1 
About 2573.19 CNY 
(414.20 US$) (2013) 2 
About 400.49 CNY 
(64.47 US$) (2013) 2 
1. For NCMS, the total revenues /person /year (370.59 CNY) was greater than the sum of government 
and individual contributions /person /year (350 CNY) because local governments can contribute 
more than the minimally required amount. The URBMI has the same situation. 
2. For UEBMI and URBMI, the total revenues /person /year were not published. The data were 
obtained through using ‘Revenues’ divided by ‘Enrolment’. 
Source: adapted from Yip et al., 2012; Barber & Yao, 2010. NHFPC, 2014; NBSC, 2015; MoHRSS & 
MoF, 2015; MoF, NHFPC & MoHRSS, 2014
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Appendix C – Framework derived from three papers 
Paper one 
 
 
Development of 
Antimicrobial Resistance
Human Antimicrobial 
Use
Agricultural 
Antimicrobial Use
Poverty & Inadequate 
Resources
User-related Factors Healthcare-provider-
related Factors
Hospitals & Small 
Health Centers
Policy & Regulatory Issues
Calamities
Human Population 
Growth
Underling Factor
Interaction factors
Framework of risk factors responsible for antimicrobial resistance in low and middle-income countries
  
293 
 
Paper two 
 
Antimicrobial 
Resistance
Misuse of  
Antimicrobials 
by Physicians
Limited Drug 
Information Resources
Unaffordable Continuing 
Medical Education
Irregular Drug Supply
Financial Constraints in 
Antimicrobials choices
Misuse of 
Antimicrobials by 
Unskilled 
Practitioners
Lack of Well-trained Health 
Personnel
Misuse of 
Antimicrobials 
by the Public
Availability of Antimicrobials from 
Unofficial Distributors without prescriptions
Self-medication
Miss Conceptions & beliefs
Poor Patients Compliance
Poor Quality of 
Antimicrobials
Adulterated Antimicrobials
Counterfeit Antimicrobials
Expired Antimicrobials
Lack of Quality Compliance & 
Monitoring
Degraded Antimicrobials
Bioinequivalent Antimicrobials
Economic & 
Political  Factors
Inadequate Data & 
Resources
Dissemination 
of Resistant 
Organisms
Lack of Antimicrobial 
Susceptibility Assays
Lack of Routine Susceptibility Testing & 
Antimicrobial Resistance Surveillance
Increased urban 
migration vs poor 
Hygienic Conditions
Inadequate Hospital Infection 
Control Practices
Socioeconomic & Behavioral Factors Contribute to Antimicrobial Resistance in Low and Middle-income Countries
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Paper three 
Antimicrobial 
Resistance
Antimicrobial 
Drug
Human/
Animal 
Antimicrobial 
Use 
Consumer Behaviour
Prescriber Behaviour
Diagnostics
Disease Burden
Effective Treatment 
Preventive Practices
Hospital Infections
Basic Supplements like water 
Cost
   Quality
Patient Care Level
Perception
Economic Interests
Expectation
Perception
Drug Supply &Delivery System Drug Procurement Drug QualityRegulatory Framework
Framework of risk factors responsible for antimicrobial resistance 
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Appendix D – Search strategy for factors influencing providers’ and parents’ 
use of antibiotics in China 
1. The searching strategy for section 2.3 (factors influencing healthcare providers’ 
behaviour with respect to the use of antibiotics in China) 
MEDLINE Ovid (29th May 2017) 
Advanced search: keyword 
1. antibiotic*.mp. or Anti-Bacterial Agents/ 
2. antimicrobial*.mp. 
3. Physicians, Family/ or Primary Health Care/ or Practice Patterns, Physicians'/ or general 
practitioner*.mp. 
4. Pharmacy Service, Hospital/ or Pharmacists/ or pharmacist*.mp. 
5. Health Personnel/ or healthcare provider*.mp. 
6. physician*.mp. 
7. pediatrician*.mp. or Pediatrics/ or Pediatricians/ 
8. China.mp. or China/ 
9. Hong Kong.mp. or Hong Kong/ 
10. Macao.mp. or Macau/ 
11. Taiwan.mp. or Taiwan/ 
12. 1 or 2 
13. 3 or 4 or 5 or 6 or 7 
14. 8 or 9 or 10 or 11 
15. 12 and 13 and 14 (in total 217 papers were found) 
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&1 (CNKI)  2016 7 6 
9)<: 3%)() I8() II8 
=0!/
:7 
!/ 1[
:7 %. 43$,'] 
        [
:7 %3 ,'] 
2  	!/* 47+ 
!/ 2[
:7 %. 43$,'] 
        [
:7 3 ,'] 
2  	!/* 749+ 
 
Translation 
Chinese database: CNKI (6th Jul 2016) 
Research areas: Medicine and health sciences, Social science I and Social science II  
Advanced search: Keyword 
Advanced search 1: [Keyword ‘antibiotic’ or Keyword ‘antibacterial drug’ exact terms] 
                           And [Keyword ‘doctor’ or Keyword ‘pharmacy’ exact terms] 
Including papers in English and papers in Chinese (in total 47 papers were founded) 
Advanced search 2: [Keyword ‘antibiotic’ or Keyword ‘antibacterial drug’ exact terms] 
                           And [Keyword ‘pharmacist’ exact terms] 
Including papers in English and papers in Chinese (in total 749 papers were founded) 
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2. The Searching strategy for section 2.4 (factors influencing public’s and parents’ 
behaviour with respect to the use of antibiotics in China 
MEDLINE Ovid (27th Jul 2017) 
Advanced search: keyword 
1. Anti-Bacterial Agents/ or antibiotic*.mp.  
2. Antimicrobial*.mp.  
3. China.mp. or China/  
4. Hong Kong.mp. or Hong Kong/  
5. Macao.mp. or Macau/  
6. Taiwan.mp. or Taiwan/  
7. Knowledge*.mp. or Health Knowledge, Attitudes, Practice/  
8. Behavio*.mp. or Behavior/  
9. Patient Compliance/ or Compliance/ or compliance*.mp.  
10. Drug Prescriptions/ or Self Medication/ or Pharmacists/ or self-medicat*.mp.  
11. Patient Satisfaction/ or expectation.mp. 
12. Middle Aged/ or Adult/ or Adolescent/ or general population.mp. or Aged/  
13. Parent*.mp.  
14. Child*.mp. or Child/ or Child Health/ or Child, Hospitalized/ 
15. Public*.mp  
16. 1 or 2  
17. 3 or 4 or 5 or 6  
18. 7 or 8 or 9 or 10 or 11  
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19. 12 or 13 or 14 or 15  
20. 16 and 17 and 18 and 19 (in total 222 papers were found) 
 
&1 (CNKI)  2017 7 27 
9)<: 3%)() I8() II8 
=0!/
:7 
!/ 1[
:7 %. 43$,'] 
        [
:7 ;# "-] 
        [
:756&"-] 
2  	!/* 44+ 
 
Translation 
Chinese database: CNKI (27th Jul 2017) 
Research areas: Medicine and health sciences, Social science I and Social science II  
Advanced search: Keyword 
                               [Keyword ‘antibiotic’ or Keyword ‘antibacterial drug’ exact terms] 
                       And [Keyword ‘parent’ or Keyword ‘resident/the public’ blurred terms] 
                       And [Keyword ‘behaviour/practice’ or Keyword ‘knowledge/cognition’ blurred terms] 
Including papers in English and papers in Chinese (in total 44 papers were founded) 
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Appendix E – Quality appraisal for the 29 Chinese language papers included in the review of literature 
The quality appraisal tool in Hawker et al.’s (2002) study was used to appraise the quality of 29 Chinese language papers located via Chinese portal of 
CNKI in this literature review. This tool assesses the quality of papers from nine aspects though clear criteria, and ranks the quality of papers in each 
aspect as ‘good’, ‘fair’, ‘poor’ and ‘very poor’. The nine aspects are related to the clear description of abstract and title (Q1), introduction and aims 
(Q2), method and data (Q3), sampling (Q4), analysis (Q5), ethics and bias (Q6), results (Q7), transferability or generalisability (Q8), and implications 
and usefulness (Q9), respectively. Based on Hawker et al.’s (2002) study, a sore of four, three, two, and one to the level of ‘good’, ‘fair’, ‘poor’ and ‘very 
poor’ was given, respectively, to each aspect. Then a summed score of each paper was calculated and 29 Chinese-language papers were divided into 
four levels (1-9 very poor; 10-18 poor; 19-27 fair; 28-36 good) in line with their quality. Table below provided more specific information related to the 
quality of 29 Chinese language papers; among them, 10 Chinese language papers were defined as fair quality while the other 19 Chinese language 
papers were poor quality. 
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Table. The quality appraisal for 29 Chinese language papers 
Authors Title Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Total 
score 
Chen & Wang, 2014 ~Bn3}@_GsqZc
AueCbySP
         
Ding et al., 2015 Nj2|G^lue?=
_tP
         
Ding et al., 2016 Nj2|G^lux\[>
%'lP
         
Ding et al., 2014 XdmaMO	"Gs
qZ ]_ux\[yS
         
Du et al., 2009 Q`~+h:Gsquey
S
         
Fan, 2010 W.9j2|34<_G^l
ueCbyS
         
Huang et al., 2013 89#!{DRBn~+G^
l_$ue[ySfi
         
Li & Tong, 2013 ~FLBn3}@_Gsq
ZcAueCbySP
         
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Lin et al., 2015 g5U3GsqZbue$?=
_CP
         
Liu et al., 2013 ;0H),-^G^lux
_exyS
         
Ma et al., 2014 (2*KqZ=oJ75U
GsqZue_\[byS
P
         
Rahmanjan et al., 
2013 
&
9g^ ]_G^lb
\[>%'lP
         
Su et al., 2012 E(m~:3IzDue
ue\[byS
         
Tan et al., 2016 5U3G^lbueY_\[b
ySP
         
Tan et al., 2014 1&09#$!

%
         
Tian et al., 2015 QT,-^3G^lue[b
yS
         
Tian et al., 2014 /995U3G^lbue
[yS
         
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Wang & Wang, 
2013 
5UGsqZue$_qt\[
bw>%'l1vfi
         
Wang et al., 2017 |V92|j#!{DRG^
l_extyS
         
Wang, 2013 E~B2|G^l_ueyS
P
         
Wang et al., 2013 Bn263GsqZ<_ux=
byS
         
Wang et al., 2013 g^GsqZue_C
ySP
         
Wu, 2009 N^G^lbue<_C
yS
         
Xie & Zhang, 2014 W.9h^G^l_ue[
ySP
         
Xiong et al., 2015 5U3G^lkqZbuep
_\[P
         
Ye et al., 2014 r)5UGsqZue$_q
t\[bw>%'l1vf
i
         
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Zhang, 2015 "# %          
Zhao et al., 2013 7dN5UG^lue_
t
         
Zheng, 2012 	' #$!%

         
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Appendix F – Information sheets and consent form for primary studies 
 
 
[Knowledge, attitudes and behaviour relevant to antibiotic use among physicians, 
pharmacists and parents in Taiyuan City of Shanxi Province, China] 
 
Participant Information Sheet 
 
A qualitative study of antibiotic use among physicians in Taiyuan City 
 
Dear Physicians,  
 
I would like to invite you to take part in the above named study. Before you decide, it is 
important for you to understand why the research is being done and what it will involve. 
Please take time to read the following information. Please feel free to ask the researcher if 
there is anything that is not clear or if you would like more information. 
 
What is the purpose of this study? 
Antimicrobial resistance (AMR), especially the development of bacteria resistant to 
antibiotics, is increasing rapidly all over the world. Compared with western countries, China 
has a higher rate of antibiotic use for the treatment of human illnesses, including among 
children. Also, China consistently ranks close to the top of global rankings for the prevalence 
of multiple antibiotic resistant strains, and the reported number of ineffective antibiotics is 
increasing. The causes of antibiotic use and resistance are multifactorial. This study aims to 
shed light on one aspect of this complex problem by learning about the views and experiences 
of physicians. The study will also include pharmacists and parents. Therefore, this part of the 
study would like to explore your views and experiences relevant to antibiotic use and 
resistance.  
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Who is doing the study?  
This study is a part of a wider programme of research at the University of York in the UK 
concerned with human health and the natural environment. The study is funded by the 
University of York as part of a PhD Studentship. The chief researcher is Tingting Zhang, who 
is a PhD student in the Department of Health Sciences of the University of York, and is 
supervised by Professor Hilary Graham and Professor Piran White. 
 
Who is being asked to participate? 
I am inviting physicians who work at different health care institutions to reflect their views 
and experiences relevant to antibiotic use and resistance. Therefore, 6 paediatricians working 
at city hospitals and 6 general practitioners working at community health institutions will be 
invited. 
 
What will be involved if I take part in this study? 
If you are willing, I would invite you to participate in an interview to explore your views and 
experiences relevant to antibiotics use and resistance. The interview will be face-to-face, 
conducted on your worksite, and last approximately 30-45 minutes. The interview will be 
audio-recorded, with your permission. The audio-files from interviews will then be 
transcribed (listened to and written down in full) and analysed by the researcher. 
 
Do I have to take part? 
No. Taking part in the research is entirely voluntary. Whether you choose to take part or not, 
will not affect your work in any way. If you decide to take part, you will be given this 
information sheet to keep, and I will explain the consent process and confirm that you are 
willing to take part in the study. I will also allow time before the start of the interview to 
answer any further questions or clarify details, as required.  
 
What are the advantages/benefits and disadvantages/risks of taking part? 
Advantages/benefits: There are no incentives or payments for taking part. Taking part may 
help you to reflect on your views and experiences relevant to antibiotic use. In addition, a 
summary of study findings (in Chinese and English) will be sent to participants who wish to 
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receive it. You may benefit from an understanding of the views and experiences of other 
physicians as well as pharmacists, and parents in Taiyuan City. 
 
Disadvantages/risks: The interview will take some of your time. You may be aware of some 
inappropriate prescribing behaviour relevant to antibiotics in hospitals or community health 
centres/stations. No information collected will allow you to be identified and all data will be 
kept securely. 
 
Can I withdraw from the study at any time?  
If you decide to take part, you are free to withdraw from this study at any time and you do 
not have to give a reason. Withdrawing from this study will not affect anything of your work. 
Data collected from participants who decided to withdraw from this study will not be used. 
 
Will the information obtained in the study be confidential?  
All the information is confidential. No information will be held that allows you to be identified, 
and all data will be kept securely. All audio-files, transcripts and analysis notes will be given a 
number to safeguard confidentiality and will be stored electronically on an encrypted storage 
device in a locked bag and at the University of York using its secure data systems (VPN - Virtual 
Private Network). Only the researcher and supervisors will have access to the data. At the end 
of the research the audio-files will be deleted securely and all electronic data will be stored 
for a maximum of five years. All data will be treated in accordance with the UK Data Protection 
Act (1998) and the University of York Department of Health Sciences’ Data Security Policy. 
 
What will happen to the results of the study? 
The results will be reported in the PhD dissertation and in papers in scientific and professional 
journals, as well as in conference presentations. We will also provide a summary of findings 
to participants who wish to receive it. 
  
Who has reviewed this study? 
Two supervisors (Professor Hilary Graham and Professor Piran White) and Research 
Governance Committee of Department of Health Sciences, University of York reviewed this 
study for ethical compliance. 
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Who do I contact in the event of a complaint? 
Please raise any difficulties or questions with the study supervisors: 
Professor Hilary Graham (Department of Health Sciences, University of York) on email 
hilary.graham@york.ac.uk  
Professor Piran White (Deputy Head of Department for Research, Environment Department, 
University of York) on email piran.white@york.ac.uk  
 
If you agree to take part, would like more information or have any questions or concerns 
about the study please contact: 
Name: Tingting Zhang 
Position: PhD student in the Department of Health Sciences, University of York 
Contact details: tz746@york.ac.uk 
 
If you would like to receive a summary of study findings, please provide the contact details 
you prefer in the card of ‘Participant Contact Details for Receiving the Study Summary’. I 
will send a summary to you and then destroy the contact details. (Please note that you 
don’t need to provide your name in the contact details) 
 
Thank you for taking the time to read this information sheet. 
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[Knowledge, attitudes and behaviour relevant to antibiotic use among physicians, 
pharmacists and parents in Taiyuan City of Shanxi Province, China] 
 
Participant Information Sheet 
 
A qualitative study of antibiotic use among pharmacists in Taiyuan City 
 
I would like to invite you to take part in the above named study. This leaflet explains why the 
study is being done and what it will involve. Please take time to read it. Please feel free to ask 
the researcher if there is anything that is not clear or if you would like more information. 
 
What is the purpose of this study? 
Antimicrobial resistance (AMR), especially the development of bacteria resistant to 
antibiotics, is increasing rapidly all over the world. Compared with western countries, China 
has a higher rate of antibiotic use for the treatment of human illnesses, including among 
children. Also, China consistently ranks close to the top of global rankings for the prevalence 
of multiple antibiotic resistant strains, and the reported number of ineffective antibiotics is 
increasing. The causes of antibiotic use and resistance are multifactorial. This study is aiming 
to learn about the views of pharmacists, as well as parents and physicians. Therefore, this 
study would like to explore your views and experiences relevant to antibiotic use and 
resistance.  
 
Who is doing the study?  
This study is a part of a wider programme of research at the University of York in the UK 
concerned with human health and the natural environment. The study is funded by the 
University of York as part of a PhD Studentship. The chief researcher is Tingting Zhang, who 
is a PhD student in the Department of Health Sciences of the University of York, and is 
supervised by Professor Hilary Graham and Professor Piran White. 
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Who is being asked to participate?  
I am inviting pharmacists who work at different kind of pharmacies. Therefore, 16 participants 
will be invited to talk about antibiotic use and resistance, including 4 pharmacists working at 
city hospitals, 4 pharmacists in community health institutions, 4 pharmacists in retail 
pharmacies and 4 untrained staff in retail pharmacies. 
 
What will be involved if I take part in this study? 
If you are willing, we would invite you to participate in an interview to explore your 
knowledge, views and experiences relevant to antibiotics use and resistance. The interview 
will be face-to-face, conducted on your worksite and last approximately 30-45 minutes. The 
interview will be audio-recorded, with your permission. The audio-files from interviews will 
then be transcribed (listened to and written down in full) and analysed by the researcher.  
 
Do I have to take part? 
No. Taking part in the research is entirely voluntary. Whether you choose to take part or not, 
will not affect your work in any way. If you decide to take part, you will be given this 
information sheet to keep, and I explain what is involved and confirm that you are willing to 
take part in the study. I will also allow time before the start of the interview to answer any 
further questions or clarify details as required.  
 
What are the advantages/benefits and disadvantages/risks of taking part? 
Advantages/benefits: There are no incentives or payments for taking part. Taking part may 
help you to reflect on your views and experiences relevant to antibiotic use. In addition, a 
summary of study findings (in Chinese) will be sent to participants who wish to receive it. You 
may benefit from an understanding of the views and experiences of other pharmacists as well 
as physicians, and parents in Taiyuan City. 
 
Disadvantages/risks: The interview will take some of your time. You may be aware of some 
inappropriate behaviour relevant to antibiotics (such as the sale of over-the-counter 
antibiotics) in pharmacies. No information collected will allow you to be identified and all data 
will be kept securely. 
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Can I withdraw from the study at any time?  
If you decide to take part, you are free to withdraw from this study at any time and you do 
not have to give a reason. Withdrawing from this study will not affect anything of your work. 
Data collected from participants who decide to withdraw from this study will not be used. 
 
Will the information obtained in the study be confidential?  
All the information is confidential. No information will be held that allows you to be identified, 
and all data will be kept securely. All audio-files, transcripts and analysis notes will be given a 
number to safeguard confidentiality and stored electronically on an encrypted storage device 
in a locked bag and at the University of York using its secure data systems (VPN - Virtual 
Private Network). Only the researcher and supervisors will have access to the data. At the end 
of the research the audio-files will be deleted securely and all electronic data will be stored 
for a maximum of five years. All data will be treated in accordance with the UK Data Protection 
Act (1998) and the University of York Department of Health Sciences’ Data Security Policy. 
 
What will happen to the results of the study? 
The results will be reported in the PhD dissertation and in papers in scientific and professional 
journals, as well as in conference presentations. We will also provide a summary of findings 
to participants who wish to receive it. 
  
Who has reviewed this study? 
Two supervisors (Professor Hilary Graham and Professor Piran White) and Research 
Governance Committee of Department of Health Sciences, University of York reviewed this 
study for ethical compliance. 
 
Who do I contact in the event of a complaint? 
Please raise any difficulties or questions with the study supervisors: 
Professor Hilary Graham (Department of Health Sciences, University of York) on email 
hilary.graham@york.ac.uk  
Professor Piran White (Deputy Head of Department for Research, Environment Department, 
University of York) on email piran.white@york.ac.uk  
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If you agree to take part, would like more information or have any questions or concerns 
about the study please contact: 
Name: Tingting Zhang 
Position: PhD student in the Department of Health Sciences, the University of York 
Contact details: tz746@york.ac.uk 
 
If you would like to receive a summary of study findings, please provide the contact details 
you prefer in the card of ‘Participant Contact Details for Receiving the Study Summary’. I 
will send a summary to you and then destroy the contact details. (Please note that you 
don’t need to provide your name in the contact details) 
 
Thank you for taking the time to read this information sheet. 
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Participant Information Sheet 
 
Giving antibiotics to children: understanding parents’ views and experiences in Taiyuan 
City 
 
I would like to invite you to take part in the above named study.  This leaflet explains why the 
study is being done and what it will involve. Please take time to read it. Please feel free to ask 
the researcher if there is anything that is not clear or if you would like more information. 
 
What is the purpose of this study? 
Children consume considerable amounts of antibiotics worldwide because they are 
susceptible to infections, particularly upper respiratory tract infections (such as cold). In China, 
children are more likely to be given antibiotics than in other countries. Therefore, this study 
aims to explore parents’ views and experiences relevant to antibiotic use for their child, as 
well as pharmacists and physicians. 
 
Who is doing the study?  
This study is a part of a wider programme of research at the University of York in the UK 
concerned with human health and the natural environment. The study is funded by the 
University of York as part of a PhD Studentship. The chief researcher is Tingting Zhang, who 
is a PhD student in the Department of Health Sciences of the University of York, and is 
supervised by Professor Hilary Graham and Professor Piran White. 
 
Who is being asked to participate? 
During the study about 100 parents of child patients in the paediatric department of two city 
hospitals (First Hospital of Shanxi Medical University and Taiyuan Hospital Health Centre for 
Women and Children) like yourself will be invited to answer a self-completion questionnaire 
about antibiotic use on their children. 
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What will be involved if I take part in this study? 
You will not be asked to give your name, your child’s name or your address. I will invite you 
to complete a questionnaire about your views and experiences of antibiotic use for your child. 
It will take about 20-25 minutes to complete within your waiting time at the paediatric clinic. 
Each questionnaire will then be given a number and the information from the questionnaires 
will be analysed by the researcher using a statistical analysis software on the computer. 
 
Do I have to take part? 
No. Taking part in the research is entirely voluntary. Whether you choose to take part or not, 
will not affect you and your child’s health care in any way. If you decide to take part, you will 
be given this information sheet to keep, and I will explain what is involved and confirm that 
you are willing to take part in the study. I will also allow time when I give you the 
questionnaire to answer any further questions or clarify details as required.  
 
What are the advantages/benefits and disadvantages/risks of taking part? 
Advantages/benefits: There are no incentives or payments for taking part. Taking part may 
help you to reflect on your views and experiences regarding using antibiotics for your child. 
In addition, a summary of study findings (in Chinese) will be sent to participants who wish to 
receive it.  
 
Disadvantages/risks: You might become more anxious about using antibiotics on your child. 
You do not need to answer any questions you do not want to and you will be given a summary 
of parents’ views and experiences of antibiotic use.  
 
Can I withdraw from the study at any time?  
If you decide to take part, you are free to withdraw from the study at any time and you do 
not have to give a reason. Withdrawing from this study will not affect you and your child’s 
health care.  
 
Will the information obtained in the study be confidential?  
All the information is confidential. No information will be held that allows you to be identified, 
and all data will be kept securely. All questionnaires will be given a number to safeguard 
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confidentiality and stored electronically on an encrypted storage device in a locked bag and 
at the University of York using its secure data systems (VPN - Virtual Private Network). Only 
the researcher and supervisors will have access to the data. The paper-based questionnaires 
will be destroyed by a shredder as soon as the information has been stored electronically and 
all electronic data will be stored for a maximum of five years. All data will be treated in 
accordance with the UK Data Protection Act (1998) and the University of York Department of 
Health Sciences’ Data Security Policy. 
 
What will happen to the results of the study? 
The results will be reported in the PhD dissertation and in papers in scientific and professional 
journals, as well as in conference presentations. We will also provide a summary of findings 
to participants who wish to receive it. 
  
Who has reviewed this study? 
Two supervisors (Professor Hilary Graham and Professor Piran White) and Research 
Governance Committee of Department of Health Sciences, University of York have reviewed 
this study for ethical compliance. 
 
Who do I contact in the event of a complaint? 
Please raise any difficulties or questions with the study supervisors: 
Professor Hilary Graham (Department of Health Sciences, University of York) on email 
hilary.graham@york.ac.uk  
Professor Piran White (Deputy Head of Department for Research, Environment Department, 
University of York) on email piran.white@york.ac.uk  
 
If you agree to take part, would like more information or have any questions or concerns 
about the study please contact: 
Name: Tingting Zhang 
Position: PhD student in the Department of Health Sciences, the University of York 
Contact details: tz746@york.ac.uk 
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If you would like to receive a summary of study findings, please provide the contact details 
you prefer in the card of ‘Participant Contact Details for Receiving the Study Summary’. I 
will send a summary to you and then destroy the contact details. (Please note that you 
don’t need to provide your name in the contact details) 
 
Thank you for taking the time to read this information sheet. 
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Participant Information Sheet 
 
Giving antibiotics to children: understanding parents’ views and experiences in Taiyuan 
City 
 
I would like to invite you to take part in the above named study.  This leaflet explains why the 
study is being done and what it will involve. Please take time to read it. Please feel free to ask 
the researcher if there is anything that is not clear or if you would like more information. 
 
What is the purpose of this study? 
Children consume considerable amounts of antibiotics worldwide because they are 
susceptible to infections, particularly upper respiratory tract infections (such as cold). In China, 
children are more likely to be given antibiotics than in other countries. Therefore, this study 
aims to explore parents’ views and experiences relevant to antibiotics use for their child, as 
well as pharmacists and physicians. 
 
Who is doing the study?  
This study is a part of a wider programme of research at the University of York in the UK 
concerned with human health and the natural environment. The study is funded by the 
University of York as part of a PhD Studentship. The chief researcher is Tingting Zhang, who 
is a PhD student in the Department of Health Sciences of the University of York, and is 
supervised by Professor Hilary Graham and Professor Piran White. 
 
Who is being asked to participate? 
During the study period, about 30 parents of children, like yourself in this nursery, will be 
invited to participate in this study. You will then be divided into different groups (there are in 
total 6 groups with 5-6 parents in each group) to talk about antibiotic use on your child with 
researcher and other parents within your group.  
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What will be involved if I take part in this study? 
You will not be asked to give your name, your child’s name or your address. I will invite you 
to talk about your views and experiences of antibiotic use on your child with the researcher 
and another 4-5 parents. The discussion will be face-to-face, conducted in this nursery, and 
last approximately 45-60 minutes. It will be audio-recorded, with your permission. The audio-
files will then be transcribed (listened to and written down in full) and analysed by the 
researcher.  
 
Do I have to take part? 
No. Taking part in the research is entirely voluntary. Whether you choose to take part or not, 
will not affect you and your child’s anything in this nursery. If you decide to take part, you will 
be given this information sheet to keep, and I will explain what is involved and confirm that 
you are willing to take part in the study. I will also allow time before the start of focus group 
to answer any further questions or clarify details as required. 
 
What are the advantages/benefits and disadvantages/risks of taking part? 
Advantages/benefits: There are no incentives or payments for taking part. Taking part may 
help you to reflect on your views and experiences regarding using antibiotics for your child. 
In addition, a summary of study findings (in Chinese) will be sent to participants who wish to 
receive it.  
 
Disadvantages/risks: You might become more anxious about using antibiotics on your child. 
You do not need to answer any questions you do not want to and you will be given a summary 
of parents’ views and experiences of antibiotic use.  
 
Can I withdraw from the study at any time?  
If you decide to take part, you are free to withdraw from the study at any time and you do 
not have to give a reason. Withdrawing from this study will not affect anything of you and 
your child in this nursery. 
 
Will the information obtained in the study be confidential?  
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All the information is confidential. No information will be held that allows you to be identified, 
and all data will be kept securely. The pseudonyms will be used in the transcripts to 
distinguish different speakers. All audio-files, transcripts and analysis notes will be given a 
number to safeguard confidentiality and stored electronically on an encrypted storage device 
in a locked bag and at the University of York using its secure data systems (VPN - Virtual 
Private Network). Only the researcher and supervisors will have access to the data UK. At the 
end of the research the audio-files will be deleted securely and all electronic data will be 
stored for a maximum of five years. All data will be treated in accordance with the UK Data 
Protection Act (1998) and the University of York Department of Health Sciences’ Data Security 
Policy. 
 
What will happen to the results of the study? 
The results will be reported in the PhD dissertation and in papers in scientific and professional 
journals, as well as in conference presentations. We will also provide a summary of findings 
to participants who wish to receive it. 
  
Who has reviewed this study? 
Two supervisors (Professor Hilary Graham and Professor Piran White) and Research 
Governance Committee of Department of Health Sciences, University of York have reviewed 
this study for ethical compliance. 
 
Who do I contact in the event of a complaint? 
Please raise any difficulties or questions with the study supervisors: 
Professor Hilary Graham (Department of Health Sciences, University of York) on email 
hilary.graham@york.ac.uk  
Professor Piran White (Deputy Head of Department for Research, Environment Department, 
University of York) on email piran.white@york.ac.uk  
 
If you agree to take part, would like more information or have any questions or concerns 
about the study please contact: 
Name: Tingting Zhang 
Position: PhD student in the Department of Health Sciences, the University of York 
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Contact details: tz746@york.ac.uk 
 
If you would like to receive a summary of study findings, please provide the contact details 
you prefer in the card of ‘Participant Contact Details for Receiving the Study Summary’. I 
will send a summary to you and then destroy the contact details. (Please note that you 
don’t need to provide your name in the contact details) 
 
Thank you for taking the time to read this information sheet. 
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Record of verbal participant consent 
 
Title of Study: Understanding antibiotic use in Taiyuan City of Shanxi Province, China 
Name of researcher: Tingting Zhang (tz746@york.ac.uk) 
 
 
 
I have confirmed the 
statements by putting my 
initials in the boxes below 
The participant has been given the information sheet 
which they have read/asked me to go through with 
them, and has had the opportunity to ask questions. 
 
I have explained that participation in the study is 
voluntary, the participant is free to withdraw from 
the study without giving any reason and that data 
provided prior to withdrawal will not be used 
 
I have explained that all the information is 
confidential and the participant will not be able to be 
identified 
 
I have explained that I may publish the results of this 
research and explained that I will not use any names 
or personal information. 
 
The participant has agreed to take part in this study  
Investigator Signature …………………………………………………………              Date  
 Participant number: 
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Appendix G – The paper based on Chapter 2 
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Introduction
 High rates of paediatric use of antibiotics by healthcare provid-
ers (hereafter ‘providers’) are a key driver of antibiotic resistance 
in China [1,2], where rates of antibiotic resistance to most common 
bacteria are particularly high [3]. Prescription rates for paediatric pa-
tients using primary healthcare and hospital outpatient clinics range 
from 57.7% to 80.3% [4-7], well above the 30% rate recommended 
by World Health Organisation [8]. Additionally, while antibiotics are 
officially available on prescription only [9], retail pharmacies are a 
major source of over-the-counter (OTC) antibiotics for children [10].
 Hospitals remain the cornerstone of China’s healthcare system 
[11] but community health institutions (CHIs), which include com-
munity health centres and smaller community health stations, and 
retail pharmacies are rapidly-growing sectors [12]. All providers sup-
port both Western medicine and Traditional Chinese Medicine (TCM) 
[12,13], a holistic knowledge system used for 2000 years to prevent, 
diagnose and treat ill-health [14-16]. In the context of TCM, disease 
indicates unbalanced yin-yang, caused by bodily excesses (liuyin) and 
emotions (qiqing) [16]. Excess bodily heat can result in inflammatory 
conditions, along with fever, sore throat and other symptoms. TCM 
treatment methods include herbal medicines and diets, while surgical 
procedures are seldom used [13,14].
 Qualitative studies are increasingly used to capture provider per-
spectives on factors influencing their behavior [17,18]; in high-in-
come countries (HICs), studies of antibiotic-related behavior (ARB) 
have identified parental pressure as a key influence [19]. However, 
few studies have been conducted in China [2,20-22]. Our search of 
English-language (MEDLINE Ovid) and Chinese (Chinese National 
Knowledge Infrastructure) databases located two qualitative studies 
reporting providers’ perceptions of influences on their ARB, both 
based in rural China [23,24]. Here we present the results of a quali-
tative study which aimed to examine the perceptions of providers in 
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Abstract
Background
 High rates of paediatric use of antibiotics by healthcare providers 
are a key driver of antibiotic resistance in China. Qualitative studies 
are increasingly used to capture provider perceptions of influences 
on their antibiotic-related behavior; however, very few studies have 
been conducted in China. We undertook a qualitative study of pro-
viders in paediatric outpatient departments, primary care and retail 
pharmacies to examine their perceptions of influences on their anti-
biotic-related behavior.
Methods
 Qualitative semi-structured interviews were conducted with 20 
providers in a Chinese city of average wealth and health expendi-
ture: 6 hospital-based paediatricians; 6 general practitioners in com-
munity health institutions; and 8 providers in retail pharmacies. Inter-
views were transcribed verbatim, translated from Chinese to English, 
and analysed using framework analysis.
Results
 Parents were the most frequently-mentioned influence on provid-
ers’ antibiotic-related behavior. Parental influences clustered under 
three themes: the importance of public understandings of disease 
and treatment within Traditional Chinese Medicine and Western 
medicine; parental trust; and good relationships with patients.
Conclusion
 To our knowledge, this is the first city-based qualitative study 
in China of providers’ perceptions of influences on their antibiot-
ic-related behavior, which points to the importance of cultural and 
system-level contexts: Public understandings of the human body 
grounded in Traditional Chinese Medicine and the role of trust and 
familiarity in provider-parent interactions. It suggests that informa-
tion campaigns to promote appropriate antibiotic use should take ac-
count of these public understandings and be supported by a further 
strengthening of primary care, including remuneration systems that 
reward the quality of clinical decision-making.
Keywords: Antibiotic resistance; Familiarity; Traditional Chinese 
Medicine; Trust; Shanxi province
  322 
Appendix H – COREQ checklist for study of parental influences on providers’ 
use of antibiotics for children in China 
Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist 
 
Topic and Item No. 
 
Guide questions/description Reported on 
Page No. 
Domain 1: Research team and reﬂexivity  
Personal Characteristics  
1. Interviewer/facilitator Which author/s conducted the interview 
or focus group?  
pp.144 
2. Credentials What were the researcher’s credentials? 
E.g. PhD, MD  
pp.20 
3. Occupation What was their occupation at the time of 
the study?  
pp.20 
4. Gender Was the researcher male or female?  pp.144 
5. Experience and training What experience or training did the 
researcher have?  
N/A 
Relationship with participants  
6. Relationship established Was a relationship established prior to 
study commencement?  
pp.142 
7. Participant knowledge 
of the interviewer  
What did the participants know about the 
researcher? e.g. personal goals, reasons 
for doing the research  
pp.142 
8. Interviewer 
characteristics 
What characteristics were reported about 
the inter viewer/facilitator? e.g. Bias, 
assumptions, reasons and interests in the 
research topic  
pp.161-162 
Domain 2: study design  
Theoretical framework  
9. Methodological 
orientation and Theory  
What methodological orientation was 
stated to underpin the study? e.g. 
grounded theory, discourse analysis, 
ethnography, phenomenology, content 
analysis  
pp.86-89 
Participant selection  
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10. Sampling How were participants selected? e.g. 
purposive, convenience, consecutive, 
snowball  
pp.142 
11. Method of approach How were participants approached? e.g. 
face-to-face, telephone, mail, email  
pp.144 
12. Sample size How many participants were in the study?  pp.141 
13. Non-participation How many people refused to participate 
or dropped out? Reasons?  
pp.141 
Setting 
14. Setting of data 
collection 
Where was the data collected? e.g. home, 
clinic, workplace  
pp.144-145 
15. Presence of non-
participants 
Was anyone else present besides the 
participants and researchers?  
N/A 
16. Description of sample What are the important characteristics of 
the sample? e.g. demographic data, date  
pp.142 
Data collection  
17. Interview guide Were questions, prompts, guides provided 
by the authors? Was it pilot tested?  
pp.143-144 
 
18. Repeat interviews Were repeat interviews carried out? If yes, 
how many?  
N/A 
 
19. Audio/visual recording Did the research use audio or visual 
recording to collect the data?  
pp.144-145 
20. Field notes Were ﬁeld notes made during and/or after 
the interview or focus group? 
pp.145 
21. Duration What was the duration of the inter views 
or focus group?  
pp.145 
 
22. Data saturation Was data saturation discussed?  pp.146 
23. Transcripts returned Were transcripts returned to participants 
for comment and/or correction?  
 N/A 
Domain 3: analysis and ﬁndings  
Data analysis  
24. Number of data coders How many data coders coded the data?  pp.145-146 
25. Description of the 
coding tree 
Did authors provide a description of the 
coding tree?  
pp.146-147 
26. Derivation of themes Were themes identiﬁed in advance or 
derived from the data?  
pp.146 
27. Software What software, if applicable, was used to 
manage the data?  
N/A 
28. Participant checking Did participants provide feedback on the 
ﬁndings?  
N/A 
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Reporting  
29. Quotations presented Were participant quotations presented to 
illustrate the themes/ﬁndings? Was each 
quotation identiﬁed? e.g. participant 
number  
pp.147-161 
30. Data and ﬁndings 
consistent 
Was there consistency between the data 
presented and the ﬁndings?  
pp.147-161 
31. Clarity of major themes Were major themes clearly presented in 
the ﬁndings?  
pp.147-161 
32. Clarity of minor themes Is there a description of diverse cases or 
discussion of minor themes?       
pp.147-161 
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Appendix J – COREQ checklist for study of organisational influences on 
providers’ use of antibiotics for children in China 
Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist 
 
Topic and Item No. 
 
Guide questions/description Reported on 
Page No. 
Domain 1: Research team and reﬂexivity  
Personal Characteristics  
1. Interviewer/facilitator Which author/s conducted the interview 
or focus group?  
pp.144 
2. Credentials What were the researcher’s credentials? 
E.g. PhD, MD  
pp.20 
3. Occupation What was their occupation at the time of 
the study?  
pp.20 
4. Gender Was the researcher male or female?  pp.144 
5. Experience and training What experience or training did the 
researcher have?  
N/A 
Relationship with participants  
6. Relationship established Was a relationship established prior to 
study commencement?  
pp.142 
7.Participant knowledge of 
the interviewer  
What did the participants know about the 
researcher? e.g. personal goals, reasons 
for doing the research  
pp.142 
8. Interviewer 
characteristics 
What characteristics were reported about 
the inter viewer/facilitator? e.g. Bias, 
assumptions, reasons and interests in the 
research topic  
pp.191 
Domain 2: study design  
Theoretical framework  
9. Methodological 
orientation and Theory  
What methodological orientation was 
stated to underpin the study? e.g. 
grounded theory, discourse analysis, 
ethnography, phenomenology, content 
analysis  
pp.86-89 
Participant selection  
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10. Sampling How were participants selected? e.g. 
purposive, convenience, consecutive, 
snowball  
pp.142 
11. Method of approach How were participants approached? e.g. 
face-to-face, telephone, mail, email  
pp.144 
12. Sample size How many participants were in the study?  pp.173 
13. Non-participation How many people refused to participate 
or dropped out? Reasons?  
pp.172-173 
Setting 
14. Setting of data 
collection 
Where was the data collected? e.g. home, 
clinic, workplace  
pp.144-145 
15. Presence of non-
participants 
Was anyone else present besides the 
participants and researchers?  
N/A 
16. Description of sample What are the important characteristics of 
the sample? e.g. demographic data, date  
pp.142, 172-
174 
Data collection  
17. Interview guide Were questions, prompts, guides provided 
by the authors? Was it pilot tested?  
pp.143-
144,174 
 
18. Repeat interviews Were repeat interviews carried out? If yes, 
how many?  
N/A 
 
19. Audio/visual recording Did the research use audio or visual 
recording to collect the data?  
pp.144-145 
20. Field notes Were ﬁeld notes made during and/or after 
the interview or focus group? 
pp.145 
21. Duration What was the duration of the inter views 
or focus group?  
pp.145 
 
22. Data saturation Was data saturation discussed?  pp.146 
23. Transcripts returned Were transcripts returned to participants 
for comment and/or correction?  
 N/A 
Domain 3: analysis and ﬁndings  
Data analysis  
24. Number of data coders How many data coders coded the data?  pp.145-146 
25. Description of the 
coding tree 
Did authors provide a description of the 
coding tree?  
pp.175-176 
26. Derivation of themes Were themes identiﬁed in advance or 
derived from the data?  
pp.175-176 
27. Software What software, if applicable, was used to 
manage the data?  
N/A 
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28. Participant checking Did participants provide feedback on the 
ﬁndings?  
N/A 
Reporting  
29. Quotations presented Were participant quotations presented to 
illustrate the themes/ﬁndings? Was each 
quotation identiﬁed? e.g. participant 
number  
pp.176-190 
30. Data and ﬁndings 
consistent 
Was there consistency between the data 
presented and the ﬁndings?  
pp.176-190 
31. Clarity of major themes Were major themes clearly presented in 
the ﬁndings?  
pp.176-190 
32. Clarity of minor themes Is there a description of diverse cases or 
discussion of minor themes?       
pp.176-190 
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Appendix K – A topic guide used for focus groups in parental study 
 
Giving antibiotics to children: understanding parents’ views and experiences in Taiyuan 
city 
Dear Parents, 
Good day. I am a PhD student at the University of York in the UK. My study is exploring antibiotic 
use by parents, doctors and pharmacists. In China, parents may not always be sure what is wrong 
with their children when they are not well and may wonder if antibiotics would be helpful. This 
focus group will help me gain a better understanding of the views and experiences of parents in 
Taiyuan City regarding the use of antibiotics for their children. I would really appreciate it if you 
could share your opinions and experiences on antibiotic use. Thanks again for your time and 
cooperation. Now, let’s start! 
 
Topics: 
1. Could you please recall what you did when your children were ill in the last 12 months? (Visit a 
doctor? Parental medication? To do nothing?) Could you please give me some examples? 
 
2. Did your children use antibiotics in the last 12 months? 
 
3. Case study 
Emma is a 4-year-old girl in this nursery who has been previously healthy. On one day of 
November, she starts to have the symptom of a runny nose and looks slightly tired.  
a) What do you think Emma’s parents should do? (Do nothing, seek professional health care, 
self-treat) 
 
Her parents do nothing for her, and on the 3rd day, she complains of feeling congested, having 
copious green nasal discharge, and intermittent headaches. She looks tired and slightly pale. 
But on examination she does not have a temperature. 
b) What should Emma’s parents do?  
Should they bring her to visit a doctor? If yes, should they go to hospitals or community 
health institutions? 
Should they treat her by themselves? If yes, what kind of treatments should they give? 
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Should they still do nothing on her?  
Why should they do that? 
 
In fact, Emma’s parents use some antiviral drugs and Chinese patent medicines on her by 
themselves from the 3rd day. However, on the next day (the 4th day), Emma becomes worse 
and has a low-grade fever with intermittent cough. 
c) What should Emma’s parents do?  
Should they bring her to visit a doctor? If yes, go to hospitals or community health 
institutions? 
Should they use some antibiotics on Emma by themselves instead of antiviral drugs and 
Chinese patent medicines? 
Why should they do that? 
 
Actually, Emma’s parents take her to a paediatrician in the hospital immediately on the 4th 
day when Emma becomes worse. After the consultation, the paediatrician diagnoses Emma’s 
disease as viral flu and prescribes some antiviral drugs to Emma. Emma’s parents use these 
drugs according to the physician’s prescription. However Emma’s symptoms still continue. 
d) What should Emma’s parents do? 
Should they still use the drugs according to the prescription and then return for further 
consultation? 
Should they take her to another doctor? If yes, hospitals or community health institutions? 
Should they start to use some antibiotics on Emma by themselves? 
Why should they do that? 
 
Finally, Emma’s parents start to use antibiotics on Emma by themselves and do not take her 
to any doctors or return for a further consultation. And after another five days, Emma 
recovers and remains healthy. 
e) Do you think that the antibiotics cured Emma’s disease? 
 
4. When you bring your children to visit a doctor, for which of the following symptom(s) do you think 
a doctor might prescribe antibiotics? 
 
A. Runny nose 
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B. Nasal congestion 
C. Cough 
D. Sore throat 
E. Fever 
F. Ache and Pains 
G. Vomiting 
H. Diarrhoea 
I. Skin wounds 
J. None 
K. Other (please specify) 
 
5. During the consultation, when you are keen that your child receive antibiotics, do you directly 
make clear your wish to the doctor to prescribe antibiotics? 
Please think about the last time you made clear you wished a doctor prescribe antibiotics for your 
child, did the doctor refuse your request?
If No, did you have to persuade the doctor to give your child a prescription for antibiotics, before 
they did so? Could you please try to describe what you said? 
If Yes, did you try to persuade the doctor to give your child a prescription for antibiotics, after 
he/she told you he/she is not going to prescribe your child any? Could you please try to describe 
what you said? 
Do you still think the doctor should have prescribed your child antibiotics? Why do you think so? 
Do you feel dissatisfied if he/she refuses your request for antibiotics? 
 
6. When a doctor prescribes antibiotics for your child, have you ever refused or been reluctant to 
accept the prescription?  
If yes, could you please give some examples (For instance, refuse any antibiotics, or refuse to use 
expensive or new generation antibiotics, or prefer oral antibiotics to the treatment of intravenous 
infusion, before or after the prescription)? 
What do you think are reasons that you refused the antibiotics? 
 
7. Do you think the communication about prescribing antibiotics to your children between you and 
doctors during the consultation is sufficient? 
Does the doctor explain to you the reasons that he/she prescribes antibiotics to your child during 
the consultation? 
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When the doctor does not explain, do you ask for the reasons for prescribing antibiotics? 
 
8. Do you usually use antibiotics on your child according to the prescription?  
For example, does your child take a full course of antibiotics?  
Does your child take the right dosage of antibiotics at the right time? 
Do you ever use a higher dose on your child? 
Do you keep unused antibiotics for future use? 
If No, could you please give me some reasons or examples? 
 
9. Do you ever visit a doctor without your child when he/she is ill? Do you ever not bring your child 
for a further consultation even though it is required by a doctor?  
 
10. Do you ever treat your child with antibiotics by yourself when he/she is ill or symptomatic? When 
you treat your child with antibiotics by yourself, what are the main sources where you get 
antibiotics?  
Where did you usually purchase the over-the-counter antibiotics? 
 
11. What kinds of side effects of antibiotics sometimes happen in your child? 
A. Nausea 
B. Vomiting  
C. Diarrhoea 
D. Rash 
E. Vaginal thrush 
F. Antibiotic resistance 
G. Others (Please specify) 
H. Never experienced any adverse effects 
 
11.1 a). Have you ever heard of antibiotic resistance? (If antibiotic resistance is not mentioned in Topic 
11) 
If No, the focus group will finish. 
 
If yes, what do you know about antibiotic resistance? 
b). As you mentioned antibiotic resistance above, what do you know about antibiotic resistance? (If 
antibiotic resistance is mentioned in Topic 9) 
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11.2 Do you think antibiotic resistance is a problem?  
If yes, what do you think is the most important cause of the resistance of antibiotics? (e.g. consumer 
behaviour, behaviour of retail pharmacies, physicians’ prescribing behaviour) 
Do you have any ideas to tackle the problems of antibiotic resistance? 
 
11.3 Where do parents usually get the information about antibiotics and antibiotic resistance? 
 
11.4 Who do you think should provide information about antibiotics and antibiotic resistance to 
parents?  
 
 
Giving antibiotics to children: understanding parents’ views and experiences in Taiyuan city 
Research Date:                    Research Place:  
1.  Your gender:   Male       Female 
2. Your age:   under 30 years old 
           30-39 years old 
           40-49 years old 
           50 or over years old 
3. Your highest educational level:   
 Primary school or below 
                        Secondary school 
                        High School/ Secondary technical college 
                        College/ University 
                        Postgraduate studies or above 
4. Your occupation:  _________ 
5. What kind(s) of health insurance(s) do you have now? (Check more than one if 
applicable) 
 Urban Employee Basic Medical Insurance 
 Urban Resident Basic Medical Insurance 
 New Rural Cooperative Medical Insurance 
 Commercial health insurance 
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 None 
Others (please specify)____________________ 
6. Would you describe the yearly income of your household in 2015 as: (the yearly 
income should be the total gross income of all residents in your household, including 
salary, bonus, business and agricultural income, pension, dividend, interest, rent and 
any other income) 
 Below 10,000 RMB 
 10,000-24,999RMB 
 25,000-49,999RMB 
 50,000 RMB and above 
7. Where did you live? 
 Taiyuan City  
 Other cities in Shanxi Province 
 Rural areas in Shanxi Province 
 Other Province 
That is all. Thank you very much for your cooperation and I wish you and your family all the best! 
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Appendix L – COREQ checklist for the focus group of parental study  
Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist 
 
Topic and Item No. 
 
Guide questions/description Reported on 
Page No. 
Domain 1: Research team and reﬂexivity  
Personal Characteristics  
1. Interviewer/facilitator Which author/s conducted the interview 
or focus group?  
pp.207 
2. Credentials What were the researcher’s credentials? 
E.g. PhD, MD  
pp.20 
3. Occupation What was their occupation at the time of 
the study?  
pp.20 
4. Gender Was the researcher male or female?  pp.144 
5. Experience and training What experience or training did the 
researcher have?  
N/A 
Relationship with participants  
6. Relationship established Was a relationship established prior to 
study commencement?  
pp.205 
7.Participant knowledge of 
the interviewer  
What did the participants know about the 
researcher? e.g. personal goals, reasons 
for doing the research  
pp.205 
8. Interviewer 
characteristics 
What characteristics were reported about 
the inter viewer/facilitator? e.g. Bias, 
assumptions, reasons and interests in the 
research topic  
pp.246-247, 
253-257 
Domain 2: study design  
Theoretical framework  
9. Methodological 
orientation and Theory  
What methodological orientation was 
stated to underpin the study? e.g. 
grounded theory, discourse analysis, 
ethnography, phenomenology, content 
analysis  
pp.86-89 
Participant selection  
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10. Sampling How were participants selected? e.g. 
purposive, convenience, consecutive, 
snowball  
pp.205 
11. Method of approach How were participants approached? e.g. 
face-to-face, telephone, mail, email  
pp.206-207 
12. Sample size How many participants were in the study?  pp.209 
13. Non-participation How many people refused to participate 
or dropped out? Reasons?  
pp.205-206 
Setting 
14. Setting of data 
collection 
Where was the data collected? e.g. home, 
clinic, workplace  
pp.206 
15. Presence of non-
participants 
Was anyone else present besides the 
participants and researchers?  
N/A 
16. Description of sample What are the important characteristics of 
the sample? e.g. demographic data, date  
pp.209-210 
Data collection  
17. Interview guide Were questions, prompts, guides provided 
by the authors? Was it pilot tested?  
pp.206-208 
 
18. Repeat interviews Were repeat interviews carried out? If yes, 
how many?  
N/A 
 
19. Audio/visual recording Did the research use audio or visual 
recording to collect the data?  
pp.207 
20. Field notes Were ﬁeld notes made during and/or after 
the interview or focus group? 
pp.207 
 
21. Duration What was the duration of the inter views 
or focus group?  
pp.207 
 
22. Data saturation Was data saturation discussed?  pp.146,209 
23. Transcripts returned Were transcripts returned to participants 
for comment and/or correction?  
 N/A 
 
Domain 3: analysis and ﬁndings  
Data analysis  
24. Number of data coders How many data coders coded the data?  pp.209 
25. Description of the 
coding tree 
Did authors provide a description of the 
coding tree?  
pp.211-212 
26. Derivation of themes Were themes identiﬁed in advance or 
derived from the data?  
pp.209, 211-
212 
27. Software What software, if applicable, was used to 
manage the data?  
N/A 
 
28. Participant checking Did participants provide feedback on the 
ﬁndings?  
N/A 
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Reporting  
29. Quotations presented Were participant quotations presented to 
illustrate the themes/ﬁndings? Was each 
quotation identiﬁed? e.g. participant 
number  
pp.212-223 
30. Data and ﬁndings 
consistent 
Was there consistency between the data 
presented and the ﬁndings?  
pp.212-223 
31. Clarity of major themes Were major themes clearly presented in 
the ﬁndings?  
pp.212-223 
32. Clarity of minor themes Is there a description of diverse cases or 
discussion of minor themes?       
pp.212-223 
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Appendix M – A questionnaire for the survey of parental study 
Code 
Giving antibiotics to children: understanding parents’ views and experiences in Taiyuan 
city 
 
Dear Parents, 
Good day. I am a PhD student at the University of York in the UK. My study is exploring antibiotic 
use by parents, doctors and pharmacists in China. Parents may not always be sure what is wrong 
with their children when they are not well and may wonder if antibiotics would be helpful. This 
questionnaire will help me gain a better understanding of the views and experiences of parents in 
Taiyuan City regarding the use of antibiotics for their children. I would really appreciate it if you 
could share your opinions and experiences of antibiotic use. In this research, all the information is 
confidential. No information will be held that allows participants to be identified, and all data will 
be kept securely. In addition, a summary of findings about this research will be sent to participants 
who wish to receive it. Thanks again for your time and cooperation. 
 
Completing the questionnaire 
• Please answer questions by ticking the box before the answer, as in the example below. 
Example Question: 
Did you have breakfast this morning? 

 Yes  
No 
• Please answer questions according to the instructions and guidelines. Please tick only one box 
when there is no instruction. Please tick more than one answer if instructions saying ‘please 
check more than one if applicable’ or ‘please tick any that apply to you’ are marked. Please 
follow the specific instructions of particular questions. 
• For some particular questions, instructions will show which question to answer next. If there 
are no instructions, please just answer the next question. 
• Important information will be in bold and (or) underlined, please pay more attention to this 
information. 
 
Now please go to Q1 and start filling in your answers. 
 
Section 1. These questions are about your views on antibiotic use  
1. Do you know what antibiotics are? 
 Yes 
 No  
 Not sure 
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2. Do you think antibiotics are the same as anti-inflammatories? 
 Yes 
 No 
 Don’t know 
 
3. In your opinion, what kind of diseases are antibiotics used for? (Check more than one if applicable) 
 Bacterial infections 
 Viral infections 
 Others (specify)____________ 
 Don’t know 
 
4. Do you think that children may suffer from any of the following side-effects as a result of taking 
antibiotics? (Check more than one if applicable) 
 Nausea 
 Vomiting 
 Diarrhoea 
 Rash 
 Vaginal thrush 
 Antibiotic resistance 
 None of the above 
 Others (please specify)______________________ 
 Don’t know 
 
5. Do you know what antibiotic resistance is? 
 Yes 
 No 
 Not sure 
 
6. Which of the following statements do you think is (are) correct? (Please write True (T)/False (F) 
against each statement) 
 Higher doses of antibiotics result in faster recovery 
 Lower doses of antibiotics result in fewer adverse effects 
 Antibiotic treatment should be stopped as soon as symptoms have disappeared 
 Continuing antibiotic use after the full treatment course will consolidate the effectiveness of 
the treatment 
 Stopping the antibiotic treatment before the course is complete will increase the risk of 
antibiotic resistance 
 The more expensive antibiotics are, the better and more effective they are 
 Broad-spectrum antibiotics (e.g. Amoxicillin) are more effective because they can kill a 
variety of bacteria 
 Antibiotics can only be prescribed by doctors 
 Antibiotics must be obtained (purchased) with a doctor’s prescription 
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7. Which of the following sources of information have you found helpful when thinking about using 
antibiotics for your child? (Please tick the 3 most helpful) 
 Doctors 
 Staff in retail pharmacies 
 Friends and family  
 Internet 
 Television 
 Radio 
 Newspaper 
 Professional training 
 Public lectures held in the community 
 None of these 
 Others (please specify)______________________ 
 
8. Please indicate whether you agree or disagree with each following statements by ticking the box 
that applies to you. 
 Disagree Uncertain Agree 
Antibiotics are used too much on children in our 
country. 
   
When my child suffers from a cough, she/he would 
be cured more quickly if she/he received 
antibiotics as early as possible. 
   
Antibiotics should be the first choice when my 
child has a fever. 
   
Parents should be given more information about 
how to use antibiotics to help their child. 
   
Scientists can produce new varieties of antibiotics 
without difficulty when these are needed. 
   
The resistance of antibiotics among children is a 
serious problem. 
   
I worry that my knowledge of resistance of 
antibiotics is not sufficient. 
   
 
Section 2. These questions are about times when your child is unwell and using antibiotics 
9. Could you please recall the number of times you brought this child to visit a doctor in the last 12 
months? _______________________ 
 
10. Here are some reasons why a parent may not take their child to the doctor when they are not 
well. Thinking back over the last 12 months to times when your child has not been well, please 
tick any that apply to you. 
 I did not have enough time to visit a doctor. 
 I thought that my child’s condition was not serious enough. 
 Some drugs previously prescribed by doctor for the similar symptoms were left over at home. 
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 It is convenient to purchase drugs like antibiotics without prescriptions. 
 I did not have enough money to pay for the hospital visit. 
 Others (please specify)______________________ 
 
11. Could you please recall whether your child has used antibiotics in the last 12 months? 
 Yes 
 No 
 Not sure 
 
12. For which of the following symptom(s) would you expect the doctor to prescribe antibiotics for 
your child? (Check more than one if applicable) 
 Runny nose 
 Nasal congestion 
 Cough   
 Sore throat 
 Fever 
 Ache and Pains 
 Vomiting  
 Diarrhoea 
 Skin wounds 
 None 
 Others (please specify)______________________ 
 
13. When you see a doctor with your child and you are keen that your child receives antibiotics, would 
you make clear your wish to the doctor to prescribe antibiotics? 
 Yes 
 No (Please go directly to Q16) 
 
14. Please thinking about the last time that you make clear your wish to a doctor to prescribe 
antibiotics to your child, did the doctor refuse your request? 
 Yes 
 No (Please go directly to Q16) 
 
15. Would you feel dissatisfaction with the doctor when he (she) refused your request for antibiotics? 
 Yes 
 No 
 
16. Have you ever been reluctant to accept a prescription from a doctor for antibiotics for your child? 
 Yes 
 No (Please go directly to Q18) 
 
17. For what reasons would you be reluctant to accept the prescription of antibiotics for your child? 
(Please tick any that are apply to you) 
 I worry about the side-effects caused by antibiotics 
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 I worry about the antibiotic resistance (ABR) caused by antibiotics  
 I do not want my child to use new generation antibiotics 
 I think there may be some financial interests between the antibiotics prescribed and doctors 
 The antibiotics prescribed are too expensive 
 Others (Please specify)________________ 
 
Thinking about the last time that your child was prescribed antibiotics by doctors, please could you 
answer each question below by ticking in the box that applies to you. 
 Yes No 
18. I was satisfied with the communication between the doctor 
and me about the reasons for prescribing antibiotics to my 
child during the consultation. 
  
19. My child came with me to see a doctor.   
20. I used antibiotics on my child in line with the dosage 
instructions with came with the antibiotics. 
  
21. My child took the full course of antibiotics.   
22. I needed to give my child antibiotics at dosages higher than 
instructed. 
  
23. I kept unused antibiotics for future use on my child.   
 
 
Sometimes when a child is not well, parents may give their child some antibiotics rather than take 
their child to a doctor. Thinking about your child. 
24. Have you ever treated your child with antibiotics yourself? 
 Yes, always  
 Yes, sometimes 
 No (Please go directly to Q27) 
 
25. If yes, thinking about the last time you treated your child with antibiotics by yourself, did your 
child get better? 
 Yes 
 No 
 Not sure 
 
26. Could you please recall the number of times you treated your child with antibiotics by yourself in 
the last 12 months? _______________________ 
 
27. Apart from the antibiotics prescribed by the doctor, what is (are) source(s) that you get antibiotics 
from? (Check more than one if applicable) 
 Unused antibiotics from previous prescription 
 Antibiotics purchased without a doctor’s prescription 
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 Antibiotics received from others (family, friends) 
 Others (please specify)______________________ 
 
28. Have you purchased antibiotics without a doctor’s prescription? 
 Yes 
 No (Please go directly to section 3) 
 
29. Where would you usually purchase antibiotics without a doctor’s prescription? (Check more than 
one if applicable) 
 Community health centres (stations) 
 Retail pharmacy 
 Online pharmacy 
 Bazaar 
 Others (please specify)______________________ 
 
Section 3. Background information 
30. Your gender:   
 Male 
 Female 
31. Your age:   
 under 30 years old 
 30-39 years old 
 40-49 years old 
 50 and over years old 
32. Your highest educational level:   
 Primary school or below 
 Secondary school 
 High School/ Secondary technical college 
 College/ University 
 Postgraduate studies or above 
33. Your occupation:  _________ 
34. What kind(s) of health insurance(s) do you have now? (Check more than one if 
applicable) 
 Urban Employee Basic Medical Insurance 
 Urban Resident Basic Medical Insurance 
 New Rural Cooperative Medical Insurance 
 Commercial health insurance 
 None 
 Not sure 
 Others (please specify)____________________ 
35. The age of your child in today’s visit: _______years (please give months if under 1 year) 
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36. Would you describe the yearly income of your household (the total gross income of all 
adults in your household, including earnings and income from other sources) in 2015 as:  
 Below 10,000 RMB 
 10,000-24,999RMB 
 25,000-49,000RMB 
 50,000 RMB and above 
37. Where did you live? 
 Taiyuan City   
 Other cities in Shanxi Province 
 Rural areas in Shanxi Province 
 Other Province 
The end. Please give the questionnaire to the interviewer. 
 
Thank you very much for your cooperation and I wish you and your family all the best! 
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List of abbreviations 
ABR Antibiotic resistance 
AIDS Acquired immune deficiency syndrome 
AMR Antimicrobial resistance 
CFDA China Food and Drug Administration 
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DDDs Defined daily doses 
EDL Essential drug list 
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OTC Over-the-counter 
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THE Total health expenditure 
  346 
UEBMI Urban Employee Basic Medical Insurance 
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